HMDB Metabolites of Enzymes Dataset

Description Biomolecular interactions between metabolites and proteins, such as processing enzymes, curated from literature
Measurement association by literature curation
Association protein-metabolite associations by manual literature curation
Category physical interactions
Resource Human Metabolome Database
Citation(s)
Last Updated Mon Apr 06 00:00:00 UTC 2015
Stats
  1. 5326 genes
  2. 22137 metabolites
  3. 845725 gene-metabolite associations

Data Access

API
Script

Visualizations

  • Attribute Similarity

  • Gene Attribute

  • Gene Similarity

metabolite Gene Sets

22137 sets of interacting proteins for metabolites from the curated HMDB Metabolites of Enzymes dataset.

Gene Set Description
TG(22:4(7Z,10Z,13Z,16Z)/16:0/20:4(8Z,11Z,14Z,17Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
TG(18:2(9Z,12Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PC(24:0/18:0)
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/22:1(13Z))
TG(22:0/18:1(11Z)/18:2(9Z,12Z))
TG(16:1(9Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Methylergonovine
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:0)
PE(22:1(13Z)/P-18:0)
TG(18:0/20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
TG(14:1(9Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
DG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
Enoximone
TG(20:0/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
5-Hydroxyindoleacetaldehyde
TG(20:3(5Z,8Z,11Z)/24:0/24:1(15Z))
DG(18:1n9/0:0/18:1n9)
Pristanoyl-CoA A multi-methyl-branched fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of pristanic acid.
TG(16:1(9Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:0)
AICAR
Vitamin K1 2,3-epoxide
TG(14:0/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(16:1(9Z)/24:0/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z)/0:0)
TG(24:0/18:3(9Z,12Z,15Z)/18:1(9Z))
SM(d18:0/22:1(13Z)(OH))
Encainide
TG(24:0/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
5-Aminoimidazole-4-carboxamide An aminoimidazole in which the amino group is at C-5 with a carboxamido group at C-4.
DG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/0:0)
PC(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Trifluoroacetic acid A monocarboxylic acid that is the trifluoro derivative of acetic acid.
TG(16:0/22:0/22:0)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/24:0)
TG(16:1(9Z)/16:0/18:4(6Z,9Z,12Z,15Z))
PC(P-18:1(11Z)/20:0)
TG(20:0/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
PI(18:2(9Z,12Z)/20:1(11Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:0)
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3n6/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/24:1(15Z)/o-18:0)
TG(20:0/20:3n6/20:3(5Z,8Z,11Z))
TG(16:0/14:1(9Z)/22:0)
TG(18:3(6Z,9Z,12Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
PC(22:2(13Z,16Z)/P-18:1(9Z))
TG(14:1(9Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
CE(18:1(9Z))
Nitrazepam
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Cefepime A cephalosporin bearing (1-methylpyrrolidinium-1-yl)methyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.
TG(24:1(15Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z))
PIP(20:3(8Z,11Z,14Z)/16:0)
TG(20:3n6/20:0/18:4(6Z,9Z,12Z,15Z))
1-Nitro-7-hydroxy-8-glutathionyl-7,8-dihydronaphthalene A peptide that has formula C20H24N4O9S.
Lactosylceramide (d18:1/26:0)
TG(14:0/18:3(6Z,9Z,12Z)/15:0)
Oxyphencyclimine
TG(22:5(4Z,7Z,10Z,13Z,16Z)/15:0/o-18:0)
TG(22:1(13Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(20:0/18:2(9Z,12Z)/o-18:0)
PE(20:4(8Z,11Z,14Z,17Z)/16:0)
TG(14:0/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
TG(14:1(9Z)/22:1(13Z)/18:1(11Z))
TG(18:1(11Z)/22:1(13Z)/22:2(13Z,16Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
5-Methylcytosine
TG(24:0/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
PE(15:0/22:2(13Z,16Z))
TG(20:1(11Z)/22:0/22:1(13Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
PC(22:0/18:2(9Z,12Z))
TG(20:2n6/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
Glucosamine-1P
8,9-Epoxyeicosatrienoic acid
TG(16:0/22:0/24:0)
PE(24:1(15Z)/18:3(9Z,12Z,15Z))
DG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/20:3(5Z,8Z,11Z)/20:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(15:0/24:0/20:0)
PE(20:4(5Z,8Z,11Z,14Z)/14:0)
Cholesterol sulfate A steroid sulfate that has formula C27H46O4S.
DG(16:0/18:1(11Z)/0:0)
TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/o-18:0/22:1(13Z))
Eplerenone A steroid acid ester that has formula C24H30O6.
TG(20:3(5Z,8Z,11Z)/o-18:0/20:3n6)
S-(2-Chloroacetyl)glutathione A peptide that has formula C12H18ClN3O7S.
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/o-18:0/20:2n6)
TG(20:0/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
Palonosetron
PC(16:1(9Z)/22:1(13Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
trans-3,4-Dihydro-3,4-dihydroxy-7,12-dimethylbenz[a]anthracene A phenanthrol that has formula C20H18O2.
TG(22:2(13Z,16Z)/14:0/18:3(9Z,12Z,15Z))
Dephospho-CoA
PC(20:3(5Z,8Z,11Z)/20:1(11Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(14:1(9Z)/14:1(9Z)/20:1(11Z))
TG(15:0/15:0/15:0)
Chlorphenesin
Ganglioside GT1b (d18:1/18:1(9Z))
TG(18:2(9Z,12Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(P-18:1(9Z)/20:1(11Z))
TG(20:2n6/20:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:1(9Z)/22:1(13Z))
TG(15:0/22:1(13Z)/16:0)
Flucytosine An organofluorine compound that has formula C4H4FN3O.
TG(20:0/18:2(9Z,12Z)/20:1(11Z))
TG(16:1(9Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:0/20:3n6)
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3n6)
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
Isoallolithocholic acid
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/20:2n6)
TG(20:2n6/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
Auranofin
PC(P-18:0/18:3(6Z,9Z,12Z))
TG(16:1(9Z)/18:2(9Z,12Z)/24:1(15Z))
N-Acetylmannosamine Any mannosamine carrying an N-acetyl substituent
DG(22:4(7Z,10Z,13Z,16Z)/14:0/0:0)
TG(15:0/20:1(11Z)/20:3n6)
TG(18:0/22:0/18:0)
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
PE(P-16:0/20:3(8Z,11Z,14Z))
TG(20:2n6/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
3-alpha,20-alpha-Dihydroxy-5-beta-pregnane 3-glucuronide
TG(22:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
DG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GM2 (d18:1/24:1(15Z))
TG(14:1(9Z)/16:0/18:3(6Z,9Z,12Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
Vigabatrin
TG(16:1(9Z)/22:1(13Z)/18:1(11Z))
PC(20:3(8Z,11Z,14Z)/24:1(15Z))
Chlorthalidone An isoindole that has formula C14H11ClN2O4S.
Isocarboxazid
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/o-18:0)
PE(P-16:0e/16:0)
CE(22:5(4Z,7Z,10Z,13Z,16Z))
PC(P-18:1(11Z)/18:1(11Z))
TG(22:2(13Z,16Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
7-Hydroxymethyl-12-methylbenz[a]anthracene sulfate A phenanthrene that has formula C20H16O4S.
TG(20:0/22:2(13Z,16Z)/24:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
5,7,24(28)-Ergostatrienol An ergostanoid that has formula C28H44O.
TG(20:4(5Z,8Z,11Z,14Z)/24:0/18:3(9Z,12Z,15Z))
3-O-beta-D-Galactopyranosyl-L-arabinose
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(16:1(9Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/18:0/20:4(8Z,11Z,14Z,17Z))
PE(20:1(11Z)/24:0)
TG(16:0/16:1(9Z)/20:2n6)
Oxyphenonium
TG(18:0/22:2(13Z,16Z)/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/15:0/22:2(13Z,16Z))
LysoPE(20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
4-Hydroxypropofol
TG(22:4(7Z,10Z,13Z,16Z)/20:3n6/o-18:0)
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
PC(20:4(5Z,8Z,11Z,14Z)/P-18:1(11Z))
TG(24:0/18:0/20:4(8Z,11Z,14Z,17Z))
PC(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(22:5n6/0:0/22:5n6)
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(22:1(13Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/24:1(15Z)/o-18:0)
TG(18:2(9Z,12Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:0/20:1(11Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/22:0)
PC(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/22:2(13Z,16Z)/18:1(9Z))
PE(20:1(11Z)/22:0)
TG(14:0/24:1(15Z)/20:2n6)
(R)-mevalonate A mevalonate that has formula C6H11O4.
TG(22:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(16:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:0/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/15:0/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/20:0/22:1(13Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
PC(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
D-Urobilinogen A biladiene that has formula C33H42N4O6.
PC(o-16:1(9Z)/16:1(9Z))
TG(18:1(9Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
DG(22:5n3/0:0/22:6n3)
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(20:0/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Tetracycline A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria.
PC(16:1(9Z)/15:0)
Ganglioside GT2 (d18:0/12:0)
TG(14:1(9Z)/22:2(13Z,16Z)/18:1(9Z))
PE(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
MG(0:0/20:0/0:0)
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:2n6/22:2(13Z,16Z))
TG(18:0/14:1(9Z)/18:1(9Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
Phenformin
TG(22:1(13Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
trans-3-Chloro-2-propene-1-ol
PE(P-18:0/14:1(9Z))
PE(20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
Domperidone
TG(18:2(9Z,12Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/16:1(9Z)/20:2n6)
TG(18:1(11Z)/20:2n6/18:3(6Z,9Z,12Z))
Homocitric acid A tricarboxylic acid that has formula C7H10O7.
TG(18:1(11Z)/20:2n6/18:2(9Z,12Z))
Inositol 1,4,5-trisphosphate
TG(20:0/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/24:0/22:2(13Z,16Z))
PC(20:1(11Z)/24:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/18:2(9Z,12Z)/18:1(11Z))
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
PC(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
DG(18:2n6/0:0/18:4n3)
PC(16:0/24:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso3]
PC(14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/22:2(13Z,16Z)/20:1(11Z))
Ganglioside GM1 (18:1/9Z-18:1)
Ganglioside GM1 (d18:1/24:0)
DG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(22:0/20:0/18:2(9Z,12Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
Argininosuccinic acid
TG(18:1(11Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
LysoPE(0:0/18:1(11Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamide A pyridine nucleoside consisting of 1,4-dihydronicotinamide with a beta-D-ribofuranosyl moiety at the 1-position.
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Thromboxane A class of oxygenated oxane derivatives, originally derived from prostaglandin precursors in platelets, that stimulate aggregation of platelets and constriction of blood vessels.
PC(o-24:0/18:3(9Z,12Z,15Z))
DG(22:0/0:0/22:5n6)
TG(24:1(15Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/15:0/20:4(5Z,8Z,11Z,14Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/0:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(22:0/16:1(9Z)/18:1(9Z))
Lauroyl-CoA A medium-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of lauric (dodecanoic) acid.
Aceprometazine
TG(16:0/20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
CDP-DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:0/0:0/16:1n7)
DG(18:4(6Z,9Z,12Z,15Z)/14:1(9Z)/0:0)
TG(15:0/14:1(9Z)/18:1(11Z))
TG(15:0/18:3(6Z,9Z,12Z)/20:3n6)
TG(15:0/22:0/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
D-Glucuronic acid 1-phosphate A uronic acid phosphate consisting of D-glucuronic acid having a phosphate group attached at the 1-position.
TG(24:0/24:1(15Z)/24:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:3(9Z,12Z,15Z)/16:0)
TG(14:0/20:0/18:3(9Z,12Z,15Z))
Ganglioside GD2 (d18:1/14:0)
Beta-D-Glucopyranuronic acid A D-glucopyranuronic acid in which the anomeric centre has beta-configuration.
Hydrogen selenide A selenium hydride that has formula H2Se.
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:1(11Z)/20:0)
PIP(18:3(6Z,9Z,12Z)/18:0)
DG(18:1n7/0:0/22:5n6)
PC(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z))
TG(18:1(9Z)/15:0/22:2(13Z,16Z))
3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
7-Methylguanosine 5'-diphosphate A guanosine 5'-phosphate that consists of guanosine 5'-diphosphate bearing a 7-methyl substituent and having a negatively charged diphosphate group.
TG(20:1(11Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
DG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:1(9Z)/20:2n6)
TG(20:2n6/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
TG(14:0/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(24:1(15Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
OPC4-CoA An organic molecule that has formula C35H56N7O18P3S.
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Emedastine
TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(24:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
PC(20:4(5Z,8Z,11Z,14Z)/15:0)
PC(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GD2 (d18:1/16:0)
Praziquantel A pyrazinoisoquinoline that has formula C19H24N2O2.
TG(16:0/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
Clotrimazole A member of the class of imidazoles that is 1H-imidazole in which the hydrogen attached to a nitrogen is replaced by a monochlorotrityl group.
TG(14:0/24:0/20:2n6)
TG(14:1(9Z)/18:1(9Z)/18:3(6Z,9Z,12Z))
TG(15:0/14:0/22:2(13Z,16Z))
TG(18:1(9Z)/15:0/18:3(6Z,9Z,12Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
DG(20:0/0:0/18:4n3)
PC(18:3(6Z,9Z,12Z)/P-18:0)
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
DG(16:0/20:1(11Z)/0:0)
TG(18:1(11Z)/14:1(9Z)/18:2(9Z,12Z))
TG(14:1(9Z)/18:2(9Z,12Z)/18:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:0/o-18:0)
TG(18:3(9Z,12Z,15Z)/14:0/18:3(9Z,12Z,15Z))[iso3]
TG(14:0/22:0/20:0)
TG(14:0/22:2(13Z,16Z)/22:0)
PIP2(20:2(11Z,14Z)/18:0)
TG(20:1(11Z)/20:2n6/20:1(11Z))
TG(18:3(6Z,9Z,12Z)/18:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/20:2n6/24:0)
TG(14:0/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0)
Tyramine
TG(22:0/18:0/20:2n6)
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/o-18:0)
DG(22:0/18:1(11Z)/0:0)
TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/22:0/o-18:0)
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z)/16:0)
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(14:0/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(15:0/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
PE(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(22:0/18:1(9Z)/18:3(6Z,9Z,12Z))
PC(P-16:0/20:2(11Z,14Z))
TG(14:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
Biotinyl-5'-AMP A biotin that has formula C20H28N7O9PS.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z)/o-18:0)
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
PC(22:2(13Z,16Z)/18:0)
DG(18:0/0:0/18:4n3)
P1,P4-Bis(5'-xanthosyl) tetraphosphate A purine ribonucleoside 5'-tetraphosphate compound having 5'-xanthosyl residues at the P(1)- and P(4)-positions.
DG(14:1(9Z)/16:1(9Z)/0:0)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(15:0/22:0/15:0)
TG(24:0/22:2(13Z,16Z)/24:1(15Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(16:0/14:1(9Z)/20:2n6)
PC(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Ganglioside GM1 (d18:0/25:0)
PC(o-22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
DG(22:0/20:4(5Z,8Z,11Z,14Z)/0:0)
PC(P-18:1(9Z)/22:2(13Z,16Z))
TG(20:0/14:0/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
DG(20:1(11Z)/20:2(11Z,14Z)/0:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GM1 (d18:0/23:0)
PC(o-18:1(9Z)/18:2(9Z,12Z))
TG(15:0/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(14:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(22:1(13Z)/22:1(13Z)/o-18:0)
TG(14:1(9Z)/18:2(9Z,12Z)/14:1(9Z))
TG(20:1(11Z)/20:2n6/22:2(13Z,16Z))
PE(24:0/18:2(9Z,12Z))
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
Metyrapone
TG(18:1(9Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Trichloroethanol glucuronide A glucosiduronic acid that has formula C8H11Cl3O7.
TG(22:4(7Z,10Z,13Z,16Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GT1c (d18:0/26:1(17Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/22:0/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/18:2(9Z,12Z)/20:1(11Z))[iso6]
PC(24:1(15Z)/18:0)
TG(18:1(9Z)/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/18:1(11Z)/22:1(13Z))
Dolichol-20
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:4(6Z,9Z,12Z,15Z)/20:1(11Z)/0:0)
TG(14:0/16:0/14:0)
TG(15:0/18:4(6Z,9Z,12Z,15Z)/24:0)
Terfenadine
DG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/0:0)
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
Ofloxacin An oxazinoquinolone carrying carboxy, fluoro, methyl and 4-methylpiperazino substituents. A synthetic fluoroquinolone antibacterial agent, it inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
PIP2(18:3(6Z,9Z,12Z)/18:1(11Z))
PE(16:0/20:4(5Z,8Z,11Z,14Z))
3-alpha-Androstanediol glucuronide
TG(24:1(15Z)/14:0/20:4(8Z,11Z,14Z,17Z))
TG(14:0/20:2n6/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PE(20:4(5Z,8Z,11Z,14Z)/24:0)
Mannosyl-diinositol-phosphorylceramide
TG(24:0/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/14:0/20:3n6)
TG(20:4(8Z,11Z,14Z,17Z)/16:0/o-18:0)
TG(16:0/18:0/22:1(13Z))
3a-Hydroxy-5b-pregnane-20-one
TG(18:3(9Z,12Z,15Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
DG(18:1n9/0:0/22:6n3)
TG(20:1(11Z)/18:0/18:3(6Z,9Z,12Z))
TG(24:0/20:1(11Z)/16:1(9Z))
TG(18:1(9Z)/20:2n6/18:3(6Z,9Z,12Z))
Ganglioside GM1 (18:1/22:0)
TG(24:1(15Z)/14:0/24:1(15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
CL(20:1(11Z)/18:2(9Z,12Z)/18:1(11Z)/18:1(11Z))
TG(14:0/24:1(15Z)/14:1(9Z))
PC(18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(16:0/16:0/14:1(9Z))
(S)-Hydroxydecanoyl-CoA
TG(16:0/18:4(6Z,9Z,12Z,15Z)/18:0)
PC(18:3(6Z,9Z,12Z)/22:1(13Z))
PIP2(16:0/22:3(10Z,13Z,16Z))
TG(20:0/18:3(9Z,12Z,15Z)/20:3n6)
Diethylphosphate
TG(18:1(11Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z)/18:1(9Z))
PI(18:1(9Z)/20:3(5Z,8Z,11Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
PE(18:2(9Z,12Z)/14:0)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
TG(16:1(9Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:3(6Z,9Z,12Z)/24:0)
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
Pyridoxine 5'-phosphate A vitamin B6 phosphate that has formula C8H12NO6P.
DG(24:1(15Z)/14:1(9Z)/0:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/o-18:0)
Topiramate A hexose derivative that is 2,3:4,5-di-O-isopropylidene-beta-D-fructopyranose in which the hydroxy group has been converted to the corresponding sulfamate ester. It blocks voltage-dependent sodium channels and is used as an antiepileptic and for the prevention of migraine.
Ganglioside GT2 (d18:0/25:0)
TG(16:1(9Z)/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
DG(18:0/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(15:0/18:1(11Z)/16:0)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/20:0)
TG(15:0/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(18:0/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/20:2n6/18:0)
Acitretin
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(18:1(9Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
TG(18:0/18:3(9Z,12Z,15Z)/20:1(11Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
TG(20:2n6/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
4-Hydroxyphenylacetaldehyde A phenylacetaldehyde that has formula C8H8O2.
TG(15:0/o-18:0/20:3n6)
PE(14:0/18:0)
B-Carotene
PE(18:2(9Z,12Z)/16:0)
TG(20:3n6/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
Betahistine
TG(22:1(13Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Propionylcarnitine
TG(20:3n6/18:1(11Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PG(16:0/20:3(5Z,8Z,11Z))
TG(15:0/16:0/18:0)
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
PC(22:2(13Z,16Z)/P-18:1(11Z))
Palmityl-CoA
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(24:0/16:0/18:3(6Z,9Z,12Z))
TG(20:0/22:1(13Z)/20:3(5Z,8Z,11Z))
TG(20:0/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
Nicotinic acid mononucleotide
PE(22:5(4Z,7Z,10Z,13Z,16Z)/14:0)
TG(16:0/24:1(15Z)/18:1(9Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(18:0/18:0/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(P-18:1(9Z)/18:1(9Z))
DG(18:0/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(24:1(15Z)/20:0/20:4(5Z,8Z,11Z,14Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:0/20:4(5Z,8Z,11Z,14Z))
TG(14:0/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(20:1(11Z)/18:1(9Z)/20:3(5Z,8Z,11Z))
TG(20:3n6/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
DG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/0:0)
TG(22:1(13Z)/22:0/22:2(13Z,16Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))
TG(18:1(11Z)/15:0/18:3(9Z,12Z,15Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
TG(18:1(11Z)/16:0/o-18:0)
TG(20:2n6/22:0/20:3n6)
TG(18:0/22:0/o-18:0)
TG(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(20:2n6/14:0/o-18:0)
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/o-18:0/18:2(9Z,12Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:0)
PE(14:1(9Z)/22:2(13Z,16Z))
LysoPC(P-18:0)
TG(18:1(9Z)/18:2(9Z,12Z)/20:2n6)
TG(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(20:0/20:1(11Z)/18:2(9Z,12Z))
Cholecalciferol
TG(15:0/14:0/20:2n6)
TG(24:1(15Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
DG(18:3(9Z,12Z,15Z)/16:0/0:0)
DG(20:1n9/0:0/18:4n3)
Enalapril A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration).
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:0/18:1(11Z))
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/20:3n6/18:2(9Z,12Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:4n6/0:0/22:4n6)
TG(20:0/22:1(13Z)/20:0)
DG(18:1(11Z)/18:0/0:0)
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/18:3(9Z,12Z,15Z)/o-18:0)
DG(14:0/16:1(9Z)/0:0)
PE(20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
Chlorpromazine A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
TG(18:0/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(14:0/22:2(13Z,16Z)/20:2n6)
TG(16:1(9Z)/22:0/20:1(11Z))
N-Acetylgalactosamine 4-sulphate
TG(18:1(11Z)/14:1(9Z)/20:2n6)
PE(20:3(5Z,8Z,11Z)/24:0)
Oxygen A chalcogen that has formula O.
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/18:1(9Z)/22:0)
Ganglioside GT1c (d18:1/18:1(11Z))
CL(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(22:1(13Z)/18:0/20:2n6)
TG(14:1(9Z)/22:2(13Z,16Z)/20:1(11Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
DG(20:1n9/0:0/20:5n3)
NAD
PE(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Nonoxynol-9
TG(20:0/22:1(13Z)/22:0)
TG(22:0/20:2n6/16:1(9Z))
TG(18:0/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
Calcitriol A hydroxycalciol that is calcidiol in which the pro-S hydrogen of calcidiol is replaced by a hydroxy group. It is the active form of vitamin D3, produced fom calciol via hydoxylation in the liver to form calcidiol, which is subsequently oxidised in the kidney to give calcitriol.
TG(20:3(5Z,8Z,11Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(14:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(14:1(9Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:2(13Z,16Z)/22:1(13Z))
TG(15:0/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z)/0:0)
DG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
PC(18:0/24:0)
TG(22:1(13Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/24:0/24:1(15Z))
Tetrahydroaldosterone-3-glucuronide
TG(20:3n6/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PIP2(16:0/18:2(9Z,12Z))
TG(24:1(15Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(16:0/18:0/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
LysoPE(0:0/14:0)
PIP2(22:5(4Z,7Z,10Z,13Z,16Z)/16:0)
N-[(3a,5b,7a,12a)-3,7-dihydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]-Glycine
TG(16:0/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
PIP(18:1(9Z)/20:1(11Z))
Ganglioside GQ1c (d18:1/16:0)
LPA(18:2(9Z,12Z)/0:0)
TG(16:0/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
Megestrol A 3-oxo Delta(4)-steroid that is pregna-4,6-diene-3,20-dione substituted by a hydroxy group at position 17.
TG(18:2(9Z,12Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]
Perphenazine A member of the class of phenothiazines that is phenothiazine having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.
Ganglioside GQ1c (d18:1/18:0)
TG(22:2(13Z,16Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:3(8Z,11Z,14Z)/24:0)
TG(20:3(5Z,8Z,11Z)/24:0/20:4(8Z,11Z,14Z,17Z))
DG(22:1(13Z)/20:2(11Z,14Z)/0:0)
cis-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA An organic molecule that has formula C31H50N7O17P3S.
TG(22:0/18:1(9Z)/24:1(15Z))
TG(20:1(11Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/24:0/18:1(9Z))
TG(16:1(9Z)/22:1(13Z)/20:1(11Z))
CDP-DG(18:1(9Z)/18:1(11Z))
TG(20:2n6/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:4(8Z,11Z,14Z,17Z)/22:0)
PIP2(18:0/18:1(9Z))
Reboxetine
TG(24:0/14:0/o-18:0)
PE(14:0/22:5(7Z,10Z,13Z,16Z,19Z))
1,2-Dihydronaphthalene-1,2-diol A member of the class of naphthalenediols that is 1,2-dihydronaphthalene substituted by hydroxy groups at positions 1 and 2 respectively.
TG(15:0/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PIP2(18:0/16:0)
TG(24:0/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(14:0/16:0/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(16:0/22:2(13Z,16Z)/22:1(13Z))
TG(20:1(11Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
Aspartame
TG(22:2(13Z,16Z)/20:0/18:3(9Z,12Z,15Z))
Formaldehyde The simplest aldehyde.
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Aripiprazole A quinolone that has formula C23H27Cl2N3O2.
PC(20:4(8Z,11Z,14Z,17Z)/24:0)
PE(18:3(6Z,9Z,12Z)/16:0)
TG(20:2n6/18:1(11Z)/18:3(9Z,12Z,15Z))
N-Acetylserotonin A member of the class of hydroxyindoles that is the N-acetyl derivative of serotonin.
TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Cefadroxil A cephalosporin bearing methyl and (2R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.
TG(14:1(9Z)/15:0/14:1(9Z))
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Doxylamine A tertiary amine that has formula C17H22N2O.
TG(18:0/18:3(9Z,12Z,15Z)/14:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/15:0/o-18:0)
DG(18:3(9Z,12Z,15Z)/22:1(13Z)/0:0)
TG(18:3(6Z,9Z,12Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
Terlipressin
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(20:0/22:1(13Z)/20:1(11Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
DG(20:3n6/0:0/22:6n3)
TG(20:1(11Z)/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
PE(18:0/P-18:1(11Z))
PE(16:1(9Z)/P-18:1(11Z))
TG(20:1(11Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(P-18:1(9Z)/18:0)
TG(20:1(11Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
LysoPE(24:0/0:0)
DG(24:1n9/0:0/22:5n6)
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
Methylphenidate A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
DG(18:0/22:0/0:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
TG(18:1(11Z)/o-18:0/22:1(13Z))
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Misoprostol A diastereoisomeric mixture composed of approximately equal amounts of a double racemate of four of the sixteen possible diastereoisomers of methyl (13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate that is racemic prostaglandin E1 which is lacking the hydroxy group at position 15, but which has an additional hydroxy group at position 16. It is a synthetic prostaglandin E1 analogue, used in the treatment of gastric and duodenal ulcers. A weak abortifacient, it is also used for cervical ripening prior to surgical termination of pregnancy. The (11R,16S)-diastereoisomer is the pharmacologically active form.
Tiludronate
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(24:0/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:4(5Z,8Z,11Z,14Z)/20:0)
1-Methylhistamine
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(15:0/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/16:1(9Z)/18:1(9Z))[iso6]
2-Methoxyestradiol
TG(20:0/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/22:2(13Z,16Z))
Methoxsalen
TG(14:0/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/14:0)
TG(14:1(9Z)/14:1(9Z)/20:3(5Z,8Z,11Z))
3,4-Dihydroxybenzeneacetic acid
Ganglioside GT3 (d18:0/22:1(13Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Grepafloxacin
TG(16:0/o-18:0/22:0)
PE(20:4(5Z,8Z,11Z,14Z)/22:0)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/16:0)
TG(20:1(11Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
Cefacetrile
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
DG(20:2(11Z,14Z)/18:3(9Z,12Z,15Z)/0:0)
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
TG(20:0/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
DG(14:0/0:0/20:3n9)
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(18:0/24:0/o-18:0)
TG(16:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
Thioproperazine
TG(15:0/18:3(9Z,12Z,15Z)/15:0)
PIP(18:0/20:4(8Z,11Z,14Z,17Z))
Meclofenamic acid An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.
PG(18:1(11Z)/20:3(8Z,11Z,14Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Coenzyme Q10 A ubiquinone having a side chain of 10 isoprenoid units. In the naturally-occurring isomer, all isoprenyl double bonds are in the E- configuration.
Pentazocine A benzazocine that has formula C19H27NO.
TG(20:0/22:1(13Z)/16:1(9Z))
TG(16:1(9Z)/18:0/20:1(11Z))[iso6]
TG(14:0/24:1(15Z)/22:1(13Z))
PC(18:3(9Z,12Z,15Z)/22:1(13Z))
2-(3-carboxy-3-(trimethylammonio)propyl)-L-histidine
PE(18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(24:1(15Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/22:0)
TG(24:0/20:1(11Z)/24:1(15Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(14:0/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/22:0/20:1(11Z))
Carboxyphosphamide A nitrogen mustard that has formula C7H15Cl2N2O4P.
TG(15:0/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/20:0/o-18:0)
Gamma-linolenoyl-CoA An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of gamma-linolenic acid.
TG(16:1(9Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:0)
Ganglioside GT1b (d18:0/16:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/15:0/18:3(9Z,12Z,15Z))
TG(20:0/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
PE(20:3(5Z,8Z,11Z)/P-18:0)
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:0/20:3n6)
TG(14:1(9Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Gentisate aldehyde
TG(15:0/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
DG(24:0/0:0/22:2n6)
Fluspirilene
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
Androsterone sulfate A steroid sulfate that is the 3-sulfate of androsterone.
TG(22:2(13Z,16Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/14:0/20:3n6)
Amprenavir
TG(18:1(11Z)/14:1(9Z)/20:1(11Z))
Ganglioside GT1b (d18:0/14:0)
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/18:0/18:1(9Z))[iso6]
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/14:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/22:0/22:2(13Z,16Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
TG(20:1(11Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(14:0/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PIP(16:0/20:3(8Z,11Z,14Z))
Sucralfate
TG(20:3n6/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/18:2(9Z,12Z)/20:2n6)
TG(15:0/18:2(9Z,12Z)/18:0)
DG(22:1(13Z)/20:3(8Z,11Z,14Z)/0:0)
TG(24:0/20:3n6/o-18:0)
TG(16:1(9Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/15:0)
PC(22:0/22:0)
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/20:3n6)
TG(20:0/22:0/24:1(15Z))
Ganglioside GD3 (d18:1/26:0)
TG(15:0/22:0/16:0)
TG(18:1(11Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
DG(14:0/0:0/18:3n6)
TG(22:2(13Z,16Z)/16:0/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
TG(22:1(13Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/18:0/22:1(13Z))
PG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
PI(18:0/18:0)
TG(24:0/14:0/18:2(9Z,12Z))
PC(18:0/14:0)
Valeric acid A straight-chain saturated fatty acid containing five carbon atoms.
TG(20:2n6/20:0/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:0/18:4(6Z,9Z,12Z,15Z))
Selenomethionine
TG(24:1(15Z)/16:0/22:2(13Z,16Z))
PC(16:1(9Z)/20:1(11Z))
Niflumic Acid
Cyanocobalamin
TG(18:2(9Z,12Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
Chenodeoxycholoyl-CoA A choloyl-CoA formed by thioester linkage between chenodeoxycholic acid and coenzyme A.
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
3-O-Sulfogalactosylceramide (d18:1/26:1(17Z))
TG(22:0/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(22:0/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
3-Hydroxypropionyl-CoA
TG(22:0/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
(24R)-Cholest-5-ene-3-beta,7-alpha,24-triol A 7alpha,24-dihydroxycholesterol that has formula C27H46O3.
TG(24:1(15Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
TG(20:1(11Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
dTDP A thymidine phosphate having a diphosphate group at the 5'-position.
TG(14:1(9Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/16:0/20:1(11Z))
TG(20:3n6/22:0/o-18:0)
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
Ganglioside GD3 (d18:0/25:0)
TG(14:0/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
PC(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/20:0/22:2(13Z,16Z))
DG(22:6n3/0:0/22:6n3)
TG(24:0/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/o-18:0/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
PS(18:2(9Z,12Z)/16:1(9Z))
DG(16:1(9Z)/18:1(11Z)/0:0)
TG(22:2(13Z,16Z)/20:1(11Z)/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/24:0/18:3(9Z,12Z,15Z))
PE(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(18:0/24:1(15Z)/20:0)
PE(20:3(8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
DG(15:0/20:3(8Z,11Z,14Z)/0:0)
TG(24:1(15Z)/18:0/24:1(15Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/18:0/18:1(11Z))[iso3]
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
PIP(18:2(9Z,12Z)/18:1(11Z))
Dihydrolipoamide A dithiol that has formula C8H17NOS2.
TG(18:0/20:1(11Z)/22:1(13Z))
TG(14:0/20:2n6/22:0)
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
DG(18:1n7/0:0/18:2n6)
TG(15:0/20:3n6/24:1(15Z))
TG(22:0/20:0/16:1(9Z))
DG(20:3(8Z,11Z,14Z)/22:1(13Z)/0:0)
TG(14:0/20:2n6/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/20:1(11Z)/14:1(9Z))
DG(14:1(9Z)/20:3(5Z,8Z,11Z)/0:0)
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
PE(P-18:1(11Z)/18:1(9Z))
TG(24:0/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(14:0/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Bupivacaine A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:0)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(22:2(13Z,16Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(14:1n5/0:0/18:3n3)
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(20:0/20:2n6/24:0)
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:3n6)
TG(20:0/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
TG(15:0/18:3(6Z,9Z,12Z)/14:1(9Z))
PE(14:0/18:2(9Z,12Z))
TG(24:0/15:0/18:2(9Z,12Z))
R-Methylmalonyl-CoA The (R)-enantiomer of methylmalonyl-CoA.
Oxidized glutathione
TG(24:0/24:0/14:1(9Z))
CE(20:1(11Z))
TG(22:0/24:0/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
14,15-Epoxy-5,8,11-eicosatrienoic acid
Xanthan
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(16:1(9Z)/18:0/20:4(8Z,11Z,14Z,17Z))
DG(14:1n5/0:0/18:1n7)
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
Amcinonide A corticosteroid that has formula C28H35FO7.
TG(20:3(5Z,8Z,11Z)/20:3n6/22:2(13Z,16Z))
TG(16:0/16:0/24:1(15Z))
Oxoadipic acid
PG(18:0/18:1(11Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)/o-18:0)
TG(18:1(11Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
Methylphenobarbital
3-Methylhistidine A histidine derivative in which the methyl group is located at N-3.
TG(18:2(9Z,12Z)/16:1(9Z)/20:3n6)
PC(14:1(9Z)/24:1(15Z))
5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate Conjugate base of 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylic acid.
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
DG(16:0/0:0/24:0)
TG(16:0/24:1(15Z)/20:1(11Z))
TG(24:0/22:1(13Z)/16:1(9Z))
Indacaterol
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
Stavudine A nucleoside analogue obtained by formal dehydration across positions 2 and 3 of thymidine. An inhibitor of HIV-1 reverse transcriptase
TG(20:1(11Z)/15:0/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/20:2n6/o-18:0)
DG(22:0/0:0/20:2n6)
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(24:1(15Z)/20:2n6/24:1(15Z))
Bupropion A propanone that is propan-1-one substituted by a tert-butylamino group at position 2 and a 3-chlorophenyl group at position 1.
TG(18:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Murocholic acid
TG(24:0/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
Gestodene
TG(14:0/16:0/22:2(13Z,16Z))
12-Ketodeoxycholic acid
PC(20:2(11Z,14Z)/18:3(6Z,9Z,12Z))
Methylimidazole acetaldehyde
PI(20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(14:0/16:0/20:3n6)
TG(14:1(9Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:1(11Z)/18:1(11Z))
Lisuride
DG(18:2n6/0:0/20:5n3)
TG(16:0/16:1(9Z)/22:1(13Z))
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
PIP(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(24:0/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(15:0/16:1(9Z)/20:3n6)
TG(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PIP2(18:1(11Z)/16:1(9Z))
DG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/0:0)
TG(14:1(9Z)/15:0/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/20:0)
PE(20:0/20:3(8Z,11Z,14Z))
PE(P-18:1(9Z)/14:1(9Z))
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(22:0/20:1(11Z)/24:0)
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
TG(22:2(13Z,16Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PC(20:3(8Z,11Z,14Z)/18:1(9Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
Sodium
Lewis X trisaccharide
PC(20:4(8Z,11Z,14Z,17Z)/20:2(11Z,14Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Pyrophosphate
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
Corticosterone A 21-hydroxy steroid that is consists of pregn-4-ene substituted by hydroxy groups at positions 11 and 21 and oxo groups at positions 3 and 20. Corticosterone is a 21-carbon steroid hormone of the corticosteroid type produced in the cortex of the adrenal glands.
PG(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:1(13Z)/20:1(11Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/22:0)
TG(18:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(16:0/15:0/18:2(9Z,12Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Hexacosanoyl-CoA A very long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of hexacosanoic (cerotic) acid..
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
MG(20:5(5Z,8Z,11Z,14Z,17Z)/0:0/0:0)
DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:0/0:0)
11beta,17beta-Dihydroxy-4-androsten-3-one A 3-hydroxy steroid that has formula C19H28O3.
TG(18:1(9Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/16:1(9Z)/20:1(11Z))
(2E)-Tetradecenoyl-CoA An acyl-CoA oxoanion arising from deprotonation of the phosphate and diphosphate OH groups of trans-tetradec-2-enoyl-CoA; major species at pH 7.3.
DG(22:1(13Z)/22:2(13Z,16Z)/0:0)
TG(15:0/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/16:0/o-18:0)
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
PE(22:4(7Z,10Z,13Z,16Z)/18:0)
TG(16:0/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(16:1(9Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
N-Acetyl-L-phenylalanine The N-acetyl derivative of L-phenylalanine.
TG(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Pentoxifylline
PIP(16:0/20:1(11Z))
TG(18:0/24:0/20:2n6)
LysoPE(20:4(8Z,11Z,14Z,17Z)/0:0)
Fosphenytoin
TG(22:0/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/18:3(6Z,9Z,12Z)/20:2n6)
TG(22:2(13Z,16Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/18:1(9Z)/16:1(9Z))[iso6]
PE(18:3(6Z,9Z,12Z)/P-18:1(9Z))
TG(15:0/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/18:0/20:0)
TG(15:0/22:0/o-18:0)
TG(15:0/20:0/18:3(6Z,9Z,12Z))
TG(18:0/24:0/18:0)
Oxalacetic acid
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:3n6/15:0)
TG(18:3(6Z,9Z,12Z)/22:0/18:4(6Z,9Z,12Z,15Z))
Hyperforin A sesquarterpenoid that has formula C35H52O4.
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/20:1(11Z)/18:2(9Z,12Z))
TG(15:0/24:1(15Z)/22:0)
TG(20:0/15:0/20:2n6)
TG(14:0/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
Sulfaphenazole A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
Ganglioside GT3 (d18:1/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
1-Hexadecanol
TG(18:0/14:1(9Z)/22:1(13Z))
DG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/0:0)
TG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(24:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(14:0/20:0)
TG(16:0/20:3n6/16:0)
DG(16:0/20:3(8Z,11Z,14Z)/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
16-alpha,17-beta-estriol 17-beta-D-glucuronide A steroid saponin that has formula C24H31O9.
DG(24:1(15Z)/20:3(8Z,11Z,14Z)/0:0)
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Porfimer
TG(15:0/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(16:0/20:3n6/18:0)
Mefenamic acid An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.
TG(20:0/o-18:0/24:0)
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
TG(24:0/22:0/24:1(15Z))
TG(24:0/14:0/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(15:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/16:1(9Z)/20:2n6)
TG(18:1(11Z)/22:2(13Z,16Z)/18:2(9Z,12Z))
TG(16:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(22:2(13Z,16Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/15:0/22:1(13Z))
Sorafenib
TG(16:0/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
PC(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/o-18:0)
PE(14:0/22:0)
TG(15:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
Indoleacetic acid
TG(18:2(9Z,12Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
PI(16:2(9Z,12Z)/18:0)
TG(22:1(13Z)/22:0/22:1(13Z))
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
Calcium
PC(22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GT3 (d18:0/12:0)
TG(24:1(15Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Zoledronate
TG(24:1(15Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z)/o-18:0)
TG(22:0/22:4(7Z,10Z,13Z,16Z)/24:0)
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
Vorinostat
TG(18:1(9Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
3-Methylguanine A methylguanine carrying the methyl substituent at position 3.
DG(18:1(9Z)/18:3(9Z,12Z,15Z)/0:0)
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/22:1(13Z)/20:3n6)
TG(20:0/20:2n6/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GQ1c (d18:1/20:0)
PC(18:1(11Z)/18:1(9Z))
PC(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
5,6-Dihydrouridine The uridine derivative obtained by formal hydrogenation of the endocyclic double bond in the uracil ring.
TG(15:0/22:1(13Z)/14:1(9Z))
TG(22:0/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/20:0/o-18:0)
TG(18:0/20:4(8Z,11Z,14Z,17Z)/20:2n6)
DG(18:3n6/0:0/22:6n3)
TG(16:0/22:0/18:2(9Z,12Z))
3a,6b,7b,12b-Tetrahydroxy-5b-cholanoic acid
TG(14:1(9Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
PE(16:0/P-18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:0/18:4(6Z,9Z,12Z,15Z))
(25S)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA An organic molecule that has formula C48H80N7O19P3S.
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/o-18:0)
TG(24:0/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Decyl alcohol
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(22:0/16:1(9Z)/22:1(13Z))
TG(22:1(13Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Hexacarboxylporphyrin III
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
3-Hydroxy-5-methylhex-4-enoyl-CoA A polyol that has formula C28H46N7O18P3S.
TG(22:0/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/20:3n6)
Ganglioside GM3 (d18:1/24:0)
PC(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
Chenodeoxycholic acid A dihydroxy-5beta-cholanic acid that is (5beta)-cholan-24-oic acid substituted by hydroxy groups at positions 3 and 7 respectively.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GM3 (d18:1/22:0)
TG(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Superoxide An oxygen radical that has formula O2.
PE(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
PC(18:3(9Z,12Z,15Z)/24:0)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
TG(20:2n6/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
Levorphanol
TG(14:1(9Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
DG(18:0/0:0/20:4n3)
TG(18:1(9Z)/24:1(15Z)/18:1(9Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/18:3(6Z,9Z,12Z)/20:2n6)
PC(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/24:0/16:1(9Z))
Cellobiose A glycosylglucose that is disaccharide containing two glucose units linked via a beta(1->4) bond.
TG(15:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(22:1(13Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
12a-Hydroxy-3-oxocholadienic acid
TG(14:0/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
CDP-DG(18:0/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:0/20:4(5Z,8Z,11Z,14Z))
Benzo[a]pyrene-4,5-oxide A carbopolycyclic compound that has formula C20H12O.
TG(24:0/15:0/20:2n6)
2-Oxosuccinamate The conjugate base of 2-oxosuccinamic acid; major species at pH 7.3.
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/20:3n6/18:3(6Z,9Z,12Z))
TG(14:0/18:3(6Z,9Z,12Z)/18:1(11Z))
TG(24:0/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
PE(18:1(9Z)/20:3(5Z,8Z,11Z))
PIP(18:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/14:0/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
DG(14:1n5/0:0/18:2n6)
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(18:1(9Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
Hypoxanthine A purine nucleobase that consists of purine bearing an oxo substituent at position 6.
TG(20:3n6/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(16:1(9Z)/P-18:0)
PE(20:1(11Z)/15:0)
PE(P-18:1(9Z)/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Cefalotin A semisynthetic, first-generation cephalosporin antibiotic with acetoxymethyl and (2-thienylacetyl)nitrilo moieties at positions 3 and 7, respectively, of the core structure. Administered parenterally during surgery and to treat a wide spectrum of blood infections.
TG(22:4(7Z,10Z,13Z,16Z)/16:0/18:3(9Z,12Z,15Z))
TG(15:0/18:3(9Z,12Z,15Z)/20:3n6)
sn-glycero-3-Phosphoethanolamine A glycerophosphatidylethanolamine that has formula C5H14NO6P.
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Ranitidine A member of the class of furans used to treat peptic ulcer disease (PUD) and gastroesophageal reflux disease.
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/24:1(15Z)/16:1(9Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Sulpiride
DG(20:3n9/0:0/20:5n3)
Ganglioside GD1b (d18:1/20:0)
TG(16:1(9Z)/18:0/22:1(13Z))
PE(20:1(11Z)/P-18:1(11Z))
TG(18:1(9Z)/18:1(9Z)/20:3(8Z,11Z,14Z))[iso3]
TG(18:1(9Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:0)
PC(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:1(11Z)/18:2(9Z,12Z))
TG(14:0/18:1(9Z)/18:0)
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
Riboflavin D-Ribitol in which the hydroxy group at position 5 is substituted by a 7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl moiety. It is a nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables, but the richest natural source is yeast. The free form occurs only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide.
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate
TG(20:0/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6/o-18:0)
TG(20:0/18:2(9Z,12Z)/20:2n6)
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:0/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/15:0/18:4(6Z,9Z,12Z,15Z))
dGTP A purine 2'-deoxyribonucleoside 5'-triphosphate having guanine as the nucleobase.
TG(18:2(9Z,12Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/14:1(9Z)/16:1(9Z))
PE(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(16:0/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:1(11Z)/22:2(13Z,16Z)/0:0)
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/o-18:0)
PE(14:1(9Z)/20:1(11Z))
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
PG(16:1(9Z)/20:3(5Z,8Z,11Z))
Tetrahydrofolyl-[Glu](2)
25-Hydroxycholesterol A 25-hydroxy steroid that has formula C27H46O2.
TG(18:1(9Z)/22:1(13Z)/22:2(13Z,16Z))
TG(24:0/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(20:0/18:1(11Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:0)
2-Polyprenyl-3-methyl-6-methoxy-1,4-benzoquinone
TG(20:0/22:1(13Z)/20:3n6)
1-Naphthaldehyde A naphthaldehyde with a formyl group at position 1.
Ardeparin
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/0:0)
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
Caproic acid A C6, straight-chain saturated fatty acid.
Methotrexate A pteridine that has formula C20H22N8O5.
Chondroitin 6'-sulfate A chondroitin sulfate in which the site of sulfation is carbon 6 of the N-acetylgalactosamine (GalNAc) sugar.
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
CDP-DG(16:0/18:1(9Z))
TG(14:0/18:3(9Z,12Z,15Z)/18:0)
TG(14:0/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/18:0)
PC(18:3(6Z,9Z,12Z)/14:1(9Z))
DG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(20:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/16:0/24:0)
TG(18:1(9Z)/20:2n6/20:3n6)
TG(14:0/15:0/o-18:0)
PIP(22:2(13Z,16Z)/16:0)
TG(18:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z))[iso3]
TG(18:3(6Z,9Z,12Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
2-Phospho-D-glyceric acid A 2-Phosphoglyceric acid in which the glyceric acid moiety has D (R) configuration.
3-Methoxy-4-hydroxyphenylglycol glucuronide
TG(15:0/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/20:1(11Z)/o-18:0)
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)
2-Oxo-4-methylthiobutanoic acid
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
PC(20:3(5Z,8Z,11Z)/P-16:0)
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
PC(P-18:1(9Z)/22:0)
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
LysoPE(18:4(6Z,9Z,12Z,15Z)/0:0)
TG(14:1(9Z)/24:1(15Z)/20:1(11Z))
TG(14:0/18:2(9Z,12Z)/18:1(11Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/22:0)
TG(14:0/20:4(8Z,11Z,14Z,17Z)/15:0)
TG(14:1(9Z)/20:1(11Z)/20:3(5Z,8Z,11Z))
Cyanide A pseudohalide anion that is the conjugate base of hydrogen cyanide.
S-Adenosylhomocysteine
DG(20:5n3/0:0/22:5n3)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:3n6/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Indecainide
Dopamine 3-O-sulfate An aryl sulfate that has formula C8H11NO5S.
TG(18:1(9Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
DG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/0:0)
Beta-Aminopropionitrile An aminopropionitrile carrying an amino group at the beta-position.
Conivaptan
TG(16:0/22:0/20:1(11Z))
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
TG(16:1(9Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/o-18:0)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z)/o-18:0)
6-Dehydrotestosterone glucuronide
PC(P-18:1(11Z)/18:2(9Z,12Z))
Sitagliptin A triazolopyrazine that exhibits hypoglycemic activity.
PE(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/18:1(11Z)/24:0)
TG(20:3n6/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
S-Acetyldihydrolipoamide-E
TG(16:0/24:0/14:1(9Z))
PI(20:2(11Z,14Z)/16:0)
PE(18:0/15:0)
PC(24:0/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
PE(14:0/18:4(6Z,9Z,12Z,15Z))
Ajmaline
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
PE(14:0/16:0)
PI(20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
7-Hydroxymethyl-12-methylbenz[a]anthracene A phenanthrene that has formula C20H16O.
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(24:0/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
TG(18:3(9Z,12Z,15Z)/16:0/18:3(9Z,12Z,15Z))[iso3]
Stearoyl-CoA A long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of stearic acid.
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(24:1(15Z)/20:0)
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
Ursocholic acid A bile acid that has formula C24H40O5.
TG(16:0/18:3(6Z,9Z,12Z)/24:1(15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/18:3(6Z,9Z,12Z)/24:0)
TG(22:1(13Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/24:1(15Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Fluorine A monoatomic fluorine that has formula F.
5-Amino-6-ribitylamino uracil
TG(20:0/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GQ1c (d18:0/12:0)
TG(14:1(9Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/18:3(9Z,12Z,15Z)/24:0)
PE(22:0/P-18:1(9Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
TG(20:0/18:3(6Z,9Z,12Z)/22:0)
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:1(11Z)/14:1(9Z))
PIP2(16:2(9Z,12Z)/16:0)
TG(14:1(9Z)/20:2n6/18:3(9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z)/o-18:0)
TG(18:1(9Z)/20:0/20:4(8Z,11Z,14Z,17Z))
Tiagabine
DG(20:1n9/0:0/18:2n6)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(16:1n7/0:0/20:1n9)
TG(15:0/18:3(9Z,12Z,15Z)/22:0)
TG(24:0/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
L-Malic acid
PE(20:4(8Z,11Z,14Z,17Z)/P-18:1(9Z))
DG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/0:0)
DG(22:2n6/0:0/22:4n6)
PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:0)
3-Dehydroxycarnitine
7alpha,25-Dihydroxy-4-cholesten-3-one A cholestanoid that has formula C27H44O3.
TG(22:0/20:1(11Z)/18:3(9Z,12Z,15Z))
PE(20:3(5Z,8Z,11Z)/16:0)
PE(22:5(4Z,7Z,10Z,13Z,16Z)/15:0)
TG(20:0/20:3n6/18:3(6Z,9Z,12Z))
PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
DG(18:1n9/0:0/20:4n6)
TG(24:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GQ1c (d18:1/18:1(9Z))
TG(14:1(9Z)/14:0/18:2(9Z,12Z))
LysoPC(P-16:0) A 1-O-(alk-1-enyl)-sn-glycero-3-phosphocholine in which the alk-1-enyl group contains 16 carbons and no additional double bonds.
TG(20:0/22:0/18:1(9Z))
TG(18:0/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
DG(20:2(11Z,14Z)/22:2(13Z,16Z)/0:0)
TG(14:1(9Z)/22:0/24:1(15Z))
TG(20:3n6/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:2n6/18:3(6Z,9Z,12Z))
PC(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
CE(20:2(6Z,9Z))
TG(20:2n6/20:3n6/20:2n6)
2-Phenyl-1,3-propanediol monocarbamate A benzene that has formula C10H13NO3.
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]
TG(15:0/14:0/22:0)
Ganglioside GD1b (d18:1/18:1(11Z))
PE(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
PE(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:3(5Z,8Z,11Z)/18:0)
TG(15:0/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
Melilotussaponin O1
PE(18:3(9Z,12Z,15Z)/16:1(9Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
TG(18:0/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/20:3(5Z,8Z,11Z)/o-18:0)
Halazepam
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
S-(Hydroxymethyl)glutathione Conjugate base of S-(hydroxymethyl)glutathione.
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/24:1(15Z))
TG(18:1(11Z)/18:1(11Z)/22:1(13Z))
DG(20:4(8Z,11Z,14Z,17Z)/16:0/0:0)
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
DG(14:0/18:4(6Z,9Z,12Z,15Z)/0:0)
PIP3(18:2(9Z,12Z)/20:1(11Z))
Trichlormethiazide
DG(20:2(11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:0/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:2(13Z,16Z)/22:1(13Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
PC(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Thiosulfate
TG(16:1(9Z)/22:2(13Z,16Z)/16:1(9Z))
Penbutolol
Valproic acid glucuronide
PG(16:0/22:4(7Z,10Z,13Z,16Z))
TG(14:0/18:0/14:1(9Z))
PC(20:3(5Z,8Z,11Z)/20:2(11Z,14Z))
PC(16:0/18:3(9Z,12Z,15Z))
3,4-Dihydroxy-trans-cinnamate
TG(18:1(11Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/15:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
DG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
PC(14:0/24:0)
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
PC(14:0/18:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Propericiazine
Nafarelin
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(18:1(11Z)/15:0/18:1(9Z))
TG(18:0/20:3(5Z,8Z,11Z)/24:0)
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(15:0/20:2n6/20:1(11Z))
TG(22:1(13Z)/14:0/20:2n6)
TG(14:0/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Carbachol An ammonium salt that has formula C6H15N2O2.Cl.
TG(14:1(9Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/16:0/22:1(13Z))
TG(14:1(9Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
PE(20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z))
Urocanic acid An alpha,beta-unsaturated monocarboxylic acid that is prop-2-enoic acid substituted by a 1H-imidazol-4-yl group at position 3. It is a metabolite of hidtidine.
TG(20:3n6/16:0/o-18:0)
4-ene-Valproic acid
TG(24:1(15Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(9Z,12Z,15Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
DG(16:0/0:0/16:0)
TG(20:0/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(20:0/20:3n6/18:1(11Z))
TG(24:0/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(15:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/22:0/18:1(9Z))
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:1(11Z))
TG(18:1(11Z)/18:0/18:1(9Z))[iso6]
TG(16:1(9Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)/0:0)
PC(22:1(13Z)/20:3(5Z,8Z,11Z))
TG(22:0/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/20:3(5Z,8Z,11Z)/o-18:0)
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
Isomaltose A glycosylglucose consisting of two D-glucopyranose units connected by an alpha-(1->6)-linkage.
TG(16:0/o-18:0/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
3beta-Hydroxypregn-5-en-20-one sulfate
PC(P-18:1(11Z)/14:0)
TG(18:1(9Z)/14:1(9Z)/22:2(13Z,16Z))
DG(18:3n6/0:0/20:4n6)
DG(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/0:0)
PC(20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
3-Demethylubiquinone-9 An ubiquinone that has formula C53H80O4.
PC(P-18:1(11Z)/16:0)
TG(18:0/16:1(9Z)/22:0)
TG(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(20:1(11Z)/22:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
TG(20:1(11Z)/18:1(9Z)/20:3n6)
PI(18:0/18:3(9Z,12Z,15Z))
TG(14:0/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z)/0:0)
TG(20:0/20:0/20:1(11Z))[iso3]
NADPH
Cetrorelix
TG(20:3n6/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/14:0/18:3(9Z,12Z,15Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
DG(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(P-18:0/22:0)
3-Hydroxyanthranilic acid An aminobenzoic acid that is benzoic acid substituted at C-2 by an amine group and at C-3 by a hydroxy group. It is an intermediate in the metabolism of the amino acid tryptophan.
N,N-Dimethylformamide A member of the class of formamides that is formamide in which the amino hydrogens are replaced by methyl groups.
TG(15:0/o-18:0/18:0)
TG(24:0/o-18:0/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/14:0/20:4(8Z,11Z,14Z,17Z))
Leukotriene B4 A leukotriene composed of (6Z,8E,10E,14Z)-icosatetraenoic acid having (5S)- and (12R)-hydroxy substituents.
TG(18:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Lactosylceramide (d18:1/26:1(17Z))
TG(24:0/24:0/24:0)
PE(18:1(9Z)/22:2(13Z,16Z))
PC(dm18:1(11Z)/dm18:1(11Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/o-18:0/22:2(13Z,16Z))
PC(20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
DG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
DG(22:5(7Z,10Z,13Z,16Z,19Z)/14:0/0:0)
TG(14:0/16:0/20:0)
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
Cholest-5-ene A cholestanoid that has formula C27H46.
PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(P-18:1(9Z)/16:0)
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/18:3(6Z,9Z,12Z)/20:1(11Z))
TG(15:0/24:0/24:1(15Z))
TG(18:1(9Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/15:0/24:0)
Tolazamide
PC(14:1(9Z)/20:1(11Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:3(9Z,12Z,15Z)/15:0)
Glucosylceramide (d18:1/12:0)
LysoPC(O-18:0)
TG(24:1(15Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
DG(18:0/24:0/0:0)
PE(20:4(5Z,8Z,11Z,14Z)/18:0)
Suramin
Theobromine
TG(18:1(11Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GT1b (d18:0/25:0)
TG(24:1(15Z)/18:2(9Z,12Z)/20:3n6)
TG(14:1(9Z)/18:2(9Z,12Z)/18:1(9Z))
PC(24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
Epirubicin
Capric acid
TG(16:0/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/18:0/0:0)
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(16:0/20:2n6/20:0)
Tirofiban
TG(20:3n6/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
MG(20:4(5Z,8Z,11Z,14Z)/0:0/0:0)
TG(24:1(15Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/24:1(15Z)/20:0)
Ganglioside GQ1c (d18:0/26:0)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(16:1(9Z)/18:0/18:3(6Z,9Z,12Z))
TG(15:0/18:1(9Z)/o-18:0)
TG(16:1(9Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Cotinine An N-alkylpyrrolidine that consists of N-methylpyrrolidinone bearing a pyridin-3-yl substituent at position C-5 (the 5S-enantiomer). It is an alkaloid commonly found in Nicotiana tabacum.
TG(18:0/20:3(5Z,8Z,11Z)/18:1(9Z))
DG(20:1n9/0:0/20:4n6)
TG(20:0/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:1(11Z)/14:0)[iso6]
TG(20:0/20:3(5Z,8Z,11Z)/18:1(9Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/o-18:0)
Hexafluronium
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
TG(16:0/20:3n6/20:0)
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
DG(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z)/0:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:1(11Z)/24:0)
TG(18:0/16:1(9Z)/18:1(11Z))
TG(20:3n6/22:0/20:4(5Z,8Z,11Z,14Z))
DG(15:0/0:0/18:1n7)
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(18:1(11Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(18:0/24:0/20:3(5Z,8Z,11Z))
TG(18:0/18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
TG(18:3(6Z,9Z,12Z)/22:0/18:3(9Z,12Z,15Z))
Cytidine monophosphate N-acetylneuraminic acid
PIP2(18:3(9Z,12Z,15Z)/18:1(11Z))
TG(20:2n6/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
Valrubicin
PC(o-18:2(9Z,12Z)/22:0)
TG(18:1(9Z)/14:0/22:4(7Z,10Z,13Z,16Z))
CL(20:1(11Z)/18:2(9Z,12Z)/18:1(11Z)/18:1(9Z))
TG(14:0/18:2(9Z,12Z)/24:1(15Z))
PC(18:3(9Z,12Z,15Z)/P-18:1(11Z))
TG(20:0/20:0/20:4(8Z,11Z,14Z,17Z))
Cortolone-3-glucuronide
Ganglioside GD1a (d18:1/23:0)
DG(15:0/24:1(15Z)/0:0)
TG(16:0/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Alpha-ketoisovaleric acid
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GQ1c (d18:0/20:0)
TG(15:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(22:0/18:2(9Z,12Z)/20:3n6)
Hydroxylansoprazole
TG(18:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(18:0/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3n6/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(24:0/20:1(11Z)/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/14:1(9Z)/16:1(9Z))
Benzaldehyde
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/20:1(11Z)/22:2(13Z,16Z))
PE(P-18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:0/16:1(9Z))
PC(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))
TG(15:0/16:0/18:1(11Z))
TG(18:1(11Z)/18:1(9Z)/24:1(15Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GM1 (18:1/18:0)
Carglumic acid
Solifenacin
TG(16:1(9Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
DG(18:1n7/0:0/18:3n6)
TG(18:3(6Z,9Z,12Z)/24:0/o-18:0)
Terbinafine
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
5'-Hydroxypiroxicam
TG(18:2(9Z,12Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GD1b (d18:1/23:0)
Irinotecan
TG(22:4(7Z,10Z,13Z,16Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
PE(18:3(6Z,9Z,12Z)/16:1(9Z))
TG(18:3(6Z,9Z,12Z)/20:0/18:4(6Z,9Z,12Z,15Z))
MG(18:0e/0:0/0:0)
TG(16:1(9Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
N-acetyl-alpha-D-galactosamine 1-phosphate The alpha-anomer of N-acetyl-D-galactosamine 1-phosphate.
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
2,5-Dioxopentanoate The conjugate base of 2,5-dioxopentanoic acid; major species at pH 7.3.
DG(18:1n9/0:0/18:4n3)
DG(18:3n3/0:0/22:6n3)
PC(18:1(11Z)/18:2(9Z,12Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(22:1(13Z)/o-18:0/18:2(9Z,12Z))
TG(20:2n6/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(14:1(9Z)/24:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
Etoposide A furonaphthodioxole that has formula C29H32O13.
Adenosine triphosphate
TG(18:0/18:1(9Z)/20:3n6)
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(16:0/20:0/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/24:0/20:1(11Z))
Propinol adenylate
TG(16:0/20:0/24:1(15Z))
TG(24:1(15Z)/22:2(13Z,16Z)/24:1(15Z))
TG(24:0/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/16:1(9Z)/22:2(13Z,16Z))
Ceramide (d18:1/16:0)
TG(24:0/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
Indolepyruvate
LysoPC(14:0) A lysophosphatidylcholine in which the remaining acyl group is specified as tetradecanoyl (myristoyl). If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
TG(20:0/o-18:0/22:2(13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/16:0/o-18:0)
Clenbuterol
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(20:3n6/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/0:0)
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
DG(20:4(8Z,11Z,14Z,17Z)/20:0/0:0)
TG(22:1(13Z)/22:0/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
TG(18:1(11Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
DG(20:1(11Z)/18:1(11Z)/0:0)
LysoPE(24:1(15Z)/0:0)
TG(15:0/22:0/18:0)
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Cer(d18:0/26:0)
TG(14:1(9Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/22:2(13Z,16Z)/20:3n6)
TG(18:1(9Z)/20:0/18:1(9Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
albendazole S-oxide A sulfoxide that has formula C12H15N3O3S.
TG(20:1(11Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(24:0/18:0)
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Sulfasalazine An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
LysoPE(0:0/22:0)
TG(20:0/22:1(13Z)/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
Ceramide (d18:1/25:0)
Gliquidone
DG(18:0e/2:0/0:0)
Homovanillin
TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:2n6/18:2(9Z,12Z))
DG(18:0/20:1(11Z)/0:0)
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/18:1(9Z))
PG(18:0/16:1(9Z))
SM(d18:0/24:1(15Z))
DG(18:1n7/0:0/18:1n9)
TG(20:2n6/15:0/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/18:1(11Z)/20:2n6)
TG(15:0/16:0/24:1(15Z))
DG(22:1n9/0:0/20:5n3)
TG(15:0/14:0/22:1(13Z))
PC(P-18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:2n6/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/18:3(6Z,9Z,12Z)/20:1(11Z))
TG(22:0/22:0/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-16:0)
TG(20:3(5Z,8Z,11Z)/22:0/18:2(9Z,12Z))
Methyl beta-D-glucopyranoside A beta-D-glucopyranoside having a methyl substituent at the anomeric position.
DG(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(20:2n6/20:1(11Z)/o-18:0)
PE(P-18:0/18:4(6Z,9Z,12Z,15Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
12b-Hydroxy-5b-cholanoic acid
TG(24:0/20:3(5Z,8Z,11Z)/14:1(9Z))
TG(18:1(9Z)/18:1(9Z)/18:1(9Z))[iso]
Felodipine The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
TG(14:1(9Z)/16:0/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
PIP2(16:1(9Z)/16:1(9Z))
PIP2(22:3(10Z,13Z,16Z)/16:0)
TG(18:2(9Z,12Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
TG(18:0/16:1(9Z)/20:1(11Z))
TG(14:1(9Z)/20:0/20:2n6)
Erythromycin Any of several wide-spectrum macrolide antibiotics obtained from actinomycete Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus).
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(20:1(11Z)/o-18:0/22:1(13Z))
TG(15:0/15:0/20:4(8Z,11Z,14Z,17Z))
p-Octopamine
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/24:1(15Z))
N-Acetyl-L-methionine A L-methionine derivative that is the N-acetyl derivative of L-methionine.
TG(20:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(20:2n6/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
DG(15:0/0:0/20:3n6)
TG(18:1(9Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Apelin-13
PE(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/o-18:0/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/14:0/24:0)
PC(20:2(11Z,14Z)/18:1(11Z))
Pectin Any mixture of complex, colloidal, macromolecular plant galacturonans containing a large proportion of D-galactopyranosyluronic acid residues in alpha-(1->4) linkage, the carboxy groups of which may be esterified to varying degrees by methyl groups or be partially or completely converted into salts. The structure shown is that of the parent polygalacturonan.
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Glucosylceramide (d18:1/25:0)
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/22:1(13Z))
Nitric oxide A nitrogen oxide which is a free radical, each molecule of which consists of one nitrogen and one oxygen atom.
1,3,12-Trihydroxycholan-24-oic acid
24-Hydroxycholesterol A 24-hydroxy steroid that has formula C27H46O2.
Acetylglycine
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/20:1(11Z))
Alfentanil A member of the class of piperidines that is piperidine having a 2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl group at the 1-position as well as N-phenylpropanamido- and methoxymethyl groups at the 4-position.
Dopamine Catechol in which the hydrogen at position 4 is substituted by a 2-aminoethyl group.
PC(24:0/20:1(11Z))
TG(14:0/18:0/22:1(13Z))
3a,4b,7a,12a-Tetrahydroxy-5b-cholanoic acid
Dihydrobiopterin
TG(18:3(9Z,12Z,15Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
N5-Formyl-THF
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:3n6)
TG(24:0/22:0/20:1(11Z))
Cotinine glucuronide
Pyrazinamide
TG(22:0/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:1(9Z)/20:1(11Z))
PE(P-18:1(11Z)/18:2(9Z,12Z))
TG(16:1(9Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PI(18:0/20:3(8Z,11Z,14Z))
PE(24:1(15Z)/22:2(13Z,16Z))
TG(22:0/15:0/14:1(9Z))
TG(18:0/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
TG(18:1(11Z)/22:1(13Z)/24:1(15Z))
TG(20:0/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]
Octadecanol
TG(22:0/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
Benzoyl glucuronide (Benzoic acid)
TG(20:1(11Z)/22:1(13Z)/20:3n6)
TG(14:1(9Z)/14:1(9Z)/16:1(9Z))
TG(24:0/22:0/18:2(9Z,12Z))
TG(20:0/16:0/16:1(9Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
PI(16:1(9Z)/18:1(11Z))
DG(15:0/0:0/20:0)
TG(20:3(5Z,8Z,11Z)/14:0/22:1(13Z))
TG(22:0/18:3(6Z,9Z,12Z)/20:2n6)
TG(24:0/16:0/20:3n6)
Amoxapine A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
PE(16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:4(5Z,8Z,11Z,14Z)/16:0/0:0)
DG(15:0/0:0/22:0)
Vapreotide
PE(18:0/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
Eprosartan
TG(20:0/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Practolol
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(22:0/16:1(9Z)/20:3n6)
DG(14:1(9Z)/18:3(6Z,9Z,12Z)/0:0)
TG(22:2(13Z,16Z)/20:2n6/22:2(13Z,16Z))
DG(20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/18:2(9Z,12Z)/22:1(13Z))
TG(18:3(9Z,12Z,15Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:0/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(18:0/24:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
1-Pyrroline-4-hydroxy-2-carboxylate
PE(20:1(11Z)/18:2(9Z,12Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
Dyphylline An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs.
TG(16:0/24:1(15Z)/22:1(13Z))
TG(18:1(9Z)/22:1(13Z)/18:1(9Z))
Rabeprazole A sulfoxide that has formula C18H21N3O3S.
TG(14:0/16:1(9Z)/18:1(11Z))
Ethosuximide A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Alosetron
TG(20:4(8Z,11Z,14Z,17Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/24:0/20:1(11Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/16:1(9Z))
MG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0/0:0)
TG(16:0/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/15:0/o-18:0)
TG(16:0/20:2n6/14:1(9Z))
Androstenedione
Valproic acid A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
PC(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/20:2n6/20:1(11Z))
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(14:1(9Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/18:1(9Z))
PE(20:2(11Z,14Z)/P-18:1(9Z))
TG(20:1(11Z)/22:0/20:4(8Z,11Z,14Z,17Z))
PIP(18:2(9Z,12Z)/18:0)
TG(18:0/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
Captopril A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.
TG(20:2n6/24:1(15Z)/20:2n6)
TG(20:0/22:0/14:1(9Z))
TG(18:1(11Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
Hydroxyzine A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.
TG(22:0/18:0/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(15:0/20:3n6/18:2(9Z,12Z))
Ganglioside GT1c (d18:1/18:1(9Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(14:1(9Z)/22:1(13Z)/20:1(11Z))
TG(18:1(11Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Mycophenolic acid O-acyl-glucuronide A carboxylic ester resulting from the formal condensation of the carboxylic acid group of mycophenolic acid with the anomeric hydroxy group of beta-D-glucuronic acid.
TG(14:1(9Z)/14:1(9Z)/18:1(11Z))
DG(20:0/0:0/22:4n6)
DG(16:1(9Z)/24:1(15Z)/0:0)
TG(24:0/16:1(9Z)/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
DG(16:0/0:0/20:2n6)
TG(18:0/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(14:0/18:3(6Z,9Z,12Z))
DG(24:0/24:0/0:0)
TG(14:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:2(13Z,16Z)/24:1(15Z))
TG(14:0/24:0/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(20:4(8Z,11Z,14Z,17Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:1(9Z)/14:1(9Z))
Bepotastine
L-2-Hydroxyglutaric acid
PE(16:0/20:2(11Z,14Z))
DG(22:4(7Z,10Z,13Z,16Z)/24:0/0:0)
TG(24:1(15Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
Biperiden
TG(15:0/18:1(9Z)/14:1(9Z))
PC(20:3(8Z,11Z,14Z)/20:2(11Z,14Z))
Ganglioside GD1a (d18:0/18:0)
TG(15:0/22:1(13Z)/20:2n6)
TG(22:0/20:1(11Z)/16:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(14:0/22:1(13Z)/18:3(9Z,12Z,15Z))
PE(22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
Hydroxycelecoxib
PE(16:0/P-16:0)
Ganglioside GT3 (d18:0/20:0)
Cyclizine
TG(15:0/16:0/16:1(9Z))
PG(18:1(11Z)/20:3(5Z,8Z,11Z))
TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(20:0/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/22:1(13Z))
Difucosyllactohexaose
TG(20:0/20:0/18:1(9Z))
D-Mannose 1-phosphate A mannose phosphate that is D-mannose carrying a phosphate group at position 1.
TG(24:1(15Z)/16:0/24:1(15Z))
TG(18:0/16:1(9Z)/18:1(9Z))
PC(20:3(5Z,8Z,11Z)/15:0)
(Z)-But-1-ene-1,2,4-tricarboxylate
DG(18:1n7/0:0/24:1n9)
TG(14:1(9Z)/24:1(15Z)/16:1(9Z))
Pralidoxime A pyridinium ion that is 1-methylpyridinium substituted by a (hydroxyimino)methyl group at position 2.
TG(18:3(9Z,12Z,15Z)/20:1(11Z)/o-18:0)
Temazepam
TG(22:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
D-2-Hydroxyglutaric acid
TG(18:0/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(14:0/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PE(20:2(11Z,14Z)/18:2(9Z,12Z))
LPA(18:0/0:0)
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PC(20:0/P-18:1(11Z))
TG(24:0/15:0/20:3n6)
TG(20:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/24:0/18:3(6Z,9Z,12Z))
Cob(II)alamin A cobalamin in which the central cobalt atom has an oxidation state of +2.
TG(18:0/20:0/16:1(9Z))
TG(16:1(9Z)/14:0/22:2(13Z,16Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(15:0/20:4(5Z,8Z,11Z,14Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
Trihexosylceramide (d18:1/24:1(15Z))
TG(16:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:2(9Z,12Z)/16:1(9Z))
TG(20:0/18:0/24:0)
TG(16:0/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(15:0/18:3(9Z,12Z,15Z)/20:2n6)
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(14:0/15:0/18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/18:0)
TG(24:0/15:0/24:0)
TG(15:0/20:0/24:1(15Z))
Ganglioside GD3 (d18:0/26:0)
PC(P-16:0/22:1(13Z))
TG(20:0/22:1(13Z)/22:1(13Z))
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
PG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:0/20:4(8Z,11Z,14Z,17Z))
DG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
5-Fluorouridine An organofluorine compound that is uridine bearing a fluoro substituent at position 5 on the uracil ring.
TG(16:1(9Z)/20:3n6/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:2n6/18:4(6Z,9Z,12Z,15Z))
DG(22:2n6/0:0/20:4n3)
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
Avenasterol
Ercalcitriol
TG(15:0/20:3(5Z,8Z,11Z)/22:1(13Z))
Quinone Compounds having a fully conjugated cyclic dione structure, such as that of benzoquinones, derived from aromatic compounds by conversion of an even number of -CH= groups into -C(=O)- groups with any necessary rearrangement of double bonds (polycyclic and heterocyclic analogues are included).
TG(15:0/14:0/16:0)
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
5-Methyltetrahydrofolic acid A tetrahydrofolic acid that has formula C20H25N7O6.
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/20:1(11Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(15:0/0:0/18:3n6)
Stearidonic acid
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
PC(18:3(9Z,12Z,15Z)/16:0)
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
TG(18:1(9Z)/20:0/20:4(5Z,8Z,11Z,14Z))[iso6]
PE(22:0/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(15:0/20:0/20:1(11Z))
Ganglioside GD2 (d18:1/23:0)
TG(20:3(5Z,8Z,11Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(20:3n6/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:1(11Z)/o-18:0)
Ganglioside GD1b (d18:0/26:1(17Z))
TG(20:3n6/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/15:0/20:4(8Z,11Z,14Z,17Z))
DG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
Ganglioside GT1b (d18:1/26:1(17Z))
DG(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/0:0)
TG(16:0/20:2n6/22:2(13Z,16Z))
4-Nitrophenyl phosphate An aryl phosphate resulting from the mono-esterification of phosphoric acid with 4-nitrophenol.
TG(22:2(13Z,16Z)/16:0/22:2(13Z,16Z))
PE(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
cis-4-Carboxymethylenebut-2-en-4-olide A 4-carboxymethylenebut-2-en-4-olide that has formula C6H4O4.
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Elatoside I
D-Ribose 5-phosphate A ribose monophosphate that is D-ribose substituted at position 5 by a phosphate group. It is an intermediate in the pentose phosphate pathway.
TG(20:0/18:1(11Z)/24:1(15Z))
TG(20:0/18:3(9Z,12Z,15Z)/22:1(13Z))
PC(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0)
TG(24:0/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
Dronabinol
Quetiapine A dibenzothiazepine that has formula C21H25N3O2S.
TG(14:1(9Z)/o-18:0/22:1(13Z))
Formamidopyrimidine nucleoside triphosphate A pyrimidine ribonucleoside 5'-triphosphate that has formula C10H18N5O15P3.
TG(20:0/18:0/20:3n6)
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
PC(o-16:1(9Z)/14:1(9Z))
MG(0:0/18:3(6Z,9Z,12Z)/0:0)
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/24:1(15Z))
TG(14:0/20:2n6/24:1(15Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(14:0/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
(S)-3-Hydroxybutyric acid The S-enantiomer of 3-hydroxybutyric acid; a normal human metabolite, that has been found elevated in geriatric patients remitting from depression.
PIP(20:2(11Z,14Z)/18:2(9Z,12Z))
TG(20:2n6/14:0/20:3n6)
N-Acetylgalactosamine
Argatroban An alpha-N-substituted L-arginine that has formula C23H36N6O5S.
DG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
DG(24:0/18:0/0:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z)/o-18:0)
Crotonoyl-CoA The (E)-isomer of but-2-enoyl-CoA.
TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(14:0/22:1(13Z)/16:0)
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(16:0/24:0/18:3(9Z,12Z,15Z))
TG(14:0/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:4(6Z,9Z,12Z,15Z)/14:0/0:0)
TG(20:1(11Z)/18:0/22:2(13Z,16Z))
PIP2(16:0/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/14:0/14:1(9Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/0:0)
Mianserin
TG(18:2(9Z,12Z)/14:1(9Z)/18:2(9Z,12Z))
DG(18:4n3/0:0/18:4n3)
TG(14:0/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
Edrophonium
PE(20:2(11Z,14Z)/14:1(9Z))
TG(22:0/16:1(9Z)/16:1(9Z))
TG(24:1(15Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(24:0/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PG(18:3(9Z,12Z,15Z)/16:1(9Z))
TG(22:2(13Z,16Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/20:0/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/20:1(11Z))
TG(22:0/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(16:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(14:0/22:1(13Z)/14:0)
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:2(9Z,12Z)/24:0)
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(22:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
DG(15:0/24:0/0:0)
PC(o-16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GT1b (d18:1/18:0)
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(20:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
7,8-Dihydropteroic acid A pteroic acid derivative arising from formal hydrogenation of the 7,8-double bond of pteroic acid.
Dopamine glucuronide
Diethylpropion An aromatic ketone that is propiophenone in which one of the hydrogens alpha- to the carbonyl is substituted by a diethylamino group. A central stimulant and indirect-acting sympathomimetic, it is an appetite depressant and is used as the hydrochloride as an anoretic in the short term management of obesity.
PC(P-18:1(11Z)/16:1(9Z))
TG(18:3(9Z,12Z,15Z)/15:0/o-18:0)
Vidarabine
TG(16:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
Ethanolamine
TG(18:0/16:1(9Z)/o-18:0)
TG(20:1(11Z)/16:0/20:4(8Z,11Z,14Z,17Z))
(S)-4-Hydroxymandelonitrile A 4-hydroxymandelonitrile that has (S)-configuration.
Poly-N-acetyllactosamine An aminoglycan composed of a backbone of N-acetyllactosamine repeating units that are joined to each other via beta-(1->3)-linkages.
3-Methoxytyramine A methoxybenzene that has formula C9H13NO2.
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
Pravastatin A carboxylic ester resulting from the formal condensation of (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin.
TG(18:0/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/24:0/20:1(11Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Prednisone A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
PIP(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
Buspirone An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the nitrogen atom.
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:1(9Z)/22:1(13Z))
TG(20:2n6/18:0/18:4(6Z,9Z,12Z,15Z))
PE(20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(20:0/18:0/24:1(15Z))
(S)-3-Hydroxytetradecanoyl-CoA A (S)-3-hydroxyacyl-CoA that has formula C35H62N7O18P3S.
TG(18:0/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
DG(18:2(9Z,12Z)/20:3(8Z,11Z,14Z)/0:0)
TG(18:0/20:3n6/o-18:0)
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
Angiotensin III
TG(22:1(13Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
PE(18:2(9Z,12Z)/P-18:0)
TG(24:1(15Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(22:2n6/0:0/22:5n6)
TG(20:0/24:0/24:0)
TG(24:0/24:0/18:1(9Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(14:1(9Z)/22:1(13Z))
TG(18:1(11Z)/o-18:0/18:3(6Z,9Z,12Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
DG(14:1(9Z)/24:1(15Z)/0:0)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/16:1(9Z)/20:0)
TG(14:0/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
3-O-Sulfogalactosylceramide (d18:1/18:1(9Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:1(9Z))
DG(14:0/0:0/24:1n9)
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/15:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/16:1(9Z)/14:1(9Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:0)
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/20:0/18:2(9Z,12Z))
TG(22:1(13Z)/14:1(9Z)/o-18:0)
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
MG(18:1(9Z)/0:0/0:0)
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/15:0/o-18:0)
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol A pyridine that has formula C10H15N3O2.
15(S)-HETE An optically active form of 15-HETE having 15(S)-configuration..
TG(14:0/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
DG(24:0/0:0/22:5n3)
DG(18:0/16:0/0:0)
PC(18:3(6Z,9Z,12Z)/14:0)
PE(P-18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/24:0)
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(14:0/o-18:0/18:1(9Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
LysoPC(20:3(8Z,11Z,14Z))
PE(18:0/18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
B-Sulfinyl pyruvate
TG(14:0/18:0/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
PE(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(18:0/20:3n6/18:3(6Z,9Z,12Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/22:0)
TG(22:0/18:1(9Z)/22:2(13Z,16Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
5'-Deoxy-5-fluorocytidine A N-glycosyl compound that has formula C9H12FN3O4.
TG(16:0/18:0/16:1(9Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(14:0/20:2n6/22:1(13Z))
DG(24:1(15Z)/18:2(9Z,12Z)/0:0)
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(14:0/0:0/22:0)
PIP(18:0/18:3(9Z,12Z,15Z))
TG(14:0/24:0/14:0)
TG(20:1(11Z)/20:2n6/20:2n6)
Ganglioside GM1 (d18:0/24:1(15Z))
TG(16:1(9Z)/16:1(9Z)/20:3n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GT1b (d18:1/18:1(11Z))
Ganglioside GT3 (d18:0/18:1(9Z))
L-Arabinose The L-enantiomer of arabinose.
Venlafaxine A tertiary amino compound that is N,N-dimethylethanamine substituted at position 1 by a 1-hydroxycyclohexyl and 4-methoxyphenyl group.
TG(24:0/18:1(9Z)/24:0)
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(18:1(9Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
Palmitoyl glucuronide
TG(16:0/22:1(13Z)/22:2(13Z,16Z))
TG(18:0/18:3(6Z,9Z,12Z)/18:0)
TG(16:1(9Z)/15:0/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/24:0/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PC(20:3(5Z,8Z,11Z)/P-18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Lipoyl-GMP
TG(16:0/15:0/18:1(9Z))
LysoPE(0:0/20:3(5Z,8Z,11Z))
TG(22:0/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
Amantadine A member of the class of adamantanes that is used as an antiviral and antiparkinson drug.
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/20:3n6)
PIP(16:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/16:1(9Z)/16:1(9Z))
TG(16:1(9Z)/16:0/18:2(9Z,12Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
4,5-Dihydroorotic acid
Fentanyl The carboxamide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
TG(20:1(11Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(16:1n7/0:0/18:3n6)
LysoPE(0:0/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/20:3(5Z,8Z,11Z))
PI(22:3(10Z,13Z,16Z)/16:0)
PC(18:0/18:3(6Z,9Z,12Z))
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/16:0/20:3n6)
TG(15:0/16:1(9Z)/18:2(9Z,12Z))
PC(14:1(9Z)/P-18:1(11Z))
Dicloxacillin A penicillin that has formula C19H17Cl2N3O5S.
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(16:1(9Z)/18:3(6Z,9Z,12Z)/0:0)
PE(22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:0/18:1(9Z))
PE(24:0/18:3(6Z,9Z,12Z))
TG(16:0/16:0/22:1(13Z))
DG(18:1(9Z)/20:0/0:0)
Sunitinib A pyrrole that has formula C22H27FN4O2.
TG(14:0/22:2(13Z,16Z)/18:1(9Z))
Galantamine
TG(20:1(11Z)/20:3n6/20:3n6)
TG(16:0/15:0/22:1(13Z))
TG(24:0/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/22:1(13Z)/24:1(15Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
TG(15:0/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Canavaninosuccinate
TG(22:0/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
N-Acetylarylamine An acetamide where at at least one of the amide hydrogens is substituted by an aryl group.
Salicylic acid A monohydroxybenzoic acid that is benzoic acid with a hydroxy group at the ortho position. It is obtained from the bark of the white willow and wintergreen leaves.
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
Saprisartan
TG(20:1(11Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/20:0/o-18:0)
TG(18:3(9Z,12Z,15Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(20:0/20:1(11Z))
TG(15:0/22:0/24:0)
Cefradine
PS(18:1(9Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/18:1(9Z)/24:1(15Z))
DG(18:4n3/0:0/22:6n3)
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Prednisolone A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
TG(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
LysoPC(20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/20:3n6/22:1(13Z))
TG(18:1(9Z)/24:1(15Z)/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:0/0:0/22:1n9)
TG(14:0/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/18:1(11Z)/22:1(13Z))
PS(18:3(9Z,12Z,15Z)/14:0)
TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(22:0/15:0/18:1(9Z))
Tazarotene
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(18:0/20:0/18:2(9Z,12Z))
TG(18:1(11Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:0/14:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(24:1(15Z)/20:3(5Z,8Z,11Z))
TG(15:0/20:2n6/20:0)
LysoPE(0:0/20:2(11Z,14Z))
Aminoacetone A propanone consisting of acetone having an amino group at the 1-position.
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
DG(24:0/15:0/0:0)
TG(18:3(6Z,9Z,12Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:2n6/22:0)
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/20:3n6)
DG(20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
PC(o-18:1(9Z)/20:0)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
DG(14:0/22:2(13Z,16Z)/0:0)
TG(16:1(9Z)/20:0/16:1(9Z))
TG(14:1(9Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
1,2,3-Propanetricarboxylic acid
DG(18:1n9/0:0/18:3n6)
TG(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(24:0/18:1(11Z)/18:1(9Z))
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
PC(18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(22:0/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
3a,6a,7b-Trihydroxy-5b-cholanoic acid
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Pterin
TG(18:2(9Z,12Z)/24:0/o-18:0)
PE(22:1(13Z)/15:0)
TG(15:0/18:3(6Z,9Z,12Z)/16:0)
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/24:0/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/24:0/22:2(13Z,16Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:0/18:1(9Z))
PE(16:0/14:0)
DG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/0:0)
TG(22:2(13Z,16Z)/22:0/o-18:0)
TG(24:0/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(18:1(9Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
SM(d18:1/12:0)
TG(20:3(5Z,8Z,11Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
DG(14:0/22:1(13Z)/0:0)
TG(24:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Aniline A primary arylamine in which an amino functional group is substituted for one of the benzene hydrogens.
TG(20:3n6/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
2,3-Diphosphoglyceric acid
Thiamine
Ganglioside GT3 (d18:1/23:0)
PG(16:1(9Z)/18:1(11Z))
TG(22:1(13Z)/18:1(9Z)/18:3(6Z,9Z,12Z))
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/22:0/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/15:0/18:1(11Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:0/P-18:0)
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/24:1(15Z))
PC(o-16:1(9Z)/18:2(9Z,12Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(22:1(13Z)/24:0/20:3n6)
PC(18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(20:2n6/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
MG(14:1(9Z)/0:0/0:0)
DG(22:1n9/0:0/24:1n9)
PC(20:4(5Z,8Z,11Z,14Z)/P-16:0)
PC(dm18:1(9Z)/dm18:1(9Z))
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
Octane A straight chain alkane composed of 8 carbon atoms.
TG(16:1(9Z)/18:0/20:0)[iso6]
TG(18:1(11Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
20-Hydroxyeicosatetraenoic acid
DG(18:1n9/0:0/20:5n3)
PE(16:1(9Z)/20:3(5Z,8Z,11Z))
TG(22:0/o-18:0/14:1(9Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
SM(d18:1/14:0)
L-Cysteine An optically active form of cysteine having L-configuration.
TG(18:4(6Z,9Z,12Z,15Z)/22:1(13Z)/o-18:0)
PE(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))
Molybdate A divalent inorganic anion obtained by removal of both protons from molybdic acid
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/24:1(15Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:0/24:1(15Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(24:0/22:0/22:1(13Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
Trihexosylceramide (d18:1/22:0)
DG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
Hydroxykynurenine
Ganglioside GT1c (d18:0/26:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/o-18:0)
Chenodeoxycholic acid glycine conjugate
PC(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
Galabiosylceramide (d18:1/16:0)
TG(22:0/22:0/22:2(13Z,16Z))
DG(14:0/18:3(6Z,9Z,12Z)/0:0)
DG(20:0/18:1(9Z)/0:0)
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
Phytosphingosine
PC(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:0/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(20:1(11Z)/14:1(9Z)/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(22:0/22:2(13Z,16Z)/24:1(15Z))
Doxorubicin An anthracycline antibiotic that has formula C27H29NO11.
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(14:0/24:0/24:0)
PC(20:3(8Z,11Z,14Z)/P-16:0)
DG(16:1(9Z)/22:0/0:0)
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(14:0/16:0/18:3(9Z,12Z,15Z))
Uridine
TG(14:0/18:3(9Z,12Z,15Z)/14:1(9Z))
TG(20:1(11Z)/20:3n6/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/20:2n6)
Penicillamine
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
TG(16:1(9Z)/16:0/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
PE(20:1(11Z)/16:1(9Z))
PIP2(18:1(9Z)/20:3(8Z,11Z,14Z))
TG(14:0/22:2(13Z,16Z)/18:2(9Z,12Z))
PC(22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
LysoPE(22:4(7Z,10Z,13Z,16Z)/0:0)
PI(20:0/18:2(9Z,12Z))
2-Hexaprenyl-6-methoxy-1,4-benzoquinone A polyprenylbenzoquinone that has formula C37H54O3.
Methylcobalamin A cobalamin that has formula C63H91CoN13O14P.
TG(20:3(5Z,8Z,11Z)/16:0/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
Tartronate semialdehyde
Clomifene
CDP-DG(18:1(9Z)/18:2(9Z,12Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(16:0/18:0/18:2(9Z,12Z))[iso6]
TG(22:0/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/24:0/20:3(5Z,8Z,11Z))
TG(20:0/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:3(5Z,8Z,11Z)/24:0)
L-Carnitine
PI(20:2(11Z,14Z)/18:2(9Z,12Z))
Ganglioside GD3 (d18:1/9Z-18:1)
Ganglioside GD1a (d18:0/18:1(9Z))
MG(0:0/18:0/0:0)
TG(14:1(9Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
Cer(d18:1/23:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/22:0/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
Orotic acid
Deoxyuridine
TG(14:1(9Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))
Ganglioside GD1a (d18:0/24:0)
PE(16:0/18:1(9Z))
TG(20:1(11Z)/22:0/20:1(11Z))
TG(24:1(15Z)/22:0/18:2(9Z,12Z))
TG(24:1(15Z)/16:0/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
Ribavirin A 1-ribosyltriazole that is the 1-ribofuranosyl derivative of 1,2,4-triazole-3-carboxamide. An inhibitor of HCV polymerase.
TG(20:2n6/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:2(9Z,12Z)/18:1(9Z)/0:0)
3-O-Sulfogalactosylceramide (d18:1/24:0)
TG(15:0/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(16:0/20:3(8Z,11Z,14Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(24:0/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
DL-Glutamate
PE(22:2(13Z,16Z)/22:0)
Mexiletine An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
TG(24:0/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
Aluminum
PC(16:1(9Z)/18:0)
Quercetin 3-O-glucuronide
PE(22:2(13Z,16Z)/24:0)
Ganglioside GD1a (d18:0/26:0)
PC(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
PC(14:1(9Z)/20:2(11Z,14Z))
PC(20:2(11Z,14Z)/18:0)
DG(14:0/22:0/0:0)
TG(18:1(9Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/22:0/22:2(13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/18:0/18:3(9Z,12Z,15Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(14:0/24:1(15Z)/16:0)
TG(22:2(13Z,16Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(22:0/20:0/24:1(15Z))
TG(20:1(11Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PE(22:2(13Z,16Z)/18:2(9Z,12Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Methoxyflurane
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
DG(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/18:1(9Z)/20:3n6)
TG(18:0/14:1(9Z)/o-18:0)
TG(16:0/18:1(11Z)/16:0)
Bromide A monoatomic bromine that has formula Br.
TG(20:0/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Procaterol
TG(24:0/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(20:0/22:1(13Z)/24:1(15Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/18:1(11Z))
TG(14:1(9Z)/20:0/20:3n6)
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/22:0/20:3n6)
Ropivacaine The piperidinecarboxamide obtained by the formal condensation of N-propylpipecolic acid and 2,6-dimethylaniline.
TG(15:0/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(14:0/24:1(15Z)/14:0)
DG(18:1(9Z)/24:1(15Z)/0:0)
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/24:1(15Z)/20:3n6)
TG(20:2n6/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
Cyclandelate
TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
TG(24:0/18:1(9Z)/o-18:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:0/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/16:0/16:1(9Z))
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(22:0/20:3n6/20:3n6)
TG(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/14:0/24:0)
PE(22:1(13Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
Lathosterol
TG(18:2(9Z,12Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:1(13Z)/20:1(11Z))
TG(24:0/18:1(9Z)/20:1(11Z))
Trehalose
TG(18:0/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
2-Phenylacetamide A monocarboxylic acid amide that is acetamide substituted by a phenyl group at position 2.
PE(18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
CDP-DG(18:1(11Z)/18:0)
TG(18:2(9Z,12Z)/24:1(15Z)/20:2n6)
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
2-Hydroxyphytanoyl-CoA A multi-methyl-branched fatty acyl-CoA having 2-hydroxyphytanoyl as the S-acyl group.
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(24:0/14:0/24:0)
TG(14:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(15:0/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:2(9Z,12Z)/20:1(11Z)/0:0)
TG(14:0/18:1(9Z)/18:1(9Z))
DG(18:0/15:0/0:0)
TG(18:0/18:3(9Z,12Z,15Z)/24:0)
TG(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
S-Methylmalonyl-CoA The (S)-enantiomer of methylmalonyl-CoA.
TG(16:0/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(9Z,12Z,15Z)/20:0/o-18:0)
TG(14:0/18:3(9Z,12Z,15Z)/24:1(15Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
Acetylcholine
TG(20:0/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
PIP2(20:2(11Z,14Z)/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
PE(24:0/18:3(9Z,12Z,15Z))
Sparfloxacin
TG(22:0/18:0/18:1(11Z))
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:2(11Z,14Z)/20:3(8Z,11Z,14Z)/0:0)
PI(20:4(5Z,8Z,11Z,14Z)/18:0)
TG(20:2n6/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/14:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/24:0/o-18:0)
Lipoamide A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of lipoic acid with ammonia.
TG(14:1(9Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/24:1(15Z))
TG(15:0/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/22:1(13Z)/24:1(15Z))
PIP2(16:0/22:4(10Z,13Z,16Z,19Z))
TG(16:1(9Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(24:0/18:1(11Z)/22:1(13Z))
3a,4b,7a-Trihydroxy-5b-cholanoic acid
1b-Hydroxycholic acid
Lisinopril A dipeptide that has formula C21H31N3O5.
TG(14:0/18:1(9Z)/18:1(11Z))
TG(16:1(9Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
PC(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
DG(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/0:0)
TG(16:0/16:1(9Z)/22:2(13Z,16Z))
TG(14:0/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
DG(22:1(13Z)/20:3(5Z,8Z,11Z)/0:0)
TG(24:0/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/o-18:0/20:3(5Z,8Z,11Z))
TG(16:0/20:3n6/16:1(9Z))
PC(P-16:0/18:1(11Z))
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/24:0/22:2(13Z,16Z))
Methylmalonyl-CoA A member of the class of malonyl-CoAs that is malonyl-CoA carrying a methyl group on the malony side chain.
TG(24:1(15Z)/22:0/20:2n6)
PIP(16:2(9Z,12Z)/16:0)
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Lactosylceramide (d18:1/18:0)
TG(16:0/18:2(9Z,12Z)/20:1(11Z))[iso6]
Acetyldigitoxin
DG(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/20:2n6/14:1(9Z))
PC(15:0/24:1(15Z))
TG(14:0/15:0/18:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/14:0/22:4(7Z,10Z,13Z,16Z))
Cyclothiazide
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
Potassium An alkali metal atom that has formula K.
TG(18:1(11Z)/22:1(13Z)/18:2(9Z,12Z))
CL(20:2(11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:2n6/20:2n6/18:4(6Z,9Z,12Z,15Z))
Phenelzine
Betavulgaroside I
TG(16:0/22:0/20:4(8Z,11Z,14Z,17Z))
4-Hydroxyproline A hydroxyproline where the hydroxy group is located at the 4-position. It is found in fibrillar collagen.
TG(24:0/14:0/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
7-a,27-Dihydroxycholesterol
Pyrroline hydroxycarboxylic acid
TG(24:1(15Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
Acetyl-N-formyl-5-methoxykynurenamine
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:2n6/22:0)
TG(20:0/22:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(P-18:1(11Z)/20:0)
DG(20:0/0:0/22:5n6)
PS(18:1(9Z)/14:1(9Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/15:0)
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
PE(20:2(11Z,14Z)/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(16:1(9Z)/16:0/24:1(15Z))
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:1(9Z)/22:1(13Z)/0:0)
TG(18:1(11Z)/24:0/18:3(9Z,12Z,15Z))
12(S)-HPETE The (S)-enantiomer of 12-HPETE.
TG(14:1(9Z)/20:1(11Z)/24:1(15Z))
TG(18:1(11Z)/20:2n6/20:3n6)
N1-Methyl-4-pyridone-3-carboxamide
Zolmitriptan
TG(20:2n6/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:1(9Z)/18:2(9Z,12Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/20:0/22:4(7Z,10Z,13Z,16Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(15:0/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/15:0/22:0)
DG(15:0/0:0/22:2n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
PC(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(18:1(11Z)/16:1(9Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:0/24:1(15Z))
TG(15:0/15:0/20:0)
(2E,6Z,9Z,12Z,15Z,18Z)-Tetracosahexa-2,6,9,12,15,18-enoyl-CoA An organic molecule that has formula C45H70N7O17P3S.
TG(20:0/18:3(6Z,9Z,12Z)/o-18:0)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
PG(18:3(9Z,12Z,15Z)/18:1(9Z))
DG(20:4(8Z,11Z,14Z,17Z)/18:0/0:0)
TG(16:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PC(P-18:1(9Z)/18:3(9Z,12Z,15Z))
5-Amino-2-oxopentanoic acid The 2-oxo-5-amino derivative of valeric acid.
TG(15:0/o-18:0/20:2n6)
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(24:1(15Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:1(11Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/24:0)
TG(18:1(9Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:3n9/0:0/18:3n3)
PE(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(22:0/22:2(13Z,16Z)/20:3n6)
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/18:1(9Z))
Tetrahexosylceramide (d18:1/26:1(17Z))
Decamethonium A quaternary ammonium ion that is a depolarising muscle relaxant whose structure comprises a decane-1,10-diamine core in which each amino group carries three methyl substituents.
3a,12b-Dihydroxy-5b-cholanoic acid
TG(14:0/20:2n6/18:2(9Z,12Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z)/0:0)
DG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/24:1(15Z)/18:1(11Z))
TG(15:0/18:1(9Z)/20:0)
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/o-18:0)
TG(16:0/14:0/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(18:0/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/14:1(9Z)/20:3(5Z,8Z,11Z))
PE(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:1(9Z)/22:0)
TG(16:0/20:3(5Z,8Z,11Z)/24:1(15Z))
TG(24:0/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GD1a (d18:1/16:0)
PC(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
PC(20:3(5Z,8Z,11Z)/16:1(9Z))
TG(15:0/18:2(9Z,12Z)/20:2n6)
DG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/0:0)
Oxoglutaric acid
TG(18:2(9Z,12Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
PE(22:4(7Z,10Z,13Z,16Z)/24:0)
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(22:1n9/0:0/20:4n6)
TG(22:0/22:1(13Z)/20:3(5Z,8Z,11Z))
4-OH-Retinal
2-Ketobutyric acid
TG(18:0/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/16:0/22:4(7Z,10Z,13Z,16Z))
PI(20:4(5Z,8Z,11Z,14Z)/16:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:0)
TG(20:0/20:2n6/20:2n6)
DG(16:0/18:0/0:0)
TG(18:1(9Z)/20:3n6/18:1(9Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
N-Arachidonoyl glycine Biologically active derivative of anandamide
TG(16:0/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(15:0/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GD1a (d18:1/14:0)
TG(15:0/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
Rizatriptan A tryptamine that has formula C15H19N5.
TG(20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(20:1(11Z)/20:2n6/o-18:0)
DG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/0:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(24:0/20:2n6/24:1(15Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/22:1(13Z)/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
Thyroxine glucuronide
Ganglioside GM3 (d18:0/25:0)
TG(22:0/14:1(9Z)/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:2n6/22:4(7Z,10Z,13Z,16Z))
LPA(P-16:0e/0:0)
TG(14:1(9Z)/18:1(11Z)/16:1(9Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/15:0/20:3(5Z,8Z,11Z))
TG(22:0/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/14:0/20:1(11Z))
Ganglioside GT2 (d18:1/23:0)
TG(20:0/16:0/20:1(11Z))
TG(14:0/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:1(11Z)/20:1(11Z))
TG(18:1(11Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
4,8-Dimethylnonanoyl-CoA A medium-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 4,8-dimethylnonanoic acid.
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/16:0/20:1(11Z))
Benzo[a]pyrene-7,8-diol A pyrene that has formula C20H14O2.
PC(15:0/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
Galabiosylceramide (d18:1/25:0)
Ganglioside GD1a (d18:1/24:1(15Z))
Salicyluric acid An N-acylglycine in which the acyl group is specified as 2-hydroxybenzoyl.
TG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
PE(15:0/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
TG(20:2n6/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/18:3(6Z,9Z,12Z)/20:3n6)
TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
PE(18:1(9Z)/18:1(11Z))
TG(18:0/22:0/16:1(9Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
DG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(22:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
Heptabarbital A barbiturate that has formula C13H18N2O3.
PE(P-18:1(11Z)/22:1(13Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
PE(24:0/22:1(13Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/14:0/20:3n6)
TG(16:0/24:0/18:2(9Z,12Z))
TG(20:1(11Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:3n6/18:1(9Z))
PC(24:1(15Z)/16:0)
PE(18:1(11Z)/24:0)
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/20:3n6)
dCMP A pyrimidine 2'-deoxyribonucleoside 5'-monophosphate having cytosine as the nucleobase.
TG(16:0/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/20:2n6)
5,10-Methylene-THF
TG(14:0/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
SM(d19:1/24:1(15Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
7a,12b-dihydroxy-5b-Cholan-24-oic acid
TG(24:0/16:0/14:1(9Z))
TG(15:0/22:2(13Z,16Z)/14:1(9Z))
TG(18:0/14:0/18:4(6Z,9Z,12Z,15Z))
TG(14:0/14:0/22:0)
DG(24:0/0:0/18:1n7)
TG(24:0/18:0/20:3n6)
TG(24:0/18:0/18:2(9Z,12Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
TG(18:4(6Z,9Z,12Z,15Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/16:1(9Z)/o-18:0)
TG(18:2(9Z,12Z)/18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/18:1(11Z)/22:1(13Z))
TG(14:0/14:1(9Z)/20:0)
TG(16:0/18:3(9Z,12Z,15Z)/16:1(9Z))
Prostaglandin G2 A prostaglandins G that has formula C20H32O6.
1D-Myo-inositol 3,4-bisphosphate A myo-inositol bisphosphate that has formula C6H14O12P2.
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
2-Hydroxyestradiol-3-methyl ether
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/16:1(9Z))
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PI(22:3(10Z,13Z,16Z)/16:2(9Z,12Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Cholic acid glucuronide
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
3a,7a,12a-Trihydroxy-5b-cholestan-26-al
TG(20:2n6/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:1(11Z)/15:0/0:0)
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
DG(18:2n6/0:0/22:2n6)
TG(20:3n6/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z)/o-18:0)
TG(18:0/18:1(9Z)/18:1(11Z))
TG(18:2(9Z,12Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
Ganglioside GM1 (d18:0/24:0)
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/20:3n6)
Glycoursodeoxycholic acid
PIP(20:3(8Z,11Z,14Z)/18:0)
PIP2(16:0/20:3(8Z,11Z,14Z))
TG(14:1(9Z)/24:0/16:1(9Z))
3-Mercaptopyruvic acid A 2-oxo monocarboxylic acid that is pyruvic acid substituted by a sulfanyl group at position 3.
DG(18:2n6/0:0/22:5n3)
TG(16:0/18:1(11Z)/18:1(11Z))
TG(18:1(9Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Fumaric acid A butenedioic acid in which the C=C double bond has E geometry. It is an intermediate metabolite in the citric acid cycle.
2-Arachidonylglycerol
TG(14:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
TG(24:1(15Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:3(6Z,9Z,12Z)/18:1(11Z))
TG(18:0/22:1(13Z)/20:1(11Z))
Zuclopenthixol
TG(22:4(7Z,10Z,13Z,16Z)/o-18:0/18:3(9Z,12Z,15Z))
DG(20:2n6/0:0/18:3n3)
TG(16:0/20:2n6/18:1(9Z))
DG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/0:0)
Palmitaldehyde
TG(18:1(9Z)/15:0/22:4(7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/16:1(9Z)/o-18:0)
PC(22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
DG(14:0/0:0/22:5n3)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(P-16:0/14:1(9Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:3n6/18:1(9Z))
PC(15:0/18:3(9Z,12Z,15Z))
TG(14:0/18:3(6Z,9Z,12Z)/14:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:1(13Z)/18:1(9Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(18:0/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:3(8Z,11Z,14Z)/22:2(13Z,16Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:2(9Z,12Z)/18:1(11Z)/0:0)
Cer(d18:1/18:1(11Z))
PC(20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/0:0)
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/20:2n6)
TG(14:0/18:2(9Z,12Z)/22:1(13Z))
TG(24:0/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/22:2(13Z,16Z))
TG(18:1(9Z)/24:0/20:4(5Z,8Z,11Z,14Z))
DG(22:1n9/0:0/22:5n3)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
PG(18:1(9Z)/18:2(9Z,12Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/22:0/18:3(9Z,12Z,15Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/15:0/22:1(13Z))
TG(18:0/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
3-Oxotetradecanoic acid A C14, long-chain fatty acid carrying an oxo- group at position 3.
5'-Hydroxylornoxicam
Losartan N2-glucuronide
MG(0:0/20:3(8Z,11Z,14Z)/0:0)
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/18:1(11Z)/20:2n6)
TG(22:1(13Z)/20:2n6/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(P-18:0/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/16:1(9Z)/20:3(5Z,8Z,11Z))
DG(22:4n6/0:0/22:6n3)
TG(18:3(6Z,9Z,12Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/16:0/18:2(9Z,12Z))[iso3]
DG(24:0/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(14:0/24:0/20:3n6)
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/22:2(13Z,16Z))
PE(18:3(6Z,9Z,12Z)/20:1(11Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(20:3n6/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(15:0/14:0)
PS(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/24:0/22:2(13Z,16Z))
TG(18:1(9Z)/22:2(13Z,16Z)/22:1(13Z))
Cloxacillin A semisynthetic penicillin antibiotic carrying a 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido group at position 6.
TG(24:0/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:0/18:1(11Z))
DG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(18:1(11Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:1(13Z)/16:0/0:0)
Metixene A thioxanthene that has formula C20H23NS.
TG(18:3(9Z,12Z,15Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:3n6/20:3(5Z,8Z,11Z))
TG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(16:0/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/15:0)
DG(14:1(9Z)/18:2(9Z,12Z)/0:0)
TG(14:0/18:0/22:2(13Z,16Z))
TG(24:1(15Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
DG(18:1(9Z)/22:0/0:0)
TG(18:0/18:0/22:0)
TG(20:0/16:1(9Z)/18:1(9Z))
PG(18:1(9Z)/20:3(5Z,8Z,11Z))
Cyclic pyranopterin monophosphate
PC(15:0/16:0)
TG(14:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/15:0/22:2(13Z,16Z))
5-Fluorodeoxyuridine monophosphate A pyrimidine 2'-deoxyribonucleoside 5'-monophosphate that has formula C9H12FN2O8P.
TG(18:1(11Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Norspermidine
PI(20:1(11Z)/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:0/22:2(13Z,16Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(20:1(11Z)/18:1(11Z)/20:2n6)
TG(18:0/20:0/20:3n6)
PE(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
3Z-dodecenoyl-CoA
3 alpha,7 alpha,24-Trihydroxy-5beta-cholestanoyl-CoA
Ganglioside GM2 (d18:0/16:0)
TG(20:1(11Z)/14:0/22:1(13Z))
PIP2(18:0/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/18:2(9Z,12Z)/22:1(13Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GM2 (d18:1/26:1(17Z))
PC(o-22:3(10Z,13Z,16Z)/22:3(10Z,13Z,16Z))
Verapamil A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
Tungsten A chromium group element atom that has formula W.
TG(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/20:2n6/22:2(13Z,16Z))
CE(24:0)
TG(18:1(9Z)/18:1(9Z)/20:3(5Z,8Z,11Z))[iso3]
TG(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
Cer(d18:1/14:0)
PC(18:3(6Z,9Z,12Z)/P-18:1(11Z))
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Nilutamide
PC(20:4(8Z,11Z,14Z,17Z)/20:0)
TG(20:2n6/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/16:0/o-18:0)
(S)-Hydroxyoctanoyl-CoA
TG(22:1(13Z)/20:2n6/20:3n6)
TG(20:0/20:1(11Z)/16:1(9Z))
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(18:3n6/0:0/18:3n3)
Chloroacetic acid A chlorocarboxylic acid that is acetic acid carrying a 2-chloro substituent.
TG(15:0/16:0/22:4(7Z,10Z,13Z,16Z))
TG(14:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:0/22:4(7Z,10Z,13Z,16Z))
FADH A flavin adenine dinucleotide that has formula C27H34N9O15P2.
TG(18:0/18:3(9Z,12Z,15Z)/24:1(15Z))
PS(18:1(9Z)/18:0)
DG(18:1(9Z)/18:2(9Z,12Z)/0:0)
DG(18:2n6/0:0/20:4n3)
Trihexosylceramide (d18:1/12:0)
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
PE(18:1(9Z)/P-18:1(11Z))
PC(20:0/20:4(5Z,8Z,11Z,14Z))
(25R)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA A 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-CoA in which the carbon at position 25 of the steroidal side chain has R configuration.
TG(18:3(9Z,12Z,15Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(22:2(13Z,16Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
DG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
PE(18:3(9Z,12Z,15Z)/15:0)
TG(18:0/18:1(9Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/18:1(9Z)/20:1(11Z))
DG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
PE(16:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/20:2n6)
DG(20:1n9/0:0/22:1n9)
TG(16:0/16:1(9Z)/18:3(9Z,12Z,15Z))
PE(P-18:1(9Z)/18:0)
TG(20:1(11Z)/20:3n6/20:2n6)
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/20:2n6)
Cortisone A C21-steroid that is pregn-4-ene substituted by hydroxy groups at positions 17 and 21 and oxo group at positions 3, 11 and 20.
CE(22:0)
TG(14:0/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
Palmitic acid A straight-chain, sixteen-carbon, saturated long-chain fatty acid.
TG(20:3n6/16:0/20:4(8Z,11Z,14Z,17Z))
DG(16:0/0:0/20:1n9)
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
PE(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
TG(16:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/18:1(11Z)/o-18:0)
TG(18:0/20:3n6/20:1(11Z))
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/20:2n6)
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(22:0/18:1(9Z)/20:3n6)
DG(20:4(5Z,8Z,11Z,14Z)/18:0/0:0)
TG(16:0/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/18:0)
PE(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:2n6)
PC(16:1(9Z)/14:1(9Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:2n6/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/18:1(11Z)/o-18:0)
TG(18:1(11Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/22:2(13Z,16Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
PE(16:1(9Z)/24:0)
L-Threonine An optically active form of threonine having L-configuration.
Oseltamivir
TG(18:0/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PI(16:0/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GT1b (d18:0/18:1(11Z))
5,10-Methylenetetrahydromethanopterin A tetrahydromethanopterin that has formula C31H45N6O16P.
TG(20:0/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:0/22:4(7Z,10Z,13Z,16Z)/0:0)
UDP-L-rhamnose A UDP-rhamnose in which the rhamnose component has L-configuration.
TG(15:0/18:1(9Z)/18:1(11Z))
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(20:3(5Z,8Z,11Z)/14:0/18:3(6Z,9Z,12Z))
Ganglioside GD2 (d18:1/9Z-18:1)
TG(18:0/22:1(13Z)/18:0)
Farnesyl pyrophosphate
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:1(13Z)/20:1(11Z))
Aprindine
TG(18:1(11Z)/24:1(15Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(16:1(9Z)/22:0)
TG(15:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(24:0/14:0/22:1(13Z))
TG(16:0/14:0/18:0)[iso6]
TG(18:4(6Z,9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PI(18:2(9Z,12Z)/18:0)
7-Methylguanine A methylguanine that is guanine substituted by a methyl group at position 7. It is a metabolite obtained during the methylation of DNA.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:0/o-18:0)
Selegiline
TG(20:0/20:3n6/24:1(15Z))
TG(20:2n6/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:0/20:3(5Z,8Z,11Z))
TG(15:0/18:2(9Z,12Z)/15:0)
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(22:0/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
PC(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/22:2(13Z,16Z)/18:1(11Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/18:1(11Z)/18:1(9Z))[iso3]
Fenofibrate A chlorobenzophenone that is (4-chlorophenyl)(phenyl)methanone substituted by a [2-methyl-1-oxo-1-(propan-2-yloxy)propan-2-yl]oxy group at position 1 on the phenyl ring.
Ganglioside GT1b (d18:0/18:0)
TG(14:1(9Z)/16:0/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:0)
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
cis,cis-3,6-Dodecadienoyl-CoA
TG(22:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(20:3(5Z,8Z,11Z)/P-16:0)
PS(14:1(9Z)/14:1(9Z))
TG(20:3(5Z,8Z,11Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/16:0/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/20:0)
TG(22:0/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
Dimethyl sulfoxide A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
DG(14:0/0:0/18:3n3)
TG(24:1(15Z)/18:1(11Z)/18:2(9Z,12Z))
CDP-DG(16:0/22:3(10Z,13Z,16Z))
TG(22:1(13Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
PC(14:1(9Z)/14:1(9Z))
TG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:1(11Z)/16:1(9Z)/0:0)
PE(18:4(6Z,9Z,12Z,15Z)/18:0)
DG(24:1(15Z)/18:3(6Z,9Z,12Z)/0:0)
DG(14:1(9Z)/24:0/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/22:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/18:3(6Z,9Z,12Z)/16:1(9Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
PC(20:2(11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(P-16:0/20:4(8Z,11Z,14Z,17Z))
TG(20:0/16:1(9Z)/24:0)
Ganglioside GM3 (d18:1/24:1(15Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(14:0/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:4(6Z,9Z,12Z,15Z)/20:2(11Z,14Z)/0:0)
TG(22:0/16:0/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/14:0/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(16:0/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/20:3n6/20:4(5Z,8Z,11Z,14Z))
DG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(22:0/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
PC(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
Tamoxifen N-oxide An N-oxide derived from tamoxifen.
TG(18:1(9Z)/18:2(9Z,12Z)/18:1(9Z))
TG(16:0/18:3(9Z,12Z,15Z)/o-18:0)
PE(18:0/P-18:1(9Z))
TG(14:1(9Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(14:0/14:0)
TG(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
5-Hydroxy-N-formylkynurenine An alpha-amino acid that is 5-hydroxykynurenine bearing an N-formyl substituent.
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:0/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/20:2n6)
TG(20:1(11Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(18:0/24:0/18:3(9Z,12Z,15Z))
DG(24:0/24:1(15Z)/0:0)
PS(18:1(9Z)/20:3(8Z,11Z,14Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PE(P-18:0/24:1(15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GT3 (d18:1/22:1(13Z))
PC(20:3(8Z,11Z,14Z)/18:0)
DG(18:2(9Z,12Z)/15:0/0:0)
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
Bendroflumethiazide A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
PS(14:0/18:1(9Z))
TG(24:0/18:1(11Z)/20:2n6)
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/20:3n6)
Quinacrine
TG(24:0/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
Ammonia
Bevantolol A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension.
TG(18:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(18:0/18:1(9Z)/24:1(15Z))
PE(20:1(11Z)/20:2(11Z,14Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
PC(18:1(9Z)/22:2(13Z,16Z))
PC(18:4(6Z,9Z,12Z,15Z)/22:0)
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/18:2(9Z,12Z)/24:0)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/18:0)
Estriol
Pancuronium A steroid ester in which a 5alpha-androstane skeleton is C-3alpha- and C-17beta-disubstituted with acetoxy groups and 2beta- and 16beta-disubstituted with 1-methylpiperidinium-1-yl groups. It is a non-depolarizing curare-mimetic muscle relaxant.
TG(18:1(11Z)/15:0/20:4(8Z,11Z,14Z,17Z))
DG(18:2(9Z,12Z)/22:2(13Z,16Z)/0:0)
TG(15:0/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
PC(20:3(8Z,11Z,14Z)/16:0)
DG(22:0/22:4(7Z,10Z,13Z,16Z)/0:0)
DG(18:2n6/0:0/18:3n3)
(1R)-Glutathionyl-(2R)-hydroxy-1,2-dihydronaphthalene A peptide that has formula C20H25N3O7S.
TG(24:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
DG(14:0/0:0/15:0)
Fexofenadine A piperidine-based anti-histamine compound.
TG(24:0/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:4(6Z,9Z,12Z,15Z)/24:0)
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(16:1(9Z)/o-18:0/22:1(13Z))
TG(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:0/0:0/24:1n9)
trans-3-Chloroacrylic acid
PI(16:0/22:4(10Z,13Z,16Z,19Z))
TG(16:0/16:1(9Z)/14:1(9Z))
Galabiosylceramide (d18:1/26:0)
Menaquinol Any polyprenylhydroquinone having a polyprenyl moiety at position 2 and a methyl group at position 3..
TG(15:0/16:1(9Z)/16:0)
Oxandrolone An oxa-steroid that has formula C19H30O3.
TG(14:1(9Z)/14:0/18:3(9Z,12Z,15Z))
Topaquinone An alpha-amino acid that is alanine substituted at position 3 by a 4-hydroxy-3,6-dioxocyclohexa-1,4-dien-1-yl group.
TG(18:1(9Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(22:2(13Z,16Z)/20:3n6/o-18:0)
DG(18:1(9Z)/20:2(11Z,14Z)/0:0)
TG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:2n6)
DG(14:1n5/0:0/20:3n6)
PE(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
DG(16:1n7/0:0/20:4n6)
TG(14:0/22:0/20:4(8Z,11Z,14Z,17Z))
Dyspropterin A tetrahydropterin that is 2-amino-5,6,7,8-tetrahydropteridin-4(3H)-one substituted by a 2-oxopropanoyl group at position 6.
TG(18:1(9Z)/20:3n6/18:3(6Z,9Z,12Z))
beta-Alanyl-L-lysine A dipeptide consisting of beta-alanine and L-lysine units joined by a peptide linkage.
TG(18:0/18:2(9Z,12Z)/22:0)
TG(14:0/18:2(9Z,12Z)/16:1(9Z))
TG(22:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
Ganglioside GD2 (d18:0/14:0)
PIP(18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(14:0/22:2(13Z,16Z)/18:0)
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Acetazolamide A thiadiazole that has formula C4H6N4O3S2.
DG(18:0/18:1(9Z)/0:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:0/20:4(8Z,11Z,14Z,17Z))
PE(P-18:1(11Z)/20:2(11Z,14Z))
PE(20:0/P-18:1(9Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/18:0)
PE(18:1(11Z)/24:1(15Z))
TG(20:1(11Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
(24R)-24,25-Dihydroxycalciol A seco-cholestane that has formula C27H44O3.
N-Acetylvaline
Chondroitin sulfate Any of a class of 10--60 kDa glycosaminoglycan sulfates, widely distributed in cartilage and other mammalian connective tissues.
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/24:0/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ethanolamine Oleate
11-Hydroxyprogesterone 11-glucuronide
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:2(9Z,12Z)/18:1(9Z))
Deoxycholic acid disulfate
TG(18:1(9Z)/22:1(13Z)/o-18:0)
TG(18:0/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
SM(d18:0/22:2(13Z,16Z)(OH))
TG(18:1(9Z)/18:1(9Z)/22:1(13Z))[iso3]
DG(22:0/24:0/0:0)
TG(16:1(9Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
TG(18:1(11Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
DG(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/16:0/20:3(8Z,11Z,14Z))[iso6]
TG(20:1(11Z)/22:1(13Z)/20:3(5Z,8Z,11Z))
TG(22:0/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Quinine A cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy.
DG(20:4(5Z,8Z,11Z,14Z)/15:0/0:0)
dTDP-D-glucose A dTDP-alpha-D-glucose that has formula C16H26N2O16P2.
PI(16:0/18:1(9Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
Levofloxacin An optically active form of ofloxacin having (S)-configuration; an inhibitor of bacterial topoisomerase IV and DNA gyrase
dIDP
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z))
5a-Pregnane-3,20-dione
L-Isoleucine The L-enantiomer of isoleucine.
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:0)
TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:0)
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:0/0:0/16:1n7)
TG(18:4(6Z,9Z,12Z,15Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Methylarsonate An organoarsonic acid anion that has formula CH3AsO3.
TG(18:1(11Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
PIP2(16:0/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/20:2n6)
10-Formyltetrahydrofolate
TG(20:1(11Z)/18:1(11Z)/20:1(11Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:0)
DG(22:0/0:0/22:5n3)
TG(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/o-18:0)
Acetic acid A simple monocarboxylic acid containing two carbons.
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoic acid A dioxo monocarboxylic acid that has formula C10H9NO5.
TG(22:0/20:3(5Z,8Z,11Z)/24:1(15Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(20:0/24:1(15Z))
TG(14:1(9Z)/o-18:0/20:3n6)
TG(18:1(9Z)/18:0/20:1(11Z))
PC(20:0/22:0)
Nalidixic Acid A monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively.
Cocaine A tropane alkaloid obtained from leaves of the South American shrub Erythroxylon coca.
PE(P-16:0/18:3(9Z,12Z,15Z))
TG(22:0/20:3(5Z,8Z,11Z)/16:1(9Z))
TG(18:0/20:0/22:1(13Z))
TG(20:2n6/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Phosphorylcholine
TG(20:0/18:2(9Z,12Z)/22:1(13Z))
Zaleplon A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position.
DG(14:1n5/0:0/16:1n7)
PC(24:0/22:1(13Z))
TG(16:1(9Z)/14:0/18:4(6Z,9Z,12Z,15Z))
PC(P-16:0/20:3(5Z,8Z,11Z))
TG(15:0/14:0/14:1(9Z))
TG(16:0/18:2(9Z,12Z)/24:1(15Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(22:0/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(20:3n6/15:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:0/24:1(15Z))
TG(18:1(11Z)/24:1(15Z)/22:1(13Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
CL(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
Formic acid
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
D-Xylono-1,5-lactone A xylonolactone that has formula C5H8O5.
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/0:0)
TG(18:1(11Z)/16:0/22:1(13Z))
PC(20:4(5Z,8Z,11Z,14Z)/20:0)
TG(15:0/20:1(11Z)/o-18:0)
TG(20:3n6/15:0/20:4(8Z,11Z,14Z,17Z))
TG(22:0/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/16:0/18:3(6Z,9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(15:0/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:4(7Z,10Z,13Z,16Z)/14:0)
Fructose 1-phosphate A ketohexose monophosphate consisting of fructose having a phosphate group located at the 1-position
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
Dextrin
TG(14:0/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GM2 (d18:0/25:0)
TG(18:1(11Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/16:1(9Z)/o-18:0)
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/20:1(11Z)/20:3n6)
TG(15:0/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/22:2(13Z,16Z)/24:1(15Z))
TG(24:1(15Z)/18:0/20:4(5Z,8Z,11Z,14Z))
PIP2(18:1(11Z)/18:1(9Z))
Flurazepam
11-cis-Retinaldehyde
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(14:1(9Z)/14:1(9Z)/22:1(13Z))
TG(20:0/15:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(22:0/15:0/18:3(9Z,12Z,15Z))
PE(18:0/16:1(9Z))
PE(22:2(13Z,16Z)/14:1(9Z))
PE(20:0/18:1(9Z))
5'-Phosphoribosyl-N-formylglycinamide
TG(18:1(11Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:3n6/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PIP2(22:2(13Z,16Z)/16:0)
TG(14:1(9Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Isoursodeoxycholic acid A dihydroxy-5beta-cholanic acid that is (5beta)-cholan-24-oic acid substituted by beta-hydroxy groups at positions 3 and 7.
PG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Estriol-3-glucuronide
TG(20:2n6/22:1(13Z)/22:2(13Z,16Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:4(7Z,10Z,13Z,16Z)/16:0)
TG(16:0/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
DG(18:0/18:0/0:0)
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(14:0/20:3n6/20:3(5Z,8Z,11Z))
Dextrothyroxine
TG(14:1(9Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(22:2(13Z,16Z)/18:0/o-18:0)
TG(20:0/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
DG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/0:0)
TG(15:0/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
Dihydroergotamine Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension.
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(22:0/18:0/24:0)
TG(18:3(6Z,9Z,12Z)/16:0/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:0/18:1(9Z))
TG(15:0/20:3n6/20:3n6)
TG(20:0/18:3(9Z,12Z,15Z)/14:1(9Z))
TG(15:0/22:0/18:4(6Z,9Z,12Z,15Z))
Glycogen A polydisperse, highly branched glucan composed of chains of D-glucopyranose residues in alpha(1->4) glycosidic linkage, joined together by alpha(1->6) glycosidic linkages. A small number of alpha(1->3) glycosidic linkages and some cumulative alpha(1->6) links also may occur. The branches in glycogen typically contain 8 to 12 glucose residues.
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(14:0/22:1(13Z)/18:1(11Z))
PC(16:1(9Z)/20:0)
Glyciram
TG(22:0/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/16:1(9Z)/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(16:0/20:3n6/20:2n6)
DG(22:5(4Z,7Z,10Z,13Z,16Z)/14:0/0:0)
TG(14:0/o-18:0/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/22:2(13Z,16Z))
TG(14:1(9Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(22:0/18:0/22:0)
PC(P-18:1(9Z)/20:3(8Z,11Z,14Z))
PIP2(20:1(11Z)/18:1(9Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
PC(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:3(6Z,9Z,12Z)/o-18:0)
TG(18:1(11Z)/20:2n6/20:2n6)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
Rolitetracycline A derivative of tetracycline in which the amide function is substituted with a pyrrolidinomethyl group.
PE(20:2(11Z,14Z)/18:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:2(13Z,16Z)/20:2(11Z,14Z))
TG(18:1(9Z)/16:0/18:1(9Z))
Histamine Phosphate A phosphate salt that is the diphosphate salt of histamine.
TG(18:1(9Z)/20:3n6/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PS(20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:3(6Z,9Z,12Z)/24:0)
Ganglioside GQ1c (d18:1/12:0)
TG(18:3(9Z,12Z,15Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GQ1c (d18:1/26:1(17Z))
TG(22:1(13Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
5-(methylthio)-2,3-Dioxopentyl phosphate
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(15:0/18:3(6Z,9Z,12Z)/22:0)
1-Methoxypyrene A pyrene that has formula C17H12O.
TG(18:0/o-18:0/18:2(9Z,12Z))
DG(20:0/18:2(9Z,12Z)/0:0)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:0)
Phenprocoumon
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:1(11Z)/18:1(11Z))
TG(24:1(15Z)/24:1(15Z)/22:2(13Z,16Z))
TG(16:1(9Z)/20:0/18:3(6Z,9Z,12Z))
Thiethylperazine
TG(22:0/18:2(9Z,12Z)/16:1(9Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
Ganglioside GT1c (d18:0/14:0)
PE(22:2(13Z,16Z)/22:1(13Z))
LysoPC(22:5(4Z,7Z,10Z,13Z,16Z))
Galactosylsphingosine
TG(16:0/18:0/24:0)
TG(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/o-18:0)
Efavirenz
TG(16:0/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/14:0/20:4(5Z,8Z,11Z,14Z))
Pyrrolidonecarboxylic acid
TG(15:0/18:2(9Z,12Z)/20:3n6)
TG(14:1(9Z)/22:1(13Z)/18:1(9Z))
LysoPE(0:0/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/16:1(9Z)/24:1(15Z))
TG(16:1(9Z)/20:2n6/20:3(5Z,8Z,11Z))
TG(14:0/18:3(6Z,9Z,12Z)/24:0)
TG(18:0/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:3(5Z,8Z,11Z)/15:0)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(20:3n6/14:0/20:4(5Z,8Z,11Z,14Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(24:1(15Z)/22:0/o-18:0)
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
DG(16:0/0:0/22:4n6)
PE(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(14:0/15:0/0:0)
TG(14:0/20:0/18:1(11Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
Digoxin Digitoxin beta-hydroxylated at C-12. A cardiac glycoside extracted from the foxglove plant, Digitalis lanata, it is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation, but the margin between toxic and therapeutic doses is small.
DG(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
CE(14:1(9Z))
SM(d18:1/22:0)
DG(20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
SM(d18:0/18:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:0/o-18:0)
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
PI(20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
TG(15:0/20:3n6/18:1(9Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
SM(d18:1/20:0)
TG(18:1(11Z)/20:0/o-18:0)
TG(18:3(9Z,12Z,15Z)/20:3n6/o-18:0)
TG(20:3n6/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
Cer(d18:0/24:1(15Z))
DG(22:0/18:3(9Z,12Z,15Z)/0:0)
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/20:3n6/20:2n6)
TG(22:0/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:1(9Z)/20:0)
TG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z)/o-18:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z)/o-18:0)
DG(14:1n5/0:0/22:2n6)
TG(18:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/24:1(15Z))
TG(20:0/18:1(9Z)/22:0)
TG(14:0/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:3n6)
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
TG(14:1(9Z)/22:0/22:2(13Z,16Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
3-Oxohexadecanoyl-CoA
3-O-Sulfogalactosylceramide (d18:1/14:0)
TG(24:0/18:0/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:1(11Z)/20:0)
Hydrogen cyanide A hydracid that has formula CHN.
TG(20:0/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(14:0/14:0/0:0)
PG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/24:1(15Z)/20:3n6)
3-O-Sulfogalactosylceramide (d18:1/12:0)
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6/o-18:0)
TG(24:0/14:0/14:1(9Z))
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/18:0/20:2n6)
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:0/18:3(6Z,9Z,12Z))
DG(18:1n7/0:0/20:5n3)
TG(18:1(11Z)/20:3n6/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:1(11Z)/22:0)
PC(dm18:1(11Z)/dm18:1(9Z))
TG(16:1(9Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(14:0/20:3(8Z,11Z,14Z))
Beta-1,4-D-Mannosylchitobiosyldiphosphodolichol Conjugate base of beta-D-mannosyldiacetylchitobiosyldiphosphodolichol.
Thymine A pyrimidine nucleobase that is uracil in which the hydrogen at position 5 is replaced by a methyl group.
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(14:0/22:0/20:4(5Z,8Z,11Z,14Z))
Procainamide 4-Aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
TG(14:1(9Z)/20:3n6/20:1(11Z))
5a-Cholesta-8,24-dien-3-one
PC(20:2(11Z,14Z)/16:1(9Z))
TG(20:1(11Z)/20:2n6/18:3(6Z,9Z,12Z))
TG(24:0/16:0/24:1(15Z))
TG(16:1(9Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(24:0/P-18:0)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
Ganglioside GD1b (d18:0/25:0)
Guanosine A purine nucleoside in which guanine is attached to ribofuranose via a beta-N(9)-glycosidic bond.
PIP(18:0/20:3(8Z,11Z,14Z))
TG(20:0/20:0/22:1(13Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
PC(22:1(13Z)/20:0)
TG(18:0/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/20:2n6)
Galabiosylceramide (d18:1/24:1(15Z))
2,5-Dichloro-carboxymethylenebut-2-en-4-olide A butenolide that has formula C6H2Cl2O4.
TG(18:0/22:0/18:1(11Z))
TG(24:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(15:0/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:0/18:3(6Z,9Z,12Z)/20:2n6)
Ganglioside GA1 (d18:1/24:1(15Z))
TG(18:2(9Z,12Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
PC(14:0/20:2(11Z,14Z))
PC(14:1(9Z)/18:0)
PE(18:3(9Z,12Z,15Z)/P-18:1(9Z))
TG(24:0/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/14:1(9Z)/18:2(9Z,12Z))
TG(16:0/18:1(11Z)/o-18:0)
TG(20:1(11Z)/18:1(9Z)/22:1(13Z))
TG(14:0/18:3(9Z,12Z,15Z)/15:0)
TG(18:2(9Z,12Z)/14:0/18:2(9Z,12Z))[iso3]
TG(16:0/22:0/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:3n6/20:1(11Z))
TG(20:0/18:3(6Z,9Z,12Z)/20:3n6)
PC(20:3(5Z,8Z,11Z)/P-18:1(11Z))
TG(24:0/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(14:0/16:0/22:1(13Z))
PC(20:3(8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:1(9Z)/14:1(9Z))
TG(24:0/20:3(5Z,8Z,11Z)/o-18:0)
TG(14:0/20:2n6/18:1(9Z))
Cadmium A zinc group element atom that has formula Cd.
TG(22:2(13Z,16Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ethyl p-anisate
Famotidine A guanidine that has formula C8H15N7O2S3.
Ganglioside GD3 (d18:1/23:0)
TG(15:0/18:3(6Z,9Z,12Z)/16:1(9Z))
TG(20:0/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/14:1(9Z)/20:2n6)
TG(18:0/18:0/18:1(9Z))[iso3]
TG(22:1(13Z)/18:0/20:4(8Z,11Z,14Z,17Z))
3,7-Dihydroxy-12-oxocholanoic acid
TG(20:0/20:1(11Z)/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:1(11Z)/24:1(15Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
TG(24:1(15Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Fe2+
TG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
CL(20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/16:1(9Z)/20:3(5Z,8Z,11Z))
PC(14:1(9Z)/18:2(9Z,12Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/15:0)
TG(18:4(6Z,9Z,12Z,15Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/16:1(9Z)/20:3n6)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:3(8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/o-18:0)
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/22:1(13Z)/24:1(15Z))
TG(16:1(9Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
DG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
MG(0:0/16:0/0:0)
TG(24:1(15Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:1(11Z)/20:3(8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
MG(0:0/16:1(9Z)/0:0)
TG(16:0/18:3(6Z,9Z,12Z)/24:0)
TG(15:0/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/18:1(9Z)/20:1(11Z))[iso6]
Keratan
PE(18:2(9Z,12Z)/22:2(13Z,16Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/20:2n6)
TG(20:0/18:2(9Z,12Z)/20:3n6)
TG(18:1(11Z)/22:0/18:4(6Z,9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
Sodium Tetradecyl Sulfate
TG(20:0/20:2n6/20:4(5Z,8Z,11Z,14Z))
6-(alpha-D-Glucosaminyl)-1D-myo-inositol A D-glucosaminide consisting of 2-aminoglucosamine attached to 1D-myo-inositol at the 6-position via an alpha-linkage.
Ganglioside GT1c (d18:1/14:0)
TG(24:0/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/16:0/20:3(5Z,8Z,11Z))
Ganglioside GT1c (d18:1/16:0)
TG(15:0/22:0/14:1(9Z))
Episterol A 9xi-episterol that has formula C28H46O.
LysoPE(16:0/0:0)
TG(15:0/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/18:1(11Z)/20:1(11Z))
TG(20:3n6/18:2(9Z,12Z)/22:2(13Z,16Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
Xanthosine 5-triphosphate
7a-Hydroxy-cholestene-3-one
TG(16:0/24:0/18:3(6Z,9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/16:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/15:0/18:3(9Z,12Z,15Z))
TG(24:0/18:0/20:1(11Z))
TG(14:1(9Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/16:0/14:1(9Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(o-18:1(9Z)/18:1(11Z))
TG(22:1(13Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))[iso3]
TG(20:0/16:1(9Z)/24:1(15Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/24:1(15Z)/18:2(9Z,12Z))
TG(18:3(9Z,12Z,15Z)/22:0/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(15:0/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(16:0/20:0/16:1(9Z))
TG(20:2n6/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
6-Mercaptopurine ribonucleoside triphosphate An organic molecule that has formula C10H15N4O13P3S.
6-Thioxanthine 5'-monophosphate An organic molecule that has formula C10H13N4O8PS.
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:2(11Z,14Z))[iso3]
TG(15:0/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Agomelatine
Glutarylglycine
TG(20:0/20:3n6/18:1(9Z))
Ganglioside GM3 (d18:0/26:0)
TG(18:0/20:4(8Z,11Z,14Z,17Z)/20:3n6)
Glyburide An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/15:0/20:3n6)
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/20:2n6)
5-Carboxy-2-pentenoyl-CoA A polyol that has formula C27H42N7O19P3S.
TG(20:0/20:1(11Z)/14:1(9Z))
TG(24:0/20:0/18:1(9Z))
TG(18:2(9Z,12Z)/20:1(11Z)/20:2n6)
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/22:1(13Z)/22:0)
PC(24:0/P-16:0)
Stachyose A tetrasaccharide consisting of sucrose having an alpha-D-galactosyl-(1->6)-alpha-D-galactosyl moiety attached at the 6-position of the glucose.
trans-Dodec-2-enoic acid
Dobutamine A catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulant action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure.
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
Pyridoxal 5'-phosphate The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
Cysteamine
TG(15:0/20:4(8Z,11Z,14Z,17Z)/20:2n6)
Vindesine
TG(20:0/15:0/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
DG(24:1(15Z)/24:0/0:0)
TG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(14:0/18:1(9Z)/o-18:0)
Nicotinamide ribotide
TG(18:2(9Z,12Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/24:1(15Z)/o-18:0)
TG(18:1(9Z)/20:3n6/20:2n6)
TG(22:0/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:2n6)
PS(18:3(9Z,12Z,15Z)/18:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0)
L-Kynurenine A kynurenine that has L configuration.
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/20:1(11Z)/18:1(11Z))
TG(15:0/20:0/20:4(5Z,8Z,11Z,14Z))
Uroporphyrinogen I An uroporphyrinogen that has formula C40H44N4O16.
TG(18:0/15:0/18:0)
TG(16:0/18:4(6Z,9Z,12Z,15Z)/20:3n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/o-18:0)
TG(18:1(11Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
PI(20:1(11Z)/18:1(9Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(24:0/18:3(6Z,9Z,12Z)/20:3n6)
TG(16:0/22:0/20:0)
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
Diazoxide A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
TG(16:0/20:3(5Z,8Z,11Z)/22:1(13Z))
TG(18:0/16:0/18:1(11Z))[iso6]
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:3n6)
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:3(5Z,8Z,11Z)/20:3n6)
Lithocholic acid A monohydroxy-5beta-cholanic acid with a alpha-hydroxy substituent at position 3. It is a bile acid obtained from chenodeoxycholic acid by bacterial action.
TG(24:1(15Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/20:0/20:2n6)
PIP(20:4(5Z,8Z,11Z,14Z)/16:0)
CL(18:2(9Z,12Z)/18:1(11Z)/18:1(9Z)/16:1(9Z))
TG(20:3(5Z,8Z,11Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/14:0/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
PC(P-18:1(11Z)/18:3(6Z,9Z,12Z))
DG(22:2(13Z,16Z)/20:0/0:0)
TG(24:0/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
TG(14:1(9Z)/24:1(15Z)/22:1(13Z))
TG(20:0/o-18:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/o-18:0/24:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
Ganglioside GT1c (d18:0/22:1(13Z))
PIP(18:1(11Z)/18:1(11Z))
TG(15:0/20:2n6/18:4(6Z,9Z,12Z,15Z))
PC(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(9Z,12Z,15Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/22:1(13Z)/o-18:0)
TG(22:0/18:1(9Z)/24:0)
TG(15:0/18:3(9Z,12Z,15Z)/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/18:1(9Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/o-18:0)
DG(18:3(6Z,9Z,12Z)/18:0/0:0)
TG(16:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
Tolmetin
TG(18:1(9Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/18:1(11Z)/18:2(9Z,12Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(18:1(11Z)/18:1(11Z)/20:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
PE(20:3(8Z,11Z,14Z)/P-16:0)
TG(24:0/22:0/18:4(6Z,9Z,12Z,15Z))
PE(P-18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
2-Chloromaleylacetate An organochlorine compound that has formula C6H5ClO5.
TG(18:1(9Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
5-Amino-6-(5'-phosphoribitylamino)uracil
Ganglioside GT3 (d18:1/18:1(9Z))
Pelargonic acid
PC(o-18:0/18:2(9Z,12Z))
1,5-Anhydrosorbitol
PE(20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/24:0)
TG(22:0/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Leukotriene E4 A leukotriene that has formula C23H37NO5S.
DG(14:0/18:3(9Z,12Z,15Z)/0:0)
TG(16:0/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(22:0/0:0/20:1n9)
TG(20:2n6/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/14:0/o-18:0)
TG(16:0/24:0/20:1(11Z))
TG(20:3n6/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(18:0/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(18:0/16:0/18:3(9Z,12Z,15Z))[iso6]
TG(16:0/22:2(13Z,16Z)/14:1(9Z))
TG(22:0/22:2(13Z,16Z)/20:2n6)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
DG(14:0/0:0/18:1n7)
TG(18:1(9Z)/22:2(13Z,16Z)/20:2n6)
PC(18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
Antazoline
TG(16:0/18:1(11Z)/24:1(15Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/24:0/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/15:0/20:2n6)
TG(24:1(15Z)/20:1(11Z)/24:1(15Z))
TG(16:1(9Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
Piperacillin A penicillin that has formula C23H27N5O7S.
TG(20:2n6/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:2n6/24:1(15Z))
TG(18:1(9Z)/24:1(15Z)/20:1(11Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:0/20:4(8Z,11Z,14Z,17Z))
(S)-2,3-Epoxysqualene A squalene triterpenoid formed by epoxidation across the 2,3 C=C bond
dADP A purine 2'-deoxyribonucleoside 5'-diphosphate having adenine as the nucleobase.
PE(14:1(9Z)/24:0)
DG(22:0/0:0/20:3n9)
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/14:0/24:1(15Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(22:2(13Z,16Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/24:0/20:4(8Z,11Z,14Z,17Z))
DG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:1(11Z))
TG(18:1(9Z)/20:2n6/20:2n6)
TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
DG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/0:0)
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
Ganglioside GM2 (d18:1/23:0)
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(18:0/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/15:0/18:3(6Z,9Z,12Z))
Xylometazoline
TG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(16:1(9Z)/P-18:0)
TG(24:1(15Z)/20:0/24:1(15Z))
TG(18:3(6Z,9Z,12Z)/20:0/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:0/20:4(8Z,11Z,14Z,17Z))
DG(14:1n5/0:0/20:1n9)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/24:0/o-18:0)
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/22:0/18:0)
TG(22:1(13Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(18:2(9Z,12Z)/22:1(13Z)/22:2(13Z,16Z))
TG(18:1(9Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(22:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/14:1(9Z)/18:3(6Z,9Z,12Z))
PE(14:0/20:2(11Z,14Z))
TG(20:0/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/24:1(15Z)/20:1(11Z))
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
Tacrine
TG(16:0/16:0/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/14:0/20:0)
L-Arginine An L-alpha-amino acid that is the L-isomer of arginine.
TG(20:3(5Z,8Z,11Z)/20:2n6/18:3(6Z,9Z,12Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/18:1(9Z))
PC(16:0/14:1(9Z))
PE(14:1(9Z)/22:0)
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/20:2n6)
DG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/0:0)
TG(22:1(13Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/22:0/20:3n6)
Estrone-2,3-quinone
TG(15:0/18:3(6Z,9Z,12Z)/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(16:0/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(15:0/16:1(9Z))
TG(16:0/20:1(11Z)/16:1(9Z))
TG(15:0/o-18:0/18:3(9Z,12Z,15Z))
DG(20:3(5Z,8Z,11Z)/24:0/0:0)
DG(22:0/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(18:1(11Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(20:2(11Z,14Z)/20:0)
Nilvadipine
TG(20:0/18:0/16:1(9Z))
Galactosylceramide (d18:1/20:0)
TG(18:0/18:0/20:2n6)
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:2(9Z,12Z)/16:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:0/22:4(7Z,10Z,13Z,16Z))
PC(22:2(13Z,16Z)/18:1(9Z))
PE(24:1(15Z)/16:0)
Tacrolimus
TG(14:1(9Z)/16:1(9Z)/22:1(13Z))
TG(18:2(9Z,12Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Tolcapone
4-Acetamidobutanoic acid An N-acylamino acid resulting from the monoacetylation of the nitrogen of GABA.
TG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/o-18:0)
TG(16:0/14:0/24:1(15Z))
PC(24:1(15Z)/22:2(13Z,16Z))
TG(14:0/14:0/20:4(8Z,11Z,14Z,17Z))
PC(o-22:2(13Z,16Z)/20:2(11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/14:0/18:3(9Z,12Z,15Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
DG(20:3(8Z,11Z,14Z)/24:0/0:0)
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(22:0/18:1(11Z)/14:1(9Z))
DG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:2(9Z,12Z)/22:1(13Z)/20:2n6)
TG(14:1(9Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(20:0/24:1(15Z)/24:0)
Myoinositol An inositol having myo- configuration.
Ergotamine A peptide ergot alkaloid that is dihydroergotamine in which a double bond replaces the single bond between positions 9 and 10.
PE(24:1(15Z)/14:0)
TG(18:0/24:0/18:1(11Z))
TG(14:0/18:3(9Z,12Z,15Z)/20:2n6)
D-1,5-Anhydrofructose
PC(20:4(5Z,8Z,11Z,14Z)/P-18:1(9Z))
TG(22:0/24:0/16:1(9Z))
PE(P-18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/15:0/22:2(13Z,16Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(16:0/20:2n6/18:1(11Z))
Ortho-Hydroxyphenylacetic acid
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(20:0/15:0/24:0)
TG(20:3n6/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PI(20:1(11Z)/18:2(9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
PI(18:1(11Z)/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/14:0/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
TG(18:3(9Z,12Z,15Z)/22:0/o-18:0)
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:0)
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/22:2(13Z,16Z)/20:3n6)
TG(18:1(11Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
DG(18:3(6Z,9Z,12Z)/20:2(11Z,14Z)/0:0)
Tyramine glucuronide
TG(20:2n6/20:3n6/20:3n6)
LysoPE(18:3(6Z,9Z,12Z)/0:0)
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
Selenophosphate A trivalent inorganic anion obtained by removal of all three protons from selenophosphoric acid.
Etonogestrel
TG(20:2n6/18:3(9Z,12Z,15Z)/20:2n6)
PEP-16:0/18:1(11Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/24:1(15Z))
TG(16:0/14:0/22:2(13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/24:1(15Z)/o-18:0)
TG(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
CE(20:4(5Z,8Z,11Z,14Z)
TG(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/o-18:0/20:1(11Z))
Benzoyl-CoA An aroyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of benzoic acid.
Cidofovir
TG(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/20:0/o-18:0)
TG(16:1(9Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
DG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(20:1(11Z)/14:0/20:2n6)
TG(22:1(13Z)/20:3n6/20:3n6)
PC(15:0/20:1(11Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
PE(14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
PG(18:2(9Z,12Z)/16:1(9Z))
TG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
TG(22:0/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:3n6/20:2n6)
PE(18:0/20:3(5Z,8Z,11Z))
TG(14:0/14:0/22:4(7Z,10Z,13Z,16Z))
TG(22:0/16:1(9Z)/22:2(13Z,16Z))
Alpha-Lactose The alpha-anomer of lactose.
DG(18:1(11Z)/14:0/0:0)
PE(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/24:0/20:4(8Z,11Z,14Z,17Z))
Maprotiline
PG(16:0/18:3(9Z,12Z,15Z))
DG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/0:0)
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
3-Oxodecanoyl-CoA An oxo-fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxylic acid group of 3-oxodecanoic acid.
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(16:0/22:4(7Z,10Z,13Z,16Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0/0:0)
PIP2(18:1(9Z)/18:3(6Z,9Z,12Z))
Ganglioside GT1b (d18:1/24:0)
TG(16:0/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(14:0/16:1(9Z)/20:0)
TG(20:3n6/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:2n6)
CoA-[4'-phosphopantetheine]
Allochenodeoxycholic acid A cholanoid that has formula C24H40O4.
DG(20:4n6/0:0/22:5n6)
Ganglioside GT1b (d18:1/26:0)
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/14:0/18:3(9Z,12Z,15Z))
PIP2(16:0/16:1(9Z))
TG(22:0/14:1(9Z)/24:1(15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:0)
TG(24:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/24:0/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/18:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GM2 (d18:1/22:1(13Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
16a-Hydroxyestrone
TG(24:0/20:0/22:4(7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/18:0/18:4(6Z,9Z,12Z,15Z))
PIP(16:0/18:2(9Z,12Z))
TG(20:2n6/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Dantron
TG(24:0/20:0/24:1(15Z))
TG(20:1(11Z)/18:1(9Z)/20:2n6)
PE(16:1(9Z)/15:0)
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
Thiamine pyrophosphate
TG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
N-Acetyl-b-glucosaminylamine
TG(16:0/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/16:0/22:4(7Z,10Z,13Z,16Z))
PE(20:1(11Z)/14:1(9Z))
TG(15:0/14:1(9Z)/18:3(6Z,9Z,12Z))
16a-Hydroxydehydroisoandrosterone
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/18:1(9Z))
PE(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
LysoPC(20:4(5Z,8Z,11Z,14Z))
TG(16:0/16:0/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PE(22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
TG(16:0/o-18:0/14:1(9Z))
TG(15:0/16:0/18:3(6Z,9Z,12Z))
DG(22:2n6/0:0/22:6n3)
TG(22:0/14:1(9Z)/20:1(11Z))
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
PC(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(20:1(11Z)/18:0/18:3(9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/22:1(13Z)/18:2(9Z,12Z))
S-aminomethyldihydrolipoamide
TG(20:0/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(16:0/18:3(9Z,12Z,15Z)/18:0)
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/22:1(13Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:0/16:0/18:2(9Z,12Z))
TG(24:0/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
Carbetocin Oxytocin in which the hydrogen on the phenolic hydroxy group is substituted by methyl, the amino group on the cysteine residue is substituted by hydrogen, and the sulfur of the cysteine residue is replaced by a methylene group. A synthetic carba-analogue of oxytocin, it is used to control bleeding after giving birth. Like oxytocin, it causes contraction of the uterus.
TG(15:0/14:1(9Z)/18:1(9Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
PE(P-18:1(9Z)/24:1(15Z))
TG(15:0/15:0/o-18:0)
PC(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/16:0/20:4(5Z,8Z,11Z,14Z))[iso6]
PC(20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/14:0/20:4(5Z,8Z,11Z,14Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(16:0/16:0/o-18:0)
PA(16:0/16:0)
TG(18:0/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/18:1(11Z)/14:1(9Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:0)
Tetrahydropteroyltri-L-glutamate
TG(22:0/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
11b,21-Dihydroxy-5b-pregnane-3,20-dione
TG(20:0/18:3(6Z,9Z,12Z)/20:1(11Z))
Dabigatran etexilate
TG(18:1(11Z)/o-18:0/20:3(5Z,8Z,11Z))
CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/18:1(9Z))
PIP2(18:1(9Z)/16:0)
TG(20:3n6/o-18:0/20:3n6)
TG(18:3(9Z,12Z,15Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/o-18:0/20:3(5Z,8Z,11Z))
TG(16:0/20:3(5Z,8Z,11Z)/16:1(9Z))
Nisoldipine
PC(18:1(11Z)/P-18:1(9Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
3 beta-Hydroxy-5-cholestenoate
Isobutanol An alkyl alcohol that is propan-1-ol substituted by a methyl group at position 2.
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/16:0/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(20:3(5Z,8Z,11Z)/o-18:0/20:2n6)
PIP(18:2(9Z,12Z)/18:2(9Z,12Z))
2-trans,6-trans-Farnesal A farnesal that has formula C15H24O.
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/22:1(13Z))
4'-Hydroxydiclofenac An monocarboxylic acid that is the 4'-hydroxylated metabolite of diclofenac.
TG(14:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
Aspirin
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PIP2(18:1(9Z)/20:1(11Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(16:1(9Z)/20:2n6/20:2n6)
PG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:0)
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(18:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(o-16:0/18:0)
TG(22:0/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/20:0/22:2(13Z,16Z))
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(16:0/18:1(11Z)/14:1(9Z))
TG(20:2n6/18:0/22:2(13Z,16Z))
Thiopental A barbiturate, the structure of which is that of 2-thiobarbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
5-Hydroxyconiferyl alcohol A methoxybenzene that has formula C10H12O4.
TG(20:2n6/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
Glucosylceramide (d18:1/9Z-18:1)
PE(16:1(9Z)/P-18:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(15:0/20:3(5Z,8Z,11Z)/0:0)
DG(22:4(7Z,10Z,13Z,16Z)/20:2(11Z,14Z)/0:0)
PC(22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/15:0/20:4(8Z,11Z,14Z,17Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Octanal A fatty aldehyde formally arising from reduction of the carboxy group of caprylic acid (octanoic acid).
19-Hydroxyandrost-4-ene-3,17-dione A 19-hydroxy steroid that has formula C19H26O3.
Leflunomide A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
TG(22:2(13Z,16Z)/22:1(13Z)/o-18:0)
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
Glucose 1-phosphate
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(20:4(5Z,8Z,11Z,14Z)/P-18:1(9Z))
TG(15:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
PC(18:2(9Z,12Z)/22:1(13Z))
PIP(18:2(9Z,12Z)/16:0)
CL(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/16:0)
TG(14:0/24:1(15Z)/22:0)
TG(14:0/22:0/18:1(11Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(22:0/24:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/22:0/18:1(9Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/22:2(13Z,16Z)/16:0)
TG(18:0/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Oxaprozin
TG(18:1(11Z)/18:1(9Z)/22:2(13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/22:2(13Z,16Z)/20:1(11Z))
PS(18:0/14:1(9Z))
TG(18:0/22:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/18:1(11Z)/20:3n6)
PC(24:0/24:1(15Z))
TG(18:1(9Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/0:0)
TG(22:0/18:3(6Z,9Z,12Z)/o-18:0)
TG(18:1(11Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
PE(P-16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PIP2(18:1(11Z)/18:1(11Z))
TG(15:0/20:3n6/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/24:0/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/14:0/22:2(13Z,16Z))
Indole-5,6-quinone An indoledione that has formula C8H5NO2.
2,5-Diaminopyrimidine nucleoside triphosphate
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/20:0/20:3n6)
TG(24:1(15Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:0/16:1(9Z))
Levallorphan
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
O-acetyl-ADP-ribose
TG(16:0/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Hexacarboxylporphyrin I
TG(18:4(6Z,9Z,12Z,15Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(22:0/20:1(11Z)/18:1(9Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:2(13Z,16Z)/18:1(11Z))
TG(24:0/18:1(9Z)/18:3(9Z,12Z,15Z))
DG(16:1n7/0:0/20:5n3)
TG(20:2n6/14:0/20:2n6)
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:0/18:0/20:2n6)
DG(14:0/0:0/16:1n7)
TG(24:0/18:3(9Z,12Z,15Z)/24:1(15Z))
TG(16:0/18:2(9Z,12Z)/18:1(11Z))
TG(18:0/15:0/16:1(9Z))
PC(o-14:0/16:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:1(9Z)/18:1(9Z))[iso3]
TG(16:0/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
Fosamprenavir
DG(18:1n9/0:0/22:2n6)
TG(16:1(9Z)/20:2n6/18:3(6Z,9Z,12Z))
TG(20:3n6/16:0/18:3(9Z,12Z,15Z))
TG(20:3n6/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
Pentanoyl-CoA A short-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of pentanoic acid.
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/16:1(9Z))
PIP(20:1(11Z)/18:1(9Z))
TG(14:0/18:1(9Z)/22:0)
N-Methylputrescine An N-monosubstituted putrescine where the N-substituent is methyl.
DG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(14:1(9Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/14:1(9Z)/18:1(11Z))
TG(18:4(6Z,9Z,12Z,15Z)/15:0/18:4(6Z,9Z,12Z,15Z))
DG(20:3(8Z,11Z,14Z)/14:1(9Z)/0:0)
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
PC(15:0/P-18:1(11Z))
TG(16:1(9Z)/22:0/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
DG(18:1n9/0:0/22:5n3)
Memantine
TG(14:1(9Z)/14:0/18:1(9Z))
TG(14:1(9Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:0/22:2(13Z,16Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/20:0)
TG(15:0/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:0/o-18:0)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(15:0/22:2(13Z,16Z)/20:2n6)
TG(14:0/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(24:0/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/18:0/22:1(13Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:0/18:3(9Z,12Z,15Z))
PE(20:0/22:1(13Z))
5-Dehydroavenasterol A steroid that has formula C29H46O.
DG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
DG(22:2(13Z,16Z)/20:1(11Z)/0:0)
TG(20:2n6/o-18:0/22:2(13Z,16Z))
PC(20:3(8Z,11Z,14Z)/15:0)
TG(16:0/20:2n6/18:0)
TG(16:0/14:1(9Z)/22:2(13Z,16Z))
PC(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:1(11Z)/o-18:0)
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
(9S,10S)-9,10-dihydroxyoctadecanoate Conjugate base of (9S,10S)-9,10-dihydroxyoctadecanoic acid.
TG(18:0/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Fomepizole A member of the class of pyrazoles that is 1H-pyrazole substituted by a methyl group at position 4.
L-Sorbose The L enantiomer of sorbose, a ketone-containing hexose (a six-carbon monosaccharide).
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(24:0/22:2(13Z,16Z)/14:1(9Z))
TG(15:0/o-18:0/16:0)
TG(18:1(9Z)/22:2(13Z,16Z)/18:1(9Z))
PC(P-16:0/16:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Riboflavin reduced
PC(o-18:1(11Z)/16:0)
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
3a,7a,12a-Trihydroxy-5b-cholestanoic acid
TG(14:0/24:1(15Z)/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/24:0/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
Tetracosatetraenoyl CoA
PE(22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
PE(22:4(7Z,10Z,13Z,16Z)/20:2(11Z,14Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)
TG(14:0/24:0/18:2(9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:0/o-18:0)
Ceramide (d18:1/22:0)
TG(24:0/22:0/20:3n6)
TG(16:1(9Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
LysoPC(22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:0/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/14:1(9Z)/18:2(9Z,12Z))
TG(22:0/14:1(9Z)/20:2n6)
Ceramide (d18:1/20:0)
Cinoxacin
(S)-Succinyldihydrolipoamide
PE(24:1(15Z)/P-18:0)
TG(24:0/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso3]
TG(22:0/18:3(6Z,9Z,12Z)/20:1(11Z))
TG(18:3(9Z,12Z,15Z)/24:1(15Z)/o-18:0)
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(22:0/20:3n6/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/o-18:0/20:3n6)
cis-Acetylacrylate
PS(14:0/18:0)
TG(24:1(15Z)/22:0/18:3(9Z,12Z,15Z))
PE(20:0/14:0)
TG(24:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(20:0/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
Kaempferol 3-glucuronide
DG(24:1(15Z)/18:1(9Z)/0:0)
TG(20:2n6/18:0/o-18:0)
Vardenafil The sulfonamide resulting from formal condensation of the sulfo group of 4-ethoxy-3-(5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one-2-yl)benzenesulfonic acid and the secondary amino group of 4-ethylpiperazine.
Protoanemonin A butenolide that has formula C5H4O2.
PE(18:2(9Z,12Z)/P-18:1(9Z))
TG(18:3(6Z,9Z,12Z)/16:0/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
PC(22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(16:1(9Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(15:0/16:0/22:0)
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(22:0/24:1(15Z)/22:0)
Ketorolac
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
PC(20:1(11Z)/P-16:0)
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(18:0/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:0/18:3(6Z,9Z,12Z))
Angiotensin II
TG(22:0/15:0/20:3n6)
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(24:1(15Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/14:0/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:0/22:2(13Z,16Z)/22:0)
PE(24:1(15Z)/P-16:0)
TG(16:0/14:0/16:0)[iso3]
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
Oxtriphylline
PC(16:1(9Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/22:2(13Z,16Z))
Ceftibuten
PC(18:2(9Z,12Z)/14:0)
Farnesol
TG(15:0/14:1(9Z)/20:1(11Z))
TG(20:0/18:3(6Z,9Z,12Z)/20:2n6)
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(22:0/16:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/24:1(15Z)/o-18:0)
TG(14:0/14:1(9Z)/14:1(9Z))
1-Hydroxyphenanthrene
TG(14:1(9Z)/24:0/o-18:0)
TG(24:0/14:1(9Z)/20:3n6)
TG(20:1(11Z)/24:0/22:1(13Z))
TG(22:0/18:0/20:3n6)
TG(20:3n6/20:3n6/20:3n6)
Ixabepilone
DG(18:3(6Z,9Z,12Z)/14:1(9Z)/0:0)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:0)
DG(18:0/22:2(13Z,16Z)/0:0)
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:1(9Z)/16:0)
TG(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
TG(20:3n6/20:3n6/22:2(13Z,16Z))
Tamoxifen A stilbenoid that has formula C26H29NO.
TG(18:1(11Z)/20:1(11Z)/o-18:0)
TG(15:0/22:1(13Z)/22:0)
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(14:1(9Z)/16:0/20:2n6)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/14:0)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/22:0/18:3(6Z,9Z,12Z))
PE(18:1(9Z)/18:1(9Z))
DG(22:0/20:2(11Z,14Z)/0:0)
TG(20:2n6/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:0/22:4(7Z,10Z,13Z,16Z))
PE(18:1(9Z)/22:1(13Z))
Glycerol A triol with a structure of propane substituted at positions 1, 2 and 3 by hydroxy groups.
4-Coumaryl alcohol
Naltrexone An organic heteropentacyclic compound that is 4,5-epoxymorphinan-6-one substituted by a cyclopropylmethyl group at position 17 and hydroxy groups at positions 3 and 14. A mu-opioid receptor antagonist, it is used to treat alcohol dependence.
TG(24:0/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(14:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/24:1(15Z))
Ganglioside GD1a (d18:1/22:0)
TG(22:0/22:2(13Z,16Z)/16:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Mesoridazine
TG(20:3n6/15:0/o-18:0)
TG(22:2(13Z,16Z)/22:0/18:3(9Z,12Z,15Z))
DG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
PIP(18:1(9Z)/18:2(9Z,12Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z)/0:0)
PE(18:1(11Z)/P-18:1(11Z))
TG(20:0/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
Treprostinil
Troleandomycin
TG(18:0/20:1(11Z)/18:1(9Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:0)
PIP(18:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/18:1(9Z)/o-18:0)
TG(20:0/20:1(11Z)/18:1(9Z))
Selenium A chalcogen that has formula Se.
TG(20:2n6/20:2n6/20:2n6)
Uridine 5'-monophosphate
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
PC(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(20:0/24:1(15Z)/22:1(13Z))
TG(22:0/18:3(6Z,9Z,12Z)/14:1(9Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
PC(o-18:0/20:4(8Z,11Z,14Z,17Z))
PE(18:3(6Z,9Z,12Z)/14:1(9Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
1,6-Dimethoxypyrene A pyrene that has formula C18H14O2.
TG(24:1(15Z)/18:1(11Z)/24:1(15Z))
TG(24:1(15Z)/20:0/22:2(13Z,16Z))
TG(20:3n6/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Cefotaxime A cephalosporin compound having acetoxymethyl and [2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side groups.
TG(20:3n6/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:2(9Z,12Z)/16:1(9Z))
Brinzolamide
TG(18:1(9Z)/22:0/20:1(11Z))
TG(14:0/16:0/24:1(15Z))
DG(24:0/20:2(11Z,14Z)/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:0/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(14:0/24:0/18:4(6Z,9Z,12Z,15Z))
TG(16:0/20:0/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(20:1(11Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
Ganglioside GT1c (d18:1/24:1(15Z))
TG(24:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(18:0/18:0/14:1(9Z))
Galabiosylceramide (d18:1/26:1(17Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(20:4(8Z,11Z,14Z,17Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/14:1(9Z)/20:3n6)
TG(18:1(9Z)/20:1(11Z)/20:3n6)
1-Butanol
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
DG(16:0/0:0/20:3n6)
DG(14:0/0:0/22:4n6)
Arachidic acid A C20 striaght-chain saturated fatty acid which forms a minor constituent of peanut (L. arachis) and corn oils. Used as an organic thin film in the production of liquid crystals for a wide variety of technical applications.
TG(14:1(9Z)/20:1(11Z)/20:3n6)
PC(18:1(11Z)/16:1(9Z))
PE(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
Chondroitin D-glucuronate A mucopolysaccharide composed of repeating beta-D-glucopyranuronosyl-(1->3)-beta-D-N-acetylgalactosaminyl units.
Vanylglycol
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
PC(P-16:0/16:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Sulfamethizole
LysoPC(15:0) An acyl-sn-glycero-3-phosphocholine in which the acyl group contains fifteen carbons with no double bonds and is attached to the glycero moiety at either position 1 or 2.
PE(22:0/22:2(13Z,16Z))
PI(20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z))
TG(22:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/18:2(9Z,12Z)/24:0)
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
Inositol 1,3,4-trisphosphate
PC(P-16:0/14:0)
TG(14:0/20:0/18:0)
TG(24:1(15Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
Ganglioside GA2 (d18:1/12:0)
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
PC(16:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
1-Hexanol
TG(22:1(13Z)/15:0/22:4(7Z,10Z,13Z,16Z))
Ethacrynic acid
trans-4-Carboxymethylenebut-2-en-4-olide A 4-carboxymethylenebut-2-en-4-olide that has formula C6H4O4.
TG(20:3(5Z,8Z,11Z)/16:0/22:2(13Z,16Z))
Cephalosporin C A cephalosporin antibiotic carrying a 3-acetoxymethyl substituent and a 6-oxo-N(6)-L-lysino group at position 7.
Aminophylline
PE(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:0)
PC(22:2(13Z,16Z)/15:0)
Heptanoic acid
Nicardipine
TG(20:4(5Z,8Z,11Z,14Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:1(9Z)/o-18:0)
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
Thiamine monophosphate
PIP2(22:3(10Z,13Z,16Z)/16:2(9Z,12Z))
TG(15:0/22:0/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:1(11Z)/18:2(9Z,12Z))
PC(20:2(11Z,14Z)/14:1(9Z))
TG(20:1(11Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/20:2n6/14:1(9Z))
PE(18:1(11Z)/14:0)
TG(20:0/20:3(5Z,8Z,11Z)/20:2n6)
DG(16:0/0:0/14:1n5)
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(15:0/20:0/16:0)
TG(16:0/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(18:3(9Z,12Z,15Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/24:1(15Z)/24:0)
TG(24:0/16:0/24:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(dm16:0/dm16:0)
TG(18:0/16:0/20:1(11Z))
TG(14:1(9Z)/18:1(11Z)/24:1(15Z))
S-(1,2-Dichlorovinyl)glutathione A peptide that has formula C12H17Cl2N3O6S.
PG(18:0/20:4(5Z,8Z,11Z,14Z))
DG(16:1n7/0:0/18:3n3)
TG(20:3(5Z,8Z,11Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/o-18:0)
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Bimatoprost
TG(20:4(8Z,11Z,14Z,17Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(16:0/22:1(13Z)/18:1(11Z))
PC(18:3(9Z,12Z,15Z)/18:1(9Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/16:0/0:0)
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(20:3n6/18:0/20:3n6)
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z)/16:1(9Z))
TG(18:0/o-18:0/20:0)
TG(20:0/18:3(6Z,9Z,12Z)/24:1(15Z))
7 alpha,24-Dihydroxy-4-cholesten-3-one
TG(20:4(8Z,11Z,14Z,17Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
Baclofen A monocarboxylic acid that is butanoic acid substituted by an amino group at position 4 and a 4-chlorophenyl group at position 3. It acts as a central nervous system depressant, GABA agonist and muscle relaxant.
Ganglioside GM1 (d18:1/26:1(17Z)))
PC(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
Epiandrosterone A 3beta-hydroxy steroid that is (5alpha)-androstane substituted by a beta-hydroxy group at position 3 and an oxo group at position 17.
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/22:2(13Z,16Z))
TG(24:0/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/15:0/18:3(9Z,12Z,15Z))
TG(15:0/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:3n6/20:0)
TG(20:0/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/24:1(15Z)/24:1(15Z))
TG(20:2n6/15:0/22:2(13Z,16Z))
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/20:3(5Z,8Z,11Z)/14:1(9Z))
Arecoline A tetrahydropyridine that is 1,2,5,6-tetrahydropyridine with a methyl group at position 1, and a methoxycarbonyl group at position 3. An alkaloid found in the areca nut, it acts as an agonist of muscarinic acetylcholine.
PC(24:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/o-18:0)
TG(24:1(15Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(20:0/15:0/o-18:0)
TG(18:0/18:0/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(24:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/22:2(13Z,16Z)/20:3n6)
TG(18:0/o-18:0/22:0)
TG(22:0/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Malic acid A 2-hydroxydicarboxylic acid that is succinic acid in which one of the hydrogens attached to a carbon is replaced by a hydroxy group.
TG(22:1(13Z)/15:0/20:3n6)
TG(18:1(9Z)/14:1(9Z)/20:3(5Z,8Z,11Z))
Raloxifene A benzothiophene that has formula C28H27NO4S.
TG(18:1(11Z)/14:1(9Z)/20:3n6)
TG(24:0/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(22:0/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/14:0/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(24:1(15Z)/15:0/o-18:0)
8,11,14-Eicosatrienoic acid
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
CE(20:5(5Z,8Z,11Z,14Z,17Z) A cholesterol ester obtained by the formal condensation of cholesterol with all-cis-5,8,11,14,17-icosapentaenoic acid.
TG(22:1(13Z)/22:0/18:2(9Z,12Z))
TG(22:1(13Z)/18:0/20:3n6)
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:1(13Z)/18:3(6Z,9Z,12Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/24:0/22:2(13Z,16Z))
DG(20:0/0:0/24:0)
TG(20:3(5Z,8Z,11Z)/22:0/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/20:3n6)
DG(20:0/0:0/22:6n3)
DG(18:1n9/0:0/18:3n3)
PC(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/22:1(13Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/14:0/22:2(13Z,16Z))
TG(15:0/20:2n6/20:3(5Z,8Z,11Z))
Pyruvic acid A 2-oxo monocarboxylic acid that is the 2-keto derivative of propionic acid. It is a metabolite obtained during glycolysis.
TG(24:0/15:0/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GT2 (d18:0/24:1(15Z))
2,3-Butanediol
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
DG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/0:0)
TG(18:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/16:0/18:2(9Z,12Z))
Indoleacetaldehyde An aldehyde that is acetaldehyde substituted by an indolyl group.
Ethotoin
TG(22:2(13Z,16Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/14:1(9Z)/18:3(6Z,9Z,12Z))
Tetrahydrocortisol A glucocorticoid that has formula C21H34O5.
TG(24:0/22:0/18:3(6Z,9Z,12Z))
Niclosamide
3b,7b,12a-Trihydroxy-5a-Cholanoic acid
TG(15:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Beta-D-Glucose D-Glucopyranose with beta configuration at the anomeric centre.
TG(16:0/18:3(9Z,12Z,15Z)/14:1(9Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(15:0/20:1(11Z)/18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
Streptomycin A amino cyclitol glycoside that consists of streptidine having a disaccharyl moiety attached at the 4-position. The parent of the streptomycin class
Ganglioside GT3 (d18:0/23:0)
TG(14:0/22:2(13Z,16Z)/14:0)
TG(24:0/20:3(5Z,8Z,11Z)/20:2n6)
TG(20:0/18:1(9Z)/14:1(9Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/14:0/18:4(6Z,9Z,12Z,15Z))
Mometasone A chlorinated steroid that has formula C22H28Cl2O4.
TG(15:0/20:2n6/14:1(9Z))
TG(14:1(9Z)/18:0/20:4(8Z,11Z,14Z,17Z))
PC(18:1(9Z)/18:1(9Z))
TG(20:1(11Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
7a-Hydroxy-3-oxo-5b-cholanoic acid
Cholesteryl acetate A cholesterol ester obtained by formal acylation of the hydroxy group of cholesterol by acetic acid.
TG(16:1(9Z)/20:0/18:4(6Z,9Z,12Z,15Z))
TG(16:0/18:3(9Z,12Z,15Z)/24:0)
TG(18:0/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:1(13Z)/20:1(11Z))
TG(22:2(13Z,16Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
PC(20:2(11Z,14Z)/20:3(8Z,11Z,14Z))
PC(20:2(11Z,14Z)/20:1(11Z))
PC(18:4(6Z,9Z,12Z,15Z)/18:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
PIP2(18:3(9Z,12Z,15Z)/18:1(9Z))
PE(14:1(9Z)/16:1(9Z))
TG(18:0/18:1(11Z)/22:1(13Z))
DG(15:0/20:2(11Z,14Z)/0:0)
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/16:0)
TG(18:1(11Z)/16:1(9Z)/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/22:2(13Z,16Z))
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(20:1(11Z)/20:0/o-18:0)
(S)-b-aminoisobutyric acid
TG(18:3(6Z,9Z,12Z)/15:0/18:3(9Z,12Z,15Z))
TG(22:0/16:0/14:1(9Z))
TG(18:1(11Z)/18:2(9Z,12Z)/18:1(9Z))
TG(18:0/24:0/18:2(9Z,12Z))
TG(24:0/22:0/18:1(11Z))
DG(16:0/15:0/0:0)
TG(20:3(5Z,8Z,11Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/15:0/o-18:0)
PE(18:1(9Z)/P-18:0)
TG(18:2(9Z,12Z)/22:1(13Z)/20:3n6)
17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide) A steroid glucosiduronic acid that has formula C24H31O11S.
TG(20:3(5Z,8Z,11Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/14:0/20:3n6)
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(14:1(9Z)/18:1(9Z)/o-18:0)
PC(P-18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(14:0/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(22:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:1(13Z)/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/22:1(13Z))
TG(20:2n6/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
DG(22:0/20:1(11Z)/0:0)
TG(18:1(11Z)/15:0/24:1(15Z))
DG(22:1(13Z)/18:1(9Z)/0:0)
TG(18:1(11Z)/22:2(13Z,16Z)/22:1(13Z))
TG(18:0/16:1(9Z)/20:3(5Z,8Z,11Z))
DG(20:1(11Z)/24:1(15Z)/0:0)
DG(18:3(9Z,12Z,15Z)/24:0/0:0)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
Arsenic trioxide
TG(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
CE(22:4(7Z,10Z,13Z,16Z)
PE(18:0/P-16:0)
TG(20:1(11Z)/20:0/22:4(7Z,10Z,13Z,16Z))
DG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
DG(20:0/20:1(11Z)/0:0)
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/14:1(9Z)/14:0)
Ganglioside GD1b (d18:1/24:1(15Z))
TG(14:1(9Z)/24:0/18:1(11Z))
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/22:1(13Z)/o-18:0)
TG(14:0/18:3(9Z,12Z,15Z)/20:0)
TG(24:0/20:1(11Z)/20:1(11Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/o-18:0)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
PE(22:0/20:3(5Z,8Z,11Z))
TG(16:0/18:1(9Z)/24:1(15Z))
TG(14:1(9Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
TG(22:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GA2 (d18:1/25:0)
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(24:1(15Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:0/20:0)
DG(22:2(13Z,16Z)/14:1(9Z)/0:0)
TG(14:0/14:1(9Z)/16:0)
dTDP-D-galactose The D-enantiomer of dTDP-galactose.
TG(15:0/16:0/15:0)
PE(18:0/20:2(11Z,14Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(24:0/15:0/24:1(15Z))
TG(18:1(9Z)/14:1(9Z)/18:2(9Z,12Z))
TG(15:0/20:3n6/22:0)
DG(20:4(5Z,8Z,11Z,14Z)/22:0/0:0)
Allolithocholic acid
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
DG(20:3(5Z,8Z,11Z)/16:1(9Z)/0:0)
Ciprofloxacin A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
TG(18:0/20:3(5Z,8Z,11Z)/20:1(11Z))
SM(d18:0/12:0)
TG(20:2n6/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PE(22:0/18:1(9Z))
PC(o-16:0/20:0)
TG(20:3(5Z,8Z,11Z)/15:0/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/16:0/22:1(13Z))
Pentolinium
TG(18:2(9Z,12Z)/24:1(15Z)/20:3n6)
TG(14:0/18:1(9Z)/15:0)
PC(20:3(8Z,11Z,14Z)/P-18:0)
L-Gulonolactone
TG(20:1(11Z)/16:0/18:2(9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/18:2(9Z,12Z)/18:1(11Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/15:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:3(5Z,8Z,11Z)/24:0)
TG(18:0/20:2n6/20:2n6)
TG(18:2(9Z,12Z)/24:0/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/20:3n6/20:3(5Z,8Z,11Z))
3a,7a-Dihydroxy-5b-cholestan-26-al
N-Acetylmuramoyl-Ala
S-Acetyldihydrolipoamide
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:0/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/o-18:0)
DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z)/0:0)
TG(16:1(9Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/18:1(9Z)/16:0)[iso6]
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(16:0/18:3(9Z,12Z,15Z)/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PIP2(18:2(9Z,12Z)/18:1(11Z))
TG(14:0/18:1(11Z)/24:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
MG(22:4(7Z,10Z,13Z,16Z)/0:0/0:0)
Isovalerylglycine
PC(14:0/P-18:1(11Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PE(18:1(9Z)/14:0)
TG(18:1(11Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/18:1(9Z)/20:2(11Z,14Z))[iso3]
TG(16:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
SN-38 A pyranoindolizinoquinoline that has formula C22H20N2O5.
1-Nitro-5,6-dihydroxy-dihydronaphthalene A nitronaphthalene that has formula C10H9NO4.
TG(16:1(9Z)/20:1(11Z)/22:1(13Z))
PE(18:1(9Z)/16:0)
DG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(20:2n6/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:0/22:1(13Z))
Glisoxepide
Nafcillin A penicillin that has formula C21H22N2O5S.
N-Acetyl-L-aspartic acid An N-acyl-L-aspartic acid in which the acyl group is specified as acetyl.
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/16:0)
TG(14:0/22:1(13Z)/18:0)
TG(18:0/18:0/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/16:0/20:1(11Z))[iso3]
Dapiprazole
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:1(9Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
TG(22:0/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(16:1(9Z)/16:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
1-Deoxynojirimycin
TG(22:0/24:1(15Z)/20:3n6)
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
Quinoline-4,8-diol A dihydroxyquinoline that has formula C9H7NO2.
TG(24:0/22:1(13Z)/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/18:1(11Z)/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/18:1(11Z)/20:0)
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/P-16:0)
TG(14:0/20:4(5Z,8Z,11Z,14Z)/16:0)
TG(20:2n6/20:2n6/20:4(5Z,8Z,11Z,14Z))
Rimonabant
TG(14:1(9Z)/24:1(15Z)/18:1(9Z))
Cer(d18:1/22:1(13Z))
TG(18:1(11Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(24:1(15Z)/P-18:1(11Z))
TG(22:0/16:1(9Z)/18:3(6Z,9Z,12Z))
PIP2(18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:3n6/22:0)
Trans-Hexa-dec-2-enoic acid
TG(20:1(11Z)/15:0/20:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PE(22:1(13Z)/18:3(9Z,12Z,15Z))
TG(24:0/18:3(9Z,12Z,15Z)/14:1(9Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
PIP2(20:1(11Z)/18:1(11Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:2n6/o-18:0)
TG(16:0/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(18:1(9Z)/18:3(6Z,9Z,12Z)/0:0)
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/o-18:0)
TG(20:1(11Z)/20:1(11Z)/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
Ganglioside GM1 (d18:1/18:1(11Z))
Ganglioside GQ1c (d18:1/22:0)
TG(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
Cefdinir A cephalosporin compound having 7beta-2-(2-amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino- and 3-vinyl side groups.
PIP2(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))
PS(18:2(9Z,12Z)/18:2(9Z,12Z))
PC(16:0/20:3(8Z,11Z,14Z))
Tryptamine An aminoalkylindole consisting of indole having a 2-aminoethyl group at the 3-position.
PC(20:4(8Z,11Z,14Z,17Z)/14:0)
TG(22:1(13Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
N-desmethylimatinib
TG(22:1(13Z)/16:0/o-18:0)
TG(22:1(13Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
N-Methyl-D-aspartic acid An aspartic acid derivative having an N-methyl substituent and D-configuration.
PE(18:3(6Z,9Z,12Z)/20:0)
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:1(11Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z)/0:0)
TG(18:2(9Z,12Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/16:1(9Z)/20:0)[iso3]
PE(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:2(13Z,16Z)/22:2(13Z,16Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
TG(18:0/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
LysoPE(18:0/0:0)
Flavoxate A carboxylic ester resulting from the formal condensation of 3-methylflavone-8-carboxylic acid with 2-(1-piperidinyl)ethanol.
Oxprenolol
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Nandrolone A 3-oxo Delta(4)-steroid that is estr-4-en-3-one substituted by a beta-hydroxy group at position 17.
TG(16:0/22:0/14:1(9Z))
5-O-Desmethyldonepezil
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(14:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/16:0/22:1(13Z))
PC(18:2(9Z,12Z)/20:2(11Z,14Z))
PC(22:2(13Z,16Z)/14:1(9Z))
PC(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(20:3(8Z,11Z,14Z)/14:1(9Z))
TG(22:1(13Z)/18:1(9Z)/24:1(15Z))
PE(18:3(6Z,9Z,12Z)/22:0)
PE(22:0/22:0)
TG(16:1(9Z)/24:0/20:4(5Z,8Z,11Z,14Z))
PE(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/14:1(9Z)/18:2(9Z,12Z))
Dihydroxyacetone Phosphate Acyl Ester A glycerone 3-phosphate having an unspecified O-acyl substituent at the 1-position.
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/24:1(15Z))
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/18:3(6Z,9Z,12Z)/o-18:0)
Ganglioside GT3 (d18:0/18:0)
Ganglioside GM1 (d18:1/22:1(13Z))
Loratadine
PC(o-22:1(13Z)/22:2(13Z,16Z))
TG(20:1(11Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/24:0/22:0)
TG(18:1(11Z)/14:1(9Z)/22:1(13Z))
TG(16:1(9Z)/16:1(9Z)/20:3(5Z,8Z,11Z))
17-Hydroxyprogesterone
TG(24:0/20:2n6/20:1(11Z))
TG(16:0/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(15:0/18:0/18:2(9Z,12Z))[iso6]
TG(22:1(13Z)/24:0/20:2n6)
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/14:1(9Z)/20:1(11Z))
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/20:0/20:1(11Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
PE(24:0/22:4(7Z,10Z,13Z,16Z))
PC(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(15:0/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
Isoflurane An organofluorine compound that has formula C3H2ClF5O.
CE(20:3(8Z,11Z,14Z))
TG(22:1(13Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:2n6)
TG(18:1(9Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:1(13Z)/o-18:0)
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
DG(24:0/0:0/20:5n3)
1,1-Dichloroethylene epoxide An epoxide that has formula C2H2Cl2O.
TG(16:1(9Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/20:0)
CL(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
5-Methoxytryptamine
TG(15:0/18:0/22:2(13Z,16Z))
TG(14:0/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(20:0/20:2n6/20:3n6)
Citalopram aldehyde A benzene that has formula C18H14FNO2.
PE(18:2(9Z,12Z)/16:1(9Z))
Presqualene diphosphate A triterpenyl phosphate that has formula C30H52O7P2.
TG(14:0/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(14:1(9Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
Coproporphyrinogen I A coproporphyrinogen that has formula C36H44N4O8.
TG(15:0/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/16:0/20:4(5Z,8Z,11Z,14Z))
TG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
DG(18:1(11Z)/16:0/0:0)
TG(18:0/14:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:3(5Z,8Z,11Z)/20:3n6)
TG(20:2n6/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
4,4-Dimethyl-5-alpha-cholest-7-en-3-beta-ol A cholestanoid that is 5alpha-cholest-7-ene substituted by a beta-hydroxy group at position 3 and two methyl groups at position 4.
TG(18:1(11Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
LysoPE(18:1(11Z)/0:0)
TG(18:1(11Z)/15:0/18:1(11Z))
PC(o-24:0/18:3(6Z,9Z,12Z))
LysoPE(22:1(13Z)/0:0)
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Oxycodone An organic heteropentacyclic compound that has formula C18H21NO4.
TG(14:1(9Z)/24:1(15Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:0/20:3n6)
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:0/22:4(7Z,10Z,13Z,16Z))
PIP2(16:1(9Z)/18:0)
TG(14:0/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:2(9Z,12Z)/22:2(13Z,16Z))
DG(20:3n9/0:0/18:3n6)
TG(16:0/20:1(11Z)/24:1(15Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(20:2n6/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/16:0/20:3n6)
TG(14:0/16:0/20:2n6)
TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Cilazapril
PE(24:1(15Z)/24:0)
TG(24:1(15Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
CDP-DG(18:1(9Z)/16:0)
2-Phenylethanol glucuronide
TG(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
LysoPC(20:1(11Z))
O-Deethylated candesartan
TG(15:0/18:1(9Z)/24:1(15Z))
PE(24:1(15Z)/22:0)
Zymosterol intermediate 2 A 3-oxo steroid that has formula C27H42O.
PE(16:0/24:0)
TG(18:1(9Z)/20:2n6/22:1(13Z))
4-Hydroxyandrostenedione glucuronide
Nandrolone decanoate A steroid ester that has formula C28H44O3.
PC(18:0/P-18:1(9Z))
TG(14:0/18:1(11Z)/14:0)
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(P-16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/14:0/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:1(9Z)/24:1(15Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)/0:0)
TG(15:0/18:0/24:1(15Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/22:0/18:3(6Z,9Z,12Z))
PC(20:3(8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
Mitoxantrone A hydroxyanthraquinone that has formula C22H28N4O6.
TG(18:4(6Z,9Z,12Z,15Z)/14:0/o-18:0)
PC(18:0/22:2(13Z,16Z))
TG(24:0/24:1(15Z)/16:1(9Z))
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(18:1(11Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Tetrahexosylceramide (d18:1/16:0)
TG(18:1(11Z)/20:2n6/20:1(11Z))
TG(14:0/22:0/14:1(9Z))
TG(18:1(9Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:0/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(22:0/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/24:0/20:3n6)
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
PE(16:1(9Z)/20:3(8Z,11Z,14Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/14:0)
DG(24:0/0:0/16:1n7)
TG(22:0/20:2n6/24:1(15Z))
Tetrahexosylceramide (d18:1/18:0)
PG(18:1(9Z)/18:3(6Z,9Z,12Z))
Milrinone A member of the class of bipyridines that is 2-pyridone which is substituted at positions 3, 5, and 6 by cyano, pyrid-4-yl, and methyl groups, respectively. It is used (particularly intravenously, as the lactate) for the short-term management of severe heart failure.
TG(18:0/16:1(9Z)/14:1(9Z))
2-hydroxy-dAMP A purine 2'-deoxyribonucleoside 5'-monophosphate in which the purine moiety is 2-hydroxyadenine.
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(15:0/14:0/20:0)
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
TG(22:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
Lornoxicam
TG(20:0/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(24:1(15Z)/o-18:0/20:2n6)
TG(20:2n6/16:0/20:3n6)
TG(22:4(7Z,10Z,13Z,16Z)/24:0/22:4(7Z,10Z,13Z,16Z))
ADP-Ribosyl-L-arginine
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(22:0/20:4(8Z,11Z,14Z,17Z)/22:0)
TG(15:0/18:1(11Z)/24:1(15Z))
TG(18:3(6Z,9Z,12Z)/20:0/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/18:1(9Z)/22:2(13Z,16Z))
TG(16:0/20:1(11Z)/22:0)
TG(18:1(11Z)/16:0/18:2(9Z,12Z))[iso3]
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(24:1(15Z)/16:1(9Z)/22:2(13Z,16Z))
2b,3a,7a-Trihydroxy-5b-cholanoic acid
TG(18:0/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
PC(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
SM(d18:0/23:0)
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(18:0/20:2n6/18:3(6Z,9Z,12Z))
DG(16:1(9Z)/16:1(9Z)/0:0)
TG(24:0/20:3n6/20:3n6)
TG(15:0/22:0/16:1(9Z))
TG(18:1(11Z)/16:1(9Z)/18:1(11Z))[iso3]
TG(15:0/18:1(11Z)/22:0)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(24:1(15Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Sildenafil
PC(P-18:0/18:2(9Z,12Z))
TG(15:0/22:0/20:0)
MG(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
5-Hydroxyindoleacetic acid
DG(18:3n6/0:0/22:4n6)
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
PE(18:2(9Z,12Z)/22:0)
TG(16:1(9Z)/20:3n6/22:1(13Z))
TG(14:0/14:0/16:0)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/20:0/22:2(13Z,16Z))
Aflatoxin B1 dialcohol
TG(15:0/20:1(11Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/15:0/24:1(15Z))
Propyl alcohol
TG(24:1(15Z)/24:0/18:2(9Z,12Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/15:0/20:3(5Z,8Z,11Z))
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(24:1(15Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
Inosine triphosphate
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
DG(18:3(9Z,12Z,15Z)/14:1(9Z)/0:0)
TG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/15:0/20:2n6)
TG(14:1(9Z)/20:2n6/20:3n6)
TG(22:1(13Z)/20:2n6/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/15:0/18:4(6Z,9Z,12Z,15Z))
PE(20:1(11Z)/24:1(15Z))
TG(16:1(9Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/24:1(15Z))
CDP-DG(18:1(11Z)/22:3(10Z,13Z,16Z))
Inodxyl glucuronide
Pyruvaldehyde
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
PC(18:3(6Z,9Z,12Z)/20:2(11Z,14Z))
TG(18:0/20:1(11Z)/o-18:0)
PIP(18:1(15Z)/20:1(11Z))
TG(20:2n6/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
Bromazepam
TG(18:0/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/22:1(13Z)/20:2n6)
TG(22:0/18:0/20:1(11Z))
DG(22:2n6/0:0/22:5n3)
TG(14:0/24:1(15Z)/22:2(13Z,16Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
Alfacalcidol
TG(15:0/18:3(9Z,12Z,15Z)/18:1(11Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:0/24:1(15Z)/22:1(13Z))
Alpha-Linolenoyl-CoA An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of alpha-linolenic acid.
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
Ganglioside GQ1c (d18:0/26:1(17Z))
TG(14:0/24:1(15Z)/o-18:0)
PE(16:1(9Z)/18:3(6Z,9Z,12Z))
DG(24:1n9/0:0/20:3n6)
TG(20:2n6/14:1(9Z)/20:2n6)
TG(22:0/18:1(9Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/22:2(13Z,16Z))
TG(15:0/18:3(9Z,12Z,15Z)/24:1(15Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/0:0)
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
D-Xylulose The D-enantiomer of xylulose.
Diphemanil Methylsulfate The alkene resulting from the formal Wittig olefination of benzophenone and 1,1-dimethyl-4-bromopiperidinium methylsulfate. A quaternary ammonium anticholinergic, it binds muscarinic acetycholine receptors and thereby decreases secretory excretion of stomach acids, saliva and sweat, It is used topically in the treatment of hyperhidorsis (excessive sweating).
PC(P-16:0/20:1(11Z))
Glutathione
TG(16:0/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(14:0/0:0/22:5n6)
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
DG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:3n6/14:0/20:3n6)
TG(20:2n6/20:2n6/20:3n6)
3-Methyl-1-hydroxybutyl-ThPP A thiamine phosphate that has formula C17H29N4O8P2S.
PIP2(20:0/18:2(9Z,12Z))
TG(14:0/20:3(5Z,8Z,11Z)/20:1(11Z))
(25R)-3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA An organic molecule that has formula C48H80N7O19P3S.
TG(24:0/22:1(13Z)/22:2(13Z,16Z))
PC(P-18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
11,12-Epoxyeicosatrienoic acid
DG(20:3(8Z,11Z,14Z)/24:1(15Z)/0:0)
TG(20:0/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
PC(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
3,4-Dihydroxymandelic acid A catechol that is the 3,4-dihydroxy derivative of mandelic acid; a metabolite of L-dopa.
TG(18:2(9Z,12Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
CDP-DG(16:0/18:0)
5-b-Cholestane-3a ,7a ,12a-triol
DHAP(18:0)
TG(18:1(9Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
Nalbuphine An organic heteropentacyclic compound that has formula C21H27NO4.
TG(20:0/14:0/o-18:0)
CL(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
PIP(18:1(9Z)/16:0)
Xanthosine A purine nucleoside in which xanthine is attached to ribofuranose via a beta-N(9)-glycosidic bond.
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/o-18:0)
TG(15:0/22:4(7Z,10Z,13Z,16Z)/20:3n6)
20alpha-Hydroxycholesterol
TG(14:1(9Z)/22:2(13Z,16Z)/20:3n6)
Glucose 6-phosphate
TG(18:2(9Z,12Z)/o-18:0/18:3(9Z,12Z,15Z))
PE(20:0/16:0)
Testosterone An androstanoid having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5..
PE(18:3(9Z,12Z,15Z)/P-18:0)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(24:0/22:0/14:1(9Z))
PE(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/14:1(9Z)/o-18:0)
TG(14:0/o-18:0/20:4(5Z,8Z,11Z,14Z))
DG(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/16:1(9Z)/24:1(15Z))
2-Methylbutyryl-CoA
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
3-Methylcrotonylglycine An N-acylglycine in which the acyl group is specified as 3-methylbut-2-enoyl.
PG(18:0/18:2(9Z,12Z))
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:2(13Z,16Z)/16:1(9Z))
2-Aminomuconic acid The 2-amino derivative of muconic acid.
7-Hydroxyticlopidine
TG(18:0/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
Isothipendyl
CL(20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:1(13Z)/18:1(11Z))
TG(14:0/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
PC(20:2(11Z,14Z)/20:3(5Z,8Z,11Z))
PE(18:4(6Z,9Z,12Z,15Z)/20:2(11Z,14Z))
TG(22:0/24:0/o-18:0)
D-Ribose A ribose in which the chiral carbon atom furthest away from the aldehyde group (C4') has the same configuration as in D-glyceraldehyde.
TG(18:1(9Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/20:3n6/16:1(9Z))
TG(22:2(13Z,16Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(16:0/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
Propylhexedrine
TG(24:0/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:0/16:1(9Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
3a,7a-Dihydroxycholanoic acid
TG(18:1(9Z)/24:0/22:1(13Z))
DG(14:0/16:0/0:0)
TG(16:0/20:2n6/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/20:0/20:2n6)
TG(16:0/22:2(13Z,16Z)/24:0)
(6Z,9Z,12Z,15Z,18Z)-3-Oxotetracosapenta-6,9,12,15,18-enoyl-CoA An organic molecule that has formula C45H70N7O18P3S.
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
PC(16:0/22:2(13Z,16Z))
PC(24:1(15Z)/P-16:0)
5-Fluoromuconolactone A butenolide that has formula C6H5FO4.
TG(16:0/14:1(9Z)/22:1(13Z))
4,4-Dimethylcholesta-8,14,24-trienol
TG(15:0/22:0/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
Mycophenolate mofetil
TG(24:0/22:1(13Z)/20:3n6)
Menthol
Clorazepate
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/22:1(13Z)/20:0)
PE(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/24:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/20:0/22:1(13Z))
Oxalic acid An alpha,omega-dicarboxylic acid that is ethane substituted by carboxyl groups at positions 1 and 2.
DG(18:3n6/0:0/20:5n3)
Uric acid An oxopurine that is the final oxidation product of purine metabolism.
TG(18:1(11Z)/20:3n6/24:1(15Z))
TG(18:1(9Z)/o-18:0/18:1(9Z))
Ganglioside GQ1c (d18:0/24:0)
Cytidine triphosphate
TG(24:0/22:2(13Z,16Z)/24:0)
TG(20:0/24:1(15Z)/18:1(11Z))
PE(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
PC(15:0/20:3(8Z,11Z,14Z))
TG(18:1(11Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/16:0/o-18:0)
TG(15:0/20:3n6/16:1(9Z))
TG(18:0/22:1(13Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GQ1c (d18:0/18:1(11Z))
PC(P-18:1(11Z)/24:0)
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/24:1(15Z)/18:0)
TG(22:1(13Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/15:0/o-18:0)
Cycrimine
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
TG(16:0/o-18:0/18:1(9Z))
PC(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(18:1(11Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
D-Mannose A mannose with D-configuration.
PIP2(18:2(9Z,12Z)/16:0)
TG(14:0/15:0/24:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
PC(P-18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
PC(24:0/18:1(9Z))
DG(20:0/18:3(9Z,12Z,15Z)/0:0)
TG(16:0/o-18:0/18:3(6Z,9Z,12Z))
TG(22:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:0/20:4(8Z,11Z,14Z,17Z)/0:0)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/14:0/20:4(8Z,11Z,14Z,17Z))
DG(20:3(8Z,11Z,14Z)/22:0/0:0)
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/o-18:0)
TG(22:1(13Z)/14:1(9Z)/22:1(13Z))
TG(20:0/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/24:1(15Z))
TG(18:0/18:1(11Z)/18:1(9Z))
TG(20:0/20:0/24:0)
TG(24:0/24:1(15Z)/22:2(13Z,16Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/22:1(13Z)/14:1(9Z))
2'-Deoxyinosine triphosphate
Ganglioside GD3 (d18:0/24:1(15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
PC(P-18:1(11Z)/22:0)
Carnosine
TG(16:0/20:3n6/22:0)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
TG(18:1(11Z)/20:3n6/18:1(9Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
Gonadorelin
TG(22:4(7Z,10Z,13Z,16Z)/14:0/18:3(9Z,12Z,15Z))
Glyceraldehyde An aldotriose comprising propanal having hydroxy groups at the 2- and 3-positions. It plays role in the formation of advanced glycation end-products (AGEs), a deleterious accompaniment to ageing.
6-Phosphonoglucono-D-lactone
TG(22:0/20:0/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
Mesalazine
TG(20:0/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/24:1(15Z)/18:3(6Z,9Z,12Z))
MG(0:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
MG(0:0/14:0/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:0/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/o-18:0)
TG(18:1(11Z)/18:0/24:1(15Z))
TG(18:1(9Z)/24:0/20:2n6)
12-Keto-tetrahydro-leukotriene B4
DG(14:0/0:0/20:5n3)
Ganglioside GD1b (d18:0/12:0)
TG(14:1(9Z)/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/14:1(9Z)/22:2(13Z,16Z))
Cysteinylglycine
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(15:0/20:3n6/20:1(11Z))
TG(22:2(13Z,16Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/22:1(13Z)/22:1(13Z))
PE(P-18:1(9Z)/15:0)
TG(18:0/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:2n6)
TG(24:0/24:0/18:1(11Z))
TG(20:0/24:1(15Z)/20:2n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/20:3n6)
TG(22:2(13Z,16Z)/18:1(11Z)/o-18:0)
TG(22:0/14:1(9Z)/16:1(9Z))
DG(20:3(8Z,11Z,14Z)/16:1(9Z)/0:0)
TG(18:3(6Z,9Z,12Z)/24:0/22:4(7Z,10Z,13Z,16Z))
Ganglioside GT1c (d18:1/26:1(17Z))
TG(18:1(11Z)/24:0/18:2(9Z,12Z))
DG(14:0/18:1(9Z)/0:0)
TG(18:1(9Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))[iso3]
TG(18:1(11Z)/22:2(13Z,16Z)/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z)/18:1(11Z))
TG(18:1(11Z)/20:0/24:1(15Z))
PC(24:1(15Z)/18:3(9Z,12Z,15Z))
TG(24:0/14:0/16:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
PE(18:1(9Z)/14:1(9Z))
PG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(16:0/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
DG(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)/0:0)
TG(15:0/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:1(13Z)/20:3n6)
TG(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
Meprobamate
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/18:1(11Z))
DG(20:1n9/0:0/18:3n6)
TG(20:1(11Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
PG(18:1(11Z)/18:2(9Z,12Z))
Ganglioside GQ1c (d18:0/24:1(15Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z)/0:0)
TG(18:3(9Z,12Z,15Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:1(11Z)/18:1(9Z))
TG(16:0/20:2n6/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/22:2(13Z,16Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Dermatan A mucopolysaccharide consisting of repeating beta-(1->4)-linked L-iduronyl-(beta1->3)-N-acetyl-D-galactosamine units.
PE(20:3(8Z,11Z,14Z)/18:1(9Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(20:2n6/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:0/16:1(9Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PE(22:4(7Z,10Z,13Z,16Z)/P-18:1(9Z))
(25S)-3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-oyl-CoA A polyol that has formula C48H80N7O20P3S.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
PC(18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
(6Z,9Z,12Z,15Z,18Z,21Z)-3-Oxotetracosahexa-6,9,12,15,18,21-enoyl-CoA
PI(16:0/20:3(5Z,8Z,11Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
TG(22:1(13Z)/22:2(13Z,16Z)/18:2(9Z,12Z))
PE(18:0/18:3(9Z,12Z,15Z))
Angiotensin IV
Ganglioside GD1b (d18:1/24:0)
LysoPC(16:0) A lysophosphatidylcholine in which the acyl group has a fully saturated C16 chain and is attached to the glycero moiety at either position 1 or 2.
TG(16:1(9Z)/14:0/18:3(6Z,9Z,12Z))
TG(18:3(9Z,12Z,15Z)/14:0/o-18:0)
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/16:0)
TG(20:1(11Z)/22:1(13Z)/22:1(13Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:0/0:0)
TG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
DG(15:0/0:0/20:2n6)
3,5-Diiodo-L-tyrosine A diiodotyrosine that is L-tyrosine carrying iodo-substituents at positions C-3 and C-5 of the benzyl group. It is an intermediate in the thyroid hormone synthesis.
O-Phosphoethanolamine The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
TG(14:1(9Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/15:0/o-18:0)
TG(20:0/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/18:3(9Z,12Z,15Z)/20:1(11Z))
MG(20:4(8Z,11Z,14Z,17Z)/0:0/0:0)
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/20:2n6/o-18:0)
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(24:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/15:0/18:3(6Z,9Z,12Z))
(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)
PE(24:1(15Z)/20:1(11Z))
TG(18:0/15:0/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Foscarnet
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:0)
MG(22:1(13Z)/0:0/0:0)
TG(16:0/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(20:1(11Z)/20:0/20:3(5Z,8Z,11Z))
Ganglioside GT1c (d18:1/25:0)
TG(18:0/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/24:1(15Z)/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:0/20:4(8Z,11Z,14Z,17Z))
PC(15:0/18:3(6Z,9Z,12Z))
5-Hydroxykynurenine A modified amino acid that is kynurenine bearing a hydroxy group at the position para to the anilino group.
TG(15:0/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
Butanal A member of the class of butanals that consists of propane bearing a formyl substituent at the 1-position. The parent of the class of butanals.
TG(15:0/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
DG(22:2(13Z,16Z)/18:0/0:0)
TG(18:1(9Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
Ganglioside GT1b (d18:1/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:3(9Z,12Z,15Z)/18:1(9Z))
L-Tryptophan The L-enantiomer of tryptophan.
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:1(9Z))
CDP-DG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PC(22:1(13Z)/14:0)
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
5-Aminoimidazole ribonucleotide
beta-D-Fructose 1,6-bisphosphate
PE(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(15:0/20:2(11Z,14Z))
TG(22:0/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(14:0/22:2(13Z,16Z)/22:1(13Z))
Indapamide
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)
TG(22:1(13Z)/18:1(11Z)/20:3n6)
DG(18:2n6/0:0/18:3n6)
TG(22:1(13Z)/15:0/22:2(13Z,16Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/18:0/20:4(8Z,11Z,14Z,17Z))
DG(18:3(9Z,12Z,15Z)/16:1(9Z)/0:0)
Amylose A glucan composed of unbranched chains of D-glucopyranose residues in alpha(1->4) glycosidic linkage.
TG(18:2(9Z,12Z)/18:1(11Z)/22:2(13Z,16Z))
TG(20:3n6/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:3n6/22:2(13Z,16Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))
TG(16:0/20:2n6/18:4(6Z,9Z,12Z,15Z))
Betamethasone A glucocorticoid that has formula C22H29FO5.
PC(22:1(13Z)/16:0)
TG(15:0/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GD1a (d18:1/18:0)
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
DG(20:0/0:0/20:4n6)
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
Formyl-5-hydroxykynurenamine A hydroxykynurenamine that is 5-hydroxykynurenamine with the hydrogen on the aryl amine replaced by a formyl group.
PC(18:1(11Z)/24:0)
TG(14:1(9Z)/20:0/22:1(13Z))
2-Chloro-5-methylmaleylacetate An oxo carboxylic acid that has formula C7H7ClO5.
PC(P-16:0/24:0)
TG(24:0/20:2n6/18:1(11Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(15:0/20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(P-18:0/22:1(13Z))
PC(18:4(6Z,9Z,12Z,15Z)/20:0)
TG(24:0/20:3(5Z,8Z,11Z)/20:1(11Z))
Methimazole A member of the class of imidazoles that it imidazole-2-thione in which a methyl group replaces the hydrogen which is attached to a nitrogen.
Desvenlafaxine
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(18:4(6Z,9Z,12Z,15Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(20:0/15:0/18:2(9Z,12Z))
PC(24:0/20:4(5Z,8Z,11Z,14Z))
TG(24:0/16:1(9Z)/18:1(11Z))
DG(20:4(8Z,11Z,14Z,17Z)/16:1(9Z)/0:0)
PE(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))
TG(22:0/18:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/22:1(13Z)/20:0)
PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
DG(18:0/0:0/20:3n6)
TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
Ganglioside GD2 (d18:1/24:1(15Z))
DL-O-Phosphoserine
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:1(11Z)/22:1(13Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GD1a (d18:1/12:0)
PC(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/22:0/16:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Choloyl-CoA A steroidal acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of cholic acid.
PC(22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
TG(18:1(11Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
DG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(15:0/24:0/16:0)
Guanosine 3'-diphosphate 5'-triphosphate A guanosine bisphosphate having a diphosphate at the 3'-position and a triphosphate at the 5'-position.
TG(22:2(13Z,16Z)/16:0/o-18:0)
PE(14:0/20:1(11Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
DG(24:0/0:0/20:4n3)
PIP(18:0/16:0)
TG(24:0/18:0/22:2(13Z,16Z))
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GT2 (d18:1/25:0)
TG(22:2(13Z,16Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/14:0/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:0/18:2(9Z,12Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(9Z))
TG(16:0/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/16:1(9Z)/20:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
Thioguanine
TG(22:0/16:0/22:2(13Z,16Z))
TG(20:3n6/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(24:0/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
L-Octanoylcarnitine
4-Hydroxy-2-oxoglutaric acid An oxo dicarboxylic acid comprising glutaric acid having oxo- and hydroxy substituents at the 2- and 4-positions respectively.
Esmolol A carboxylic ester that is methyl 3-(4-hydroxyphenyl)propanoate in which the hydrogen attached to the phenoic hydroxy group is substituted by a 2-hydroxy-3-(isopropylamino)propyl group. A cardioselective and short-acting beta1 receptor blocker with rapid onset but lacking intrinsic sympathomimetic and membrane-stabilising properties, it is used as the hydrochloride salt in the management of supraventricular arrhythmias, and for the control of hypertension and tachycardia during surgery.
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(22:1(13Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z))
Gamma Hydroxybutyric Acid
3a,7a,12a-Trihydroxy-5b-cholest-24-enoyl-CoA
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/20:2n6)
TG(14:0/20:3n6/o-18:0)
Phenacemide
Xanthylic acid
PE(20:4(8Z,11Z,14Z,17Z)/20:2(11Z,14Z))
TG(24:0/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:3n6/20:2n6)
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
Itraconazole A dioxolane that has formula C35H38Cl2N8O4.
TG(24:0/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(20:3n6/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
Abacavir
TG(24:0/o-18:0/22:2(13Z,16Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Liotrix
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/20:2n6)
TG(16:0/18:0/20:0)[iso6]
TG(15:0/20:0/16:1(9Z))
TG(18:1(11Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Erythrityl Tetranitrate
PIP(20:1(11Z)/18:1(11Z))
TG(18:1(11Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
DG(18:1(11Z)/18:3(9Z,12Z,15Z)/0:0)
DG(22:5(4Z,7Z,10Z,13Z,16Z)/18:0/0:0)
TG(20:3n6/14:1(9Z)/o-18:0)
TG(18:0/16:1(9Z)/18:2(9Z,12Z))
TG(14:0/20:3n6/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
PE(20:3(5Z,8Z,11Z)/20:0)
TG(24:0/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/16:1(9Z)/20:3n6)
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
PE(O-16:1(1Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
SM(d18:0/18:0)
Tocainide
PE(20:3(5Z,8Z,11Z)/22:0)
Bezafibrate
PS(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
PI(16:0/16:0) A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is also hexadecanoyl.
TG(18:0/20:4(5Z,8Z,11Z,14Z)/24:0)
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
TG(20:1(11Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/16:0/20:4(8Z,11Z,14Z,17Z))
Genistein 7-Hydroxyisoflavone with additional hydroxy groups at positions 5 and 4'. It is a phytoestrogenic isoflavone with antioxidant properties.
PC(18:3(9Z,12Z,15Z)/14:0)
TG(18:1(9Z)/20:2n6/18:1(9Z))
TG(20:2n6/18:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/14:0/20:1(11Z))
2-Polyprenyl-6-methoxy-1,4-benzoquinone
TG(20:0/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:2(11Z,14Z)/18:1(11Z)/0:0)
Triphosphate
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(16:0/20:1(11Z)/16:0)
TG(22:0/22:0/16:1(9Z))
Moxifloxacin A quinolone that consits of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid bearing a cyclopropyl substituent at position 1, a fluoro substitiuent at position 6, a (4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl group at position 7 and a methoxy substituent at position 8. A member of the fluoroquinolone class of antibacterial agents.
Fluorouracil
TG(14:0/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/16:0/18:1(9Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/o-18:0)
PG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
PC(16:1(9Z)/18:1(11Z))
DG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/0:0)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)
DG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/0:0)
TG(20:3(5Z,8Z,11Z)/20:0/o-18:0)
DG(20:0/0:0/22:5n3)
TG(16:1(9Z)/20:0/18:1(9Z))
DG(16:0/24:0/0:0)
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(16:0/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
Hemin
TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(18:1(9Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/24:0/o-18:0)
TG(22:0/14:0/22:2(13Z,16Z))
PE(18:3(6Z,9Z,12Z)/24:1(15Z))
Isocitric acid A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions substituted with a carboxy group.
2,8-Dihydroxyquinoline-beta-D-glucuronide
PC(20:2(11Z,14Z)/22:0)
LPA(16:0/0:0)
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(20:0/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(18:1(11Z)/24:0/20:4(5Z,8Z,11Z,14Z))
TG(24:0/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(15:0/16:0/20:1(11Z))
TG(14:1(9Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:2(11Z,14Z)/24:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(P-18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Zonisamide A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
PC(18:2(9Z,12Z)/24:1(15Z))
Diphthine A quaternary ammonium ion consisting of L-histidine with a 3-(trimethylammonio)-3-carboxypropyl group at the 2-position of the the imidazole ring.
PC(20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
DG(24:1(15Z)/20:0/0:0)
Molybdenum A chromium group element atom that has formula Mo.
PS(16:0/16:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GD1a (d18:0/26:1(17Z))
DG(22:1(13Z)/24:1(15Z)/0:0)
TG(14:0/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/22:0)
TG(15:0/20:2n6/20:4(8Z,11Z,14Z,17Z))
Nitroglycerin A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
TG(20:2n6/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Diflunisal An organofluorine compound comprising salicylic acid having a 2,4-difluorophenyl group at the 5-position.
TG(18:0/18:0/20:0)[iso3]
L-Aspartic acid The L-enantiomer of aspartic acid.
TG(14:1(9Z)/16:0/22:4(7Z,10Z,13Z,16Z))
TG(24:0/20:3n6/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(20:3n6/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
Pheniramine
TG(18:0/22:2(13Z,16Z)/14:1(9Z))
TG(22:1(13Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:3n6/20:1(11Z))
DG(20:4(8Z,11Z,14Z,17Z)/14:0/0:0)
TG(16:0/20:0/18:1(11Z))
PC(22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/20:0/22:2(13Z,16Z))
Trypanothione disulfide Trypanothione disulfide is the oxidized form of N(1),N(8)-bis(glutathionyl)-spermidine from the insect-parasitic trypanosomatid Crithidia fasciculata.
TG(16:0/18:3(9Z,12Z,15Z)/22:0)
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:0/22:2(13Z,16Z))
TG(20:0/20:2n6/16:1(9Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/o-18:0/18:3(9Z,12Z,15Z))
Melibiose A glycosylglucose formed by an alpha-(1->6)-linkage between D-galactose and D-glucose.
TG(14:1(9Z)/20:3n6/22:2(13Z,16Z))
Tridecanoyl-CoA A long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of tridecanoic acid.
TG(18:0/18:0/24:0)
PE(22:4(7Z,10Z,13Z,16Z)/P-16:0)
TG(18:3(9Z,12Z,15Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/22:0/22:1(13Z))
TG(18:1(9Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
CE(10:0)
TG(20:1(11Z)/14:0/o-18:0)
CE(12:0)
TG(14:0/20:3(5Z,8Z,11Z)/18:1(11Z))
TG(15:0/18:3(9Z,12Z,15Z)/20:1(11Z))
TG(14:0/20:0/20:4(5Z,8Z,11Z,14Z))
DG(20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z)/0:0)
TG(24:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/18:1(9Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GM3 (d18:1/23:0)
Cinnavalininate A phenoxazine that has formula C14H8N2O6.
TG(20:0/16:0/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/24:0/18:2(9Z,12Z))
CE(18:1(11Z))
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:3(8Z,11Z,14Z))[iso3]
TG(20:2n6/22:1(13Z)/o-18:0)
TG(24:1(15Z)/22:1(13Z)/24:1(15Z))
TG(14:0/24:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/14:0/22:1(13Z))
DG(20:4(8Z,11Z,14Z,17Z)/22:1(13Z)/0:0)
TG(20:1(11Z)/22:0/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/o-18:0/18:3(9Z,12Z,15Z))
3-Aminosalicylic acid
TG(14:0/14:0/18:1(9Z))
Delta7-Avenasterol A steroid that has formula C29H48O.
DG(16:1(9Z)/15:0/0:0)
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:1(9Z)/24:1(15Z))
TG(18:3(9Z,12Z,15Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
TG(16:1(9Z)/18:2(9Z,12Z)/20:2n6)
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/o-18:0)
PI(16:0/18:0)
TG(22:0/18:1(9Z)/18:1(11Z))
DG(18:1n9/0:0/20:4n3)
TG(22:0/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
PE(24:1(15Z)/20:3(8Z,11Z,14Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(18:1(11Z)/20:1(11Z)/20:3(5Z,8Z,11Z))
TG(16:0/24:1(15Z)/18:0)
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/22:1(13Z)/18:2(9Z,12Z))
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
L-Palmitoylcarnitine
TG(22:1(13Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:3(8Z,11Z,14Z)/P-18:1(11Z))
PG(16:0/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GD2 (d18:0/22:0)
DG(20:0/20:2(11Z,14Z)/0:0)
TG(22:0/22:1(13Z)/22:0)
PC(o-18:2(9Z,12Z)/18:2(9Z,12Z))
PC(22:0/P-18:0)
PE(P-18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Olanzapine A benzodiazepine that has formula C17H20N4S.
Levosimendan
TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
PE(P-18:0/22:2(13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
Bismuth Subsalicylate A bismuth salt of salicylic acid.
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(20:2n6/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
L-Iditol The L-enantiomer of iditol.
DG(20:3n9/0:0/20:3n9)
TG(14:1(9Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
PI(18:2(9Z,12Z)/18:1(9Z))
TG(24:0/18:2(9Z,12Z)/14:1(9Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:0/18:4(6Z,9Z,12Z,15Z))
Glyceric acid 1,3-biphosphate
TG(20:2n6/18:1(11Z)/22:2(13Z,16Z))
TG(18:1(9Z)/20:0/18:2(9Z,12Z))
DG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/0:0)
Allodeoxycholic acid
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PIP(18:1(11Z)/16:1(9Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(22:2(13Z,16Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
Prostaglandin H2 A prostaglandins H that has formula C20H32O5.
DG(18:3(9Z,12Z,15Z)/20:1(11Z)/0:0)
CL(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(20:3n6/20:0/20:4(8Z,11Z,14Z,17Z))
(S)-3-Hydroxy-N-methylcoclaurine An isoquinoline alkaloid having a tetrahydroisoquinoline core with 3,4-dihydroxybenzyl, methoxy and hydroxy groups at the 1-, 6- and 7-positions respectively; major species at pH 7.3.
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
PE(24:0/15:0)
TG(20:0/22:0/20:2n6)
PC(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z)/0:0)
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
PIP2(16:1(9Z)/18:1(9Z))
TG(18:0/15:0/20:2n6)
TG(18:3(9Z,12Z,15Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:3n6/20:2n6)
Oxybutynin An acetylenic compound that has formula C22H31NO3.
TG(16:0/18:2(9Z,12Z)/o-18:0)
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(14:0/20:1(11Z)/22:0)
TG(15:0/18:1(9Z)/15:0)
Diethylcarbamazine
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/22:1(13Z))
DG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
Rescinnamine
DG(22:1n9/0:0/22:1n9)
PC(16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/24:0/20:4(5Z,8Z,11Z,14Z))
PE(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:2(13Z,16Z)/20:0)
DG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/0:0)
Riluzole
DG(18:3n6/0:0/22:5n6)
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/20:3n6)
TG(16:1(9Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
3-O-Sulfogalactosylceramide (d18:1/16:0)
TG(16:0/20:0/20:1(11Z))[iso6]
PC(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
Pentostatin
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Carbon dioxide A one-carbon compound with formula CO2 in which the carbon is attached to each oxygen atom by a double bond. A colourless, odourless gas under normal conditions, it is produced during respiration by all animals, fungi and microorganisms that depend directly or indirectly on living or decaying plants for food.
TG(20:1(11Z)/14:0/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/22:1(13Z)/20:2n6)
TG(22:1(13Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(18:1(11Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
6-Methylthiopurine 5'-monophosphate ribonucleotide An organic molecule that has formula C11H15N4O7PS.
TG(20:1(11Z)/20:1(11Z)/20:1(11Z))
TG(15:0/20:3(5Z,8Z,11Z)/24:1(15Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(18:3(6Z,9Z,12Z)/20:0/0:0)
Calcidiol A hydroxycalciol that is calciol in which the hydrogen at position 25 has been replaced by a hydroxy group. A prehormone resulting from the oxidation of calciol in the liver, it is further hydroxylated in the kidney to give calcitriol, the active form of vitamin D3.
TG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
PC(18:1(11Z)/P-18:1(11Z))
PE(24:1(15Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
19-Hydroxytestosterone A 3-oxo Delta(4)-steroid that is testosterone which is substituted by a hydroxy group at positions 19.
TG(20:3n6/20:1(11Z)/22:2(13Z,16Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
Deoxyhypusine An L-lysine derivative in which the N(6) of the lysine is substituted with a 4-aminobutyl group.
DG(18:2n6/0:0/22:5n6)
TG(18:0/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(16:0/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
Acamprosate
TG(16:0/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
PIP3(18:0/18:1(11Z))
DG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
PC(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))
N-Desmethylaminopyrine
Betaine aldehyde A quaternary ammonium ion that is nitrogen substituted by three methyl groups and a 2-oxoethyl group. It is an intermediate in the metabolism of amino acids like glycine, serine and threonine.
TG(22:1(13Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(20:1(11Z)/16:0/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]
TG(20:1(11Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/18:2(9Z,12Z)/22:1(13Z))
TG(14:0/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
Methylcysteine
TG(20:1(11Z)/20:0/20:3n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
Tiglyl-CoA
TG(18:3(6Z,9Z,12Z)/20:2n6/18:3(9Z,12Z,15Z))
Prunasin A cyanogenic glycoside that has formula C14H17NO6.
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0)
TG(16:0/22:1(13Z)/16:1(9Z))
PS(18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
PC(24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/24:1(15Z)/22:2(13Z,16Z))
TG(20:0/16:1(9Z)/22:0)
TG(22:0/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
4-Hydroxyphenylpyruvic acid An oxo carboxylic acid that is pyruvic acid in which one of the methyl hydrogens is substituted by a 4-hydroxyphenyl group.
DG(20:0/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/24:0)
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/15:0)
PIP(16:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/16:0/22:0)
TG(24:0/14:0/22:4(7Z,10Z,13Z,16Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
Quercetin A pentahydroxyflavone having the five hydroxy groups placed at the 3-, 3'-, 4'-, 5- and 7-positions.
TG(14:0/18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
Daidzin
TG(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:3(6Z,9Z,12Z)/P-18:0)
TG(20:2n6/20:3n6/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
Thiothixene
TG(18:1(9Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/15:0)
3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid A methoxybenzoic acid that has formula C38H56O4.
TG(18:0/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/20:2n6/20:1(11Z))
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
1b,3a,12a-Trihydroxy-5b-cholanoic acid
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
DG(22:4n6/0:0/18:4n3)
TG(20:0/22:1(13Z)/18:1(9Z))
LysoPC(22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:0/20:2n6)
TG(18:1(11Z)/20:0/18:2(9Z,12Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/15:0/18:4(6Z,9Z,12Z,15Z))
Allantoic acid A member of the class of ureas that consists of acetic acid in which the two methyl hydrogens are replaced by carbamoylamino groups respectively.
PC(18:2(9Z,12Z)/18:1(9Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
D-Arginine A D-alpha-amino acid that is the D-isomer of arginine.
TG(24:1(15Z)/20:0/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:0/o-18:0)
DG(18:1(11Z)/20:0/0:0)
PC(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:1(9Z)/o-18:0)
TG(20:2n6/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/22:2(13Z,16Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
PE(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(22:0/16:1(9Z)/18:1(11Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/24:0/24:1(15Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(18:2(9Z,12Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
3-Sulfopyruvic acid A carboxyalkanesulfonic acid comprising pyruvic acid with a sulfo group attached at the C-3 position.
Oxamniquine
TG(20:3(5Z,8Z,11Z)/15:0/18:2(9Z,12Z))
TG(24:0/14:1(9Z)/o-18:0)
TG(16:1(9Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
DG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
DG(16:1(9Z)/20:3(8Z,11Z,14Z)/0:0)
TG(22:2(13Z,16Z)/18:0/18:3(9Z,12Z,15Z))
D-Tagatose 1,6-bisphosphate A ketohexose bisphosphate that is D-tagatose carrying phosphate groups at positions 1 and 6.
Sibutramine
PIP(20:3(8Z,11Z,14Z)/18:1(11Z))
TG(18:1(11Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
DG(16:1(9Z)/14:1(9Z)/0:0)
DG(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(18:1(11Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Hydrogen Ion
TG(18:3(6Z,9Z,12Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/22:0/20:2n6)
TG(24:1(15Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/24:1(15Z)/14:1(9Z))
DG(18:3n6/0:0/18:3n6)
TG(18:1(11Z)/20:3n6/18:2(9Z,12Z))
DG(22:0/0:0/14:1n5)
TG(18:0/16:1(9Z)/16:1(9Z))
PC(24:0/14:1(9Z))
TG(15:0/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
DG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(18:3(6Z,9Z,12Z)/18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:3(9Z,12Z,15Z)/22:0)
TG(16:0/18:3(6Z,9Z,12Z)/22:1(13Z))
5-Methylthioribulose 1-phosphate
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
7-Ketocholesterol A cholestanoid that consists of cholesterol bearing an oxo substituent at position 7.
TG(14:1(9Z)/20:1(11Z)/o-18:0)
Nicotinuric acid An N-acylglycine having nicotinoyl as the acyl substituent.
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0/o-18:0)
TG(20:0/14:1(9Z)/20:3(5Z,8Z,11Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(24:0/24:1(15Z)/24:1(15Z))
Cyclobenzaprine 5-Methylidene-5H-dibenzo[a,d]cycloheptene in which one of the hydrogens of the methylidene group is substituted by a 2-(dimethylamino)ethyl group. A centrally acting skeletal muscle relaxant, it is used as its hydrochloride salt in the symptomatic treatment of painful muscle spasm.
TG(22:0/15:0/20:1(11Z))
TG(16:1(9Z)/22:2(13Z,16Z)/20:1(11Z))
TG(18:1(11Z)/20:2n6/18:3(9Z,12Z,15Z))
TG(16:0/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(14:0/22:0/18:1(9Z))
TG(14:0/o-18:0/18:2(9Z,12Z))
TG(20:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
PE(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
Nebularine A purine ribonucleoside that is 9H-purine attached to a beta-D-ribofuranosyl residue at position 9 via a glycosidic (N-glycosyl) linkage.
TG(22:0/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
PC(15:0/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
TG(22:0/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(14:0/22:0/20:3(5Z,8Z,11Z))
TG(20:2n6/22:0/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(14:1(9Z)/16:1(9Z))
Cytidine A pyrimidine nucleoside in which cytosine is attached to ribofuranose via a beta-N(1)-glycosidic bond.
TG(15:0/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Anandamide A fatty amide obtained by the formal condensation of arachidonic acid with ethanolamine.
Sphingosine 1-phosphate A phosphosphingolipid that consists of sphingosine having a phospho group attached at position 1
Dimethyl selenide An organoselenium compound of two methyl groups covalently bound to a selenium.
DG(22:5n6/0:0/18:3n3)
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z))
TG(18:0/20:1(11Z)/20:0)
PC(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:0/o-18:0)
TG(22:0/o-18:0/20:3n6)
(S)-N-Methylcoclaurine The (S)-enantiomer of N-methylcoclaurine.
TG(14:1(9Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/14:0/22:1(13Z))
TG(14:0/20:1(11Z)/15:0)
TG(24:0/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(22:0/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(14:0/24:0/20:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))
TG(18:1(11Z)/16:1(9Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/20:2n6/18:3(9Z,12Z,15Z))
TG(24:0/14:0/20:1(11Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:0/o-18:0)
TG(16:1(9Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
beta-Alanyl-L-arginine A dipeptide that has formula C9H19N5O3.
Vinblastine
PE(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/15:0/14:1(9Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/14:0/20:3n6)
PE(18:1(11Z)/20:1(11Z))
PI(22:5(4Z,7Z,10Z,13Z,16Z)/18:0)
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(18:3n6/0:0/22:2n6)
TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(22:1(13Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/16:0/18:3(9Z,12Z,15Z))[iso6]
TG(20:0/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(18:0/18:0/20:3n6)
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:3(9Z,12Z,15Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Butenafine
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
Propranolol A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
PE(20:3(5Z,8Z,11Z)/18:1(9Z))
TG(15:0/20:2n6/20:3n6)
TG(18:3(6Z,9Z,12Z)/20:3n6/22:2(13Z,16Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/24:0)
TG(14:0/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/24:1(15Z)/20:3n6)
TG(20:0/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(16:0/o-18:0/16:0)
Succinyl-CoA An omega-carboxyacyl-CoA having succinoyl as the S-acyl component.
TG(24:1(15Z)/15:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/24:1(15Z)/20:2n6)
TG(15:0/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/22:0/o-18:0)
DG(20:2(11Z,14Z)/18:3(6Z,9Z,12Z)/0:0)
PC(22:4(7Z,10Z,13Z,16Z)/20:0)
DG(16:1(9Z)/16:0/0:0)
Didemethylcitalopram An organic amino compound that has formula C18H17FN2O.
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/16:1(9Z))
TG(20:1(11Z)/14:0/18:3(9Z,12Z,15Z))
TG(16:0/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Mannose 6-phosphate
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/20:2n6/18:3(9Z,12Z,15Z))
Ganglioside GD1a (d18:1/26:0)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/20:2n6)
DG(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
CMP-2-aminoethylphosphonate A nucleotide 2-aminoethylphosphonate that has formula C11H20N4O10P2.
Nicotinic acid A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.
CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/16:0)
TG(18:3(9Z,12Z,15Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
TG(20:0/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(20:0/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(14:0/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:1(13Z)/18:1(11Z))
TG(20:1(11Z)/15:0/24:1(15Z))
MG(24:1(15Z)/0:0/0:0)
Allopurinol A bicyclic structure comprising a pyrazole ring fused to a hydroxy-substituted pyrimidine ring.
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
TG(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
L-3-Hydroxykynurenine Tha amino acid zwitterion formed from 5-hydroxy-L-kynurenine by transfer of a proton from the carboxy to the amino group; principal microspecies at pH 7.3.
TG(24:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
Hydroxyzileuton
PE(15:0/18:1(11Z))
TG(22:0/o-18:0/24:1(15Z))
TG(18:1(9Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
DG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(24:0/14:1(9Z)/24:1(15Z))
DG(20:3(8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(18:0/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
DG(22:0/15:0/0:0)
TG(14:1(9Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
LysoPC(18:1(11Z))
TG(22:0/18:3(9Z,12Z,15Z)/14:1(9Z))
Ketoleucine
TG(22:0/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(o-18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
3-Oxo-OPC4-CoA An organic molecule that has formula C35H54N7O19P3S.
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(16:0/18:3(9Z,12Z,15Z)/18:1(11Z))
TG(22:1(13Z)/18:2(9Z,12Z)/22:1(13Z))
Ganglioside GD3 (d18:0/18:0)
TG(20:2n6/20:3n6/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/14:1(9Z)/24:1(15Z))
DG(18:1(9Z)/18:1(9Z)/0:0)
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
Tropicamide
PE(15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
Meperidine
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
PG(18:0/20:3(8Z,11Z,14Z))
TG(20:2n6/22:0/22:2(13Z,16Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:0)
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(15:0/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS(14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
5-Fluorouridine monophosphate
TG(22:0/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:0/dm18:0)
TG(20:2n6/22:0/22:4(7Z,10Z,13Z,16Z))
Pimecrolimus
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:0)
TG(16:0/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Cholesterol
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GT1b (d18:0/24:0)
TG(14:0/14:0/14:0)
Dihydroneopterin triphosphate
TG(24:1(15Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(22:1(13Z)/15:0/22:1(13Z))
TG(18:1(9Z)/20:1(11Z)/18:1(9Z))
TG(24:0/20:0/24:0)
TG(22:0/24:0/24:0)
Phenol sulphate
3-Mercaptolactic acid A (2R)-2-hydroxy monocarboxylic acid consisting of lactic acid having a sulfanyl group at the 3-position.
Diadenosine hexaphosphate
PE(16:1(9Z)/14:0)
TG(18:0/18:1(9Z)/18:1(9Z))[iso3]
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
Benzocaine A benzoate ester having 4-aminobenzoic acid as the acid component and ethanol as the alcohol component. A surface anaesthetic, it is used to suppress the gag reflex, and as a lubricant and topical anaesthetic on the larynx, mouth, nasal cavity, respiratory tract, oesophagus, rectum, urinary tract, and vagina.
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/22:2(13Z,16Z))
DG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
DG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(18:3(9Z,12Z,15Z)/20:2n6/o-18:0)
Ganglioside GT1b (d18:0/22:0)
TG(20:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(14:0/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
PC(18:3(9Z,12Z,15Z)/22:0)
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
Dalfopristin
Hydroxymethylbilane
(S)-2-amino-6-oxohexanoate
TG(24:1(15Z)/18:0/18:3(6Z,9Z,12Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/14:0)
DG(16:1n7/0:0/20:4n3)
Carmustine
DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
PIP(18:1(9Z)/18:1(9Z))
TG(18:1(11Z)/22:1(13Z)/18:1(11Z))
PC(18:1(11Z)/P-18:0)
TG(20:3(5Z,8Z,11Z)/18:0/22:1(13Z))
PC(20:2(11Z,14Z)/P-18:1(9Z))
TG(20:0/16:0/20:2n6)
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
PC(o-22:0/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
Ceramide (d18:1/9Z-18:1)
LysoSM(d18:1)
TG(22:1(13Z)/16:0/20:4(5Z,8Z,11Z,14Z))
TG(18:0/16:1(9Z)/18:0)
SM(d18:1/23:0)
TG(18:3(6Z,9Z,12Z)/16:0/20:2n6)
Phendimetrazine
TG(20:0/24:0/24:1(15Z))
PC(20:1(11Z)/18:2(9Z,12Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
Hydroxyacetone A propanone that is acetone in which one of the methyl hydrogens is replaced by a hydroxy group.
TG(14:1(9Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:0/18:3(9Z,12Z,15Z))
CL(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/16:1(9Z))
Glycochenodeoxycholic acid 3-glucuronide
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(24:0/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
D-Tryptophan The D-enantiomer of tryptophan.
TG(18:1(9Z)/16:0/22:2(13Z,16Z))
PA(18:1(11Z)/18:1(11Z))
TG(20:0/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:2n6/16:0/22:2(13Z,16Z))
TG(20:0/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:1(11Z)/P-18:0)
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/20:3n6)
TG(20:3n6/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
Olomoucine
TG(24:1(15Z)/18:0/18:2(9Z,12Z))
DG(14:1(9Z)/16:0/0:0)
3a,7a-Dihydroxy-5b-24-oxocholestanoyl-CoA
25-Hydroxyvitamin D2-25-glucuronide
TG(20:3n6/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:2(13Z,16Z)/P-16:0)
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/16:0/18:3(6Z,9Z,12Z))
Ganglioside GM1 (d18:0/20:0)
DG(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/0:0)
Ganglioside GM2 (d18:1/26:0)
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Dopaquinone
TG(14:1(9Z)/20:0/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GM2 (d18:1/24:0)
TG(22:0/24:0/18:1(9Z))
TG(22:2(13Z,16Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/15:0/0:0)
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z))
PE(24:1(15Z)/P-18:1(9Z))
TG(20:3n6/24:0/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:4(7Z,10Z,13Z,16Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:1(11Z)/24:0)
TG(18:0/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(20:0/18:3(9Z,12Z,15Z)/16:1(9Z))
Methylimidazoleacetic acid
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(20:0/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/o-18:0)
PC(o-18:1(9Z)/16:0)
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/15:0/18:2(9Z,12Z))
TG(16:1(9Z)/20:0/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:1(11Z)/16:0)
TG(22:0/16:0/16:1(9Z))
Podofilox
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/16:0/18:3(6Z,9Z,12Z))
Phenmetrazine
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/20:3n6/20:2n6)
PS(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/20:3n6/18:3(9Z,12Z,15Z))
PE(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Cer(d18:0/25:0)
PE(15:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/16:1(9Z)/18:2(9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:1(13Z)/18:1(11Z))
TG(20:0/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(15:0/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:4n6/0:0/22:5n3)
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/22:1(13Z))
DG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/0:0)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
Prochlorperazine A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.
PC(14:1(9Z)/14:0)
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/20:3(5Z,8Z,11Z)/18:0)
PC(P-18:0/18:4(6Z,9Z,12Z,15Z))
PC(18:1(11Z)/18:0)
PC(24:1(15Z)/20:3(8Z,11Z,14Z))
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
Decanoyl-CoA (n-C10:0CoA)
TG(18:3(6Z,9Z,12Z)/18:0/o-18:0)
TG(20:0/14:1(9Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(16:0/0:0/22:1n9)
2-Hydroxyestrone-4-S-glutathione
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(18:0/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
3,4-Dihydroxyphenylacetaldehyde A phenylacetaldehyde in which the 3 and 4 positions of the phenyl group are substituted by hydroxy groups.
Hesperidin A disaccharide derivative that consists of hesperetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.
TG(14:0/18:3(9Z,12Z,15Z)/16:0)
Phosphoribosyl-ATP
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
N-Acetylneuraminic acid An N-acylneuraminic acid where the N-acyl group is specified as acetyl.
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(18:2(9Z,12Z)/20:2n6/18:3(6Z,9Z,12Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/24:1(15Z)/18:1(11Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:0)
Procaine A benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol.
Dactinomycin
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
DG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
PIP(18:0/18:1(11Z))
PE(20:3(8Z,11Z,14Z)/22:2(13Z,16Z))
Undecanoic acid A straight-chain, eleven-carbon saturated medium-chain fatty acid found in body fluids; the most fungitoxic of the C7:0 - C18:0 fatty acid series.
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/20:2n6)
TG(18:1(11Z)/24:0/20:3(5Z,8Z,11Z))
PE(22:0/18:0)
TG(18:3(9Z,12Z,15Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:1(11Z)/22:2(13Z,16Z))
TG(16:1(9Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/20:2n6/24:0)
TG(16:1(9Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PS(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(14:0/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Fusidic Acid A steroid antibiotic that is isolated from the fermentation broth of Fusidium coccineum.
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(18:3(9Z,12Z,15Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(18:1(9Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
Benzylamine A primary amine compound having benzyl as the N-substituent. It has been isolated from Moringa oleifera (horseradish tree).
TG(14:0/20:3n6/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(16:0/14:1(9Z)/14:1(9Z))
TG(20:1(11Z)/16:1(9Z)/22:1(13Z))
TG(18:1(9Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
Nelarabine
TG(22:2(13Z,16Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/14:1(9Z)/16:1(9Z))
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/16:0)
TG(18:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GD1b (d18:0/20:0)
TG(20:1(11Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
PIP2(20:3(8Z,11Z,14Z)/18:1(9Z))
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
Talbutal
TG(22:0/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/22:1(13Z)/14:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
1-Methylpyrrolinium An organic cation that is 1-pyrroline bearing an N-methyl substituent.
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:2(9Z,12Z)/18:1(11Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
3a,11b,21-Trihydroxy-20-oxo-5b-pregnan-18-al
Ethyl pyruvate
Mevalonic acid-5P
TG(22:0/22:1(13Z)/18:2(9Z,12Z))
TG(24:1(15Z)/20:0/20:2n6)
TG(16:1(9Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/20:3(5Z,8Z,11Z)/18:1(9Z))
PG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
(3a,5b,7a)-23-Carboxy-7-hydroxy-24-norcholan-3-yl-b-D-Glucopyranosiduronic acid
TG(22:0/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(14:0/22:0/18:3(9Z,12Z,15Z))
3b,12b-Dihydroxy-5b-cholanoic acid
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(24:0/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CDP-DG(18:1(11Z)/18:2(9Z,12Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
Porphobilinogen A dicarboxylic acid that is pyrole bearing aminomethyl, carboxymethyl and 2-carboxyethyl substituents at positions 2, 3 and 4 respectively.
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
3b,7b,12a-Trihydroxy-5b-cholanoic acid
TG(20:4(8Z,11Z,14Z,17Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/16:0/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(16:0/18:3(6Z,9Z,12Z)/22:0)
TG(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PA(18:1(11Z)/18:1(9Z))
TG(18:0/18:3(6Z,9Z,12Z)/20:0)
TG(22:0/18:1(9Z)/20:3(5Z,8Z,11Z))
TG(14:0/18:1(11Z)/24:1(15Z))
1D-Myo-inositol 1,3-bisphosphate
N-Desmethylcitalopram
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Adenosyl cobyrinic acid a,c diamide
TG(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(P-18:1(11Z)/16:0)
TG(22:1(13Z)/22:0/24:1(15Z))
TG(18:0/18:3(6Z,9Z,12Z)/22:0)
TG(22:0/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
PE(P-18:1(9Z)/22:0)
TG(14:0/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Masoprocol
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
TG(15:0/24:0/18:4(6Z,9Z,12Z,15Z))
TG(15:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(22:0/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:3(6Z,9Z,12Z)/20:0)
PE(P-18:1(9Z)/18:3(9Z,12Z,15Z))
PC(P-18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/0:0)
TG(22:2(13Z,16Z)/20:2n6/18:3(9Z,12Z,15Z))
TG(16:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/22:1(13Z)/18:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/24:0/o-18:0)
N-Methylserotonin A member of the class of tryptamines that is serotonin in which one of the hydrogens attached to the primary amino group is replaced by a methyl group.
PE(P-18:1(11Z)/14:0)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/o-18:0/24:1(15Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/0:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/o-18:0)
PE(P-18:1(9Z)/20:0)
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
PC(14:0/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/20:3n6)
TG(20:1(11Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Carbenicillin
2-Chloro-5-methyl-cis-dienelactone A butenolide that has formula C7H5ClO4.
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(22:1(13Z)/15:0/o-18:0)
DG(18:0/0:0/20:1n9)
DG(24:0/18:4(6Z,9Z,12Z,15Z)/0:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
PC(20:1(11Z)/20:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:3n6/18:1(9Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/24:0/20:1(11Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/20:3n6)
PE(22:1(13Z)/18:1(11Z))
TG(18:1(9Z)/22:1(13Z)/20:3(5Z,8Z,11Z))
TG(15:0/20:0/22:1(13Z))
TG(20:1(11Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
5-Thymidylic acid
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/18:0/18:1(9Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/o-18:0/18:2(9Z,12Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/16:0/o-18:0)
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/22:1(13Z))
TG(20:1(11Z)/o-18:0/22:2(13Z,16Z))
TG(20:1(11Z)/20:2n6/18:2(9Z,12Z))
TG(16:0/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:3(6Z,9Z,12Z)/16:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Paliperidone
TG(20:0/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Pregnanediol-3-glucuronide
TG(22:0/20:3(5Z,8Z,11Z)/24:0)
TG(20:1(11Z)/18:2(9Z,12Z)/24:1(15Z))
Arachidonyl-CoA
TG(20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
Propylthiouracil
PS(18:3(9Z,12Z,15Z)/16:1(9Z))
TG(14:0/16:0/16:1(9Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:3n6/o-18:0)
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
Phenylpropanolamine
TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
DG(20:3(8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/0:0)
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(16:1(9Z)/24:1(15Z)/20:2n6)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
PC(P-18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0)
Ganglioside GM3 (d18:0/23:0)
TG(18:2(9Z,12Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:2(9Z,12Z)/20:3n6)
DG(15:0/18:3(9Z,12Z,15Z)/0:0)
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(18:1(9Z)/20:1(11Z)/18:2(9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
20a-Dihydroprogesterone
TG(15:0/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/14:1(9Z)/20:3n6)
TG(20:3(5Z,8Z,11Z)/18:0/20:4(8Z,11Z,14Z,17Z))
SM(d18:1/18:1(11Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/22:1(13Z))
TG(18:1(11Z)/24:0/22:1(13Z))
D-erythro-Eritadenine
TG(18:4(6Z,9Z,12Z,15Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/14:0/o-18:0)
TG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
Metronidazole A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/18:3(9Z,12Z,15Z)/20:3n6)
TG(16:0/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/18:1(9Z)/20:2n6)
TG(15:0/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/22:2(13Z,16Z))
Ethopropazine
Purine A heterobicyclic aromatic organic compound comprising a pyrimidine ring fused to an imidazole ring; the parent compound of the purines.
TG(18:1(9Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:0/20:3(5Z,8Z,11Z))
TG(22:0/18:1(9Z)/22:0)
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
Nimodipine A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
PC(20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/o-18:0/24:1(15Z))
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:4n6/0:0/20:4n3)
PC(20:0/18:1(11Z))
TG(18:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
TG(20:1(11Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(20:1(11Z)/20:1(11Z)/0:0)
PE(18:3(9Z,12Z,15Z)/20:1(11Z))
TG(20:1(11Z)/14:0/20:3n6)
Imiquimod An imidazoquinoline that has formula C14H16N4.
PC(22:0/20:2(11Z,14Z))
TG(16:1(9Z)/18:1(11Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/20:2n6/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/22:0/20:3n6)
TG(20:0/22:0/20:1(11Z))
PS(16:0/18:0)
9(S)-HPODE An HPODE (hydroperoxy-octadecadienoic acid) in which the double bonds are at positions 10 and 12 (E and Z geometry, respectively) and the hydroperoxy group is at position 9 (S configuration). It is an intermediate in the metabolic pathway for linoleic acid.
PC(18:2(9Z,12Z)/20:1(11Z))
PG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/20:1(11Z)/22:1(13Z))
DG(22:2(13Z,16Z)/22:0/0:0)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))
TG(22:2(13Z,16Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
Neuraminic acid
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:0)
TG(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Edetic Acid
TG(14:0/20:3n6/20:2n6)
PE(18:1(11Z)/16:1(9Z))
TG(20:0/18:2(9Z,12Z)/18:1(9Z))
TG(16:0/20:0/20:3n6)
TG(24:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/24:1(15Z))
PC(20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
Phenethylamine glucuronide
TG(20:0/18:0/14:1(9Z))
TG(20:1(11Z)/18:0/20:3(5Z,8Z,11Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/20:0/22:2(13Z,16Z))
TG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
PC(24:0/15:0)
DG(20:2(11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(20:2n6/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/22:0/24:1(15Z))
DG(18:2n6/0:0/22:4n6)
Ranolazine
3-Hydroxy-N6,N6,N6-trimethyl-L-lysine The 3-hydroxy derivative of N(6),N(6),N(6)-trimethyl-L-lysine
TG(15:0/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(22:0/20:3(5Z,8Z,11Z)/0:0)
DG(22:0/0:0/20:4n3)
PIP2(18:1(9Z)/18:2(9Z,12Z))
TG(14:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:0/20:1(11Z))
PE(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(18:3(9Z,12Z,15Z)/20:0/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/15:0/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
TG(14:0/20:1(11Z)/18:1(11Z))
Perillyl alcohol
TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/o-18:0)
Ecabet
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
Acetohexamide An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is replaced by a p-acetylphenylsulfonyl group, while a hydrogen attached to the other nitrogen is replaced by a cyclohexyl group.
Celecoxib
TG(18:1(11Z)/22:2(13Z,16Z)/20:3n6)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6/o-18:0)
5-HETE A HETE having a 5-hydroxy group and (6E)-, (8Z)-, (11Z)- and (14Z)-double bonds.
TG(18:0/16:0/22:2(13Z,16Z))
PC(P-18:1(11Z)/24:1(15Z))
TG(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(24:0/24:0/22:1(13Z))
3a,4b,12a-Trihydroxy-5b-cholanoic acid
TG(16:1(9Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/18:1(9Z)/22:1(13Z))
TG(18:1(11Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
CDP-glycerol A nucleotide-alditol having cytidine-5'-diphosphate and glycerol as the nucleotide and alditol components respectively.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:1(11Z)/18:1(11Z))
TG(20:1(11Z)/20:0/22:1(13Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
TG(18:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(16:1(9Z)/18:0/20:3n6)
TG(22:2(13Z,16Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z)/o-18:0)
TG(24:1(15Z)/22:1(13Z)/20:2n6)
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
PE(18:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:3(9Z,12Z,15Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/15:0/22:4(7Z,10Z,13Z,16Z))
PC(18:1(9Z)/16:0)
DG(16:1n7/0:0/22:6n3)
TG(20:2n6/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Galactosylglycerol
TG(18:1(11Z)/o-18:0/18:1(11Z))
TG(14:1(9Z)/20:2n6/o-18:0)
TG(14:1(9Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
PI(16:0/18:2(9Z,12Z))
Dodecanoic acid A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil.
TG(16:0/22:2(13Z,16Z)/24:1(15Z))
TG(18:1(11Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(14:1(9Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/20:3(5Z,8Z,11Z)/16:1(9Z))
TG(18:0/18:1(11Z)/18:2(9Z,12Z))
Bethanechol The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
PE(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
PE(16:1(9Z)/22:2(13Z,16Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(24:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(18:1(9Z)/14:0)
TG(15:0/18:0/14:1(9Z))
Phenylethylamine
11,12-EpETrE
DG(14:1n5/0:0/20:2n6)
TG(16:1(9Z)/22:1(13Z)/18:2(9Z,12Z))
Mannosyl-inositol-phosphorylceramide A class of complex phosphoglycosphingolipids with a mannose-inositol-P head group. As with other ceramide derivatives, substituents R(1) and R(2) vary with different sphingoid bases and fatty acyl moieties.
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:0/20:4(8Z,11Z,14Z,17Z))
5,6-Epoxy-8,11,14-eicosatrienoic acid
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:0)
PC(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:1(9Z)/18:0)
PE(22:2(13Z,16Z)/14:0)
TG(24:0/22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
PS(20:3(8Z,11Z,14Z)/18:1(9Z))
5-Aminopentanal An aldehyde that has formula C5H11NO.
TG(15:0/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(14:0/16:0/20:3(5Z,8Z,11Z))
Griseofulvin Antibiotic produced by Penicillium griseofulvum.
DG(22:2(13Z,16Z)/16:0/0:0)
TG(20:1(11Z)/22:2(13Z,16Z)/18:2(9Z,12Z))
Toremifene
TG(24:0/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
DG(20:1(11Z)/18:0/0:0)
Hexylcaine
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(o-18:1(11Z)/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
DG(18:2(9Z,12Z)/14:0/0:0)
TG(24:1(15Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/24:0/22:2(13Z,16Z))
TG(16:1(9Z)/24:0/o-18:0)
Pantoprazole A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
TG(20:2n6/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6/o-18:0)
TG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:2(11Z,14Z)/15:0/0:0)
TG(14:0/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
PE(16:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:2(13Z,16Z)/16:0)
TG(22:2(13Z,16Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
Isohyodeoxycholic acid
Ganglioside GT2 (d18:0/18:0)
TG(16:0/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(20:0/24:1(15Z)/22:2(13Z,16Z))
TG(16:1(9Z)/20:1(11Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/24:0/18:3(6Z,9Z,12Z))
TG(18:0/18:0/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/24:1(15Z)/18:1(11Z))
TG(20:0/24:1(15Z)/20:0)
TG(20:1(11Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(20:1(11Z)/18:2(9Z,12Z)/0:0)
DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/20:0)
TG(16:1(9Z)/18:1(9Z)/18:3(6Z,9Z,12Z))
CDP-DG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GD1a (d18:1/18:1(9Z))
TG(18:1(9Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
Estriol-17-glucuronide
TG(15:0/o-18:0/20:4(8Z,11Z,14Z,17Z))
Phenoxybenzamine
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(16:1(9Z)/16:1(9Z)/18:1(9Z))[iso3]
TG(20:0/22:2(13Z,16Z)/18:2(9Z,12Z))
TG(22:1(13Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/18:0/18:4(6Z,9Z,12Z,15Z))
PG(18:0/18:3(6Z,9Z,12Z))
PC(14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
DG(20:3(5Z,8Z,11Z)/16:0/0:0)
Olsalazine
Ganglioside GM1 (18:1/12:0)
TG(20:3(5Z,8Z,11Z)/14:0/20:3n6)
TG(24:0/16:0/18:3(9Z,12Z,15Z))
Tetrahydrofolyl-[Glu](n)
TG(20:4(5Z,8Z,11Z,14Z)/24:0/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/15:0/22:2(13Z,16Z))
PC(18:3(6Z,9Z,12Z)/24:1(15Z))
TG(22:1(13Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Brompheniramine Pheniramine in which the hydrogen at position 4 of the phenyl substituent is substituted by bromine. A histamine H1 receptor antagonist, brompheniramine is used (commonly as its maleate salt) for the symptomatic relief of allergic conditions, including rhinitis and conjunctivitis.
Ganglioside GM1 (d18:0/18:1(11Z))
TG(16:0/20:2n6/22:0)
TG(20:2n6/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
L-Asparagine An optically active form of asparagine having L-configuration.
TG(18:4(6Z,9Z,12Z,15Z)/22:0/18:4(6Z,9Z,12Z,15Z))
Acetohydroxamic Acid
DG(22:4n6/0:0/22:5n3)
TG(15:0/20:3n6/18:3(9Z,12Z,15Z))
PC(16:0/20:0)
Cerulenin An epoxydodecadienamide isolated from several species, including Acremonium, Acrocylindrum and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function.
TG(20:3n6/20:1(11Z)/20:3n6)
TG(20:0/20:3n6/20:4(5Z,8Z,11Z,14Z))
PC(16:0/22:0)
PE(20:0/18:3(9Z,12Z,15Z))
Ganglioside GT1b (d18:1/25:0)
TG(24:0/20:0/14:1(9Z))
PC(22:0/15:0)
PC(P-16:0/18:0)
TG(22:0/20:0/20:4(5Z,8Z,11Z,14Z))
TG(18:0/20:3n6/22:4(7Z,10Z,13Z,16Z))
D-Galactose
DG(16:0/18:3(6Z,9Z,12Z)/0:0)
TG(16:0/24:0/22:2(13Z,16Z))
TG(18:0/14:0/20:2n6)
Mepyramine An ethylenediamine derivative that is ethylenediamine in which one of the amino nitrogens is substituted by two methyl groups and the remaining amino nitrogen is substituted by a 4-methoxybenzyl and a pyridin-2-yl group.
TG(24:1(15Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:1(11Z)/16:1(9Z))
DG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/22:1(13Z))
PE(20:2(11Z,14Z)/P-18:0)
DG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
Heparin A highly sulfated linear glycosaminoglycan comprising complex patterns of uronic acid-(1->4)-D-glucosamine repeating subunits. Used as an injectable anticoagulant, it has the highest negative charge density of any known biological molecule.
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(16:1(9Z)/22:0/22:2(13Z,16Z))
Pyrimethamine
Tiaprofenic acid An aromatic ketone that is thiophene substituted at C-2 by benzoyl and at C-4 by a 1-carboxyethyl group.
TG(18:2(9Z,12Z)/14:0/18:3(9Z,12Z,15Z))[iso6]
PE(20:2(11Z,14Z)/P-16:0)
PIP2(20:4(8Z,11Z,14Z,17Z)/18:0)
TG(15:0/14:0/20:1(11Z))
DG(22:1n9/0:0/22:5n6)
TG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:2(11Z,14Z)/14:0/0:0)
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/18:1(11Z))
TG(20:2n6/18:3(6Z,9Z,12Z)/20:2n6)
TG(16:1(9Z)/o-18:0/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(20:0/14:1(9Z)/18:1(9Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]
TG(15:0/22:2(13Z,16Z)/16:1(9Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(20:0/18:0/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GD3 (d18:0/26:1(17Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:0/18:1(9Z))
Ganglioside GT3 (d18:0/24:1(15Z))
Ganglioside GT1b (d18:1/23:0)
TG(15:0/22:0/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/20:2n6/20:2n6)
TG(18:0/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
Retinyl ester A carboxylic ester obtained by formal condensation of the hydroxy group of retinol with the carboxy group of any carboxylic acid.
PC(P-18:1(9Z)/14:1(9Z))
TG(18:0/22:1(13Z)/o-18:0)
PE(P-18:0/16:0)
TG(16:0/20:3(5Z,8Z,11Z)/22:0)
PS(20:4(5Z,8Z,11Z,14Z)/14:0)
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/20:0/18:3(6Z,9Z,12Z))
TG(14:0/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/15:0/22:1(13Z))
TG(14:1(9Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:0/18:3(6Z,9Z,12Z))
TG(14:0/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/20:3(5Z,8Z,11Z)/20:0)
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
Lofexidine
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z)/o-18:0)
PE(P-18:0/14:0)
Galabiosylceramide (d18:1/22:0)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0/0:0)
DG(20:3n6/0:0/20:3n6)
Ganglioside GD2 (d18:1/12:0)
TG(18:0/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/22:0/20:2n6)
Ganglioside GD2 (d18:0/16:0)
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/20:3n6)
4-Methylpentanal An alpha-CH2-containing aldehyde that has formula C6H12O.
TG(18:2(9Z,12Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Galabiosylceramide (d18:1/24:0)
TG(22:1(13Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:3(5Z,8Z,11Z)/20:0)
TG(15:0/18:3(6Z,9Z,12Z)/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/15:0/o-18:0)
TG(20:2n6/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(24:0/o-18:0/18:1(9Z))
PC(20:1(11Z)/22:0)
TG(16:0/20:1(11Z)/20:2n6)
TG(22:0/20:2n6/22:0)
PE(22:0/18:1(11Z))
TG(22:0/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(22:0/20:3n6/18:1(9Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(18:1(11Z)/22:0/22:2(13Z,16Z))
Ceramide (d18:1/12:0)
DG(16:0/0:0/18:1n9)
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
PIP2(18:1(9Z)/18:0)
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
2-Bromoacetaldehyde An organobromine compound that has formula C2H3BrO.
TG(18:0/22:0/22:1(13Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(22:2(13Z,16Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/20:3n6/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/20:0/18:4(6Z,9Z,12Z,15Z))
TG(14:0/22:2(13Z,16Z)/20:0)
TG(20:4(8Z,11Z,14Z,17Z)/14:1(9Z)/o-18:0)
Propoxyphene A racemate of the (1R,2R)- and (1S,2R)- diastereoisomers.
TG(20:0/20:0/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(20:1(11Z)/16:1(9Z)/20:1(11Z))
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
8-oxo-dGDP A purine 2'-deoxyribonucleoside 5'-diphosphate having 8-oxoguanine as the nucleobase.
TG(20:2n6/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:1(9Z)/20:2n6)
Testosterone Propionate A steroid ester that has formula C22H32O3.
PE(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/22:0/22:1(13Z))
Metoclopramide A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
TG(18:3(6Z,9Z,12Z)/15:0/20:3n6)
TG(18:0/15:0/18:1(11Z))
Galactosylceramide (d18:1/18:0)
PG(18:2(9Z,12Z)/18:1(11Z))
Codeine-6-glucuronide A morphinane alkaloid that has formula C24H29NO9.
TG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:3n9/0:0/18:2n6)
Betazole Pyrazole in which a hydrogen adjacent to one of the nitrogen atoms is substituted by a 2-aminoethyl group. It is a histamine H2-receptor agonist used clinically to test gastric secretory function.
Terbutaline A member of the class of phenylethanolamines that is catechol substuted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
5a-Cholest-8-en-3b-ol
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(15:0/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
S-(Formylmethyl)glutathione A peptide that has formula C12H19N3O7S.
TG(15:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Metocurine Iodide
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Biotin An organic heterobicyclic compound that consists of 2-oxohexahydro-1H-thieno[3,4-d]imidazole having a valeric acid substituent attached to the tetrahydrothiophene ring. The parent of the class of biotins.
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
Allocholic acid A bile acid that has formula C24H40O5.
PE(P-16:0/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/16:0/20:3n6)
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(22:1(13Z)/14:1(9Z)/20:2n6)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0/0:0)
TG(20:1(11Z)/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/18:0/18:1(9Z))
Mevalonic acid A dihydroxy monocarboxylic acid comprising valeric acid having two hydroxy groups at the 3- and 5-positions together with a methyl group at the 3-position.
(S)-3-Hydroxyisobutyric acid A 3-hydroxyisobutyric acid that has formula C4H8O3.
TG(24:0/18:0/14:1(9Z))
TG(14:0/20:3(5Z,8Z,11Z)/20:0)
Phosphocreatine
TG(16:1(9Z)/18:2(9Z,12Z)/18:2(9Z,12Z))[iso3]
Galactosylceramide (d18:1/26:1(17Z))
TG(22:0/16:1(9Z)/24:1(15Z))
PIP(18:2(9Z,12Z)/20:1(11Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
DG(18:3(6Z,9Z,12Z)/22:1(13Z)/0:0)
DG(14:0/0:0/18:0)
Dezocine
PC(P-16:0/24:1(15Z))
PC(22:2(13Z,16Z)/16:0)
Trihexyphenidyl
N-Acetylglutamic acid
DG(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
Nelfinavir
TG(18:0/20:0/22:4(7Z,10Z,13Z,16Z))
TG(15:0/16:1(9Z)/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
MG(0:0/20:1(11Z)/0:0)
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/24:1(15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z)/o-18:0)
TG(18:2(9Z,12Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/24:0/22:2(13Z,16Z))
PC(22:2(13Z,16Z)/14:0)
Biocytin A monocarboxylic acid amide that results from the formal condensation of the carboxylic acid group of biotin with the N(6)-amino group of L-lysine.
Perhexiline
TG(20:2n6/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/22:2(13Z,16Z)/18:1(11Z))
TG(24:1(15Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/16:0/16:0)
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Orotidylic acid
Adenosylcobalamin
PI(20:3(8Z,11Z,14Z)/16:0)
Trospium
TG(14:1(9Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:3(6Z,9Z,12Z)/18:1(11Z))
CL(20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z))
Pectic acid An polyanionic polymer obtained by global deprotonation of the carboxy groups of pectin.
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
(S)-p-Mentha-1,8-dien-7-ol
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/24:1(15Z)/22:1(13Z))
TG(20:1(11Z)/22:2(13Z,16Z)/o-18:0)
PG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
D-1-Piperideine-2-carboxylic acid
PI(22:4(10Z,13Z,16Z,19Z)/16:0)
PS(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(22:0/o-18:0/24:0)
PG(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
DG(18:2(9Z,12Z)/16:1(9Z)/0:0)
TG(22:1(13Z)/20:2n6/20:2n6)
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
Tetrahexosylceramide (d18:1/25:0)
Coniferyl alcohol
PIP2(18:1(9Z)/16:1(9Z))
TG(18:0/18:3(9Z,12Z,15Z)/18:1(11Z))
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(20:0/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Heparan sulfate A linear polysaccharide in which the backbone consists of a variably sulfated repeating disaccharide unit.
TG(18:0/20:2n6/18:1(9Z))
Trandolapril
TG(24:1(15Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
TG(16:1(9Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(18:0/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z)/0:0)
DG(20:0/18:0/0:0)
Sotalol A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is sustituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
TG(14:0/16:1(9Z)/20:2n6)
PG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:0/16:1(9Z)/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:1(11Z)/20:3(5Z,8Z,11Z))
Diethylthiophosphate
TG(20:1(11Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PI(16:1(9Z)/18:1(9Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/20:3n6)
TG(14:0/14:1(9Z)/18:0)
PS(16:0/16:1(9Z))
Clobazam
TG(20:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/24:0/20:4(8Z,11Z,14Z,17Z))
PC(P-16:0/20:3(8Z,11Z,14Z))
TG(18:0/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:3(9Z,12Z,15Z)/P-16:0)
PE(P-18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/15:0/18:1(11Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
TG(14:0/20:1(11Z)/18:0)
TG(22:0/18:1(9Z)/20:2n6)
PE(16:0/P-18:1(11Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(24:1(15Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
PC(P-18:1(9Z)/18:1(11Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/24:0/18:2(9Z,12Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/14:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
LysoPE(0:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/o-18:0/15:0)
TG(22:0/20:3(5Z,8Z,11Z)/18:1(11Z))
TG(22:1(13Z)/24:0/22:4(7Z,10Z,13Z,16Z))
DG(18:0/14:1(9Z)/0:0)
TG(24:0/22:2(13Z,16Z)/16:1(9Z))
Ganglioside GD1b (d18:0/18:1(9Z))
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(P-18:1(11Z)/16:1(9Z))
Lactosamine A disaccharide that consists of D-glucosamine having a beta-D-galactosyl residue attached at position 4.
CL(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
PE(20:2(11Z,14Z)/18:1(11Z))
TG(20:1(11Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/14:0/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(16:0/20:3(5Z,8Z,11Z)/16:0)
TG(16:0/18:0/20:3n6)
PS(18:2(9Z,12Z)/14:1(9Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/15:0/18:3(6Z,9Z,12Z))
TG(15:0/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/14:0/24:1(15Z))
PS(14:0/14:0)
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
DG(20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)/0:0)
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(18:0/20:4(8Z,11Z,14Z,17Z)/24:0)
PE(20:2(11Z,14Z)/P-18:1(11Z))
DG(20:2(11Z,14Z)/20:1(11Z)/0:0)
PC(18:3(9Z,12Z,15Z)/18:0)
TG(16:0/15:0/22:0)
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
Minoxidil A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
R-95913
TG(20:0/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/20:2n6)
Nicotine glucuronide
TG(22:1(13Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/14:0/24:1(15Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/15:0/0:0)
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/24:0)
DG(22:0/0:0/22:6n3)
TG(20:0/22:1(13Z)/24:0)
TG(18:0/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
Amaranthin A disaccharide derivative that is betanidin in which a beta-D-glucuronosyl-(1->2)-beta-D-glucosyl moiety is attached at position 5.
Ganglioside GD3 (d18:1/26:1(17Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(18:0/18:3(6Z,9Z,12Z)/24:1(15Z))
PE(P-18:0/24:0)
TG(24:0/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:2(13Z,16Z)/22:2(13Z,16Z))
PC(18:0/22:0)
TG(16:0/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
Creatine
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GD1a (d18:0/12:0)
TG(18:3(6Z,9Z,12Z)/24:0/20:4(5Z,8Z,11Z,14Z))
Cholestenone
TG(22:2(13Z,16Z)/20:2n6/o-18:0)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
TG(22:0/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/15:0/22:2(13Z,16Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(18:2(9Z,12Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
PE(18:3(9Z,12Z,15Z)/22:1(13Z))
TG(18:1(9Z)/14:0/22:1(13Z))
TG(14:0/20:0/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
5-Hydroxy-6-methoxyindole glucuronide
PE(18:3(9Z,12Z,15Z)/18:0)
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/14:0/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/18:0/o-18:0)
TG(22:0/22:2(13Z,16Z)/24:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:0/20:0)
TG(20:2n6/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(20:3(5Z,8Z,11Z)/14:0/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:0/22:1(13Z))
TG(16:1(9Z)/20:0/20:1(11Z))[iso6]
TG(22:2(13Z,16Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(24:0/24:0/20:4(5Z,8Z,11Z,14Z))
TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))[iso3]
TG(18:1(9Z)/16:0/22:1(13Z))
Dimethylsulfide A methyl sulfide in which the sulfur atom is substituted by two methyl groups. It is produced naturally by some marine algae.
TG(16:0/22:0/18:3(6Z,9Z,12Z))
TG(16:0/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:2(11Z,14Z)/24:1(15Z))
27-Hydroxycholesterol
TG(18:1(11Z)/15:0/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Fondaparinux sodium An organic sodium salt, being the decasodium salt of fondaparinux.
PE(15:0/20:0)
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GQ1c (d18:1/14:0)
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
PS(14:0/18:3(9Z,12Z,15Z))
Primaquine A N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.
PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/o-18:0/24:1(15Z))
PE(20:0/20:2(11Z,14Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(16:0/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:3n6/o-18:0)
PC(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
LysoPE(0:0/16:0)
DG(20:4n3/0:0/22:6n3)
Fospropofol
PC(P-18:1(11Z)/18:1(9Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
Phenylbutazone A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
TG(22:0/16:0/18:1(11Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/18:2(9Z,12Z)/14:0)
5(S)-Hydroperoxyeicosatetraenoic acid
Probenecid
PE(24:0/20:0)
TG(18:3(9Z,12Z,15Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)/o-18:0)
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(15:0/18:1(9Z)/18:0)
TG(14:0/18:2(9Z,12Z)/16:0)
TG(24:1(15Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
MG(18:4(6Z,9Z,12Z,15Z)/0:0/0:0)
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(14:1(9Z)/22:0/22:1(13Z))
PE(P-18:0/20:3(5Z,8Z,11Z))
TG(14:0/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:3(6Z,9Z,12Z)/14:0)
PE(24:1(15Z)/20:2(11Z,14Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(24:1(15Z)/16:0/20:2n6)
TG(20:3(5Z,8Z,11Z)/14:0/20:3(5Z,8Z,11Z))
TG(22:2(13Z,16Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:1(13Z)/22:1(13Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(24:0/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
PE(22:1(13Z)/20:0)
TG(18:1(9Z)/18:2(9Z,12Z)/24:1(15Z))
TG(22:0/18:3(9Z,12Z,15Z)/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
PI(20:3(5Z,8Z,11Z)/18:1(9Z))
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/20:0/20:4(5Z,8Z,11Z,14Z))
TG(18:0/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
TG(20:2n6/22:0/20:4(5Z,8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
Chloroprocaine Procaine in which one of the hydrogens ortho- to the carboxylic acid group is substituted by chlorine. It is used as its monohydrochloride salt as a local anaesthetic, particularly for oral surgery. It has the advantage over lidocaine of constricting blood vessels, so reducing bleeding.
TG(22:1(13Z)/20:1(11Z)/22:2(13Z,16Z))
Cytarabine A pyrimidine nucleoside in which cytosine is attached to D-arabinofuranose via a beta-N(1)-glycosidic bond.
TG(15:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
PE(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
S-(2,2-Dichloro-1-hydroxy)ethyl glutathione A peptide that has formula C12H19Cl2N3O7S.
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
DG(16:0/0:0/18:2n6)
TG(22:0/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
Malonic acid An alpha,omega-dicarboxylic acid in which the two carboxy groups are separated by a single methylene group.
7 alpha,26-Dihydroxy-4-cholesten-3-one
DG(20:0/18:1(11Z)/0:0)
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(18:0/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/20:0/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:4(6Z,9Z,12Z,15Z)/15:0)
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/22:1(13Z)/22:2(13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/24:0/22:4(7Z,10Z,13Z,16Z))
3b-Hydroxy-5-cholenoic acid
D-Maltose
DG(24:1n9/0:0/20:4n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Hexanoylglycine
TG(16:0/o-18:0/24:0)
PC(22:0/20:0)
TG(14:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/24:0/20:4(8Z,11Z,14Z,17Z))
PG(18:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/14:0/18:2(9Z,12Z))[iso6]
PC(20:1(11Z)/P-18:1(11Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
Phenindamine
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/o-18:0)
PC(18:2(9Z,12Z)/14:1(9Z))
PG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/20:0/18:2(9Z,12Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(16:1(9Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(22:0/20:2n6/20:2n6)
TG(15:0/24:1(15Z)/22:2(13Z,16Z))
Glucaric acid A hexaric acid derived by oxidation of sugar such as glucose with nitric acid.
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PE(18:0/22:2(13Z,16Z))
Canavanine
DG(16:0/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(14:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:2n6/16:1(9Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/22:2(13Z,16Z)/16:1(9Z))
TG(22:1(13Z)/22:1(13Z)/22:1(13Z))
TG(22:1(13Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
DG(18:1n9/0:0/22:5n6)
PC(20:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:2(9Z,12Z)/22:1(13Z))
PC(P-18:0/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GA2 (d18:1/18:0)
TG(15:0/14:1(9Z)/16:0)
DG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/0:0)
TG(24:1(15Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/24:0/18:4(6Z,9Z,12Z,15Z))
2-Methylhippuric acid
PE(18:0/18:2(9Z,12Z))
TG(20:1(11Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/20:3n6/o-18:0)
TG(14:0/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
TG(20:3(5Z,8Z,11Z)/20:0/20:3n6)
TG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(16:0/15:0/22:2(13Z,16Z))
TG(24:0/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z))
all-trans-Decaprenyl diphosphate A decaprenyl diphosphate having (E)-stereochemistry exclusively in the double bonds.
TG(20:3n6/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
DG(18:1n7/0:0/20:4n6)
TG(16:1(9Z)/18:1(9Z)/20:3n6)
TG(18:1(11Z)/20:1(11Z)/20:1(11Z))
TG(20:3n6/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/14:0/18:3(9Z,12Z,15Z))
TG(24:0/15:0/16:1(9Z))
TG(24:0/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
DG(15:0/0:0/22:5n6)
TG(20:3n6/24:1(15Z)/o-18:0)
TG(15:0/15:0/20:3n6)
TG(18:3(9Z,12Z,15Z)/18:1(11Z)/o-18:0)
PG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GM2 (d18:1/14:0)
Dexbrompheniramine The (pharmacologically active) (S)-(+)-enantiomer of brompheniramine. A histamine H1 receptor antagonist, it is used (commonly as its maleate salt) for the symptomatic relief of allergic conditions, including rhinitis and conjunctivitis.
TG(18:1(11Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/15:0/22:1(13Z))
TG(14:0/20:0/24:1(15Z))
TG(22:0/15:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
PC(18:1(9Z)/P-18:0)
N-Acetylglutamine
TG(22:0/20:1(11Z)/24:1(15Z))
TG(15:0/16:1(9Z)/24:1(15Z))
TG(24:0/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/16:0/20:4(8Z,11Z,14Z,17Z))
DG(20:3n9/0:0/20:2n6)
TG(16:1(9Z)/14:0/18:1(11Z))[iso6]
TG(20:0/20:1(11Z)/20:2n6)
Ganglioside GM2 (d18:1/12:0)
Phosphite
TG(20:2n6/22:2(13Z,16Z)/20:2n6)
PI(18:3(9Z,12Z,15Z)/18:1(9Z))
DG(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(14:0/20:1(11Z)/o-18:0)
TG(18:0/18:0/16:1(9Z))
DG(20:0/0:0/18:1n9)
DG(18:1n7/0:0/18:3n3)
PI(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
UDP-D-galacturonate
TG(20:3(5Z,8Z,11Z)/20:0/20:2n6)
DG(18:4(6Z,9Z,12Z,15Z)/22:1(13Z)/0:0)
Ganglioside GM1 (d18:1/14:0)
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/18:1(9Z)/18:2(9Z,12Z))[iso3]
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PIP2(18:2(9Z,12Z)/20:1(11Z))
TG(18:3(6Z,9Z,12Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/14:1(9Z)/18:1(9Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(18:1(9Z)/22:0/22:2(13Z,16Z))
TG(20:2n6/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/20:2n6)
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:2n6)
TG(14:0/20:0/14:1(9Z))
TG(20:2n6/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/14:0/20:3(5Z,8Z,11Z))
PC(P-18:1(9Z)/20:1(11Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
DG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(22:0/20:3(5Z,8Z,11Z)/18:1(9Z))
TG(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(9Z,12Z,15Z)/24:0/18:3(9Z,12Z,15Z))
PIP(22:4(7Z,10Z,13Z,16Z)/16:0)
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(22:2(13Z,16Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(14:0/20:2n6/16:1(9Z))
2-Hydroxyphenethylamine
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(24:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:2(13Z,16Z)/20:2n6)
PE(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(16:1(9Z)/20:3n6/18:2(9Z,12Z))
PE(P-18:1(9Z)/20:3(8Z,11Z,14Z))
Trimeprazine
PC(P-18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(18:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
PE(22:1(13Z)/20:3(5Z,8Z,11Z))
Perillic acid A cyclohexenecarboxylic acid that has formula C10H14O2.
TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(24:1(15Z)/22:1(13Z)/20:3n6)
TG(16:0/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
PE(18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
TG(22:1(13Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:2n6/22:2(13Z,16Z))
TG(18:1(9Z)/22:0/20:2n6)
TG(16:0/16:0/18:1(9Z))[iso3]
N-Desmethyltamoxifen A stilbenoid that has formula C25H27NO.
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:0/18:4(6Z,9Z,12Z,15Z)/0:0)
CDP-DG(18:0/18:1(11Z))
PE(18:3(9Z,12Z,15Z)/P-18:1(11Z))
Propafenone An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
TG(16:0/20:0/22:0)
PI(18:1(11Z)/16:1(9Z))
TG(22:1(13Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/20:3n6/22:4(7Z,10Z,13Z,16Z))
DG(24:1(15Z)/20:3(5Z,8Z,11Z)/0:0)
Estrone glucuronide
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(16:0/16:1(9Z)/18:2(9Z,12Z))[iso6]
TG(18:1(11Z)/20:3n6/20:1(11Z))
TG(22:0/15:0/18:4(6Z,9Z,12Z,15Z))
PC(18:4(6Z,9Z,12Z,15Z)/16:0)
TG(22:0/14:1(9Z)/20:3(5Z,8Z,11Z))
PE(20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
2-Methylpropan-2-ol A tertiary alcohol alcohol that is isobutane substituted by a hydroxy group at position 2.
TG(15:0/18:1(9Z)/20:1(11Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/18:1(9Z)/20:1(11Z))[iso6]
Cyclic AMP
TG(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))
Salmeterol
PE(18:1(11Z)/22:2(13Z,16Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:0)
TG(15:0/20:3(5Z,8Z,11Z)/20:2n6)
TG(14:1(9Z)/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PIP2(18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(16:0/20:0/24:0)
TG(18:0/18:2(9Z,12Z)/14:1(9Z))
N-Dealkylated tolterodine
PE(P-18:0/18:2(9Z,12Z))
PA(16:0/18:2(9Z,12Z))
N-Acetylmuramate
TG(16:1(9Z)/24:0/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PIP(18:2(9Z,12Z)/20:2(11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/18:1(11Z)/o-18:0)
TG(20:0/20:2n6/24:1(15Z))
TG(22:0/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(24:0/24:0/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(16:0/22:1(13Z)/0:0)
PC(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(P-18:1(9Z)/20:0)
CDP-DG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/18:0/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
Indinavir
TG(15:0/24:0/18:2(9Z,12Z))
TG(15:0/22:2(13Z,16Z)/18:1(11Z))
TG(18:1(9Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
PE(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/15:0/24:1(15Z))
TG(14:0/22:1(13Z)/24:0)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
DG(18:0/18:3(6Z,9Z,12Z)/0:0)
PC(18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
N-Methylphenylethanolamine An alkaloid that is ethanolamine having the phenyl group at the 1-position and a methyl group attached to the nitrogen. It has been isolated from Halostachys caspica.
TG(18:3(6Z,9Z,12Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/14:1(9Z)/18:1(11Z))
TG(20:1(11Z)/20:1(11Z)/22:2(13Z,16Z))
TG(18:0/14:0/20:3(5Z,8Z,11Z))
Deoxyribose
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/18:3(6Z,9Z,12Z)/16:1(9Z))
TG(15:0/15:0/22:2(13Z,16Z))
Rosuvastatin
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/14:0/20:4(5Z,8Z,11Z,14Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Glycylproline
TG(20:1(11Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/22:2(13Z,16Z)/20:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/20:3n6/24:0)
TG(20:3n6/18:0/20:4(5Z,8Z,11Z,14Z))
TG(22:0/20:1(11Z)/22:0)
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
Trimethyl sulfonium A sulfonium compound in which the substituents on sulfur are three methyl groups. It is found in the midgut gland of the sea hare, Aplysia brasiliana, and exhibits probable ability to inhibit cholinergic responses.
TG(22:1(13Z)/20:0/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(14:1(9Z)/22:0/0:0)
PE(P-18:1(11Z)/24:1(15Z))
PE(22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Estradiol-17alpha 3-D-glucuronoside
Citalopram propionic acid A benzene that has formula C18H14FNO3.
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(16:0/18:3(6Z,9Z,12Z)/16:0)
TG(14:1(9Z)/16:1(9Z)/18:1(11Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:0)
TG(18:0/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
PE(P-18:1(11Z)/24:0)
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Chlormezanone
TG(14:1(9Z)/14:1(9Z)/o-18:0)
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:4n3/0:0/20:4n3)
PE(P-18:1(11Z)/22:0)
TG(18:0/20:1(11Z)/14:1(9Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z)/o-18:0)
TG(15:0/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:3(9Z,12Z,15Z)/22:0)
TG(18:1(9Z)/16:0/18:3(6Z,9Z,12Z))
TG(20:2n6/15:0/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:2n6)
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/14:0/16:1(9Z))[iso6]
TG(20:0/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:0/o-18:0)
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(20:0/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
Aflatoxin B1exo-8,9-epoxide-GSH
Vildagliptin
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:3(5Z,8Z,11Z)/20:2n6)
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/o-18:0/24:1(15Z))
TG(20:3n6/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:0/20:4(5Z,8Z,11Z,14Z))
PC(15:0/22:0)
Oxiconazole
TG(14:0/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(20:2(11Z,14Z)/24:0)
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/20:3n6)
DG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
11-Oxo-androsterone glucuronide
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
PE(16:0/18:0)
TG(18:1(9Z)/22:2(13Z,16Z)/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(20:3n6/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/22:1(13Z)/18:2(9Z,12Z))
PE(18:1(9Z)/15:0)
DG(16:0/0:0/22:2n6)
TG(14:0/20:2n6/20:1(11Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
2-Oxoclopidogrel
TG(22:0/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(20:0/15:0/20:1(11Z))
TG(20:2n6/15:0/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
PE(18:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(14:0/18:1(11Z)/22:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
L-Alanine The L-enantiomer of alanine.
TG(18:0/15:0/22:0)
PE(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
DG(20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z)/0:0)
PE(20:3(8Z,11Z,14Z)/20:1(11Z))
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:0/22:4(7Z,10Z,13Z,16Z))
Ganglioside GM1 (d18:0/26:1(17Z))
PC(16:0/20:4(5Z,8Z,11Z,14Z))
Risperidone A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
TG(18:0/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
cyclic GMP-AMP An organophosphate oxoanion obtained by deprotonation of the phosphate OH groups of c-GMP-AMP; major species at pH 7.3.
TG(20:0/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Lycopene An acyclic carotene commonly obtained from tomatoes and other red fruits.
DG(20:1(11Z)/24:0/0:0)
TG(18:2(9Z,12Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
CL(20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z))
TG(24:1(15Z)/20:2n6/20:3n6)
Lenalidomide
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(24:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/20:3n6)
PC(20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(14:0/18:1(11Z)/20:0)
TG(18:1(11Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PIP(18:0/16:1(9Z))
TG(20:0/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/22:1(13Z))
PE(20:3(5Z,8Z,11Z)/20:2(11Z,14Z))
TG(18:3(9Z,12Z,15Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(o-22:0/20:1(11Z))
TG(20:0/20:0/18:1(11Z))
TG(16:0/20:1(11Z)/22:1(13Z))
PE(20:4(5Z,8Z,11Z,14Z)/15:0)
TG(20:3(5Z,8Z,11Z)/20:3n6/24:1(15Z))
TG(18:0/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/22:0/20:3(5Z,8Z,11Z))
Aflatoxin B1 diol A coumarin that has formula C17H14O8.
TG(16:1(9Z)/20:2n6/20:3n6)
TG(18:1(9Z)/o-18:0/18:2(9Z,12Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(16:1(9Z)/24:1(15Z))
TG(20:2n6/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(22:0/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
Remoxipride
TG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/15:0/24:1(15Z))
Acetoacetic acid A 3-oxo monocarboxylic acid that is butyric acid bearing a 3-oxo substituent.
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
DG(18:0/0:0/22:4n6)
DG(24:0/16:0/0:0)
TG(18:0/20:2n6/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/24:1(15Z)/20:2n6)
PIP(16:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(9Z))
TG(18:0/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/24:0/18:3(9Z,12Z,15Z))
PIP2(16:0/22:4(7Z,10Z,13Z,16Z))
Phenazopyridine
11b-PGF2a
PC(P-18:1(11Z)/15:0)
TG(20:0/20:3n6/o-18:0)
Phenindione
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/o-18:0/22:2(13Z,16Z))
Methionine sulfoxide
PS(18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:2n6/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GQ1c (d18:1/24:0)
PS(16:0/18:1(9Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
CDP-DG(18:1(11Z)/18:1(11Z))
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/18:1(9Z)/20:3n6)
Ganglioside GT3 (d18:0/14:0)
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/18:3(9Z,12Z,15Z)/16:1(9Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/20:3n6)
DG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
Pipecolic acid A piperidinemonocarboxylic acid in which the carboxy group is located at position C-2.
PI(18:2(9Z,12Z)/20:0)
CDP-DG(18:0/22:3(10Z,13Z,16Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/20:2n6/18:2(9Z,12Z))
DG(14:0/0:0/18:1n9)
TG(15:0/16:1(9Z)/14:1(9Z))
Ganglioside GQ1c (d18:1/26:0)
TG(16:0/22:0/16:1(9Z))
TG(14:1(9Z)/18:0/18:2(9Z,12Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/15:0/22:2(13Z,16Z))
DG(16:0/14:1(9Z)/0:0)
(R)-3-Hydroxydodecanoic acid
PC(16:1(9Z)/20:3(8Z,11Z,14Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
(2R)-2-Hydroxy-2-methylbutanenitrile The (2R)-enantiomer of 2-hydroxy-2-methylbutanenitrile.
TG(16:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:0/20:0)[iso3]
PIP(16:0/20:2(11Z,14Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Fluticasone Propionate A trifluorinated corticosteroid that consits of 6alpha,9-difluoro-11beta,17alpha-dihydroxy-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-16-methyl-3-oxoandrosta-1,4-diene bearing a propionyl substituent at position 17; has anti-inflammatory, anti-asthmatic and anti-allergic activity.
TG(20:2n6/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
(R)-3-Hydroxyoctanoic acid The (R)-enantiomer of 3-hydroxyoctanoic acid; an important building block in the biomedical and pharmaceutical fields.
Aminosalicylic Acid
TG(14:0/20:3n6/15:0)
TG(18:0/o-18:0/18:1(9Z))
TG(22:1(13Z)/14:1(9Z)/20:3n6)
TG(20:3n6/22:2(13Z,16Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
PE(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/18:0/18:1(11Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(20:3n6/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Phosphatidylserine
TG(18:1(11Z)/16:1(9Z)/18:1(9Z))[iso6]
Pipotiazine
TG(22:5(7Z,10Z,13Z,16Z,19Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
Alclometasone A prednisolone compound having an alpha-chloro substituent at the 7-position and an alpha-methyl substituent at the 16-position.
TG(20:3n6/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
Methazolamide
TG(18:1(9Z)/18:2(9Z,12Z)/o-18:0)
TG(16:1(9Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
7-Hydroxygliclazide
Oxacillin A penicillin antibiotic carrying a 5-methyl-3-phenylisoxazole-4-carboxamide group at position 6.
TG(20:0/24:1(15Z)/o-18:0)
Testosterone glucuronide
PE(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(16:0/20:0/20:3(5Z,8Z,11Z))
DG(20:1n9/0:0/24:1n9)
TG(18:1(9Z)/18:0/18:2(9Z,12Z))
PC(o-18:0/18:0)
TG(15:0/22:2(13Z,16Z)/22:0)
TG(14:1(9Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:0/18:3(9Z,12Z,15Z))
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(20:3n6/18:1(11Z)/20:3n6)
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(14:0/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/16:1(9Z)/22:2(13Z,16Z))
Fenoprofen Propanoic acid in which one of the hydrogens at position 2 is substituted by a 3-phenoxyphenyl group. A non-steroidal anti-inflammatory drug, the dihydrate form of the calcium salt is used for the management of mild to moderate pain and for the relief of pain and inflammation associated with disorders such as arthritis. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.
TG(15:0/22:2(13Z,16Z)/20:0)
PS(16:0/18:2(9Z,12Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(22:2(13Z,16Z)/14:0/18:4(6Z,9Z,12Z,15Z))
Guanosine 3',5'-bis(diphosphate) A guanosine bisphosphate having diphosphate groups at both the 3' and 5'-positions.
TG(16:0/14:1(9Z)/16:0)
DG(14:1(9Z)/20:3(8Z,11Z,14Z)/0:0)
TG(20:0/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
Ganglioside GM1 (d18:1/25:0)
TG(14:0/20:3(5Z,8Z,11Z)/24:1(15Z))
Methanol
PG(16:1(9Z)/18:3(9Z,12Z,15Z))
MG(0:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(24:0/20:1(11Z)/18:1(11Z))
PA(P-16:0e/18:2(9Z,12Z))
TG(18:1(9Z)/20:3n6/20:3n6)
TG(16:1(9Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
Lactosylceramide (d18:1/12:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(16:0/20:1(11Z)/20:1(11Z))[iso3]
TG(14:1(9Z)/22:2(13Z,16Z)/20:2n6)
Ganglioside GD1b (d18:1/26:0)
PE(22:1(13Z)/P-18:1(9Z))
PI(18:3(6Z,9Z,12Z)/22:3(10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(24:1(15Z)/24:1(15Z)/18:2(9Z,12Z))
TG(16:0/18:1(9Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:2n6)
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:0/0:0/18:1n9)
Tubocurarine
TG(18:2(9Z,12Z)/22:0/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/22:2(13Z,16Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(14:1(9Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/20:0/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Caprylic acid
TG(22:0/18:1(11Z)/18:1(9Z))
PE(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/14:1(9Z)/18:1(9Z))
TG(18:0/18:1(9Z)/14:1(9Z))
PC(24:1(15Z)/18:3(6Z,9Z,12Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
D-Xylulose 1-phosphate
TG(18:1(11Z)/18:2(9Z,12Z)/20:1(11Z))
TG(18:0/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
PC(22:1(13Z)/18:0)
Dihydropteridine
TG(20:2n6/24:0/20:2n6)
PC(18:2(9Z,12Z)/20:0)
DG(22:1(13Z)/18:3(6Z,9Z,12Z)/0:0)
TG(24:1(15Z)/24:0/24:1(15Z))
TG(14:1(9Z)/18:0/24:1(15Z))
Almotriptan
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/24:0/22:1(13Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Trimetrexate
TG(14:1(9Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
LysoPC(22:2(13Z,16Z))
TG(24:0/20:3n6/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(20:0/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(15:0/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/o-18:0)
PI(16:0/20:3(8Z,11Z,14Z))
TG(16:0/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/14:0/18:4(6Z,9Z,12Z,15Z))
PE(22:1(13Z)/18:2(9Z,12Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/15:0/20:4(5Z,8Z,11Z,14Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z))
Norelgestromin
Amrinone
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:0/20:4(8Z,11Z,14Z,17Z))
DG(24:0/0:0/20:4n6)
TG(18:4(6Z,9Z,12Z,15Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
DG(22:5(4Z,7Z,10Z,13Z,16Z)/16:0/0:0)
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(16:0/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:0/20:4(5Z,8Z,11Z,14Z))
TG(20:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/14:1(9Z)/o-18:0)
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
Tofisopam
Ganglioside GM1 (18:1/20:0)
TG(20:0/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/20:3n6/24:1(15Z))
TG(16:1(9Z)/18:1(9Z)/22:1(13Z))
DG(18:0/22:1(13Z)/0:0)
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/15:0/22:4(7Z,10Z,13Z,16Z))
TG(15:0/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
Cephaloglycin
Amifostine An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
TG(14:1(9Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PI(20:3(8Z,11Z,14Z)/18:0)
TG(24:0/16:1(9Z)/22:1(13Z))
Sandosaponin B
Sandosaponin A
TG(15:0/24:1(15Z)/24:0)
DG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
DG(18:0/0:0/14:1n5)
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Citrulline
DG(18:4(6Z,9Z,12Z,15Z)/16:1(9Z)/0:0)
TG(16:0/20:1(11Z)/22:2(13Z,16Z))
TG(22:1(13Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/24:0)
TG(18:3(6Z,9Z,12Z)/14:0/22:4(7Z,10Z,13Z,16Z))
Deoxyuridine triphosphate
TG(20:3n6/18:1(9Z)/18:3(9Z,12Z,15Z))
DG(24:0/20:4(8Z,11Z,14Z,17Z)/0:0)
Hesperetin A trihydroxyflavanone having the three hydroxy gropus located at the 3'-, 5- and 7-positions and an additional methoxy substituent at the 4'-position.
Dolichyl beta-D-mannosyl phosphate
PC(P-18:1(9Z)/18:2(9Z,12Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(20:3(8Z,11Z,14Z)/P-18:1(9Z))
TG(15:0/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:2n6/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PIP2(18:0/18:2(9Z,12Z))
DG(15:0/0:0/18:4n3)
TG(24:0/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
Dolichol phosphate
TG(20:4(8Z,11Z,14Z,17Z)/20:0/20:4(8Z,11Z,14Z,17Z))
PE(P-18:0/20:3(8Z,11Z,14Z))
TG(18:1(11Z)/22:2(13Z,16Z)/20:1(11Z))
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
DG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:1(9Z)/20:3n6/22:2(13Z,16Z))
Imidazole
PE(20:3(8Z,11Z,14Z)/20:2(11Z,14Z))
PS(20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
Amoxicillin A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group.
TG(20:3(5Z,8Z,11Z)/15:0/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(22:0/22:1(13Z)/22:1(13Z))
Ganglioside GQ1c (d18:0/16:0)
trans-2-Methyl-5-isopropylhexa-2,5-dienoyl-CoA An organic molecule that has formula C31H50N7O17P3S.
TG(16:0/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
5b-Dihydrotestosterone
TG(20:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
TG(20:2n6/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:4(5Z,8Z,11Z,14Z)/P-16:0)
PC(20:1(11Z)/P-18:1(9Z))
PE(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:1(11Z)/18:2(9Z,12Z))
TG(16:0/24:1(15Z)/18:3(9Z,12Z,15Z))
11b,17a,21-Trihydroxypreg-nenolone
TG(15:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/18:0/o-18:0)
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
TG(16:0/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
PS(18:1(9Z)/16:1(9Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/16:0)
TG(22:4(7Z,10Z,13Z,16Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(16:1(9Z)/18:3(9Z,12Z,15Z)/0:0)
TG(14:1(9Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PE(18:1(9Z)/18:2(9Z,12Z))
TG(14:1(9Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GQ1c (d18:0/14:0)
TG(18:2(9Z,12Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
N-Acetyllactosamine A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre.
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(o-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:1(13Z)/20:3n6)
TG(18:0/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/24:0/18:3(9Z,12Z,15Z))
TG(24:0/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/18:0/o-18:0)
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
CL(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
MG(18:3(6Z,9Z,12Z)/0:0/0:0)
TG(16:1(9Z)/22:2(13Z,16Z)/20:3n6)
Porphinehexacarboxylic acid
Cholestane-3,7,12,25-tetrol-3-glucuronide
TG(14:0/24:1(15Z)/24:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
LysoPC(20:2(11Z,14Z))
PC(20:3(5Z,8Z,11Z)/14:1(9Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(20:3(5Z,8Z,11Z)/14:0)
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
PC(18:0/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/22:1(13Z)/14:1(9Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
D-Tartaric acid The D-enantiomer of tartaric acid.
DG(20:3(5Z,8Z,11Z)/18:0/0:0)
DG(15:0/0:0/16:1n7)
Selenocystathionine A member of the class of cystathionines derived from homoselenocysteine and serine residues joined by a selenide bond.
TG(24:1(15Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/18:1(11Z)/20:2n6)
TG(18:0/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(20:1n9/0:0/20:3n6)
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Adenosine A ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a beta-N(9)-glycosidic bond.
TG(14:1(9Z)/24:0/22:1(13Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
DG(16:1(9Z)/18:1(9Z)/0:0)
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
2-Hydroxychlorpropamide
TG(18:1(11Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:1(11Z)/20:3n6)
Deoxycholic acid 3-glucuronide
TG(16:0/20:1(11Z)/18:1(9Z))
CL(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/16:0)
TG(18:1(11Z)/15:0/o-18:0)
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z)/0:0)
TG(20:0/20:0/20:3n6)
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(16:1(9Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
1D-Myo-inositol 1,4-bisphosphate A myo-inositol bisphosphate that has formula C6H14O12P2.
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/18:2(9Z,12Z))
TG(18:1(11Z)/20:3n6/22:2(13Z,16Z))
Trichloroethylene
DG(22:1n9/0:0/18:3n3)
DG(22:0/18:2(9Z,12Z)/0:0)
TG(20:1(11Z)/15:0/20:4(8Z,11Z,14Z,17Z))
PG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(20:4(8Z,11Z,14Z,17Z)/18:0)
TG(22:1(13Z)/22:2(13Z,16Z)/20:2n6)
TG(20:3(5Z,8Z,11Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:0/18:1(11Z))
TG(15:0/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(20:0/14:0/14:1(9Z))
PC(20:4(8Z,11Z,14Z,17Z)/P-18:1(11Z))
TG(14:1(9Z)/15:0/20:3(5Z,8Z,11Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:1(9Z)/20:3n6)
PE(20:3(8Z,11Z,14Z)/20:0)
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(18:0/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/18:0/22:2(13Z,16Z))
Risedronate
DG(18:3(9Z,12Z,15Z)/15:0/0:0)
TG(16:1(9Z)/24:0/24:1(15Z))
DG(14:1(9Z)/20:2(11Z,14Z)/0:0)
DG(20:4(5Z,8Z,11Z,14Z)/14:0/0:0)
Glutaric acid An alpha,omega-dicarboxylic acid that is a linear five-carbon dicarboxylic acid.
TG(18:3(6Z,9Z,12Z)/o-18:0/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/18:0/22:4(7Z,10Z,13Z,16Z))
TG(22:0/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
PIP(18:0/18:1(9Z))
Trihydroxycoprostanoic acid
Methylhippuric acid An N-acylamino acid that is the N-benzoyl derivative of alanine.
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
PC(14:0/P-16:0)
PIP(18:1(9Z)/18:1(11Z))
TG(18:1(11Z)/20:3n6/18:1(11Z))
TG(20:3n6/24:0/18:3(9Z,12Z,15Z))
TG(24:0/18:1(9Z)/22:1(13Z))
TG(18:2(9Z,12Z)/20:3n6/18:2(9Z,12Z))
DG(18:1n9/0:0/22:4n6)
N-Acetyl-D-Glucosamine 6-Phosphate An N-acyl-D-glucosamine 6-phosphate that is the N-acetyl derivative of D-glucosamine 6-phosphate. It is a component of the aminosugar metabolism.
Amiloride A monocarboxylic acid amide that is N-carbamimidoylpyrazine-2-carboxamide substituted by amino groups at positions 3 and 5 and a chloro group at position 6.
TG(20:0/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Sedoheptulose 1-phosphate A ketoheptose phosphate that has formula C7H15O10P.
TG(18:2(9Z,12Z)/18:0/o-18:0)
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
3-Methyladenine A methyladenine that is adenine substituted with a methyl group at position N-3.
TG(16:0/16:1(9Z)/20:0)[iso6]
TG(22:0/20:2n6/20:3n6)
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(15:0/20:0/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(14:1(9Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(16:1(9Z)/16:1(9Z))
TG(20:3(5Z,8Z,11Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PS(16:0/14:0)
TG(20:4(8Z,11Z,14Z,17Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/22:1(13Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
LysoPE(0:0/18:0)
TG(22:0/18:2(9Z,12Z)/22:1(13Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(14:1(9Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:2(13Z,16Z)/18:1(9Z))
TG(22:2(13Z,16Z)/15:0/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(20:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
trans-3-Chloroallyl aldehyde
16b-Hydroxyestrone
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3n6)
TG(24:1(15Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
LysoPE(14:0/0:0)
TG(18:0/24:0/22:1(13Z))
TG(16:0/16:0/20:3n6)
TG(22:0/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
PIP(18:2(9Z,12Z)/20:0)
Glucosylceramide (d18:1/18:0)
PA(16:0/18:1(11Z))
PIP2(18:2(9Z,12Z)/18:0)
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
DG(18:0/0:0/18:1n7)
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]-4'-O-beta-D-glucuronide
Isodeoxycholic acid A cholanoid that has formula C24H40O4.
PE(18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
DG(18:4n3/0:0/22:5n3)
TG(20:0/20:2n6/18:1(9Z))
TG(15:0/16:0/20:4(8Z,11Z,14Z,17Z))
heparan sulfate alpha-D-glucosaminide A heparan sulfate having an alpha-D-glucosaminyl residue at the non-reducing end. The heparan sulfate part consists of a variably sulfated repeating disaccharide unit.
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/18:0/18:2(9Z,12Z))[iso3]
TG(22:0/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
CL(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z))
Granisetron
TG(20:4(5Z,8Z,11Z,14Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:0/20:4(8Z,11Z,14Z,17Z))
MG(0:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
PC(18:0/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
2-Methoxyestrone 3-glucuronide
Didanosine A purine 2',3'-dideoxyribonucleoside that is inosine in which the hydroxy groups at both the 2' and the 3' positions on the sugar moiety have been replaced by hydrogen.
TG(24:0/18:1(11Z)/16:1(9Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:1(9Z)/20:3(8Z,11Z,14Z)/0:0)
PS(18:1(9Z)/16:0)
Ceftriaxone A cephalosporin compound having 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetylamino and [(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl side-groups.
TG(18:4(6Z,9Z,12Z,15Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(14:0/18:0/0:0)
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
DG(20:0/14:0/0:0)
TG(22:2(13Z,16Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:0/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/16:0/18:1(9Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
Alcaftadine
4a-Methylzymosterol-4-carboxylic acid
Deoxyribose 1-phosphate
TG(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/15:0/20:0)
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/22:2(13Z,16Z)/18:1(9Z))
TG(20:0/o-18:0/20:2n6)
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/22:1(13Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/20:3n6/24:0)
LysoPE(18:2(9Z,12Z)/0:0)
PC(18:1(9Z)/22:1(13Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
PE(P-18:1(9Z)/16:0)
TG(24:1(15Z)/20:3n6/18:3(9Z,12Z,15Z))
Disopyramide A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
PS(18:1(9Z)/14:0)
TG(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PS(18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
PE(24:0/18:1(11Z))
Prostaglandin E1 A prostaglandins E that has formula C20H34O5.
Prostaglandin E2 Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.
Atomoxetine A secondary amino compound having methyl and 3-(2-methylphenoxy)-3-phenylpropan-1-yl substituents.
Retinoyl b-glucuronide
TG(16:0/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
PE(15:0/P-18:0)
TG(18:0/18:2(9Z,12Z)/o-18:0)
TG(22:0/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(20:1(11Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(15:0/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/18:3(9Z,12Z,15Z)/22:1(13Z))
DG(18:1(11Z)/18:2(9Z,12Z)/0:0)
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(22:0/14:0/22:0)
TG(20:1(11Z)/16:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/18:1(11Z)/18:2(9Z,12Z))
Minocycline A tetracycline analogue having a dimethylamino group at position 7 and lacking the methyl and hydroxy groups at position 5.
TG(20:3n6/15:0/18:4(6Z,9Z,12Z,15Z))
DG(14:1(9Z)/18:1(9Z)/0:0)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/22:0/20:3n6)
CE(20:3(5Z,8Z,11Z))
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/18:3(9Z,12Z,15Z)/24:1(15Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
PC(o-22:0/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
PE(15:0/P-16:0)
TG(14:0/14:0/18:1(11Z))
DG(15:0/15:0/0:0)
TG(18:1(11Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:1(11Z)/16:0)
Quinethazone
PC(20:3(8Z,11Z,14Z)/18:1(11Z))
TG(24:0/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/16:0/22:4(7Z,10Z,13Z,16Z))
TG(14:0/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(16:0/24:0/16:1(9Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(24:0/22:1(13Z)/24:1(15Z))
DG(20:1n9/0:0/22:2n6)
TG(15:0/16:0/20:4(5Z,8Z,11Z,14Z))[iso6]
PE(P-16:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/22:1(13Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PIP2(20:4(5Z,8Z,11Z,14Z)/18:0)
TG(18:0/18:3(6Z,9Z,12Z)/16:1(9Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GD1a (d18:1/24:0)
TG(18:3(6Z,9Z,12Z)/16:0/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/20:3(5Z,8Z,11Z))
PE(20:0/14:1(9Z))
DG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/0:0)
TG(24:1(15Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS(18:1(9Z)/18:2(9Z,12Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/18:1(11Z))
TG(16:1(9Z)/20:2n6/22:1(13Z))
TG(15:0/20:0/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/o-18:0)
TG(22:0/14:0/24:0)
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/16:1(9Z)/18:0)
Linezolid
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(20:0/16:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/18:0/22:2(13Z,16Z))
PC(20:3(8Z,11Z,14Z)/20:1(11Z))
PE(P-18:1(9Z)/18:1(11Z))
PE(16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
PC(P-18:1(11Z)/20:2(11Z,14Z))
Diphenylpyraline
4-Hydroxyphenyl acetate
DG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:3(5Z,8Z,11Z)/24:0/22:1(13Z))
TG(18:1(9Z)/15:0/18:4(6Z,9Z,12Z,15Z))
DG(20:3(8Z,11Z,14Z)/20:1(11Z)/0:0)
TG(20:3n6/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
2-Aminobenzoic acid An aminobenzoic acid that is benzoic acid having a single amino substituent located at position 2. It is a metabolite produced in L-tryptophan-kynurenine pathway in the central nervous system.
TG(18:4(6Z,9Z,12Z,15Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/24:1(15Z)/24:1(15Z))
TG(20:0/22:0/o-18:0)
TG(22:0/18:3(6Z,9Z,12Z)/18:1(9Z))
TG(18:2(9Z,12Z)/22:0/o-18:0)
PC(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(22:1(13Z)/14:0/24:1(15Z))
Glycerophosphocholine The glycerol phosphate ester of a phosphocholine. A nutrient with many different roles in human health.
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:2n6/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
SM(d18:0/20:0)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
TG(20:1(11Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
Sorbitol
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
Probucol
TG(24:0/o-18:0/18:4(6Z,9Z,12Z,15Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:0)
PC(P-18:1(11Z)/22:1(13Z))
TG(18:0/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(P-16:0/18:4(6Z,9Z,12Z,15Z))
TG(18:0/o-18:0/18:3(6Z,9Z,12Z))
TG(20:0/18:0/22:1(13Z))
Salicylate-sodium
TG(18:4(6Z,9Z,12Z,15Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
Ribose 1-phosphate
PC(18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/16:0)
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/o-18:0)
TG(22:0/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-16:0)
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
cis-3-Chloro-2-propene-1-ol
Ganglioside GT1c (d18:1/24:0)
TG(16:1(9Z)/24:1(15Z)/20:1(11Z))
TG(24:0/22:0/20:4(5Z,8Z,11Z,14Z))
PE(22:0/20:2(11Z,14Z))
TG(16:1(9Z)/16:0/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
TG(22:0/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(24:0/o-18:0/18:1(11Z))
TG(14:1(9Z)/15:0/20:1(11Z))
TG(14:1(9Z)/16:1(9Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/18:2(9Z,12Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
4-Hydroxycyclophosphamide A phosphorodiamide that consists of 2-amino-1,3,2-oxazaphosphinan-4-ol 2-oxide having two 2-chloroethyl groups attached to the exocyclic nitrogen.
TG(18:1(11Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
1D-Myo-inositol 1,4,5,6-tetrakisphosphate A myo-inositol tetrakisphosphate having the four phosphate groups at the 1-, 4-, 5- and 6-positions.
DG(18:1(11Z)/18:3(6Z,9Z,12Z)/0:0)
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
PS(18:0/14:0)
Farnesylcysteine
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/15:0)
TG(22:1(13Z)/18:2(9Z,12Z)/20:3n6)
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
Guanadrel Sulfate A sulfate salt resulting from the reaction of 2 eq. guanadrel with 1 eq. sulfuric acid. A postganglionic adrenergic blocking agent formerly used for the management of hypertension, it has been largely superseded by other drugs less likely to cause orthostatic hypotension (dizzy spells on standing up or stretching).
Sulfurous acid A sulfur oxoacid that has formula H2O3S.
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
Clidinium The ester resulting from formal condensation of benzilic acid and 3-hydroxy-1-methyl-1-azoniabicyclo[2.2.2]octane. It is used, generally as the bromide, for the symptomatic treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:0/20:4(8Z,11Z,14Z,17Z))
PC(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/18:1(11Z)/o-18:0)
TG(15:0/14:1(9Z)/24:1(15Z))
Ganglioside GM2 (d18:0/24:1(15Z))
TG(18:0/22:1(13Z)/22:2(13Z,16Z))
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GT1c (d18:1/22:0)
Adenosine 3',5'-diphosphate
1-hydroxy-2-Oxopropyl tetrahydropterin
TG(18:3(6Z,9Z,12Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/24:1(15Z)/20:3n6)
Ganglioside GM1 (d18:0/12:0)
TG(18:0/24:0/24:1(15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/22:2(13Z,16Z))
Neolactotetraose
TG(15:0/20:0/18:2(9Z,12Z))
TG(14:0/16:0/18:1(9Z))
TG(24:0/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(24:0/16:0)
TG(15:0/18:0/20:2n6)
TG(20:0/20:1(11Z)/18:1(11Z))
(R)-3-Hydroxy-tetradecanoic acid A C14, long-chain hydroxy fatty acid which plays an intermediate role in fatty acid biosynthesis.
PE(24:0/14:0)
DG(20:2(11Z,14Z)/16:0/0:0)
TG(16:0/20:3n6/18:3(6Z,9Z,12Z))
TG(16:0/16:0/24:0)
TG(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
TG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(P-16:0/18:3(9Z,12Z,15Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)
Hydrocortisone
TG(24:0/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/16:0/18:4(6Z,9Z,12Z,15Z))
Chloropyramine
TG(22:0/14:0/18:4(6Z,9Z,12Z,15Z))
Nitrofurazone
TG(14:0/18:0/20:4(5Z,8Z,11Z,14Z))
6-Hydroxyfluvastatin
TG(16:0/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:2n6/o-18:0)
TG(20:0/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(16:1(9Z)/14:0)
TG(18:0/16:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(20:0/o-18:0/18:2(9Z,12Z))
TG(16:0/14:0/22:0)
Candoxatril The 2,3-dihydro-1H-inden-5-yl ester of the active enantiomer of candoxatrilat. Candoxatril is an orally active prodrug of candoxatrilat, a potent neutral endopeptidase (NEP, neprilysin) inhibitor used in the treatment of chronic heart failure.
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0)
TG(18:3(6Z,9Z,12Z)/20:3n6/20:2n6)
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/22:0/18:3(9Z,12Z,15Z))
TG(22:0/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/14:0/20:0)
3-Hydroxybutyryl-CoA
TG(20:1(11Z)/22:2(13Z,16Z)/24:1(15Z))
TG(20:0/20:3(5Z,8Z,11Z)/14:1(9Z))
TG(14:0/22:0/18:3(6Z,9Z,12Z))
PG(18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/16:1(9Z)/20:3n6)
LysoPE(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:0/18:3(9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
Testolactone
TG(22:1(13Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(18:1(9Z)/22:0)
TG(14:0/24:0/16:1(9Z))
TG(14:1(9Z)/16:1(9Z)/16:1(9Z))
3 beta,7 alpha-Dihydroxy-5-cholestenoate A cholanoid that has formula C27H44O4.
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
Promethazine A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.
TG(22:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GT2 (d18:1/24:0)
Pentanal A fatty aldehyde composed from five carbons in a straight chain
TG(14:1(9Z)/15:0/16:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
Anagrelide A 1,5-dihydroimidazo[2,1-]quinazoline having an oxo substituent at the 2-position and chloro substituents at the 6- and 7-positions.
TG(22:0/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/20:3n6/o-18:0)
TG(24:0/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(16:0/18:1(9Z))
Norepinephrine
TG(18:2(9Z,12Z)/18:0/18:2(9Z,12Z))
PE(22:1(13Z)/18:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PC(22:0/16:0)
DG(18:3(6Z,9Z,12Z)/24:0/0:0)
TG(18:0/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/20:1(11Z)/20:3(5Z,8Z,11Z))
TG(18:0/20:2n6/22:1(13Z))
Pyrimidine The parent compound of the pyrimidines; a diazine having the two nitrogens at the 1- and 3-positions.
7,12-Dimethylbenz[a]anthracene 5,6-oxide A dibenzooxazepine that has formula C20H16O.
TG(18:1(9Z)/20:1(11Z)/o-18:0)
Fluocinolone Acetonide A fluorinated steroid that is flunisolide in which the hydrogen at position 9 is replaced by fluorine. A corticosteroid with glucocorticoid activity, it is used (both as the anhydrous form and as the dihydrate) in creams, gels and ointments for the treatment of various skin disorders.
Ergothioneine A L-histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine in which the hydrogen at position 2 on the imdazole ring is replaced by a mercapto group. A naturally occurring metabolite of histidine with antioxidant properties; abundant in most plants and animals, obtained in animals through the diet.
3-Phosphoadenylylselenate An organoselenium compound that is adenylyl selenate with the hydroxy at position 3' replaced by a phosphate group.
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(15:0/24:0/18:3(9Z,12Z,15Z))
PE(14:0/15:0)
PS(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
PE(14:0/P-18:1(9Z))
DG(15:0/0:0/24:0)
Digoxin n
TG(22:2(13Z,16Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:1(11Z)/20:2n6)
TG(22:2(13Z,16Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(16:0/20:1(11Z))
DG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(22:0/14:0/o-18:0)
TG(18:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
Apraclonidine An imidazoline compound having a 4-amino-2,6-dichloroanilino group at the 2-position.
PC(22:0/14:0)
PE(16:0/18:1(11Z))
(1S)-Hydroxy-(2S)-glutathionyl-1,2-dihydronaphthalene A peptide that has formula C20H25N3O7S.
TG(22:0/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/22:1(13Z)/24:1(15Z))
Isopentanol
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
8-Oxo-dGTP A purine 2'-deoxyribonucleoside 5'-triphosphate having 8-oxo-7,8-dihydroguanine as the nucleobase.
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(22:1(13Z)/24:0/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:3n6/24:0)
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/24:1(15Z))
TG(22:1(13Z)/18:0/18:2(9Z,12Z))
TG(18:1(11Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
L-Tyrosine An optically active form of tyrosine having L-configuration.
TG(14:0/20:0/15:0)
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
Suberylglycine
TG(20:1(11Z)/22:1(13Z)/20:1(11Z))
PIP3(16:0/16:1(9Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/14:0/o-18:0)
TG(18:1(11Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
PIP(16:2(9Z,12Z)/22:3(10Z,13Z,16Z))
TG(18:2(9Z,12Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:0/18:0)[iso3]
TG(20:4(5Z,8Z,11Z,14Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:3n6/o-18:0)
TG(22:0/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(20:4(8Z,11Z,14Z,17Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:0/18:4(6Z,9Z,12Z,15Z))
Bopindolol
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(18:1(9Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:3n6/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(14:1(9Z)/20:0/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/22:2(13Z,16Z)/22:1(13Z))
PG(18:3(9Z,12Z,15Z)/16:0)
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(16:0/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/24:0/o-18:0)
Arachidonic acid A long-chain fatty acid that is a C20, polyunsaturated fatty acid having four (Z)-double bonds at positions 5, 8, 11 and 14.
TG(24:0/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(14:1(9Z)/18:3(9Z,12Z,15Z))
DG(18:1n9/0:0/20:3n9)
PC(16:1(9Z)/P-18:1(11Z))
TG(20:2n6/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/18:0/20:1(11Z))[iso6]
TG(18:2(9Z,12Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:1n9/0:0/20:1n9)
TG(18:0/22:4(7Z,10Z,13Z,16Z)/18:0)
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(18:2(9Z,12Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
3-Keto-b-D-galactose
TG(18:0/20:4(5Z,8Z,11Z,14Z)/o-18:0)
Hypusine An L-lysine derivative that is L-lysine bearing A (2R)-4-amino-2-hydroxybutyl substituent at position N6.
TG(22:1(13Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(22:0/22:0/22:0)
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
4-Hydroxynonenal
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(14:0/22:0/20:2n6)
PI(18:1(9Z)/16:1(9Z))
PG(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))
PIP2(18:1(11Z)/18:2(9Z,12Z))
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
Prostaglandin F2a
TG(20:2n6/20:3(5Z,8Z,11Z)/20:2n6)
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(18:0/20:1(11Z)/16:1(9Z))
TG(14:0/o-18:0/16:0)
Olopatadine
TG(14:1(9Z)/20:1(11Z)/20:2n6)
PIP2(16:0/22:2(13Z,16Z))
PI(22:3(10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
2'-Deoxyguanosine 5'-monophosphate
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/o-18:0/18:0)
TG(14:0/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
D-Xylitol
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
L-Proline Pyrrolidine in which the pro-S hydrogen at position 2 is substituted by a carboxylic acid group. L-Proline is the only one of the twenty DNA-encoded amino acids which has a secondary amino group alpha to the carboxyl group. It is an essential component of collagen and is important for proper functioning of joints and tendons. It also helps maintain and strengthen heart muscles.
TG(20:3n6/22:0/18:4(6Z,9Z,12Z,15Z))
TG(18:0/20:2n6/18:2(9Z,12Z))
PIP(18:1(11Z)/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
4-Glutathionyl cyclophosphamide A peptide that has formula C17H30Cl2N5O8PS.
PC(16:0/18:2(9Z,12Z))
TG(20:2n6/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(16:0/20:0/20:0)[iso3]
Inositol-P-ceramide
TG(16:0/22:0/22:1(13Z))
TG(16:1(9Z)/18:1(9Z)/16:1(9Z))
TG(14:1(9Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:1(13Z)/18:2(9Z,12Z))
Lindane
DG(18:1n7/0:0/18:4n3)
TG(18:3(6Z,9Z,12Z)/18:0/20:2n6)
D-Fructose Fructose is a levorotatory monosaccharide and an isomer of glucose. Although fructose is a hexose (6 carbon sugar), it generally exists as a 5-member hemiketal ring (a furanose).
TG(20:3n6/15:0/20:3n6)
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/0:0)
N-Desmethyleletriptan
Ganglioside GT1b (d18:1/14:0)
3b,7a,12a-Trihydroxy-5b-cholanoic acid
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Cimetidine A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
TG(18:0/24:1(15Z)/18:1(11Z))
PC(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
PE(P-18:0/18:3(6Z,9Z,12Z))
PE(20:1(11Z)/P-16:0)
4-Guanidinobutanoic acid The 4-guanidino derivative of butanoic acid.
DG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/0:0)
PC(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
(+)-Limonene
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(P-18:1(9Z)/22:2(13Z,16Z))
TG(14:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
LysoPE(20:4(5Z,8Z,11Z,14Z)/0:0)
PS(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Gallamine Triethiodide
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(15:0/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
DG(16:1n7/0:0/16:1n7)
Ganglioside GM2 (d18:0/22:1(13Z))
1-Phosphatidyl-1D-myo-inositol 3-phosphate A phosphatidylinositol 3-phosphate in which the inositol moiety is the D-myo-isomer.
DG(22:1(13Z)/18:3(9Z,12Z,15Z)/0:0)
TG(18:1(11Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GT1b (d18:0/26:0)
DG(14:0/24:1(15Z)/0:0)
Vitamin K1
Vitamin K2
TG(24:1(15Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
Pemirolast
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(14:0/14:1(9Z)/18:1(11Z))
PS(16:0/18:3(9Z,12Z,15Z))
Flavin Mononucleotide
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
Topotecan A pyranoindolizinoquinoline used as an antineoplastic agent. It is a derivative of camptothecin and works by binding to the topoisomerase I-DNA complex and preventing religation of these 328 single strand breaks.
TG(18:3(9Z,12Z,15Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GQ1c (d18:0/22:1(13Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
7-Methylguanosine 5'-phosphate
TG(14:1(9Z)/14:1(9Z)/20:2n6)
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PI(18:0/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/24:1(15Z))
PE(16:0/14:1(9Z))
TG(16:0/15:0/18:0)
SM(d18:1/24:0)
TG(15:0/14:0/18:0)
Dihydroceramide A ceramide consisting of sphinganine in which one of the amino hydrogens is substituted by a fatty acyl group.
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(22:1(13Z)/22:0/22:4(7Z,10Z,13Z,16Z))
PC(14:0/18:1(9Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
PI(20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(24:0/22:0/22:4(7Z,10Z,13Z,16Z))
TG(22:0/22:0/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/20:3n6)
TG(24:0/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GD2 (d18:0/23:0)
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(14:0/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
Ganglioside GM1 (d18:0/14:0)
PE(20:0/22:2(13Z,16Z))
Methyprylon
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
Ibuprofen A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group.
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/22:1(13Z))
CE(19:0)
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z)/0:0)
Alpha-Linolenic acid A linolenic acid with cis-double bonds at positions 9, 12 and 15. Shown to have an antithrombotic effect.
TG(22:1(13Z)/22:1(13Z)/20:3n6)
Ganglioside GD1b (d18:1/16:0)
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
LysoPE(20:3(8Z,11Z,14Z)/0:0)
TG(16:0/18:3(6Z,9Z,12Z)/o-18:0)
TG(18:1(9Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Lanosterin
TG(20:2n6/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PC(18:1(11Z)/P-16:0)
TG(24:1(15Z)/18:1(9Z)/24:1(15Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
DG(22:4n6/0:0/20:5n3)
TG(16:0/24:1(15Z)/22:2(13Z,16Z))
Tetrahexosylceramide (d18:1/24:1(15Z))
TG(22:0/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:0/o-18:0)
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
PE(20:3(8Z,11Z,14Z)/P-18:1(11Z))
TG(18:1(11Z)/16:0/18:1(11Z))[iso3]
Fluorometholone A member of the class of glucocorticoids that is Delta(1)-progesterone substituted at positions 11beta and 17 by hydroxy groups, at position 6alpha by a methyl group and at position 9 by a fluoro group. Used for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
3-Acetamidobutanal
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:3n6/20:3n6)
PE(18:4(6Z,9Z,12Z,15Z)/20:0)
TG(22:1(13Z)/o-18:0/24:1(15Z))
Trimethadione
DG(22:0/0:0/18:4n3)
TG(18:0/24:1(15Z)/24:1(15Z))
PC(16:1(9Z)/24:0)
TG(16:0/14:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
DG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
D-Myo-inositol 3,4,5,6-tetrakisphosphate
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(14:0/20:3(5Z,8Z,11Z)/15:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GT1c (d18:1/22:1(13Z))
TG(18:1(11Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/16:0/18:2(9Z,12Z))
TG(24:0/16:1(9Z)/24:0)
TG(18:3(6Z,9Z,12Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(16:0/14:1(9Z)/24:0)
TG(15:0/18:2(9Z,12Z)/20:0)
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/18:1(9Z))
PC(14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
Paricalcitol
PC(P-18:0/20:3(8Z,11Z,14Z))
TG(16:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:2(9Z,12Z)/22:0)
1,2-Dihydroxy-3-keto-5-methylthiopentene
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:0/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:0/20:2n6)
TG(18:1(11Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(16:1(9Z)/20:3n6/o-18:0)
TG(22:0/18:1(11Z)/22:1(13Z))
DG(22:0/0:0/20:5n3)
TG(18:0/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
DG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
PE(22:0/24:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.
TG(20:2n6/16:1(9Z)/18:3(9Z,12Z,15Z))
DG(18:0/0:0/22:5n3)
3-O-Sulfogalactosylceramide (d18:1/18:0)
PC(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/20:0)
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/15:0/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:2(13Z,16Z)/20:2n6)
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GD1a (d18:0/24:1(15Z))
DG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
PC(16:1(9Z)/22:0)
MG(20:1(11Z)/0:0/0:0)
PC(P-18:0/14:0)
TG(14:1(9Z)/20:3n6/16:1(9Z))
7a,12a-Dihydroxy-5b-cholestan-3-one
TG(20:0/24:0/20:0)
PC(20:4(8Z,11Z,14Z,17Z)/16:0)
TG(20:2n6/18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
5-Hydroxylysine The lysine derivative that is 2,6-diamino-5-hydroxyhexanoic acid, a chiral alpha-amino acid.
DG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/0:0)
Secalciferol
PIP2(18:1(9Z)/18:1(9Z))
PE(14:1(9Z)/P-18:1(9Z))
TG(18:0/20:2n6/16:1(9Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(P-18:0/16:0)
4-Hydroxy-L-glutamic acid An amino dicarboxylic acid that is L-glutamic acid substituted by a hydroxy group at position 4.
TG(22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
Donepezil Donepezil is a centrally acting reversible acetyl cholinesterase inhibitor. Its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
TG(15:0/18:0/18:3(6Z,9Z,12Z))
PG(18:1(9Z)/18:0)
TG(15:0/20:2n6/20:2n6)
TG(24:0/22:2(13Z,16Z)/20:1(11Z))
PE(18:1(11Z)/P-18:1(9Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GM3 (d18:1/9Z-18:1)
TG(14:0/18:1(11Z)/16:1(9Z))
Montelukast An aliphatic sulfide that has formula C35H36ClNO3S.
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/o-18:0)
17a-Ethynylestradiol
TG(14:0/18:1(11Z)/16:0)
Uridine diphosphategalactose
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/24:1(15Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
3-Methoxyanthranilate An aminobenzoate that results from the removal of a proton from the carboxylic acid group of 3-methoxyanthranilic acid.
TG(22:1(13Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Docetaxel
PE(14:0/20:3(8Z,11Z,14Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/22:1(13Z)/16:1(9Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:1(11Z)/18:1(11Z))
TG(18:0/22:1(13Z)/20:2n6)
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(14:0/22:1(13Z)/o-18:0)
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:1(11Z)/20:2n6)
TG(14:0/18:0/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
3-Carbamoyl-2-phenylpropionaldehyde A phenylacetaldehyde that has formula C10H11NO3.
TG(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
PC(o-20:0/22:0)
PG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(24:0/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:2n6/0:0/22:5n6)
Phosphoroselenoic acid A phosphoric acid derivative in which one of the OH groups of phosphoric acid is replaced by SeH.
TG(20:3(5Z,8Z,11Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
3b,12a-Dihydroxy-5a-cholanoic acid
PC(20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/o-18:0/18:2(9Z,12Z))
N(6)-(Octanoyl)lysine
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(15:0/22:2(13Z,16Z)/18:2(9Z,12Z))
MG(0:0/14:1(9Z)/0:0)
PC(22:4(7Z,10Z,13Z,16Z)/14:0)
TG(20:2n6/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:2n6/0:0/20:3n6)
TG(22:1(13Z)/18:1(11Z)/18:2(9Z,12Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
TG(18:1(11Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(P-16:0/20:1(11Z))
TG(14:1(9Z)/22:0/18:2(9Z,12Z))
S-Adenosylmethionine
N-[(3a,5b,7b)-7-hydroxy-24-oxo-3-(sulfooxy)cholan-24-yl]-Glycine
TG(14:0/18:3(9Z,12Z,15Z)/18:1(11Z))
DG(20:0/0:0/14:1n5)
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
PI(20:3(8Z,11Z,14Z)/18:1(9Z))
TG(20:1(11Z)/16:0/22:2(13Z,16Z))
TG(18:1(9Z)/22:2(13Z,16Z)/24:1(15Z))
Disulfiram An organic disulfide that is 1,1'-[disulfanediylbis(carbonothioylimino)]diethane substituted by ethyl groups at the N atom. An EC 1.2.1.3 [aldehyde dehydrogenase (NAD+)] inhibitor, it is used as an alcohol deterrent.
TG(16:0/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
DG(20:2n6/0:0/20:4n3)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/20:3n6/18:3(6Z,9Z,12Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/15:0)
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
PC(20:0/20:3(8Z,11Z,14Z))
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Clobetasol 16beta-Methylpregna-1,4-diene-3,20-dione bearing hydroxy groups at the 11beta and 17alpha positions, fluorine at position 9, and a chlorine substituent at position 21. It is used as its 17alpha-propionate ester to treat various skin disorders, including exzema and psoriasis.
PE(20:2(11Z,14Z)/20:3(8Z,11Z,14Z))
TG(22:4(7Z,10Z,13Z,16Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PIP(22:4(10Z,13Z,16Z,19Z)/16:0)
PIP2(16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/24:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/16:0/18:3(9Z,12Z,15Z))[iso6]
TG(22:0/24:1(15Z)/18:1(9Z))
TG(14:0/22:2(13Z,16Z)/15:0)
TG(20:0/18:3(9Z,12Z,15Z)/20:1(11Z))
Quinupristin
TG(24:1(15Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:1(11Z)/20:0)
TG(16:1(9Z)/14:1(9Z)/20:2n6)
12(R)-HPETE A HPETE that is (5Z,8Z,10E,12R,14Z)-icosa-5,8,10,14-tetraenoic acid with the hydroperoxy group located at position 12 (the R-enantiomer).
Sphingosine A sphing-4-enine in which the double bond is trans.
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:1(11Z)/18:1(9Z))
TG(20:3n6/20:2n6/20:4(8Z,11Z,14Z,17Z))
PA(20:4(5Z,8Z,11Z,14Z)e/2:0)
TG(16:0/20:1(11Z)/18:1(11Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/18:1(9Z))
TG(18:2(9Z,12Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:1(11Z)/24:1(15Z))
4-Fumarylacetoacetic acid A beta-diketone that has formula C8H8O6.
TG(18:3(6Z,9Z,12Z)/o-18:0/20:3n6)
MG(P-18:0e/0:0/0:0)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(22:1(13Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
DG(15:0/0:0/15:0)
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
PE(20:2(11Z,14Z)/16:1(9Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:0/22:2(13Z,16Z))
TG(24:1(15Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
PC(24:0/18:3(6Z,9Z,12Z))
3-Oxodecanoic acid An oxo fatty acid that is the 3-oxo derivative of decanoic acid.
7a,12a-Dihydroxy-3-oxo-4-cholenoic acid
PC(18:0/22:1(13Z))
4-Hydroxyestrone-2-S-glutathione
Mephentermine
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
4a-Hydroxytetrahydrobiopterin A tetrahydropterin that is 5,6,7,8-tetrahydrobiopterin carrying an additional hydroxy substituent at the 4a-position.
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(18:1(11Z)/20:1(11Z)/20:3n6)
SAICAR A 1-(phosphoribosyl)imidazolecarboxamide resulting from the formal condesation of the darboxy group of 5-amino-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazole-4-carboxylic acid with the amino group of L-aspartic acid.
TG(18:1(9Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/20:0/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/16:0/22:1(13Z))
TG(14:1(9Z)/14:0/18:3(6Z,9Z,12Z))
Spirapril
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
PS(14:0/20:4(5Z,8Z,11Z,14Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
Posaconazole
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/o-18:0)
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:0/18:1(11Z))
Mepivacaine A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic.
TG(14:0/20:3n6/20:3n6)
TG(14:0/18:2(9Z,12Z)/20:3n6)
TG(22:0/22:1(13Z)/16:1(9Z))
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
(N-Acetylglucosaminyl)2-diphosphodolichol
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/18:1(9Z))
TG(14:1(9Z)/18:0/20:3(5Z,8Z,11Z))
CDP-DG(16:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/18:1(11Z)/22:1(13Z))
Heme A
TG(18:1(9Z)/24:1(15Z)/18:2(9Z,12Z))
Heme O A heme that has formula C49H58FeN4O5.
PC(18:3(9Z,12Z,15Z)/14:1(9Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
PE(22:0/18:2(9Z,12Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
PC(18:0/22:4(7Z,10Z,13Z,16Z))
3a,7a-Dihydroxy-5b-cholestane
TG(16:1(9Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
Thiomorpholine 3-carboxylate The conjugate base of thiomorpholine-3-carboxylic acid.
TG(18:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/24:1(15Z)/15:0)
TG(18:1(9Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(15:0/22:0/22:0)
TG(24:1(15Z)/18:0/20:4(8Z,11Z,14Z,17Z))
Lactosyceramide (d18:1/18:1(9Z))
TG(14:1(9Z)/24:0/18:3(6Z,9Z,12Z))
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:0/22:2(13Z,16Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(16:1(9Z)/22:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
24-Methylenecholesterol A 3beta-sterol having the structure of cholesterol with a methylene group at C-24.
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
PI(18:1(11Z)/20:3(5Z,8Z,11Z))
DG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/24:1(15Z)/20:2n6)
TG(18:3(6Z,9Z,12Z)/22:0/20:4(8Z,11Z,14Z,17Z))
Iminoerythrose 4-phosphate An alditol 4-phosphate that has formula C4H10NO6P.
TG(20:4(8Z,11Z,14Z,17Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PI(18:0/16:0)
TG(20:0/14:0/20:4(8Z,11Z,14Z,17Z))
PC(20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/24:1(15Z)/24:1(15Z))
TG(14:0/18:1(9Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
Linoleoyl-CoA The S-linoleoyl derivative of coenzyme A.
TG(24:0/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(15:0/20:2n6/24:0)
PE(16:1(9Z)/18:1(9Z))
TG(20:2n6/16:0/20:4(8Z,11Z,14Z,17Z))
PS(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Dimethylaniline-N-oxide
PI(18:1(9Z)/16:0)
TG(24:0/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(18:1(9Z)/16:0/22:4(7Z,10Z,13Z,16Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
Ureidoisobutyric acid
TG(22:4(7Z,10Z,13Z,16Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Sterol A 3-hydroxy steroid closely related to cholestan-3-ol.
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ascorbic acid
DG(20:0/22:1(13Z)/0:0)
3-Methoxy-4-hydroxyphenylglycolaldehyde A glycolaldehyde that has formula C9H10O4.
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(15:0/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/20:1(11Z)/24:0)
cis-3-Chloroallyl aldehyde An organochlorine compound that has formula C3H3ClO.
PC(14:1(9Z)/20:3(8Z,11Z,14Z))
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(22:1(13Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(12:0/12:0/12:0)
TG(20:1(11Z)/20:2n6/24:1(15Z))
Hypothiocyanite
PIP2(16:0/22:5(7Z,10Z,13Z,16Z,19Z))
Ximelagatran A member of the class of azetidines that is melagatran in which the carboxylic acid group has been converted to the corresponding ethyl ester and in which the amidine group has been converted to the corresponding amidoxime. A prodrug for melagatran, ximelagatran was the first orally available direct thrombin inhibitor to be brought to market as an anticoagulant, but was withdrawn in 2006 following reports of it causing liver damage.
PE(15:0/14:1(9Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(20:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/22:0/24:1(15Z))
Levamisole
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(20:1(11Z)/16:1(9Z)/18:2(9Z,12Z))
PIP(20:4(8Z,11Z,14Z,17Z)/18:0)
DG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/o-18:0)
TG(16:1(9Z)/20:0/20:3n6)
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(15:0/18:0/18:3(9Z,12Z,15Z))[iso6]
TG(24:0/20:3(5Z,8Z,11Z)/18:1(11Z))
TG(24:0/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(18:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(16:1(9Z)/20:2(11Z,14Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
DG(14:1(9Z)/20:0/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/14:0/22:2(13Z,16Z))
Nitroxoline
TG(20:4(8Z,11Z,14Z,17Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/14:1(9Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
3b,4b,7a,12a-Tetrahydroxy-5b-cholanoic acid
TG(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
PE(24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/18:1(9Z)/18:1(9Z))
TG(20:0/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/18:1(9Z)/22:2(13Z,16Z))
TG(16:1(9Z)/16:1(9Z)/20:1(11Z))[iso3]
TG(18:1(9Z)/14:0/o-18:0)
TG(20:3n6/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/16:1(9Z)/22:2(13Z,16Z))
TG(22:1(13Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
20-Hydroxy-leukotriene B4 The 20-hydroxy derivative of leukotriene B4.
TG(20:3n6/16:0/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/15:0/18:2(9Z,12Z))
SM(d18:1/16:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/o-18:0/20:2n6)
TG(18:1(9Z)/14:0/18:2(9Z,12Z))[iso6]
TG(20:1(11Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:0/18:1(11Z))
TG(16:0/15:0/24:1(15Z))
TG(20:2n6/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(14:0/18:0/18:0)
TG(20:3n6/20:2n6/18:3(9Z,12Z,15Z))
TG(22:0/20:2n6/14:1(9Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
N-palmitoyl-phosphoethanolamine
TG(15:0/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GT1c (d18:0/22:0)
TG(14:0/20:4(8Z,11Z,14Z,17Z)/o-18:0)
PI(22:3(10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Ganglioside GM2 (d18:0/20:0)
TG(18:4(6Z,9Z,12Z,15Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:0/18:1(11Z))[iso3]
TG(24:0/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/20:0/20:1(11Z))
PC(dm18:0/dm18:1(9Z))
LysoPE(0:0/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GT1c (d18:0/20:0)
TG(18:3(6Z,9Z,12Z)/24:0/20:4(8Z,11Z,14Z,17Z))
PE(20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
Ganglioside GT2 (d18:1/14:0)
TG(16:0/14:0/18:2(9Z,12Z))[iso6]
TG(24:0/20:3(5Z,8Z,11Z)/18:1(9Z))
TG(18:0/18:0/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/24:0/20:2n6)
TG(14:0/24:1(15Z)/20:1(11Z))
Carteolol A quinolone that has formula C16H24N2O3.
TG(20:0/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
3-Fumarylpyruvate
Chlorotrianisene
Uridine diphosphate glucuronic acid
N-Formyl-L-glutamic acid A N-formyl amino acid that has formula C6H9NO5.
DG(20:3n6/0:0/18:3n3)
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/16:0/18:2(9Z,12Z))
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(14:1(9Z)/18:1(11Z)/0:0)
PE(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/18:1(9Z)/18:3(6Z,9Z,12Z))
LysoPC(16:1(9Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(14:0/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(15:0/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
Sumatriptan A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family).
TG(16:0/18:1(9Z)/20:0)[iso6]
Doxepin A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
PS(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid
PE(20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
Oxytocin A cyclic nonapeptide hormone with amino acid sequence CYIQNCPLG that also acts as a neurotransmitter in the brain; the principal uterine-contracting and milk-ejecting hormone of the posterior pituitary. Together with the neuropeptide vasopressin, it is believed to influence social cognition and behaviour.
TG(18:1(9Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:3n6/20:1(11Z))
TG(20:0/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(14:0/o-18:0/20:0)
PI(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(22:0/22:0/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:0)
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
N-[(3a,5b,7a)-3-hydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine
DG(16:0/0:0/24:1n9)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:1(13Z)/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(20:1(11Z)/18:3(9Z,12Z,15Z))
TG(15:0/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/20:0/18:1(11Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
Aliskiren
(2R)-Ethylmalonyl-CoA
TG(14:1(9Z)/16:1(9Z)/18:2(9Z,12Z))
PC(14:0/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Ganglioside GD1a (d18:0/20:0)
PC(22:1(13Z)/18:2(9Z,12Z))
PC(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/14:1(9Z)/14:1(9Z))
TG(16:0/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/o-18:0)
TG(20:0/14:0/22:2(13Z,16Z))
TG(22:1(13Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:2n6/18:3(6Z,9Z,12Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:2n6/15:0/o-18:0)
TG(22:1(13Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Cytidine monophosphate
PC(18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/24:1(15Z)/20:2n6)
TG(14:0/20:0/22:4(7Z,10Z,13Z,16Z))
PC(18:1(9Z)/18:2(9Z,12Z))
TG(20:1(11Z)/18:1(9Z)/18:3(6Z,9Z,12Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
8-Hydroxycarvedilol
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GD1a (d18:0/22:0)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:0/20:2n6)
Adenosine 5'-pentaphosphate An organophosphate oxoanion resulting from the removal of all six protons from the phosphate groups of adenosine 5'-pentaphosphate; the major species at pH 7.3.
PG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(16:1(9Z)/P-18:1(9Z))
TG(14:1(9Z)/20:2n6/20:3(5Z,8Z,11Z))
Ethchlorvynol
TG(18:3(6Z,9Z,12Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/18:0/20:3(5Z,8Z,11Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
TG(22:0/18:1(9Z)/20:1(11Z))
Thromboxane B2 A member of the class of thromboxanes B that is (5Z,13E)-thromboxa-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15.
L-Glutamic gamma-semialdehyde
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
Iodotyrosine A tyrosine derivative which has at least one iodo-substituent on the benzyl moiety.
TG(14:0/15:0/22:0)
Pyridoxamine 5'-phosphate A vitamin B6 phosphate that is the phosphoric ester derivative of pyridoxamine.
TG(14:0/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:1(11Z)/14:1(9Z))
TG(24:1(15Z)/20:0/o-18:0)
TG(16:0/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:0/14:0/0:0)
TG(18:4(6Z,9Z,12Z,15Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:2(9Z,12Z)/o-18:0)
TG(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Bortezomib
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/16:0/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/14:0/14:1(9Z))
PIP2(18:1(11Z)/20:1(11Z))
TG(22:1(13Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
Deoxyadenosine triphosphate
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(20:2n6/18:0/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/18:2(9Z,12Z)/24:1(15Z))
Acetaminophen glucuronide
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
PC(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:2(9Z,12Z)/16:1(9Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/24:0)
Hydroxypyruvic acid
TG(18:0/18:3(9Z,12Z,15Z)/22:0)
PC(20:4(8Z,11Z,14Z,17Z)/P-18:1(9Z))
PG(16:1(9Z)/20:3(8Z,11Z,14Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Beta-Sitosterol
TG(18:0/14:0/20:0)
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
PC(20:2(11Z,14Z)/14:0)
3-Hydroxy-L-proline The L-stereoisomer of 3-hydroxyproline.
DG(16:0/24:1(15Z)/0:0)
Bromobenzene-2,3-dihydrodiol An organic hydroxy compound that has formula C6H7BrO2.
TG(20:0/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/14:0/18:3(6Z,9Z,12Z))
TG(14:0/24:0/20:4(8Z,11Z,14Z,17Z))
Iloprost
TG(16:1(9Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(24:0/P-18:1(11Z))
TG(20:2n6/24:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Camelliasaponin A2
Camelliasaponin A1
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
Cromoglicic acid
TG(15:0/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
PE(22:0/14:1(9Z))
Sitaxentan
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Lactosylceramide (d18:1/24:1(15Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:0/20:4(8Z,11Z,14Z,17Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(14:1(9Z)/20:1(11Z)/22:2(13Z,16Z))
D-Lactaldehyde
TG(20:1(11Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/20:3n6/18:3(9Z,12Z,15Z))
(R)-Mevalonic acid-5-pyrophosphate
TG(20:0/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:3(9Z,12Z,15Z)/20:0)
TG(18:0/14:0/22:0)
TG(22:1(13Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(18:2(9Z,12Z)/20:2(11Z,14Z)/0:0)
TG(18:1(9Z)/24:0/18:2(9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Cer(d18:0/18:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
Ganglioside GM2 (d18:0/26:1(17Z))
Leukotriene C4 A leukotriene that contains cysteine in their structure.
PIP(20:3(5Z,8Z,11Z)/18:1(9Z))
TG(20:0/14:0/18:4(6Z,9Z,12Z,15Z))
TG(16:0/18:2(9Z,12Z)/18:1(9Z))
Chondroitin 4-sulfate A chondroitin sulfate in which the site of sulfation is carbon 4 of the N-acetylgalactosamine (GalNAc) sugar.
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
PE(22:0/14:0)
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(24:0/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
LysoPC(18:3(9Z,12Z,15Z))
Hydralazine The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
DG(18:1n7/0:0/20:1n9)
TG(16:0/18:1(11Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/20:3n6)
TG(14:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(14:1(9Z)/20:2n6/20:2n6)
Lidocaine The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Ursodeoxycholic acid A bile acid found in the bile of bears (Ursidae) as a conjugate with taurine. Used therapeutically, it prevents the synthesis and absorption of cholesterol and can lead to the dissolution of gallstones.
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))
TG(18:1(9Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:0)
TG(18:1(9Z)/14:1(9Z)/24:1(15Z))
Moexipril
TG(15:0/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)/0:0)
PE(22:0/16:0)
TG(14:0/15:0/22:4(7Z,10Z,13Z,16Z))
TG(15:0/18:3(9Z,12Z,15Z)/18:0)
4-Hydroxybenzoic acid A monohydroxybenzoic acid that is benzoic acid carrying a hydroxy substituent at C-4 of the benzene ring.
TG(18:0/14:1(9Z)/22:0)
TG(20:1(11Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(18:0/18:3(6Z,9Z,12Z)/o-18:0)
TG(15:0/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:1(9Z)/18:1(9Z))
TG(15:0/14:1(9Z)/14:1(9Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/22:1(13Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
PC(P-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:0/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(16:0/0:0/18:3n6)
Methdilazine
TG(18:1(11Z)/20:1(11Z)/18:1(9Z))
2-(3-Carboxy-3-(methylammonio)propyl)-L-histidine An ammonium ion that is a derivative of L-histidine having a 3-carboxy-3-(methylammonio)propyl group at the 2-position on the imidazole ring.
PC(20:3(8Z,11Z,14Z)/P-18:1(9Z))
TG(18:1(9Z)/20:2n6/20:3(5Z,8Z,11Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)/0:0)
Diadenosine triphosphate
TG(20:0/20:0/14:1(9Z))
TG(24:0/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:2(13Z,16Z))
TG(22:1(13Z)/20:0/18:4(6Z,9Z,12Z,15Z))
Ganglioside GT2 (d18:0/26:1(17Z))
Chenodeoxyglycocholoyl-CoA
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
DG(24:1n9/0:0/20:2n6)
Sedoheptulose A ketoheptose that has formula C7H14O7.
Diphthamide A quaternary ammonium ion that is the derivative of L-histidine having a 4-amino-4-oxo-3-(trimethylammonio)butyl group at the 2-position of the imidazole ring.
TG(22:0/18:3(6Z,9Z,12Z)/18:1(11Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
Reduced Vitamin K (phylloquinone)
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(15:0/15:0/16:0)
TG(14:0/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:3n6/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Dyclonine N-Ethylpiperidine in which one of the hydrogens attached to the methyl group is substituted by a 4-butoxybenzoyl group.
TG(18:3(9Z,12Z,15Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:0/22:4(7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:1(13Z)/o-18:0)
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
Buclizine
TG(18:3(9Z,12Z,15Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
Glucosamine 6-phosphate
TG(18:0/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:0/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/18:0/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(16:0/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/16:1(9Z)/24:1(15Z))
TG(14:0/20:0/20:4(8Z,11Z,14Z,17Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
Clodronate
TG(16:0/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
DG(18:4(6Z,9Z,12Z,15Z)/15:0/0:0)
3a,21-Dihydroxy-5b-pregnane-11,20-dione
TG(14:0/15:0/15:0)
TG(22:1(13Z)/18:1(9Z)/20:2n6)
PIP(22:5(4Z,7Z,10Z,13Z,16Z)/16:0)
7a,12a-Dihydroxy-cholestene-3-one
TG(15:0/15:0/24:0)
Loxapine A dibenzoxazepine that has formula C18H18ClN3O.
TG(20:2n6/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z)/0:0)
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:2n6/15:0)
TG(18:0/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(16:0/22:4(7Z,10Z,13Z,16Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
N-Acetylleucine
TG(18:3(6Z,9Z,12Z)/20:0/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/15:0/18:3(9Z,12Z,15Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
DG(18:3n3/0:0/18:3n3)
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(16:0/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(o-22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:0/16:1(9Z)/0:0)
TG(24:0/20:1(11Z)/18:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/14:0/o-18:0)
Carbidopa The hydrate of 3-(3,4-dihydroxyphenyl)propanoic acid in which the hydrogens alpha- to the carboxyl group are substituted by hydrazinyl and methyl groups (S-configuration). Carbidopa is a dopa decarboxylase inhibitor, so prevents conversion of levodopa to dopamine. It has no antiparkinson activity by itself, but is used in the management of Parkinson's disease to reduce peripheral adverse effects of levodopa.
TG(18:3(6Z,9Z,12Z)/18:0/20:3n6)
TG(24:0/22:1(13Z)/20:2n6)
PC(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/24:1(15Z)/16:0)
TG(18:0/22:0/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/16:0/18:3(6Z,9Z,12Z))
Phensuximide
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:0/0:0/20:5n3)
1-Pentanol
PE(18:1(9Z)/22:0)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:1(11Z)/20:1(11Z))
LysoPE(0:0/16:1(9Z))
Flutamide A (trifluoromethyl)benzene that has formula C11H11F3N2O3.
Isopropyl alcohol
5'-Methylthioadenosine
TG(16:0/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/16:0/20:4(8Z,11Z,14Z,17Z))
Tetrahexosylceramide (d18:1/20:0)
TG(24:1(15Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
Ganglioside GT3 (d18:1/16:0)
DG(15:0/0:0/22:6n3)
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/22:2(13Z,16Z)/20:3n6)
TG(14:1(9Z)/o-18:0/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/20:3(5Z,8Z,11Z))
PI(20:0/20:3(8Z,11Z,14Z))
TG(18:1(9Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
TG(15:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:0)
Ganglioside GT3 (d18:1/18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
S-(2-Methylbutanoyl)-dihydrolipoamide
TG(14:1(9Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:0/18:2(9Z,12Z))
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/15:0/20:1(11Z))
PC(14:0/18:3(9Z,12Z,15Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:0)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/20:2n6)
Cevimeline
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
Pirbuterol
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Tranylcypromine An alkylamine that has formula C9H11N.
PG(18:3(9Z,12Z,15Z)/18:0)
TG(24:1(15Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/18:0/20:4(5Z,8Z,11Z,14Z))
DG(20:4n3/0:0/20:5n3)
TG(22:0/20:3(5Z,8Z,11Z)/22:0)
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/o-18:0/16:1(9Z))
DG(15:0/20:1(11Z)/0:0)
PC(15:0/P-18:0)
TG(15:0/18:2(9Z,12Z)/14:1(9Z))
Chlordiazepoxide A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2.
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PIP2(18:2(9Z,12Z)/18:1(9Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Agmatine A primary amino compound that has formula C5H14N4.
Gentian Violet
Temozolomide
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
D-4'-Phosphopantothenate
TG(20:0/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/o-18:0)
DG(18:2(9Z,12Z)/24:0/0:0)
TG(14:0/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
TG(24:0/15:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
MG(0:0/20:3(5Z,8Z,11Z)/0:0)
Ganglioside GT2 (d18:0/23:0)
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
Halofantrine
TG(20:4(8Z,11Z,14Z,17Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:2n6/18:3(9Z,12Z,15Z))
PC(22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
PC(24:0/18:3(9Z,12Z,15Z))
PC(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:2(9Z,12Z)/18:0/0:0)
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/22:2(13Z,16Z)/20:0)
TG(14:0/20:1(11Z)/20:3n6)
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:0/22:4(7Z,10Z,13Z,16Z))
Ubiquinone-1 A compound composed of the standard 2,3-dimethoxy-5-methylbenzoquinone nucleus common to ubiquinones; and a side chain of a single isoprenoid unit.
Ubiquinone-2 A compound composed of the 2,3-dimethoxy-5-methylbenzoquinone nucleus common to ubiquinones; and a side chain of two isoprenoid units.
TG(22:0/24:1(15Z)/16:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Octanoylglucuronide
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Trimethylselenonium An organic cation consisting of three methyl groups covalently bound to a central selenium atom.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
DG(20:3(5Z,8Z,11Z)/24:1(15Z)/0:0)
TG(24:0/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(24:0/14:1(9Z)/22:2(13Z,16Z))
21-Hydroxy-5b-pregnane-3,11,20-trione
TG(20:0/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
Haloperidol A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
CL(20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
Sulfite Sulfite is an inorganic anion, which is the conjugate base of hydrogen sulfite.
TG(15:0/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(dm18:0/18:1(11Z))
PE(18:1(11Z)/18:1(11Z))
2-Phosphoglyceric acid A monophosphoglyceric acid having the phospho group at the 2-position.
PS(18:2(9Z,12Z)/18:0)
TG(18:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
Cer(d18:1/24:1(15Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
PG(18:3(9Z,12Z,15Z)/18:1(11Z))
PE(18:1(11Z)/18:3(9Z,12Z,15Z))
PE(22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(14:0/20:1(11Z)/18:2(9Z,12Z))
Gluconic acid
PC(18:1(9Z)/P-18:1(11Z))
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/24:0/o-18:0)
TG(22:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/22:1(13Z))
Obtusifoliol A 3beta-sterol that has formula C30H50O.
TG(22:0/24:1(15Z)/24:0)
6-Phosphogluconic acid
TG(24:1(15Z)/24:1(15Z)/20:3n6)
Quazepam
PC(18:0/20:3(5Z,8Z,11Z))
Inosine 2',3'-cyclic phosphate
Alpha-L-fucose A L-fucopyranose having alpha-configuration at the anomeric centre.
PS(14:0/16:0)
DG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(20:2n6/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/18:3(6Z,9Z,12Z)/18:0)
Fesoterodine
TG(18:0/24:0/16:1(9Z))
DG(20:2n6/0:0/20:2n6)
4a-Carboxy-4b-methyl-5a-cholesta-8,24-dien-3b-ol
TG(16:0/15:0/20:0)
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(18:0/20:1(11Z)/20:3n6)
TG(14:1(9Z)/16:0/22:2(13Z,16Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
DG(22:0/0:0/18:2n6)
DG(24:0/18:3(6Z,9Z,12Z)/0:0)
PE(20:0/22:4(7Z,10Z,13Z,16Z))
Novobiocin
PC(P-18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
Mecamylamine
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
DG(22:0/0:0/22:2n6)
TG(14:1(9Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
trans-2-Hexenoyl-CoA
TG(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(18:1(9Z)/18:3(9Z,12Z,15Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/20:0/20:3n6)
PC(18:0/P-18:1(11Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/18:1(9Z)/20:2n6)
CL(18:1(9Z)/18:1(9Z)/18:1(9Z)/18:1(9Z))
Clopidogrel A thienopyridine that has formula C16H16ClNO2S.
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z)/0:0)
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(20:3(5Z,8Z,11Z)/16:1(9Z))
Coenzyme Q9
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:3n6)
Ganglioside GD3 (d18:0/20:0)
Eicosanoyl-CoA
TG(20:0/18:1(11Z)/20:3n6)
11H-14,15-EETA A hydroxy fatty acid that has formula C20H32O4.
PC(15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
PC(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:1(13Z)/20:1(11Z))
Famciclovir 2-Amino-9H-purine in which the hydrogen at position 9 is substituted by a 4-acetoxy-3-(acetoxymethyl)but-1-yl group. A prodrug of the antiviral penciclovir, it is used for the treatment of acute herpes zoster (shingles), for the treatment or suppression of recurrent genital herpes in immunocompetent patients and for the treatment of recurrent mucocutaneous herpes simplex infections in HIV infected patients.
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(14:1(9Z)/22:0/14:1(9Z))
PS(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
5alpha-Pregnan-20alpha-ol-3-one A corticosteroid hormone that has formula C21H34O2.
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(16:1(9Z)/o-18:0/20:3n6)
TG(14:0/o-18:0/22:1(13Z))
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
14,15-DiHETrE
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z)/o-18:0)
TG(16:0/22:1(13Z)/18:0)
TG(20:3(5Z,8Z,11Z)/20:2n6/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
PC(22:1(13Z)/18:3(9Z,12Z,15Z))
TG(14:0/24:0/18:0)
TG(14:0/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PS(14:1(9Z)/18:0)
TG(22:2(13Z,16Z)/20:0/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/16:1(9Z)/24:1(15Z))
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/20:2n6/22:2(13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(18:2(9Z,12Z)/14:0/20:4(8Z,11Z,14Z,17Z))
Ganglioside GD1b (d18:0/26:0)
TG(16:0/24:1(15Z)/14:1(9Z))
Ketoprofen An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.
TG(18:1(11Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))
TG(22:1(13Z)/14:0/22:1(13Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
PC(14:0/22:1(13Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
PIP2(20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
PI(20:3(8Z,11Z,14Z)/18:1(11Z))
TG(20:3n6/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Adenosine 2'-phosphate A purine ribonucleoside 2'-monophosphate that has formula C10H14N5O7P.
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
PE(22:2(13Z,16Z)/15:0)
TG(18:1(11Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(22:0/18:3(6Z,9Z,12Z)/24:1(15Z))
TG(22:2(13Z,16Z)/18:0/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(20:2n6/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PC(18:1(9Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(20:0/22:0/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
3-Hydroxykynurenamine A hydroxykynurenamine that has formula C9H12N2O2.
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
3-O-Sulfogalactosylceramide (d18:1/24:1(15Z))
DG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(15:0/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
PIP2(18:1(11Z)/20:3(8Z,11Z,14Z))
trans-5,6-Dihydro-5,6-dihydroxy-7,12-dimethylbenz[a]anthracene A phenanthrene that has formula C20H18O2.
TG(18:1(11Z)/16:1(9Z)/20:3(5Z,8Z,11Z))
TG(22:0/18:1(9Z)/16:1(9Z))
PE(18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(18:1(9Z)/16:1(9Z)/20:3(5Z,8Z,11Z))
TG(20:3n6/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
Disialosyl galactosyl globoside
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/20:2n6)
TG(20:2n6/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/14:0/22:2(13Z,16Z))
PC(18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
TG(20:1(11Z)/24:0/20:2n6)
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
Dihydrotachysterol
TG(16:1(9Z)/15:0/24:1(15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]
TG(24:1(15Z)/22:0/18:4(6Z,9Z,12Z,15Z))
Trihexosylceramide (d18:1/16:0)
Ethanol A primary alcohol that is ethane in which one of the hydrogens is substituted by a hydroxy group.
PC(16:0/18:3(6Z,9Z,12Z))
Butabarbital A barbiturate that has formula C10H16N2O3.
TG(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
PIP2(18:0/20:3(8Z,11Z,14Z))
Suprofen
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:2n6/22:2(13Z,16Z))
TG(20:1(11Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:1(11Z)/18:2(9Z,12Z))
TG(16:0/24:1(15Z)/18:1(11Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
Benzoic acid A compound comprising a benzene ring core carrying a carboxylic acid substituent.
TG(18:1(11Z)/20:0/22:1(13Z))
DG(20:3n9/0:0/20:3n6)
PE(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/o-18:0/18:2(9Z,12Z))
TG(24:1(15Z)/18:0/22:2(13Z,16Z))
TG(16:0/20:3n6/20:3(5Z,8Z,11Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/16:0/18:4(6Z,9Z,12Z,15Z))
Cyproterone
TG(18:0/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Naphthalene-1,2-diol A naphthalenediol that has formula C10H8O2.
TG(20:0/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/15:0/20:1(11Z))
TG(18:1(9Z)/18:0/o-18:0)
TG(14:0/16:1(9Z)/20:3n6)
TG(18:1(11Z)/20:2n6/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/20:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(14:1n5/0:0/14:1n5)
TG(22:0/20:2n6/18:2(9Z,12Z))
PI(20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/24:0/20:2n6)
TG(15:0/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
beta-nicotinamide D-ribonucleotide
TG(18:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/o-18:0/18:1(9Z))
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(15:0/16:0/20:0)
TG(22:0/15:0/18:1(11Z))
TG(24:0/14:1(9Z)/18:1(9Z))
TG(14:0/16:0/18:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:0/o-18:0)
TG(20:3n6/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/20:3n6)
TG(22:4(7Z,10Z,13Z,16Z)/20:2n6/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/18:1(9Z)/16:1(9Z))
Aldosterone A pregnane-based steroidal hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.
PI(18:3(6Z,9Z,12Z)/18:1(11Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
Cortisol A C21-steroid that is pregn-4-ene substituted by oxo groups at positions 3 and 20 and hydroxy groups at positions 11, 17 and 21. Cortisol is a corticosteroid hormone or glucocorticoid produced by zona fasciculata of the adrenal cortex, which is a part of the adrenal gland. It is usually referred to as the stress hormone as it is involved in response to stress and anxiety, controlled by corticotropin-releasing hormone (CRH). It increases blood pressure and blood sugar, and reduces immune responses
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
N2-Galacturonyl-L-lysine
Mifepristone
TG(22:1(13Z)/20:1(11Z)/o-18:0)
TG(22:1(13Z)/20:1(11Z)/24:1(15Z))
TG(18:0/18:1(9Z)/20:0)[iso6]
TG(22:1(13Z)/16:1(9Z)/24:1(15Z))
TG(22:0/18:0/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/20:1(11Z)/24:0)
TG(15:0/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
PC(o-16:0/20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:3n6/14:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
Lacto-N-triaose
TG(22:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:1(11Z)/16:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:0/o-18:0)
TG(18:1(9Z)/24:1(15Z)/o-18:0)
TG(16:1(9Z)/18:0/18:1(9Z))[iso6]
TG(14:1(9Z)/14:0/18:4(6Z,9Z,12Z,15Z))
Lactaldehyde A propanal that has formula C3H6O2.
PIP(20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(18:2(9Z,12Z)/20:3n6/22:2(13Z,16Z))
PI(16:0/20:0)
Ridogrel
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:0)
PIP2(20:1(11Z)/18:2(9Z,12Z))
TG(20:2n6/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/24:1(15Z)/18:2(9Z,12Z))
TG(18:1(11Z)/24:1(15Z)/20:1(11Z))
PC(15:0/20:3(5Z,8Z,11Z))
TG(14:0/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(15:0/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
2,3-Epoxymenaquinone
Nitroprusside An iron coordination entity that has formula C5FeN6O.
TG(14:0/o-18:0/18:4(6Z,9Z,12Z,15Z))
DG(22:0/0:0/20:4n6)
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/16:1(9Z)/20:2n6)
PC(18:3(6Z,9Z,12Z)/20:1(11Z))
LPA(18:0e/0:0)
Phentermine A primary amine that has formula C10H15N.
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
11-cis-Retinol A retinol that has formula C20H30O.
TG(18:3(9Z,12Z,15Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:0/18:1(11Z)/18:1(11Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(14:1(9Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
Beclometasone dipropionate
TG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GM3 (d18:1/18:0)
NPC A pyranoindolizinoquinoline that has formula C28H30N4O6.
5,6-Dihydroxyindole A dihydroxyindole that has formula C8H7NO2.
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
Acoric acid
TG(24:1(15Z)/14:1(9Z)/24:1(15Z))
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/16:1(9Z)/20:3n6)
TG(20:3(5Z,8Z,11Z)/14:0/o-18:0)
TG(24:0/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:1(11Z)/22:2(13Z,16Z))
CDP A pyrimidine ribonucleoside 5'-diphosphate having cytosine as the nucleobase.
PC(20:3(8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/22:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
DG(20:1(11Z)/18:3(9Z,12Z,15Z)/0:0)
DG(24:0/22:1(13Z)/0:0)
PE(16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PC(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
3-Oxohexadecanoic acid An oxo-fatty acid comprising palmitic acid having an oxo group at the 3-position; an intermediate in fatty acid biosynthesis.
TG(18:3(9Z,12Z,15Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/22:1(13Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
TG(22:0/16:0/20:3(5Z,8Z,11Z))
PC(20:4(5Z,8Z,11Z,14Z)/14:0)
TG(24:0/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/18:1(11Z)/16:1(9Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(18:2(9Z,12Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(15:0/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GM2 (d18:1/16:0)
Inositol cyclic phosphate
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/16:0/18:3(9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GM3 (d18:1/12:0)
TG(22:1(13Z)/16:0/24:1(15Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/15:0/18:1(9Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
PI(20:0/20:4(5Z,8Z,11Z,14Z))
TG(18:4(6Z,9Z,12Z,15Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
Labetalol A secondary amino compound formally derived from ammonia by replacing two of the hydrogens by 2-(3-carbamoyl-4-hydroxyphenyl)-2-hydroxyethyl and 4-phenylbutan-2-yl groups. It is an adrenergic antagonist used to treat high blood pressure.
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
PE(18:4(6Z,9Z,12Z,15Z)/16:0)
TG(18:1(11Z)/22:2(13Z,16Z)/24:1(15Z))
PE(18:0/20:3(8Z,11Z,14Z))
Aldosterone 18-glucuronide
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(18:2(9Z,12Z)/20:2(11Z,14Z))
PI(18:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(16:1(9Z)/24:0/20:3n6)
PC(dm18:1(11Z)/dm16:0)
TG(16:1(9Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/16:1(9Z)/20:2n6)
TG(18:1(9Z)/16:0/18:2(9Z,12Z))
PE(18:4(6Z,9Z,12Z,15Z)/14:0)
TG(16:1(9Z)/20:3n6/18:3(9Z,12Z,15Z))
PS(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
PIP2(20:1(11Z)/16:0)
TG(15:0/16:0/22:2(13Z,16Z))
TG(20:0/14:0/22:1(13Z))
Meloxicam
TG(18:1(11Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(24:0/20:0/o-18:0)
DG(20:4n6/0:0/20:4n3)
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/o-18:0/22:0)
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
PC(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/14:1(9Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(18:1(11Z)/20:1(11Z)/22:1(13Z))
TG(24:0/14:1(9Z)/24:0)
Dihydroxyaluminium
TG(18:1(11Z)/18:1(11Z)/18:1(9Z))
PI(18:1(11Z)/18:1(9Z))
TG(20:2n6/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
PIP2(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:1(11Z)/18:2(9Z,12Z))
PC(dm18:1(11Z)/dm18:0)
TG(15:0/o-18:0/18:2(9Z,12Z))
TG(18:1(9Z)/20:2n6/20:1(11Z))
Hyaluronan
TG(18:0/14:1(9Z)/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Guanfacine
TG(20:3n6/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
PS(18:0/18:1(9Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
PC(18:1(9Z)/14:1(9Z))
Gentamicin
TG(24:0/14:0/24:1(15Z))
PC(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(20:1(11Z)/22:1(13Z)/18:2(9Z,12Z))
TG(15:0/18:1(9Z)/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/o-18:0)
PC(14:1(9Z)/18:1(11Z))
Levonordefrin
5beta-Cholestanone
DG(18:4(6Z,9Z,12Z,15Z)/16:0/0:0)
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:3n6/24:1(15Z)/18:3(9Z,12Z,15Z))
PG(18:0/18:0)
TG(15:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
PG(16:0/16:1(9Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/22:0)
PC(22:4(7Z,10Z,13Z,16Z)/24:0)
TG(18:2(9Z,12Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/16:0/20:3(5Z,8Z,11Z))
Se-Methylselenocysteine An alpha-amino acid compound having methylselanylmethyl as the side-chain.
DG(14:0/20:4(5Z,8Z,11Z,14Z)/0:0)
Ganglioside GT1c (d18:0/18:1(11Z))
TG(22:1(13Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
PG(18:0/16:0)
Loracarbef
TG(14:0/22:0/18:4(6Z,9Z,12Z,15Z))
(6Z,9Z,12Z,15Z,18Z,21Z)-3-Hydroxytetracosahexa-6,9,12,15,18,21-enoyl-CoA
PC(22:4(7Z,10Z,13Z,16Z)/22:0)
3-Hydroxyisovaleryl-CoA A hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3-hydroxyisovaleric acid.
DG(24:1n9/0:0/18:3n3)
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(20:2n6/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:1(9Z)/20:3(8Z,11Z,14Z))
TG(14:0/20:2n6/15:0)
TG(20:0/22:4(7Z,10Z,13Z,16Z)/20:2n6)
PI(18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(24:0/20:3(5Z,8Z,11Z)/22:1(13Z))
TG(20:3n6/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:2(9Z,12Z)/18:1(11Z))
TG(15:0/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
Prostaglandin I2 A prostaglandins I that has formula C20H32O5.
TG(14:1(9Z)/18:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/20:3n6)
Dantrolene The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin.
TG(18:1(9Z)/20:1(11Z)/24:1(15Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
DG(14:1n5/0:0/20:4n6)
TG(20:1(11Z)/24:1(15Z)/20:1(11Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(16:1(9Z)/14:0/16:1(9Z))[iso3]
TG(16:1(9Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))[iso6]
TG(16:0/20:0/22:1(13Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
SM(d18:0/16:0)
Telaprevir
TG(14:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/24:1(15Z)/20:3n6)
PE(18:2(9Z,12Z)/20:1(11Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:0)
TG(15:0/22:2(13Z,16Z)/22:1(13Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
Hexachlorophene
TG(18:1(9Z)/o-18:0/18:3(6Z,9Z,12Z))
TG(14:0/15:0/18:4(6Z,9Z,12Z,15Z))
DG(22:4(7Z,10Z,13Z,16Z)/22:0/0:0)
TG(14:0/22:0/16:1(9Z))
TG(16:0/18:1(9Z)/24:0)
TG(20:3n6/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
All-trans-retinoic acid A retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry.
N-Methyltryptamine A tryptamine alkaloid that has formula C11H14N2.
TG(16:1(9Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
SM(d18:1/22:1(13Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/24:0)
DG(14:0/0:0/20:4n6)
TG(18:1(9Z)/14:1(9Z)/20:3n6)
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(14:0/o-18:0/18:3(9Z,12Z,15Z))
TG(16:0/16:1(9Z)/20:3n6)
TG(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(14:1(9Z)/18:1(11Z))
TG(18:2(9Z,12Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
1-(sn-Glycero-3-phospho)-1D-myo-inositol A myo-inositol monophosphate derivative that is 1D-myo-inositol substituted at position 1 by an sn-glycero-3-phospho group.
TG(16:0/18:1(9Z)/22:0)
TG(14:0/22:2(13Z,16Z)/24:1(15Z))
TG(24:1(15Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/22:0/24:1(15Z))
TG(14:0/15:0/16:1(9Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(22:2(13Z,16Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
Pentobarbital A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Glycyrrhetinic acid
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
PC(20:0/20:0)
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/20:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(15:0/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(22:1(13Z)/18:1(11Z)/o-18:0)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
Phytanoyl-CoA The S-phytanoyl derivative of coenzyme A.
19-Oxotestosterone An androstanoid that is testosterone with an oxo group at position 19.
PE(18:0/24:0)
TG(24:0/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(9Z,12Z,15Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PE(16:0/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(20:2n6/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/18:1(11Z)/22:2(13Z,16Z))
Heptanoyl-CoA A medium-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of heptanoic acid.
(3a,5b,7a,12a)-24-[(carboxymethyl)amino]-1,12-dihydroxy-24-oxocholan-3-yl-b-D-Glucopyranosiduronic acid
TG(22:1(13Z)/18:0/18:3(9Z,12Z,15Z))
TG(18:0/24:0/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
TG(20:0/22:1(13Z)/20:2n6)
TG(16:0/18:2(9Z,12Z)/18:2(9Z,12Z))[iso3]
TG(16:0/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(18:0/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
PC(15:0/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Chenodeoxycholic acid sulfate
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
Cobalamin A cobalt-corrinoid hexaamide that is cobalamin with the oxidation state of the central cobalt atom unspecified.
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
Ganglioside GM2 (d18:0/23:0)
TG(18:2(9Z,12Z)/20:0/20:2n6)
TG(14:1(9Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(20:4(8Z,11Z,14Z,17Z)/14:0/o-18:0)
PC(18:1(11Z)/24:1(15Z))
PE(14:0/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(15:0/20:3n6/18:0)
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:3(5Z,8Z,11Z)/22:0/0:0)
TG(20:0/24:1(15Z)/18:2(9Z,12Z))
PE(22:2(13Z,16Z)/20:3(8Z,11Z,14Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]
Ganglioside GM3 (d18:1/26:1(17Z)))
Papaverine A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
TG(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z))
OPC8-CoA An organic molecule that has formula C39H64N7O18P3S.
TG(24:1(15Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
LysoPC(14:1(9Z))
Ganglioside GT1b (d18:0/24:1(15Z))
TG(15:0/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/15:0/18:2(9Z,12Z))
PE(18:4(6Z,9Z,12Z,15Z)/P-18:0)
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Trihexosylceramide (d18:1/25:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0/o-18:0)
TG(18:1(11Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Glimepiride A N-acylurea that has formula C24H34N4O5S.
TG(20:1(11Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:1(9Z)/20:2n6)
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
PS(14:1(9Z)/18:2(9Z,12Z))
TG(14:1(9Z)/o-18:0/14:1(9Z))
TG(22:1(13Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
DG(14:0/18:2(9Z,12Z)/0:0)
TG(20:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/20:1(11Z)/20:2n6)
TG(20:3n6/24:0/o-18:0)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
7-Methyladenine Adenine substituted with a methyl group at position N-7.
DG(24:1n9/0:0/24:1n9)
PC(16:0/15:0)
TG(18:2(9Z,12Z)/15:0/18:3(6Z,9Z,12Z))
MG(0:0/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(18:1(9Z)/16:1(9Z)/24:1(15Z))
TG(16:0/18:2(9Z,12Z)/20:0)[iso6]
PC(dm16:0/dm18:1(11Z))
TG(15:0/18:0/18:1(11Z))
PC(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
PIP(18:1(11Z)/20:3(8Z,11Z,14Z))
TG(14:1(9Z)/24:0/18:4(6Z,9Z,12Z,15Z))
PC(18:2(9Z,12Z)/P-18:1(11Z))
DG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
DG(24:1(15Z)/16:0/0:0)
CL(18:1(11Z)/18:1(11Z)/18:1(11Z)/18:2(9Z,12Z))
TG(20:1(11Z)/20:0/20:2n6)
TG(16:0/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/o-18:0/20:1(11Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/18:0)
TG(20:0/14:0/22:0)
D-Gal alpha 1->6D-Gal alpha 1->6D-Glucose
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/18:1(9Z)/20:3n6)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/15:0/18:1(11Z))
TG(20:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(20:3(8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
Alizapride
TG(14:0/18:2(9Z,12Z)/15:0)
Imipramine A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/24:1(15Z))
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Glucosylsphingosine
TG(24:0/20:3n6/18:1(11Z))
TG(22:0/14:0/22:1(13Z))
Pentosan Polysulfate
Guanidoacetic acid
TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(24:0/24:1(15Z)/22:1(13Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/20:3n6)
TG(18:0/18:2(9Z,12Z)/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
Hexadecenal
TG(20:1(11Z)/18:0/20:3n6)
TG(24:1(15Z)/14:0/18:3(6Z,9Z,12Z))
PC(20:4(8Z,11Z,14Z,17Z)/18:0)
TG(18:1(9Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/o-18:0)
PC(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/20:3n6/o-18:0)
PE(14:0/18:1(11Z))
PE(20:3(8Z,11Z,14Z)/16:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/24:0/20:3n6)
PI(18:0/18:2(9Z,12Z))
Minaprine
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:0/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
I(-) A canonical ribonucleotide residue derived from IMP.
Pregnenolone
TG(18:3(6Z,9Z,12Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PE(P-18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(14:0/18:3(6Z,9Z,12Z)/20:0)
2-Methylhexanoyl-CoA
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(20:2(11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GT1c (d18:0/16:0)
TG(18:1(11Z)/18:0/22:1(13Z))
TG(24:0/22:1(13Z)/24:0)
TG(14:1(9Z)/16:0/14:1(9Z))
TG(24:0/16:0/18:1(9Z))
Cer(d18:1/26:0)
Olmesartan A biphenylyltetrazole that has formula C24H26N6O3.
TG(22:0/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
TG(16:0/22:0/24:1(15Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/14:0/24:1(15Z))
TG(20:3n6/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:1(11Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/20:3n6/22:2(13Z,16Z))
DG(20:3n6/0:0/22:2n6)
Dienestrol
PE(18:1(11Z)/P-16:0)
Ferrocytochrome Any cytochrome containing a ferroheme.
TG(20:3(5Z,8Z,11Z)/16:0/18:3(9Z,12Z,15Z))
TG(20:0/20:2n6/18:1(11Z))
PE(24:0/P-18:1(9Z))
TG(14:0/18:3(6Z,9Z,12Z)/22:0)
PC(24:0/P-18:1(11Z))
TG(15:0/18:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:2n6/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:0/22:4(7Z,10Z,13Z,16Z))
PC(o-20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Alpha-Muricholic acid A bile acid that has formula C24H40O5.
TG(22:4(7Z,10Z,13Z,16Z)/20:2n6/o-18:0)
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/20:3n6)
Adenosyl cobinamide A cobalt-corrinoid hexaamide comprising cobinamide having an adenosyl group attached to cobalt.
D-Erythrose 4-phosphate An erythrose phosphate that is D-erythrose carrying a phosphate group at position 4. It is an intermediate in the pentose phosphate pathway and Calvin cycle.
TG(15:0/22:4(7Z,10Z,13Z,16Z)/15:0)
TG(24:1(15Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/15:0/20:1(11Z))
TG(16:1(9Z)/14:1(9Z)/16:1(9Z))
TG(14:1(9Z)/20:2n6/18:3(6Z,9Z,12Z))
PC(20:2(11Z,14Z)/18:1(9Z))
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
2-(a-Hydroxyethyl)thiamine diphosphate
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/24:0)
TG(20:4(8Z,11Z,14Z,17Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
PG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:0/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/22:2(13Z,16Z)/14:1(9Z))
Medroxyprogesterone A 3-oxo Delta(4)-steroid that is pregn-4-ene-3,20-dione substituted by an alpha-hydroxy group at position 17 and a methyl group at position 6.
TG(14:0/18:3(6Z,9Z,12Z)/24:1(15Z))
PS(18:0/20:3(8Z,11Z,14Z))
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/24:1(15Z)/20:3n6)
TG(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(15:0/18:2(9Z,12Z)/24:1(15Z))
TG(16:0/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/20:0)
PC(P-18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/14:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Uridine diphosphate glucose
TG(14:0/20:2n6/24:0)
TG(20:0/18:4(6Z,9Z,12Z,15Z)/22:0)
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/14:0)
TG(14:1(9Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:3(9Z,12Z,15Z)/20:3n6)
TG(15:0/20:0/14:1(9Z))[iso6]
TG(22:2(13Z,16Z)/15:0/22:2(13Z,16Z))
TG(24:0/14:1(9Z)/14:1(9Z))
TG(22:1(13Z)/14:0/18:2(9Z,12Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(22:1n9/0:0/20:3n6)
TG(24:0/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/15:0/18:2(9Z,12Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/0:0)
Lamotrigine A member of the class of 1,2,4-triazines in which the triazene skeleton is substituted by amino groups at positions 3 and 5, and by a 2,3-dichlorophenyl group at position 6.
TG(18:2(9Z,12Z)/14:0/18:3(6Z,9Z,12Z))
Ganglioside GM1 (d18:0/16:0)
TG(22:2(13Z,16Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(16:0/18:3(9Z,12Z,15Z)/18:1(9Z))
PC(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Glucosylceramide (d18:1/24:1(15Z))
TG(16:0/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Cefazolin A cephalosporin compound having [(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl and (1H-tetrazol-1-ylacetyl)amino side-groups.
(+)-7-Isojasmonic acid CoA An organic molecule that has formula C33H52N7O18P3S.
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(20:3n6/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
PC(16:0/22:1(13Z))
TG(14:0/18:1(9Z)/14:1(9Z))
TG(20:0/14:1(9Z)/18:2(9Z,12Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:3n6/20:4(5Z,8Z,11Z,14Z))
PC(22:4(7Z,10Z,13Z,16Z)/P-18:1(9Z))
DG(20:3(5Z,8Z,11Z)/14:1(9Z)/0:0)
TG(16:1(9Z)/16:1(9Z)/18:2(9Z,12Z))[iso3]
DG(22:0/18:1(9Z)/0:0)
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(16:0/0:0/22:6n3)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z)/o-18:0)
TG(18:0/15:0/o-18:0)
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z)/0:0)
TG(16:0/22:1(13Z)/20:2n6)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
TG(18:1(9Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Chlorine A monoatomic chlorine that has formula Cl.
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
PIP2(18:0/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso3]
TG(18:1(9Z)/24:1(15Z)/24:1(15Z))
TG(18:1(11Z)/16:0/20:3n6)
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:3(5Z,8Z,11Z)/24:1(15Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Metipranolol 3-(Propan-2-ylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by a 4-acetoxy-2,3,5-trimethylphenoxy group. A non-cardioselective beta-blocker, it is used to lower intra-ocular pressure in the management of open-angle glaucoma.
Cytidine 2'-phosphate A cytidine phosphate compound having the phosphate group at the 2'-position.
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
PIP(20:3(8Z,11Z,14Z)/18:1(9Z))
TG(20:2n6/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
PE(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(18:1(9Z)/16:1(9Z))
TG(24:0/20:1(11Z)/20:3n6)
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/16:1(9Z))
dIMP
Fludrocortisone A mineralocorticoid that has formula C21H29FO5.
TG(22:0/15:0/22:4(7Z,10Z,13Z,16Z))
Adenine
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
TG(16:1(9Z)/18:0/20:2n6)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/20:3n6)
Streptozocin
PE(20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(15:0/24:1(15Z)/18:0)
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
nicotinate beta-D-ribonucleotide
TG(18:1(9Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(15:0/20:2n6/24:1(15Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/18:1(11Z)/20:2n6)
TG(20:0/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(16:0/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
4-alpha-Methyl-5-alpha-cholest-7-en-3-one A cholestanoid that is lathosterone bearing an alpha-methyl substituent at position 4.
TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/14:1(9Z)/18:1(9Z))
TG(18:1(9Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
PE(18:4(6Z,9Z,12Z,15Z)/P-16:0)
TG(24:0/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(20:0/P-18:1(11Z))
PE(15:0/22:1(13Z))
TG(18:0/20:1(11Z)/20:2n6)
TG(15:0/18:4(6Z,9Z,12Z,15Z)/16:0)
3-Sulfinoalanine
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(15:0/24:0/15:0)
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
Etiocholanolone
TG(15:0/22:2(13Z,16Z)/18:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:0/16:1(9Z)/0:0)
Trimethoprim An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
TG(20:3n6/20:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/20:3n6)
Galactosylceramide (d18:1/12:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(24:0/0:0/24:1n9)
TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(8Z,11Z,14Z,17Z))
DG(20:3(8Z,11Z,14Z)/22:2(13Z,16Z)/0:0)
TG(22:0/24:0/20:1(11Z))
TG(20:1(11Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/18:0/22:0)
PC(24:0/P-18:1(9Z))
Albendazole
Ergoloid mesylate A mixture of hydrogenated ergot alkaloids consisting of the methanesulfonic acid salts of dihydroergocornine (R = CHMe2), dihydroergocristine (R = CH2Ph), and alpha- and beta-dihydroergocryptine (R = CH2CHMe2 and CH(Me)Et, respectively). It is used for the symptomatic treatment of mild to moderate dementia in the elderly, although its value is not established.
TG(14:0/16:0/22:4(7Z,10Z,13Z,16Z))
Meclizine
TG(22:0/20:1(11Z)/20:1(11Z))
TG(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PE(20:2(11Z,14Z)/16:0)
TG(20:0/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/20:0/18:2(9Z,12Z))
PS(16:1(9Z)/18:3(9Z,12Z,15Z))
DG(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
Ganglioside GT1c (d18:1/12:0)
TG(20:0/18:1(11Z)/20:2n6)
PIP(18:0/20:4(5Z,8Z,11Z,14Z))
CE(22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:2n6/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(20:0/24:0/22:1(13Z))
TG(18:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:1(13Z)/P-18:0)
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
Protriptyline An organic tricyclic compound that has formula C19H21N.
TG(14:0/18:0/24:0)
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/20:3n6)
TG(15:0/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(18:1(11Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Molindone
TG(15:0/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GA1 (d18:1/18:0)
TG(16:1(9Z)/18:0/18:4(6Z,9Z,12Z,15Z))
4-Hydroxy-3-polyprenylbenzoate A member of the class of benzoates obtained by deprotonation of the carboxy group of any 4-hydroxy-3-polyprenylbenzoic acid; major species at pH 7.3.
TG(18:0/20:3(5Z,8Z,11Z)/22:1(13Z))
PC(16:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
PIP2(22:4(10Z,13Z,16Z,19Z)/16:0)
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
Salbutamol
TG(18:1(9Z)/16:0/o-18:0)
PE(20:2(11Z,14Z)/14:0)
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(18:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
Cer(d18:0/16:0)
PE(18:2(9Z,12Z)/14:1(9Z))
TG(18:0/18:1(9Z)/18:2(9Z,12Z))[iso6]
PG(18:1(11Z)/18:1(11Z))
TG(18:0/24:0/14:1(9Z))
DG(22:2n6/0:0/18:3n3)
Heptadecanoyl CoA A long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of heptadecanoic acid,
TG(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/20:2n6/18:2(9Z,12Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(15:0/22:1(13Z)/22:1(13Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(24:0/24:0/18:2(9Z,12Z))
4,6-Dideoxy-4-oxo-dTDP-D-glucose
Acetylhydrazine
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(16:1(9Z)/20:3n6/16:1(9Z))
PE(18:1(11Z)/20:2(11Z,14Z))
PC(20:2(11Z,14Z)/P-18:0)
Ganglioside GT3 (d18:0/26:0)
TG(22:4(7Z,10Z,13Z,16Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)/o-18:0)
PE(22:5(4Z,7Z,10Z,13Z,16Z)/dm18:0)
TG(18:2(9Z,12Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/20:3n6/22:0)
TG(22:1(13Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/14:1(9Z)/20:3(5Z,8Z,11Z))
Malonic semialdehyde
TG(20:0/20:1(11Z)/22:1(13Z))
TG(20:0/20:3n6/16:1(9Z))
Dehydroepiandrosterone sulfate A steroid sulfate that is the 3-sulfate of dehydroepiandrosterone.
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:3n6/20:0)
TG(22:0/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/18:1(9Z)/18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
2-Methylacetoacetyl-CoA A 3-oxoacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 2-methylacetoacetic acid.
Ganglioside GM3 (d18:1/22:1(13Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)/0:0)
DG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(20:0/24:0/22:4(7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
N-Acetyl-D-mannosamine 6-phosphate An N-acyl-D-mannosamine 6-phosphate having the N-acyl specified as acetyl.
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/24:1(15Z)/20:3n6)
TG(20:3(5Z,8Z,11Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:3(5Z,8Z,11Z)/o-18:0)
TG(14:0/18:3(6Z,9Z,12Z)/16:0)
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:1(11Z)/14:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/15:0/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Ganglioside GT2 (d18:1/18:1(11Z))
DG(16:1n7/0:0/20:3n9)
DG(22:1n9/0:0/18:3n6)
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
Androstenol
TG(15:0/14:0/24:0)
TG(24:0/16:1(9Z)/14:1(9Z))
TG(20:0/16:0/20:3n6)
DG(20:0/20:3(5Z,8Z,11Z)/0:0)
TG(16:0/20:1(11Z)/18:3(9Z,12Z,15Z))
Beta-D-Glucose 6-phosphate A D-glucopyranose 6-phosphate in which the anomeric centre has beta-configuration.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:0/18:4(6Z,9Z,12Z,15Z))
PC(14:0/22:0)
N1,N12-Diacetylspermine An acetylspermine that has formula C14H30N4O2.
TG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:2(13Z,16Z)/o-18:0)
TG(24:1(15Z)/18:1(9Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/20:1(11Z)/18:2(9Z,12Z))
5-Phosphoribosylamine
PE(18:3(9Z,12Z,15Z)/P-16:0)
TG(16:0/o-18:0/22:4(7Z,10Z,13Z,16Z))
PE(20:1(11Z)/20:3(5Z,8Z,11Z))
TG(14:0/22:1(13Z)/20:0)
Pimozide
TG(16:1(9Z)/24:0/18:2(9Z,12Z))
TG(22:0/14:0/16:1(9Z))
PC(dm18:1(9Z)/dm18:1(11Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
Amphetamine An amphetamine, the parent of the class of amphetamines, having the structure 1-phenylpropan-2-amine. It exists as a racemate.
TG(24:1(15Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:4n3/0:0/22:5n3)
PE(22:0/P-16:0)
TG(18:2(9Z,12Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/20:3n6)
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
Lablaboside E
Lablaboside D
Nortriptyline An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
Lablaboside F
Flucloxacillin A penicillin compound having a 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido] side-chain.
PE(20:0/24:1(15Z))
Hydrogen A monoatomic hydrogen that has formula H.
PE(20:4(8Z,11Z,14Z,17Z)/14:0)
TG(18:1(11Z)/20:0/18:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
4a-Carbinolamine tetrahydrobiopterin
TG(24:0/24:0/20:3n6)
PE(20:2(11Z,14Z)/22:1(13Z))
PE(22:0/20:0)
DG(20:3(8Z,11Z,14Z)/18:1(9Z)/0:0)
PE(18:3(6Z,9Z,12Z)/20:2(11Z,14Z))
N-Acetylasparagine
(S)-lipoic acid The (S)-enantiomer of lipoic acid. Not found in nature, it may exert detrimental effects on biosystems.
TG(22:0/16:1(9Z)/14:1(9Z))
TG(20:0/20:3n6/14:1(9Z))
25-Hydroxyvitamin D2 25-(beta-glucuronide)
DG(18:1n7/0:0/20:4n3)
PI(18:0/20:2(11Z,14Z))
PC(18:3(6Z,9Z,12Z)/P-18:1(9Z))
Ecgonine methyl ester The O-debenzoyl analogue of cocaine.
Tuberoside B (Ullucus tuberosus)
TG(20:0/22:2(13Z,16Z)/24:1(15Z))
TG(18:1(11Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
trans-1,2-Dihydrobenzene-1,2-diol
TG(22:1(13Z)/18:2(9Z,12Z)/o-18:0)
Frovatriptan
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Degarelix
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(15:0/0:0/22:5n3)
TG(18:2(9Z,12Z)/22:0/18:4(6Z,9Z,12Z,15Z))
Estrone A 17-oxo steroid that is estra-1,3,5(10)-triene substituted by an hydroxy group at position 3 and an oxo group at position 17.
PC(P-18:1(9Z)/20:3(5Z,8Z,11Z))
LysoPE(0:0/20:0)
DG(22:5(7Z,10Z,13Z,16Z,19Z)/15:0/0:0)
DG(20:3(5Z,8Z,11Z)/20:1(11Z)/0:0)
Allocystathionine
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(18:0/18:1(9Z)/16:1(9Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/20:2n6/24:1(15Z))
2-Hydroxyestrone A 2-hydroxy steroid that is estrone substituted by a hydroxy group at position 2.
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
PE(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
Nepafenac
PA(18:0/18:2(9Z,12Z))
TG(14:1(9Z)/14:0/18:1(11Z))
4-Aminobutyraldehyde
TG(16:1(9Z)/20:1(11Z)/24:1(15Z))
TG(20:0/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Sulfinpyrazone A pyrazolidine that has formula C23H20N2O3S.
TG(22:5(7Z,10Z,13Z,16Z,19Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]
PC(15:0/20:2(11Z,14Z))
8Z,11Z,14Z-eicosatrienoyl-CoA
PE(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:1(9Z))
TG(22:2(13Z,16Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Entacapone
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/24:1(15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/24:1(15Z)/18:3(9Z,12Z,15Z))
DG(16:0/20:0/0:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/20:3n6)
CL(18:2(9Z,12Z)/18:1(9Z)/18:1(9Z)/16:0)
TG(15:0/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(24:0/15:0/18:3(6Z,9Z,12Z))
DG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(20:3n6/15:0/22:2(13Z,16Z))
Sedoheptulose 1,7-bisphosphate A sedoheptulose derivative that has formula C7H16O13P2.
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/20:0/18:1(9Z))
17a,20a-Dihydroxycholesterol
Androstanedione
TG(20:0/20:3n6/18:2(9Z,12Z))
Digitoxin
TG(15:0/o-18:0/18:3(6Z,9Z,12Z))
PC(22:1(13Z)/22:1(13Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(14:0/14:0/24:0)
TG(20:2n6/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
CDP-DG(18:0/20:4(5Z,8Z,11Z,14Z))
DG(22:0/0:0/18:3n3)
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(22:2(13Z,16Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Pentamidine A diether compound consisting of pentane-1,5-diol with both hydroxyls bearing 4-amidinophenyl groups.
TG(20:3n6/14:0/18:3(9Z,12Z,15Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
PE(14:1(9Z)/20:0)
TG(20:0/o-18:0/16:1(9Z))
5-Hydroxykynurenamine A hydroxykynurenamine where the hydroxy group is located at the 5-position.
TG(14:1(9Z)/18:0/20:3n6)
TG(20:0/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
Glutethimide
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GQ1c (d18:1/25:0)
TG(15:0/18:1(11Z)/16:1(9Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
PC(18:3(9Z,12Z,15Z)/20:1(11Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/22:1(13Z)/o-18:0)
DG(18:3(6Z,9Z,12Z)/14:0/0:0)
TG(18:1(9Z)/16:1(9Z)/18:2(9Z,12Z))
TG(16:1(9Z)/16:0/o-18:0)
PC(20:0/22:1(13Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/15:0/o-18:0)
PE(22:0/20:1(11Z))
TG(18:3(6Z,9Z,12Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Voacamine A citraconoyl group that has formula C43H52N4O5.
TG(14:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:3n9/0:0/22:2n6)
13-HETE
2-Ethoxyethanol
TG(14:1(9Z)/20:1(11Z)/20:1(11Z))
UDP-L-iduronate A nucleotide-sugar oxoanion arising from deprotonation of the diphosphate and carboxy groups of UDP-L-iduronic acid; major species at pH 7.3.
TG(20:2n6/18:1(9Z)/o-18:0)
TG(18:1(11Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
(2-Naphthyl)methanol A naphthylmethanol that is methanol in which one of the methyl hydrogens has been replaced by a (2-naphthyl) group.
Voriconazole A triazole-based antifungal agent used for the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. It is an inhibitor of cytochrome P450 2C9 (CYP2C9) and CYP3A4.
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/20:3n6/22:2(13Z,16Z))
Cisatracurium Besylate The (1R,1'R,2R,2'R)-diastereoisomer of atracurium besylate. Commercial preparations of atracurium are mixtures of 10 stereoisomers, of which cisatracurium generally constitutes about 15%. Cisatracurium besylate is about 3 times more potent than the mixture of atracurium isomers as a neuromuscular blocking agent, and is used as a muscle relaxant for endotracheal intubation, to aid controlled ventilation, and in general anaesthesia.
TG(18:4(6Z,9Z,12Z,15Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
5-Methoxyindoleacetate An indole-3-acetic acid that has formula C11H11NO3.
PE(18:1(11Z)/18:3(6Z,9Z,12Z))
Coprocholic acid
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/22:1(13Z))
TG(24:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(14:0/16:1(9Z)/16:0)
TG(20:2n6/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:2(13Z,16Z)/24:0/0:0)
TG(18:1(9Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
3a,7a-Dihydroxycoprostanic acid
TG(16:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:0/22:4(7Z,10Z,13Z,16Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(20:0/24:1(15Z)/22:0)
TG(14:0/16:1(9Z)/14:0)
PC(20:3(8Z,11Z,14Z)/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Chloral hydrate An organochlorine compound that is the hydrate of trichloroacetaldehyde.
TG(20:3(5Z,8Z,11Z)/20:3n6/20:2n6)
DG(18:0/0:0/20:2n6)
TG(18:0/20:2n6/18:4(6Z,9Z,12Z,15Z))
PPPi
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:3n6/16:1(9Z))
DG(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/0:0)
TG(20:3n6/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(20:4(8Z,11Z,14Z,17Z)/22:0)
TG(18:3(9Z,12Z,15Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(16:1n7/0:0/22:5n3)
Ganglioside GD2 (d18:0/18:1(11Z))
PC(P-16:0/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:0/0:0/20:5n3)
PC(14:0/P-18:1(9Z))
TG(22:2(13Z,16Z)/18:1(9Z)/22:2(13Z,16Z))
PS(20:4(5Z,8Z,11Z,14Z)/16:0)
TG(24:1(15Z)/20:0/18:3(9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
PC(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/15:0/20:3n6)
TG(22:4(7Z,10Z,13Z,16Z)/22:0/o-18:0)
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:1(11Z)/20:3n6)
TG(18:0/18:3(6Z,9Z,12Z)/18:1(9Z))
p-Synephrine
TG(18:1(9Z)/15:0/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/20:3n6/20:3n6)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
TG(14:1(9Z)/20:3n6/20:2n6)
Raltitrexed
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GD1b (d18:1/25:0)
TG(15:0/20:0/18:1(11Z))
PE(24:1(15Z)/14:1(9Z))
TG(20:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/0:0)
TG(18:1(11Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:1(11Z)/18:2(9Z,12Z))
TG(14:0/18:3(6Z,9Z,12Z)/18:1(9Z))
3-Oxocholic acid
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
Ganglioside GD3 (d18:1/16:0)
DG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
PC(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
3',4'-Dihydrodiol
PE(20:4(8Z,11Z,14Z,17Z)/24:0)
TG(16:0/22:0/22:4(7Z,10Z,13Z,16Z))
TG(22:0/18:0/18:2(9Z,12Z))
TG(20:0/18:0/20:3(5Z,8Z,11Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
Selenite
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
PE(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PIP3(18:1(9Z)/18:1(9Z))
Almitrine
Tolazoline
TG(22:2(13Z,16Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:1(11Z)/20:2n6)
Acetamidopropanal
PC(22:0/22:1(13Z))
TG(16:1(9Z)/16:1(9Z)/22:1(13Z))
TG(14:0/18:1(11Z)/20:3n6)
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(20:0/22:0/22:2(13Z,16Z))
TG(15:0/16:0/20:2(11Z,14Z))[iso6]
TG(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(20:1(11Z)/14:1(9Z)/20:2n6)
TG(24:0/20:3n6/16:1(9Z))
TG(20:1(11Z)/14:0/18:4(6Z,9Z,12Z,15Z))
PC(18:1(11Z)/20:0)
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
PI(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
Ganglioside GD3 (d18:1/18:0)
DG(14:0/20:3(8Z,11Z,14Z)/0:0)
Norfloxacin A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Icatibant
PC(18:1(11Z)/22:0)
PE(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
Cytosine An aminopyrimidine that is pyrimidin-2-one having the amino group located at position 4.
DG(20:0/14:1(9Z)/0:0)
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
7-Hydroxy-3-oxocholanoic acid
TG(24:1(15Z)/14:0/o-18:0)
TG(20:0/18:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/22:0/o-18:0)
TG(20:0/18:3(9Z,12Z,15Z)/o-18:0)
Tetracosahexaenoyl CoA
TG(20:1(11Z)/18:2(9Z,12Z)/o-18:0)
Cinitapride
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/24:0/18:1(9Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(14:0/22:0/24:1(15Z))
CDP-Ethanolamine A phosphoethanolamine consisting of ethanolamine having a cytidine 5'-diphosphate moiety attached to the oxygen.
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:0/20:2(11Z,14Z)/0:0)
DG(24:0/0:0/18:4n3)
TG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
Metharbital
TG(18:0/15:0/20:4(5Z,8Z,11Z,14Z))
11-Dehydrocorticosterone An 11-oxo steroid that is corticosterone in which the hydroxy substituent at the 11beta position has been oxidised to give the corresponding ketone.
PE(22:0/20:3(8Z,11Z,14Z))
TG(18:0/24:1(15Z)/o-18:0)
PC(18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/24:0/18:4(6Z,9Z,12Z,15Z))
Telmisartan
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/0:0)
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/20:1(11Z))
TG(16:0/20:3n6/20:4(5Z,8Z,11Z,14Z))
PC(20:3(8Z,11Z,14Z)/14:0)
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/18:1(9Z)/18:1(9Z))[iso3]
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/24:0/22:2(13Z,16Z))
TG(18:0/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(P-18:1(11Z)/14:1(9Z))
DG(24:0/22:0/0:0)
PC(o-20:0/18:3(6Z,9Z,12Z))
Clindamycin A carbohydrate-containing antibiotic that is the semisynthetic derivative of lincomycin, a natural antibiotic.
PI(18:1(9Z)/18:2(9Z,12Z))
TG(22:2(13Z,16Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
PS(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(15:0/16:0)
TG(20:3(5Z,8Z,11Z)/o-18:0/24:1(15Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/22:0)
TG(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:2n6/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/16:0/20:2n6)
TG(20:0/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/o-18:0/22:2(13Z,16Z))
TG(18:1(9Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(15:0/18:3(6Z,9Z,12Z)/0:0)
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
PE(P-16:0/18:0)
PC(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
DG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z))
TG(20:1(11Z)/20:0/24:1(15Z))
TG(18:1(9Z)/15:0/20:1(11Z))
TG(20:0/20:3(5Z,8Z,11Z)/22:1(13Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(14:0/14:1(9Z)/18:3(9Z,12Z,15Z))
DG(18:2(9Z,12Z)/16:0/0:0)
TG(16:0/20:3n6/22:2(13Z,16Z))
PE(20:3(8Z,11Z,14Z)/P-18:0)
Hydroxyphenylacetylglycine
PE(15:0/14:0)
Etiocholanedione
24,25-Dihydrolanosterol A 3beta-sterol formed from lanosterol by reduction across the C-24-C-25 double bond.
TG(15:0/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/15:0/o-18:0)
TG(18:2(9Z,12Z)/o-18:0/20:3n6)
L(-)-Nicotine pestanal
TG(16:1(9Z)/14:1(9Z)/22:2(13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/0:0)
TG(15:0/22:0/20:3n6)
DG(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/0:0)
TG(20:2n6/24:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
SM(d18:0/24:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Zanamivir
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
Adinazolam A triazolo[4,3-a][1,4]benzodiazepine having a dimethylaminomethyl group at the 1-position, a phenyl group at the 6-position and a chloro substituent at the 8-position.
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/o-18:0)
TG(14:0/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
Kudzusaponin SA4
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/o-18:0/20:3n6)
TG(24:0/o-18:0/14:1(9Z))
Azathioprine A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Protoporphyrin IX
TG(16:0/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:4(6Z,9Z,12Z,15Z)/20:2(11Z,14Z))
PC(15:0/18:1(11Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/24:0)
TG(14:0/20:2n6/14:0)
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(24:1(15Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
PE(18:0/16:0)
TG(22:2(13Z,16Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/14:0/22:4(7Z,10Z,13Z,16Z))
TG(14:0/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6/o-18:0)
Vincristine A vinca alkaloid that has formula C46H56N4O10.
15H-11,12-EETA A carbonyl compound that has formula C20H32O4.
TG(24:1(15Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:3(5Z,8Z,11Z)/22:1(13Z))
PC(22:0/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Cefmetazole
TG(14:1(9Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
12-Hydroxynevirapine
Adrenosterone A 3-hydroxy steroid that has formula C19H24O3.
7a,12a-Dihydroxy-5a-cholestan-3-one
TG(22:1(13Z)/22:0/20:4(8Z,11Z,14Z,17Z))
PC(22:0/18:0)
TG(16:0/22:4(7Z,10Z,13Z,16Z)/18:0)
TG(20:1(11Z)/24:0/24:1(15Z))
TG(16:0/18:1(9Z)/20:2n6)
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
PE(18:0/18:0)
Eucalyptol
Lovastatin A fatty acid ester that is mevastatin carrying an additional methyl group on the carbobicyclic skeleton. It is used in as a antilipemic drug and has been found in fungal species such as Aspergillus terreus and Pleurotus ostreatus (oyster mushroom).
TG(18:3(9Z,12Z,15Z)/18:1(11Z)/18:3(9Z,12Z,15Z))[iso3]
TG(24:0/16:0/20:4(8Z,11Z,14Z,17Z))
Mequitazine
TG(16:0/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/15:0/18:1(9Z))
PG(18:1(9Z)/20:3(8Z,11Z,14Z))
PI(16:1(9Z)/16:0)
Dehydrodolichol diphosphate
PE(22:0/20:5(5Z,8Z,11Z,14Z,17Z))
3-Aminoisobutanoic acid
PC(dm18:1(9Z)/dm18:0)
TG(16:1(9Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/22:2(13Z,16Z))
Promazine 5-sulfoxide
TG(15:0/20:0/22:0)
5-Aminolevulinic acid The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group.
TG(18:2(9Z,12Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/o-18:0/22:1(13Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/20:0)
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
PIP(16:0/18:0)
DG(24:1(15Z)/18:3(9Z,12Z,15Z)/0:0)
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
PE(18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(15:0/16:1(9Z)/15:0)
TG(18:0/15:0/22:4(7Z,10Z,13Z,16Z))
Ganglioside GD1b (d18:0/22:1(13Z))
TG(22:0/22:1(13Z)/24:1(15Z))
TG(14:0/16:1(9Z)/24:0)
TG(18:0/18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
PC(24:1(15Z)/14:0)
DG(18:3(6Z,9Z,12Z)/20:1(11Z)/0:0)
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(P-18:0/20:0)
TG(14:1(9Z)/14:1(9Z)/20:3n6)
TG(14:1(9Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Hexanal
TG(16:1(9Z)/20:3n6/18:1(11Z))
TG(14:0/22:0/22:1(13Z))
TG(20:3n6/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/22:0/20:2n6)
TG(15:0/20:0/20:0)
DG(18:2(9Z,12Z)/24:1(15Z)/0:0)
L-Lactic acid
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(20:0/0:0/18:3n3)
DG(24:0/0:0/18:2n6)
TG(16:0/18:0/18:1(11Z))
DG(18:3n6/0:0/20:2n6)
TG(16:1(9Z)/16:0/20:2n6)
PE(20:1(11Z)/P-18:1(9Z))
2-Hydroxybutyric acid A hydroxybutyric acid having a single hydroxyl group located at position 2; urinary secretion of 2-hydroxybutyric acid is increased with alcohol ingestion or vigorous physical exercise and is associated with lactic acidosis and ketoacidosis in humans and diabetes in animals.
1-(alpha-Methyl-4-(2-methylpropyl)benzeneacetate)-beta-D-Glucopyranuronic acid
20a,22b-Dihydroxycholesterol
TG(14:1(9Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Etidronic acid A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
TG(18:1(9Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
PG(18:1(11Z)/18:0)
TG(14:0/24:1(15Z)/20:0)
PC(20:0/22:5(4Z,7Z,10Z,13Z,16Z))
epsilon-Caprolactone
PC(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/20:3n6/20:2n6)
TG(18:1(9Z)/16:1(9Z)/20:2n6)
2-Hydroxyestrone-1-S-glutathione
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
TG(22:0/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(24:1(15Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0/0:0)
Naproxen A methoxynaphthalene that is 2-methoxynaphthalene substituted by a carboxy ethyl group at position 6. Naproxen is a non-steroidal anti-inflammatory drug commonly used for the reduction of pain, fever, inflammation and stiffness caused by conditions such as osteoarthritis, kidney stones, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, menstrual cramps, tendinitis, bursitis, and for the treatment of primary dysmenorrhea. It works by inhibiting both the COX-1 and COX-2 enzymes.
Homocysteine A sulfur-containing amino acid consisting of a glycine core with a 2-mercaptoethyl side-chain.
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Taurolithocholic acid 3-sulfate
1-Hydroxymethylnaphthalene
PE(24:0/16:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Telithromycin
TG(20:3n6/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/18:3(6Z,9Z,12Z)/22:1(13Z))
TG(16:0/20:3(5Z,8Z,11Z)/20:2n6)
TG(20:3(5Z,8Z,11Z)/24:0/20:2n6)
DG(15:0/18:0/0:0)
MG(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0/0:0)
TG(14:0/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Okadaic acid A polycyclic ether that has formula C44H68O13.
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
DG(16:0/16:0/0:0)
TG(18:0/18:3(9Z,12Z,15Z)/o-18:0)
TG(14:0/14:0/15:0)
TG(16:0/18:3(6Z,9Z,12Z)/20:2n6)
TG(18:2(9Z,12Z)/20:0/20:4(5Z,8Z,11Z,14Z))[iso6]
DG(14:1n5/0:0/20:5n3)
TG(15:0/20:4(8Z,11Z,14Z,17Z)/15:0)
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(18:1(11Z)/16:0/22:2(13Z,16Z))
TG(18:0/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
PE(16:0/18:4(6Z,9Z,12Z,15Z))
PIP(16:0/22:5(7Z,10Z,13Z,16Z,19Z))
Hydroxypropionic acid
3-Methyl-2-oxovaleric acid A 2-oxo monocarboxylic acid that is valeric acid carrying oxo- and methyl substituents at C-2 and C-3, respectively. An alpha-keto acid analogue and metabolite of isoleucine in man, animals and bacteria. Used as a clinical marker for maple syrup urine disease (MSUD).
TG(20:3(5Z,8Z,11Z)/14:0/20:2n6)
TG(14:0/18:1(9Z)/20:0)
TG(20:3(5Z,8Z,11Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GT1b (d18:0/23:0)
PE(24:0/P-18:0)
TG(18:2(9Z,12Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Aprobarbital
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
MG(18:0/0:0/0:0) A 1-acyl-sn-glycerol that has octadecanoyl (stearoyl) as the 1-acyl group.
Ibudilast
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(24:0/16:1(9Z)/22:2(13Z,16Z))
TG(20:0/22:0/24:0)
PE(22:4(7Z,10Z,13Z,16Z)/P-18:0)
PE(18:3(9Z,12Z,15Z)/16:0)
Ribothymidine A methyluridine having a single methyl substituent at the 5-position on the uracil ring.
TG(24:0/20:2n6/o-18:0)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/15:0)
TG(18:1(11Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(24:1(15Z)/14:0/18:4(6Z,9Z,12Z,15Z))
Lipoyl-AMP A purine ribonucleoside 5'-monophosphate having adenine as the nucleobase and a lipoyl group attached to one of the phosphate OH groups.
Isobutyryl-CoA A short-chain, methyl-branched fatty acyl-CoA that is the S-isobutyryl derivative of coenzyme A.
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
Ketoconazole A N-carbonylpiperazine that has formula C26H28Cl2N4O4.
PS(18:0/20:0)
Ganglioside GD1b (d18:1/22:1(13Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/20:3(5Z,8Z,11Z))
Ganglioside GQ1c (d18:1/22:1(13Z))
PE(22:1(13Z)/24:0)
TG(14:1(9Z)/22:1(13Z)/20:2n6)
TG(15:0/18:0/20:3n6)
TG(20:0/14:0/18:1(11Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Ganglioside GD2 (d18:0/26:0)
TG(20:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
1,7-Dimethyluric acid An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by methyl groups at N-1 and N-7. It is a metabolite of caffeine and is often found in human urine samples.
Sulfide Any sulfur molecular entity that involves either covalently bonded or anionic sulfur.
PE(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Isosorbide Mononitrate A glucitol derivative that has formula C6H9NO6.
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/0:0)
PC(24:0/18:2(9Z,12Z))
TG(20:0/18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
3-hydroxyoctadecanoyl-CoA A 3-hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3-hydroxyoctadecanoic acid.
Ganglioside GD2 (d18:0/24:0)
Methsuximide
6-Methylthioguanosine monophosphate An organic molecule that has formula C11H16N5O7PS.
DG(22:1(13Z)/15:0/0:0)
TG(20:2n6/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
PIP(18:2(9Z,12Z)/18:1(9Z))
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/14:1(9Z)/24:1(15Z))
TG(20:3n6/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
PE(22:1(13Z)/22:0)
TG(18:1(9Z)/22:0/24:1(15Z))
TG(14:1(9Z)/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)/o-18:0)
TG(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:0/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:0/22:4(7Z,10Z,13Z,16Z))
TG(24:0/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/14:0/20:2n6)
PIP(20:0/18:2(9Z,12Z))
TG(14:1(9Z)/o-18:0/24:1(15Z))
Galactosylceramide (d18:1/18:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:0/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(18:1(11Z)/18:1(11Z)/20:3n6)
TG(15:0/22:1(13Z)/24:0)
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
DG(20:3(5Z,8Z,11Z)/18:1(9Z)/0:0)
TG(22:1(13Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PG(18:2(9Z,12Z)/18:0)
2-Maleylacetate
TG(22:0/20:0/14:1(9Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0)
TG(16:0/20:1(11Z)/20:3n6)
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(18:0/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
TG(18:1(11Z)/14:0/o-18:0)
TG(18:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:0/18:1(11Z))
DG(20:5n3/0:0/20:5n3)
Fludiazepam A 1,4-benzodiazepinone that has formula C16H12ClFN2O.
TG(20:1(11Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/22:2(13Z,16Z)/o-18:0)
TG(18:0/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
Carphenazine A propanone that has formula C24H31N3O2S.
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0/0:0)
Drostanolone
Ketotifen
(+)-trans-Carveol
PE(14:0/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(20:4(8Z,11Z,14Z,17Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/24:1(15Z)/16:0)
TG(18:1(9Z)/18:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/18:3(9Z,12Z,15Z)/20:1(11Z))
Alvimopan
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
Bretylium
PE(18:2(9Z,12Z)/18:1(9Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
11-cis-Retinyl palmitate The 11-cis-isomer of retinyl palmitate.
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(P-16:0/15:0)
Copper
PE(15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/24:0/16:1(9Z))
Ubiquinone 6 A ubiquinone compound having a (2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaen-1-yl substituent at position 2.
alpha-Fluoro-beta-alanine An organonitrogen compound that has formula C3H6FNO2.
DG(18:1(9Z)/18:0/0:0)
TG(24:0/20:1(11Z)/o-18:0)
3a,7a-Dihydroxy-5b-cholest-24-enoyl-CoA
DG(14:1(9Z)/18:0/0:0)
TG(16:1(9Z)/18:0/o-18:0)
Ambenonium
TG(24:0/20:0/20:3n6)
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/20:3n6)
TG(22:0/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PC(14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/20:1(11Z)/22:1(13Z))
TG(18:3(9Z,12Z,15Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
PI(18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
PC(24:0/16:1(9Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
Androstan-3alpha,17beta-diol
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/18:2(9Z,12Z)/18:1(11Z))
PC(P-18:0/18:0)
DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:0/0:0)
DG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(20:0/15:0/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:0/18:3(6Z,9Z,12Z))
PC(22:2(13Z,16Z)/20:1(11Z))
Diphenhydramine An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:1(9Z)/18:3(6Z,9Z,12Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/22:1(13Z)/16:1(9Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(18:1(11Z)/14:0/24:1(15Z))
TG(14:1(9Z)/18:0/22:1(13Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(24:0/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
3-Dechloroethylifosfamide A phosphorodiamide that has formula C5H12ClN2O2P.
2-Propyn-1-al
TG(20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/20:3n6)
TG(16:0/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
Ganglioside GD1a (d18:1/20:0)
TG(18:1(9Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Rifampin
TG(18:1(11Z)/20:1(11Z)/20:2n6)
TG(14:1(9Z)/16:1(9Z)/22:2(13Z,16Z))
PC(22:4(7Z,10Z,13Z,16Z)/16:0)
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:0/20:4(8Z,11Z,14Z,17Z))
DG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/18:0/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
PC(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CL(20:2(11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
Carprofen Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs.
dUMP A pyrimidine 2'-deoxyribonucleoside 5'-monophosphate having uracil as the nucleobase.
TG(22:4(7Z,10Z,13Z,16Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(24:0/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:3(6Z,9Z,12Z)/18:0)
PC(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
CL(20:1(11Z)/18:2(9Z,12Z)/18:1(9Z)/18:1(11Z))
TG(22:1(13Z)/16:1(9Z)/o-18:0)
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
PE(P-18:1(9Z)/16:1(9Z))
DG(18:0/0:0/18:0)
Lactosylcermide (d18:1/20:0)
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/14:0/20:1(11Z))
TG(24:0/20:1(11Z)/22:1(13Z))
Alpha-Tocopherol
Uridine diphosphate-N-acetylglucosamine
SM(d17:1/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/24:0/22:4(7Z,10Z,13Z,16Z))
TG(16:0/22:2(13Z,16Z)/18:1(9Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:0/20:4(8Z,11Z,14Z,17Z))
L-Glutamic acid 5-phosphate
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(16:0/22:0/20:4(5Z,8Z,11Z,14Z))
TG(18:3(9Z,12Z,15Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/14:1(9Z)/22:2(13Z,16Z))
3-Oxotetradecanoyl-CoA A 3-oxo-fatty acyl-CoA that has formula C35H60N7O18P3S.
Darunavir
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(22:0/14:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(18:0/20:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:2(9Z,12Z)/P-16:0)
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/24:0/18:1(9Z))
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/20:2n6)
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z)/16:0)
PE(14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
5-alpha-Dihydrotestosterone glucuronide
Oxytetracycline A tetracycline used for treatment of infections caused by a variety of Gram positive and Gram negative microorganisms including Mycoplasma pneumoniae, Pasteurella pestis, Escherichia coli, Haemophilus influenzae (respiratory infections), and Diplococcus pneumoniae.
TG(20:4(8Z,11Z,14Z,17Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/14:0)
Hydrocortamate A glycinyl ester that has formula C27H41NO6.
PIP(18:3(6Z,9Z,12Z)/18:1(11Z))
TG(18:1(9Z)/20:0/20:3(5Z,8Z,11Z))
Methyclothiazide
TG(18:3(6Z,9Z,12Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
Oleoyl-CoA An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of oleic acid.
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/14:1(9Z)/20:1(11Z))
TG(14:0/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
Galactosylceramide (d18:1/16:0)
TG(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:3(5Z,8Z,11Z)/24:0)
DG(16:0/0:0/20:4n6)
TG(14:0/20:2n6/18:3(9Z,12Z,15Z))
N6-Methyladenosine A methyladenosine compound with one methyl group attached to N(6) of the adenine nucleobase.
Doxazosin A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
TG(18:2(9Z,12Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Guanabenz
TG(22:0/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/18:1(9Z)/18:1(9Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:0/22:2(13Z,16Z)/24:1(15Z))
TG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
DG(24:1(15Z)/16:1(9Z)/0:0)
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(18:0/22:1(13Z)/18:1(11Z))
TG(16:1(9Z)/20:2n6/24:1(15Z))
MG(18:3(9Z,12Z,15Z)/0:0/0:0)
PE(14:0/22:2(13Z,16Z))
TG(18:0/20:3(5Z,8Z,11Z)/o-18:0)
TG(24:0/18:1(11Z)/20:1(11Z))
Modafinil
LysoPC(18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/20:2n6)
TG(14:0/14:0/o-18:0)
TG(16:1(9Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/P-16:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Thiamylal A member of the class of barbiturates that is 2-thioxodihydropyrimidine-4,6(1H,5H)-dione substituted by a pentan-2-yl and prop-2-en-1-yl group at position 5.
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(18:2(9Z,12Z)/16:0/20:2n6)
TG(24:1(15Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
Cis-stilbene oxide A stilbene oxide that has formula C14H12O.
Malonyl-CoA The S-malonyl derivative of coenzyme A.
TG(18:1(11Z)/16:1(9Z)/20:1(11Z))
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(P-18:1(11Z)/20:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
PG(18:1(11Z)/18:3(6Z,9Z,12Z))
TG(20:3n6/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/20:3n6/22:1(13Z))
TG(14:1(9Z)/18:1(9Z)/22:2(13Z,16Z))
PI(18:1(11Z)/18:1(11Z))
TG(24:0/24:1(15Z)/18:3(9Z,12Z,15Z))
PC(20:2(11Z,14Z)/P-16:0)
TG(24:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/16:0/24:1(15Z))
N-Oleoylethanolamine
DG(24:0/18:3(9Z,12Z,15Z)/0:0)
TG(22:1(13Z)/14:0/20:3n6)
PC(20:1(11Z)/14:0)
TG(20:3(5Z,8Z,11Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
16(R)-HETE An optically active form of 16-HETE having (16R)-configuration.
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)
Ganglioside GA1 (d18:1/20:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/14:0/18:3(9Z,12Z,15Z))
TG(15:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(14:0/18:1(11Z)/0:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
Ubiquinol 8 A ubiquinol in which the polyprenyl substituent is octaprenyl.
TG(22:1(13Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/o-18:0/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/20:1(11Z)/o-18:0)
TG(20:2n6/16:0/22:4(7Z,10Z,13Z,16Z))
PC(20:1(11Z)/20:2(11Z,14Z))
5-beta-Cholestan-3-one A 3-oxo steroid that is 5beta-cholestane substituted by an oxo group at position 3.
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)
TG(22:1(13Z)/20:3n6/o-18:0)
Arsenite An arsenite ion resulting from the removal of all three protons from the hydroxy groups of arsenous acid.
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
PE(20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
Fluoxymesterone An anabolic androgenic steroid that has formula C20H29FO3.
TG(16:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:0/20:4(8Z,11Z,14Z,17Z))
DG(22:0/0:0/18:1n7)
PIP(16:0/22:2(13Z,16Z))
TG(18:1(11Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
PC(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:1(11Z)/16:0)
Pentadecanoic acid A straight-chain, fifteen-carbon carboxylic acid with no heteroatoms; a long-chain of mainly ruminant origin.
TG(20:0/20:3n6/20:0)
TG(14:0/20:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:0/18:2(9Z,12Z))
PE(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)/o-18:0)
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(18:3(9Z,12Z,15Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/16:1(9Z)/16:1(9Z))[iso]
DG(20:4n6/0:0/22:2n6)
TG(22:0/16:1(9Z)/24:0)
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
PE(20:3(8Z,11Z,14Z)/18:1(11Z))
TG(18:0/o-18:0/20:2n6)
CDP-DG(18:0/18:0)
Sialyl-Lewis X
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Acrylyl-CoA
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
DG(16:0/0:0/20:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
Budesonide A glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis.
Hydrogen carbonate The carbon oxoanion resulting from the removal of a proton from carbonic acid.
TG(15:0/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(16:0/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:0/20:2n6)
TG(20:1(11Z)/20:1(11Z)/o-18:0)
TG(16:0/16:0/18:1(11Z))[iso3]
TG(22:0/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:0/18:3(9Z,12Z,15Z))[iso6]
TG(14:0/18:1(9Z)/20:1(11Z))
Triprolidine
TG(15:0/18:1(9Z)/20:3(5Z,8Z,11Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0/0:0)
TG(20:1(11Z)/22:0/24:1(15Z))
TG(16:1(9Z)/16:0/18:3(9Z,12Z,15Z))[iso6]
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/24:1(15Z))
TG(20:3n6/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
TG(18:3(9Z,12Z,15Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
17a,21-Dihydroxy-5b-pregnane-3,11,20-trione
TG(14:0/20:3n6/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(14:0/20:3n6/22:1(13Z))
PIP(18:1(11Z)/16:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
Ganglioside GT3 (d18:0/25:0)
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
Fosaprepitant A morpholine derivative that is the (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl ether of (3-{[(2R,3S)-3-(4-fluorophenyl)-2-hydroxymorpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid.
PC(24:0/22:0)
DG(22:0/14:1(9Z)/0:0)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z)/0:0)
Repaglinide
PE(24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/24:0)
Cinolazepam A 1,4-benzodiazepinone compound having a 2-cyanoethyl substituent at the 1-position, a hydroxy substituent at the 3-position, a 2-fluorophenyl group at the 5-position and a chloro substituent at the 7-position, it has general properties similar to those of diazepam and has been used for the short-term management of sleep disorders.
TG(24:0/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:1(9Z)/22:2(13Z,16Z))
TG(16:0/18:3(9Z,12Z,15Z)/20:0)
TG(15:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/18:3(6Z,9Z,12Z)/18:0)
TG(22:2(13Z,16Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/24:0/18:2(9Z,12Z))
PE(22:0/P-18:0)
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
Cer(d18:1/26:1(17Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
DG(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/0:0)
TG(20:3n6/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:2n6/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
Queuine A pyrrolopyrimidine that has formula C12H15N5O3.
PE(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GA2 (d18:1/24:1(15Z))
PIP[3'](16:0/18:1(9Z))
PC(24:0/24:0)
TG(16:0/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/22:1(13Z)/18:1(11Z))
TG(20:0/15:0/22:0)
TG(22:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
Fe3+
TG(16:0/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
TG(16:1(9Z)/14:1(9Z)/22:1(13Z))
TG(14:0/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:0/15:0)
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
TG(20:0/15:0/20:0)
TG(16:0/16:1(9Z)/16:1(9Z))[iso3]
1,4-Dithiothreitol The threo-diastereomer of 1,4-dimercaptobutane-2,3-diol.
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/18:0/20:1(11Z))
D-Ribulose 5-phosphate The D-enantiomer of ribulose 5-phosphate that is one of the end-products of the pentose phosphate pathway.
Beta-D-Fructose 2-phosphate
TG(22:0/18:2(9Z,12Z)/20:2n6)
TG(20:0/20:0/22:2(13Z,16Z))
Ganglioside GT3 (d18:1/25:0)
TG(18:3(9Z,12Z,15Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
TG(14:0/18:3(9Z,12Z,15Z)/24:0)
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z)/0:0)
TG(15:0/16:1(9Z)/18:0)
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Forasartan
TG(14:0/20:3n6/18:2(9Z,12Z))
Bismuth
TG(22:0/16:1(9Z)/18:2(9Z,12Z))
TG(16:0/15:0/22:4(7Z,10Z,13Z,16Z))
PC(18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
TG(22:0/18:0/20:3(5Z,8Z,11Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PG(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CL(20:1(11Z)/18:2(9Z,12Z)/18:1(9Z)/18:1(9Z))
TG(15:0/20:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
15(S)-HPETE The (S)-enantiomer of 15-HPETE.
TG(14:0/14:0/18:0)
TG(18:1(11Z)/24:1(15Z)/22:2(13Z,16Z))
TG(24:1(15Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
QH(2)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
PC(16:0/18:0)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:0)
TG(22:0/16:0/22:1(13Z))
TG(15:0/24:1(15Z)/18:1(11Z))
TG(18:3(6Z,9Z,12Z)/16:0/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:0/15:0/0:0)
12,13-EpOME
TG(20:3n6/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/22:1(13Z)/15:0)
TG(18:0/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:3(5Z,8Z,11Z)/14:0)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(20:1(11Z)/18:0/20:4(8Z,11Z,14Z,17Z))
TG(20:0/o-18:0/20:0)
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(16:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(14:0/14:0/18:2(9Z,12Z))
7-Methylxanthine An oxopurine that is xanthine in which the hydrogen attached to the nitrogen at position 7 is replaced by a methyl group. It is an intermediate metabolite in the synthesis of caffeine.
PE(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:1(9Z)/18:1(9Z))
TG(14:0/24:0/22:0)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(18:2(9Z,12Z)/18:1(9Z)/20:2(11Z,14Z))[iso6]
D-Glucaric acid The D-enantiomer of glucaric acid.
Ganglioside GD3 (d18:0/12:0)
Galactosylceramide (d18:1/24:1(15Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/20:1(11Z)/18:3(6Z,9Z,12Z))
Clofazimine
TG(22:1(13Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:0/22:0)
TG(18:0/22:2(13Z,16Z)/20:2n6)
PE(18:3(9Z,12Z,15Z)/24:0)
TG(16:1(9Z)/22:2(13Z,16Z)/o-18:0)
TG(18:0/22:0/24:0)
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
Adrenochrome
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(20:1(11Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
DG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
PC(22:4(7Z,10Z,13Z,16Z)/P-18:0)
DG(22:1(13Z)/14:0/0:0)
Nonanoyl-CoA A medium-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of nonanoic acid.
TG(20:0/22:1(13Z)/22:2(13Z,16Z))
TG(16:0/15:0/16:0)
Prenyl benzoate
Rocuronium A 5alpha-androstane compound having 3alpha-hydroxy-, 17beta-acetoxy-, 2beta-morpholino- and 16beta-N-allyllyrrolidinium substituents.
TG(14:0/20:2n6/20:2n6)
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/22:1(13Z))
PI(16:0/18:1(11Z))
PIP3(18:1(11Z)/18:1(11Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
Galactosylceramide (d18:1/14:0)
TG(14:0/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GD2 (d18:1/22:0)
DG(15:0/0:0/22:4n6)
Orlistat
DG(18:2n6/0:0/20:2n6)
Gamma-Linolenic acid A C18, omega-6 acid fatty acid comprising a linolenic acid having cis- double bonds at positions 6, 9 and 12.
TG(20:0/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
TG(24:0/22:2(13Z,16Z)/o-18:0)
TG(22:0/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
Tiglylglycine An N-acylglycine that is glycine with an amine hydrogen substituted by a 2-methylbut-2-enoyl (tiglyl) group.
TG(24:1(15Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:2n6/24:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
Thromboxane A2 A thromboxane which is produced by activated platelets and has prothrombotic properties: it stimulates activation of new platelets as well as increases platelet aggregation.
TG(18:0/20:2n6/14:1(9Z))
TG(18:1(9Z)/18:1(9Z)/20:0)[iso3]
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
PC(22:4(7Z,10Z,13Z,16Z)/P-16:0)
TG(20:3n6/22:2(13Z,16Z)/22:2(13Z,16Z))
PC(o-20:0/18:3(9Z,12Z,15Z))
TG(22:2(13Z,16Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
DG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/0:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Tiotropium
TG(18:0/18:1(11Z)/20:0)
Acarbose A tetrasaccharide derivative consisting of a dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl C7 cyclitol moiety [called valienol (or valienamine)] linked via nitrogen to isomaltotriose.
DG(22:2n6/0:0/20:5n3)
PC(o-16:0/16:1(9Z))
TG(18:1(11Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
TG(24:1(15Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/20:1(11Z)/22:2(13Z,16Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/14:1(9Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PI(18:1(11Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(20:0/24:0/20:4(8Z,11Z,14Z,17Z))
PC(o-22:2(13Z,16Z)/22:3(10Z,13Z,16Z))
TG(22:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
Sulfanilamide A sulfonamide in which the sulfamoyl functional group is attached to aniline at the 4-position.
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
LysoPC(20:0) A lysophosphatidylcholine in which the remaining acyl group contains 20 carbons and 0 double bonds. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PS(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))
Ursodeoxycholic acid 3-sulfate
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GD1b (d18:0/18:1(11Z))
TG(18:2(9Z,12Z)/o-18:0/20:2n6)
TG(14:1(9Z)/14:0/20:1(11Z))
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:3n6)
LysoPE(0:0/24:1(15Z))
TG(18:0/o-18:0/20:3(5Z,8Z,11Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z)/o-18:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
Taurocholic acid A bile acid taurine conjugate of cholic acid that usually occurs as the sodium salt of bile in mammals.
TG(18:1(9Z)/22:0/18:2(9Z,12Z))
Bromobenzene-2,3-oxide An epoxide that has formula C6H5BrO.
TG(22:0/14:1(9Z)/22:0)
PC(18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/o-18:0/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/20:2n6/18:2(9Z,12Z))
PI(20:4(8Z,11Z,14Z,17Z)/16:0)
Vitamin D2 3-glucuronide
Cisapride The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
L-Leucine The L-enantiomer of leucine.
Drospirenone
TG(22:0/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(14:0/22:1(13Z)/15:0)
TG(20:0/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Leukotriene F4 A leukotriene composed of (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid having (5S)-hydroxy and (6R)-(L-gamma-glutamyl-L-cystein-S-yl) substituents.
MG(0:0/18:2(9Z,12Z)/0:0)
TG(22:0/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(24:1(15Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(14:0/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(P-18:0/15:0)
Pyridoxine A hydroxymethylpyridine with hydroxymethyl groups at positions 4 and 5, a hydroxy group at position 3 and a methyl group at position 2.
TG(22:0/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Dolichyl phosphate D-mannose
TG(14:1(9Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/20:0/18:3(9Z,12Z,15Z))
PE(18:3(6Z,9Z,12Z)/24:0)
TG(24:0/24:1(15Z)/20:2n6)
TG(18:1(11Z)/20:0/20:3(5Z,8Z,11Z))
Docosahexaenoic acid Any C22 polyunsaturated fatty acid containing six double bonds.
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/20:0/o-18:0)
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(14:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(24:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
DG(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(18:1(9Z)/20:0/24:1(15Z))
PC(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
22b-Hydroxycholesterol
Ganglioside GM2 (d18:1/18:1(11Z))
TG(18:2(9Z,12Z)/20:0/22:4(7Z,10Z,13Z,16Z))
DG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
PIP2(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(22:1(13Z)/22:0/18:3(6Z,9Z,12Z))
DG(22:1(13Z)/16:1(9Z)/0:0)
PC(22:0/20:1(11Z))
2-Amino-3-carboxymuconic acid semialdehyde
PE(P-16:0/22:0)
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
PIP(18:0/16:2(9Z,12Z))
Bromocriptine An indole alkaloid that has formula C32H40BrN5O5.
TG(20:1(11Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(20:3n6/20:3n6/20:4(5Z,8Z,11Z,14Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/24:0)
4-Hydroxy-L-proline The L-stereoisomer of 4-hydroxyproline.
PE(18:4(6Z,9Z,12Z,15Z)/P-18:1(11Z))
TG(15:0/o-18:0/18:1(9Z))
N6-Galacturonyl-L-lysine
TG(16:1(9Z)/20:0/20:2n6)
TG(22:2(13Z,16Z)/18:1(11Z)/22:2(13Z,16Z))
TG(20:2n6/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z)/16:1(9Z))
DG(16:0/0:0/18:3n3)
TG(24:0/20:2n6/18:3(6Z,9Z,12Z))
PE(P-18:1(9Z)/22:1(13Z))
TG(15:0/20:3(5Z,8Z,11Z)/20:3n6)
CDP-DG(18:1(11Z)/16:0)
TG(16:0/15:0/18:3(6Z,9Z,12Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
DG(16:0/0:0/18:1n7)
Dacarbazine A monocarboxylic acid amide that is 1H-imidazole-4-carboxamide which is substituted at position 5 by a 3,3-dimethyltriaz-1-en-1-yl group. It is used for the treatment of metastatic malignant melanoma, and in combination with other drugs for the treatment of Hodgkin's disease and soft-tissue sarcoma.
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/14:0/24:1(15Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(24:0/20:2n6/18:2(9Z,12Z))
SM(d18:0/16:1(9Z)(OH))
TG(20:3n6/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/o-18:0/18:1(11Z))
PG(16:0/18:2(9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
4-Acetamido-2-amino-6-nitrotoluene
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0/o-18:0)
Phosphoserine
PE(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Melphalan A phenylalanine derivative comprising L-phenylalanine having [bis(2-chloroethyl)amino group at the 4-position on the phenyl ring.
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(20:2n6/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
DG(20:1(11Z)/22:0/0:0)
TG(20:3n6/16:0/20:3n6)
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
DG(18:3(6Z,9Z,12Z)/16:0/0:0)
TG(22:0/18:3(6Z,9Z,12Z)/20:3n6)
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
2b,3a,7a,12a-Tetrahydroxy-5b-cholanoic acid
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
Thioridazine A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
TG(18:0/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
Lotaustralin A cyanogenic glycoside that has formula C11H19NO6.
TG(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/18:1(11Z)/24:1(15Z))
TG(20:3n6/24:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
TG(20:5(5Z,8Z,11Z,14Z,17Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(15:0/14:1(9Z)/20:0)
TG(14:1(9Z)/20:2n6/18:1(9Z))
Bromfenac Amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure.
TG(18:2(9Z,12Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/20:1(11Z)/20:2n6)
Flurbiprofen A fluorobiphenyl that has formula C15H13FO2.
TG(18:0/18:3(9Z,12Z,15Z)/16:1(9Z))
TG(20:0/20:3(5Z,8Z,11Z)/20:1(11Z))
DG(14:1n5/0:0/24:1n9)
5-phosphonooxy-L-lysine
TG(20:2n6/20:2n6/22:2(13Z,16Z))
TG(16:1(9Z)/20:1(11Z)/20:2n6)
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z))
TG(22:1(13Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(24:0/22:0/18:1(9Z))
PC(20:0/P-18:0)
Oxirane A saturated organic heteromonocyclic parent that is a three-membered heterocycle of two carbon atoms and one oxygen atom.
TG(14:0/24:0/15:0)
6-Thiourate An oxopurine that has formula C5H4N4O2S.
Oleic acid An octadec-9-enoic acid in which the double bond at C-9 has Z (cis) stereochemistry.
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(16:0/20:1(11Z)/18:2(9Z,12Z))
TG(15:0/14:1(9Z)/22:0)
TG(15:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/18:3(6Z,9Z,12Z)/20:3n6)
TG(24:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
DG(16:1n7/0:0/18:1n9)
TG(18:4(6Z,9Z,12Z,15Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:3n6/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
Rosiglitazone
Rifabutin
Adipate semialdehyde
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
Gemfibrozil An aromatic ether that has formula C15H22O3.
TG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
3a,7a,12a,19-Tetrahydroxy-5b-cholanoic acid
TG(22:2(13Z,16Z)/18:1(9Z)/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z)/o-18:0)
PC(14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Fructosamine
TG(16:1(9Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/14:1(9Z)/24:1(15Z))
Taurochenodesoxycholic acid
Nitrofurantoin An imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a (5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA.
QH2
PI(20:0/16:0)
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/24:0/20:2n6)
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/16:1(9Z)/16:0)
DG(22:5n6/0:0/18:4n3)
TG(18:2(9Z,12Z)/16:1(9Z)/o-18:0)
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(18:1(9Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
LysoPE(0:0/18:1(9Z))
TG(22:0/24:1(15Z)/18:3(6Z,9Z,12Z))
Tetrahexosylceramide (d18:1/12:0)
TG(20:0/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(22:0/20:1(11Z)/14:1(9Z))
TG(18:1(11Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/16:0/15:0)
TG(18:0/16:0/20:3(5Z,8Z,11Z))
TG(15:0/24:0/18:3(6Z,9Z,12Z))
Chlormerodrin Urea in which one of the hydrogens is substituted by a 3-chloromercury-2-methoxyprop-1-yl group. It was formerly used as a diuretic, but more potent and less toxic drugs are now available. Its radiolabelled ((197)Hg, (203)Hg) forms were used in diagnostic aids in renal imaging and brain scans.
TG(22:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
Trimethaphan
TG(20:2n6/24:1(15Z)/22:2(13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(15:0/20:0/22:2(13Z,16Z))
PE(20:0/22:5(4Z,7Z,10Z,13Z,16Z))
3b,7a,12a-Trihydroxy-5a-Cholanoic acid
TG(14:1(9Z)/24:1(15Z)/14:1(9Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
Ganglioside GT2 (d18:0/26:0)
TG(14:1(9Z)/14:1(9Z)/18:2(9Z,12Z))
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
DG(15:0/18:1(9Z)/0:0)
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:0)
TG(18:0/16:0/24:1(15Z))
TG(14:1(9Z)/16:0/18:3(9Z,12Z,15Z))
PE(P-16:0/22:2(13Z,16Z))
TG(18:1(11Z)/14:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PC(22:1(13Z)/16:1(9Z))
Ganglioside GT2 (d18:0/24:0)
TG(18:3(9Z,12Z,15Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:0/24:1(15Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/20:0/22:2(13Z,16Z))
PE(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(14:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
PC(P-16:0/14:1(9Z))
TG(22:2(13Z,16Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ciclesonide
TG(16:0/20:2n6/24:1(15Z))
2-Keto-glutaramic acid
DG(16:1(9Z)/24:0/0:0)
TG(15:0/18:1(11Z)/20:0)
TG(14:1(9Z)/20:2n6/20:1(11Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/o-18:0)
Dutasteride Finasteride in which the tert-butyl group is replaced by a 2,5-bis(trifluoromethyl)phenyl group. A synthetic 4-azasteroid, dutasteride is a selective inhibitor of both the type 1 and type 2 isoforms of steroid 5alpha-reductase, an intracellular enzyme that converts testosterone to 5alpha-dihydrotestosterone. Dutasteride is used for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate gland.
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
PE(22:1(13Z)/P-16:0)
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
DG(24:0/20:0/0:0)
Myristic acid A straight-chain, fourteen-carbon, long-chain saturated fatty acid mostly found in milk fat.
PE(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
PI(20:2(11Z,14Z)/18:0)
TG(20:2n6/22:0/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:2n6/22:2(13Z,16Z))
DG(18:0/0:0/22:5n6)
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/22:1(13Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
1-Salicylate glucuronide A beta-D-glucosiduronic acid that is the glucuronide conjugate of salicyclic acid.
TG(14:0/18:2(9Z,12Z)/22:0)
PE(18:2(9Z,12Z)/20:0)
TG(14:1(9Z)/24:0/18:1(9Z))
TG(18:0/16:1(9Z)/20:2n6)
DG(18:2(9Z,12Z)/20:0/0:0)
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/18:3(6Z,9Z,12Z))
L-Alpha-aminobutyric acid An optically active form of alpha-aminobutyric acid having L-configuration.
TG(22:4(7Z,10Z,13Z,16Z)/15:0/o-18:0)
TG(14:0/18:2(9Z,12Z)/24:0)
TG(15:0/18:0/18:0)
L-Lysine An L-alpha-amino acid; the L-isomer of lysine.
Chloroacetaldehyde Acetaldehyde substituted at C-2 by chlorine.
PIP(20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
PIP(20:3(5Z,8Z,11Z)/16:0)
TG(20:3n6/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/24:0/18:3(9Z,12Z,15Z))
PC(P-16:0/18:4(6Z,9Z,12Z,15Z))
LysoPE(20:0/0:0)
DG(20:0/16:0/0:0)
TG(18:0/18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/14:0/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:1(11Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(20:1(11Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
3-Oxoadipyl-CoA The S-(3-oxoadipyl) derivative of coenzyme A.
TG(18:3(6Z,9Z,12Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(20:0/15:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:1(11Z))
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
beta-L-fucose A L-fucopyranose with a beta-configuration at the anomeric position.
Ceftazidime A cephalosporin bearing pyridinium-1-ylmethyl and {[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.
TG(15:0/18:2(9Z,12Z)/18:2(9Z,12Z))[iso3]
Luteolin 7-O-[beta-D-glucuronosyl-(1->2)-beta-D-glucuronide]
TG(14:0/20:3n6/20:1(11Z))
TG(14:0/16:1(9Z)/14:1(9Z))
PE(15:0/24:0)
7a-Hydroxy-5b-cholestan-3-one
TG(18:1(11Z)/14:0/18:1(9Z))[iso6]
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/20:2n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:0/18:4(6Z,9Z,12Z,15Z))
PE(15:0/22:0)
TG(24:0/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/16:0/o-18:0)
TG(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(20:1(11Z)/20:2n6/22:1(13Z))
PG(16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
DG(18:1(9Z)/22:2(13Z,16Z)/0:0)
DG(20:2n6/0:0/22:5n3)
Ganglioside GT1c (d18:0/23:0)
Betaxolol A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydoxy is substituted by a 4-[2-(cyclopropylmethoxy)ethyl]phenyl group and one of the hydrogens attached to the amino group is substituted by isopropyl. It is a selective beta1-receptor blocker and is used in the treatment of glaucoma as well as hypertension, arrhythmias, and coronary heart disease. It is also used to reduce non-fatal cardiac events in patients with heart failure.
TG(15:0/18:3(6Z,9Z,12Z)/15:0)
TG(16:0/14:1(9Z)/20:1(11Z))
TG(14:0/16:1(9Z)/18:2(9Z,12Z))
TG(20:2n6/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/o-18:0/20:1(11Z))
TG(15:0/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:1(13Z)/20:3(5Z,8Z,11Z))
PS(20:3(8Z,11Z,14Z)/14:1(9Z))
Phosphatidylethanolamine
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/16:1(9Z)/18:3(6Z,9Z,12Z))
Tasosartan
TG(22:1(13Z)/20:1(11Z)/20:2n6)
TG(18:0/18:1(11Z)/18:3(6Z,9Z,12Z))
Dehydroascorbic acid A tetrahydrofuranone that has formula C6H6O6.
PIP2(18:3(6Z,9Z,12Z)/18:1(9Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(16:1(9Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
2,4-Diamino-6-nitrotoluene
DG(14:1(9Z)/15:0/0:0)
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(14:0/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(15:0/0:0/22:1n9)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/16:0/18:2(9Z,12Z))
Water An inorganic hydroxy compound that has formula H2O.
Spermidine A triamine that is the 1,5,10-triaza derivative of decane.
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
PI(16:0/20:2(11Z,14Z))
TG(16:1(9Z)/22:1(13Z)/18:1(9Z))
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
Ganglioside GT1c (d18:0/25:0)
S-(2-Methylpropionyl)-dihydrolipoamide-E
TG(22:0/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
DG(24:0/0:0/18:3n3)
TG(22:2(13Z,16Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:2n6/0:0/20:4n6)
5-Diphosphoinositol pentakisphosphate
N-Acetyl-L-alanine An N-acetyl-L-amino acid that is L-alanine in which one of the nitrogens attached to the nitrogen is replaced by an acetyl group.
TG(14:1(9Z)/18:0/20:1(11Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:0)
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(16:0/22:2(13Z,16Z)/20:0)
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PE(15:0/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/18:1(9Z)/20:2n6)
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/20:1(11Z))
TG(20:1(11Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/14:1(9Z)/20:3n6)
Dimethylallylpyrophosphate
TG(18:0/18:3(6Z,9Z,12Z)/22:1(13Z))
DG(22:4n6/0:0/18:3n3)
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
DG(15:0/20:4(8Z,11Z,14Z,17Z)/0:0)
Calcipotriol A seco-cholestane that has formula C27H40O3.
TG(18:0/24:1(15Z)/22:1(13Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/16:0/16:1(9Z))[iso3]
TG(20:2n6/20:3n6/18:4(6Z,9Z,12Z,15Z))
Achyranthoside D
Achyranthoside C
TG(18:4(6Z,9Z,12Z,15Z)/14:0/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
LPA(0:0/18:1(9Z))
TG(14:1(9Z)/20:3n6/14:1(9Z))
LysoPE(0:0/15:0)
PE(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
PS(14:0/16:1(9Z))
2-Aminomuconic acid semialdehyde
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/14:0/22:2(13Z,16Z))
DG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(24:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(20:1(11Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(16:0/o-18:0/20:3n6)
TG(16:1(9Z)/18:0/18:0)[iso3]
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/o-18:0/20:2n6)
Chondroitin A mucopolysaccharide composed of repeating beta-D-glucopyranuronosyl-(1->3)-beta-D-N-acetylgalactosaminyl units.
TG(18:2(9Z,12Z)/18:0/18:3(9Z,12Z,15Z))[iso6]
TG(15:0/15:0/18:0)
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:3(6Z,9Z,12Z)/15:0)
PIP2(18:0/16:1(9Z))
4-Fluoromuconolactone A butenolide that has formula C6H5FO4.
TG(24:1(15Z)/20:2n6/18:2(9Z,12Z))
TG(22:0/15:0/18:3(6Z,9Z,12Z))
TG(20:0/18:2(9Z,12Z)/14:1(9Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/0:0)
DG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z)/0:0)
TG(20:3(5Z,8Z,11Z)/20:2n6/18:2(9Z,12Z))
Brimonidine A quinoxaline derivative that has formula C11H10BrN5.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
L-2-Amino-3-oxobutanoic acid A 2-amino-3-oxobutanoic acid that has formula C4H7NO3.
UDP-N-acetyl-alpha-D-galactosamine A UDP-N-acetyl-D-galactosamine in which the anomeric centre of the galactosamine moiety has alpha-configuration.
TG(15:0/14:0/18:3(9Z,12Z,15Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:1(9Z)/24:1(15Z))
TG(18:2(9Z,12Z)/20:1(11Z)/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
Geranylgeranyl-PP
TG(14:1(9Z)/20:0/18:1(9Z))
TG(18:1(11Z)/14:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(P-16:0/18:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
Niacinamide
DG(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
Phosphoribosyl pyrophosphate
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/22:0/20:4(5Z,8Z,11Z,14Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
PC(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/18:2(9Z,12Z)/20:1(11Z))
Ganglioside GM1 (18:1/16:0)
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(20:0/15:0/22:1(13Z))
PE(22:2(13Z,16Z)/18:0)
DG(16:0/14:0/0:0)
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/20:2n6/20:4(5Z,8Z,11Z,14Z))
Trihexosylceramide (d18:1/18:0)
TG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(22:0/20:2n6/20:4(5Z,8Z,11Z,14Z))
PE(24:1(15Z)/18:1(9Z))
TG(20:0/14:1(9Z)/22:1(13Z))
TG(22:0/18:0/24:1(15Z))
TG(20:3n6/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/16:1(9Z)/24:1(15Z))
Metolazone
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/24:1(15Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:3n6/18:3(9Z,12Z,15Z))
PI(16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:1(11Z)/24:1(15Z))
CL(18:1(11Z)/18:1(11Z)/18:1(11Z)/18:1(11Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
(24S)-7alpha,24-Dihydroxycholesterol A 7alpha,24-dihydroxycholesterol that has formula C27H46O3.
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(16:0/18:3(6Z,9Z,12Z)/20:1(11Z))
PC(P-18:1(9Z)/15:0)
1-Nitronaphthalene-7,8-oxide A nitronaphthalene that has formula C10H7NO3.
Ganglioside GT2 (d18:0/14:0)
TG(16:1(9Z)/18:2(9Z,12Z)/o-18:0)
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
LysoPC(17:0) An lysophosphatidylcholine in which the acyl group contains seventeen carbons and no double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphoethanolaminecholine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
TG(20:1(11Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:0/22:0)
DG(15:0/14:0/0:0)
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(14:0/24:1(15Z)/15:0)
TG(18:1(9Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:2(11Z,14Z)/15:0)
Glutaryl-CoA An omega-carboxyacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with one of the carboxy groups of glutaric acid.
TG(14:0/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(24:1(15Z)/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Arformoterol
TG(18:1(9Z)/16:1(9Z)/18:1(9Z))
TG(20:2n6/18:1(9Z)/22:2(13Z,16Z))
Ganglioside GD1b (d18:0/16:0)
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Secobarbital
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(22:0/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/15:0/20:4(8Z,11Z,14Z,17Z))
DG(16:1n7/0:0/18:2n6)
Ganglioside GD1b (d18:0/14:0)
Ethylmorphine
TG(20:0/20:0/o-18:0)
Trans-2-all-cis-6,9,12,15,18,21-tetracosaheptaenoyl-CoA
TG(20:3n6/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/24:1(15Z)/20:3(5Z,8Z,11Z))
Cer(d18:0/22:0)
TG(20:1(11Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/o-18:0/20:3n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(14:1(9Z)/16:1(9Z)/20:1(11Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/20:3n6)
Rutin A rutinoside that is quercetin with the hydroxy group at position C-3 substituted with glucose and rhamnose sugar groups.
TG(20:2n6/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
PE(22:0/15:0)
PS(18:0/16:0)
TG(16:0/22:1(13Z)/20:3(5Z,8Z,11Z))
TG(20:3n6/24:0/20:3n6)
TG(20:1(11Z)/20:3n6/24:1(15Z))
TG(14:0/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:2(13Z,16Z)/20:3(8Z,11Z,14Z))
TG(24:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
MG(0:0/18:3(9Z,12Z,15Z)/0:0)
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
DG(16:0/22:2(13Z,16Z)/0:0)
PIP(16:1(9Z)/16:1(9Z))
TG(16:0/20:2n6/22:1(13Z))
TG(24:0/18:2(9Z,12Z)/24:1(15Z))
PC(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
N-Acetylhistamine A member of the class of acetamides that is acetamide comprising histamine having an acetyl group attached to the side-chain amino function.
TG(24:0/20:2n6/18:4(6Z,9Z,12Z,15Z))
Nadolol Nadolol is a diastereoisomeric mixture consisting of equimolar amounts of the four possible 2,3-cis-isomers of 5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol.
TG(24:1(15Z)/18:0/o-18:0)
TG(18:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronide A glucosiduronic acid that has formula C16H23N3O8.
TG(24:0/15:0/o-18:0)
DG(15:0/0:0/20:4n3)
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/18:1(9Z)/20:2n6)
CL(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/16:1(9Z))
TG(22:1(13Z)/18:0/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/14:0/18:3(6Z,9Z,12Z))
TG(18:0/14:1(9Z)/22:2(13Z,16Z))
TG(18:1(11Z)/18:1(9Z)/18:2(9Z,12Z))
DG(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(16:0/14:0/20:4(8Z,11Z,14Z,17Z))
TG(24:0/14:1(9Z)/20:1(11Z))
Ganglioside GD3 (d18:1/24:1(15Z))
TG(16:1(9Z)/15:0/18:2(9Z,12Z))
TG(22:1(13Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/22:2(13Z,16Z)/20:1(11Z))
TG(24:0/18:1(9Z)/18:1(9Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
Scopolamine A tropane alkaloid that is the (S)-tropic acid ester of 6beta,7beta-epoxy-1alphaH,5alphaH-tropan-3alpha-ol.
PE(P-16:0/15:0)
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/24:0/20:4(8Z,11Z,14Z,17Z))
Dinoprost Tromethamine An organic molecular entity that has formula C20H34O5.C4H11NO3.
TG(15:0/20:2n6/22:4(7Z,10Z,13Z,16Z))
Ivacaftor
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
DG(15:0/22:4(7Z,10Z,13Z,16Z)/0:0)
MG(16:0/0:0/0:0)
Ganglioside GM2 (d18:0/18:1(11Z))
1-Methylxanthine A monomethylxanthine having the methyl group located at the 1-position. It is a metabolite of caffeine in humans.
TG(22:4(7Z,10Z,13Z,16Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/16:0/20:3n6)
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
PE(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
TG(18:1(9Z)/18:1(9Z)/24:1(15Z))
TG(24:1(15Z)/24:1(15Z)/20:2n6)
Busulfan
Colchicine An alkaloid that is a carbotricyclic compound comprising 5,6,7,9-tetrahydrobenzo[a]heptalene having four methoxy substituents at the 1-, 2-, 3- and 10-positions as well as an oxo group at the 9-position and an acetamido group at the 7-position. It has been isolated from the plants belonging to genus Colchicum.
TG(24:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
Isometheptene
TG(18:1(9Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/14:0/22:4(7Z,10Z,13Z,16Z))
PC(14:0/18:0)
TG(18:0/24:0/22:2(13Z,16Z))
DG(18:1(9Z)/14:1(9Z)/0:0)
DG(20:1n9/0:0/22:4n6)
CL(18:1(9Z)/18:1(9Z)/18:1(9Z)/18:2(9Z,12Z))
LysoPE(0:0/22:1(13Z))
PS(16:1(9Z)/18:1(9Z))
Ganglioside GD1a (d18:1/22:1(13Z))
TG(15:0/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/15:0/14:1(9Z))
TG(18:2(9Z,12Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/20:0/18:1(9Z))
Dimenhydrinate The diphenhydramine salt of 8-chlorotheophylline. Its effects are similar to those of diphenhydramine, but it is less potent. It was thought that by combining the antiemetic effects of diphenhydramine with the mild stimulant effects of 8-chlorotheophyline, the extreme drowsiness induced by the former would be mitigated. However, the sedation caused by diphenhydramine is considerably stronger than the stimulation caused by 8-chlorotheophylline. Dimenhydrinate is used mainly as an antiemetic in the prevention and treatment of motion sickness.
Decitabine
PG(18:3(6Z,9Z,12Z)/16:1(9Z))
TG(16:0/22:1(13Z)/18:2(9Z,12Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
Cisplatin A diamminedichloroplatinum compound in which the two ammine ligands and two chloro ligands are oriented in a cis planar configuration around the central platinum ion. An anticancer drug that interacts with, and forms cross-links between, DNA and proteins, it is used as a neoplasm inhibitor to treat solid tumours, primarily of the testis and ovary.
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:0)
TG(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/14:1(9Z)/20:3n6)
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(18:1(9Z)/20:2(11Z,14Z))
TG(18:2(9Z,12Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:0/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
DG(20:4n6/0:0/20:4n6)
PC(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(18:3(6Z,9Z,12Z)/P-16:0)
TG(24:0/14:1(9Z)/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(15:0/16:1(9Z)/22:1(13Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(14:0/20:3(5Z,8Z,11Z)/24:0)
PC(16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/o-18:0/20:4(5Z,8Z,11Z,14Z))
Desipramine A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
TG(14:1(9Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/16:1(9Z)/o-18:0)
TG(24:1(15Z)/22:2(13Z,16Z)/18:2(9Z,12Z))
PE(18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
Dimethindene
Chitin An aminoglycan consisting of beta-(1->4)-linked N-acetyl-D-glucosamine residues.
TG(16:1(9Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]
TG(18:1(11Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
PG(18:1(9Z)/18:1(9Z)) A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which both acyl groups are specified as oleoyl.
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z)/o-18:0)
DG(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(22:0/20:3(5Z,8Z,11Z)/20:3n6)
TG(15:0/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
4-beta-Hydroxymethyl-4-alpha-methyl-5-alpha-cholest-7-en-3-beta-ol A 3beta-hydroxy steroid that has formula C29H50O2.
TG(22:0/15:0/16:1(9Z))
TG(18:0/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
CDP-DG(18:0/16:0)
Gefitinib
N-acetyl-O-acetylneuraminate
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(18:0/20:3(5Z,8Z,11Z)/14:1(9Z))
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
Tetradecanol
TG(16:0/20:0/18:2(9Z,12Z))
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(14:0/24:1(15Z)/24:1(15Z))
TG(20:0/22:0/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
PE(P-18:0/18:1(9Z))
TG(15:0/20:1(11Z)/18:3(6Z,9Z,12Z))
Solanesyl-PP
2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinol
DG(16:0/0:0/20:5n3)
PE(20:4(8Z,11Z,14Z,17Z)/P-16:0)
TG(20:1(11Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/20:3n6/18:3(6Z,9Z,12Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
Thyroxine An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
TG(15:0/22:1(13Z)/o-18:0)
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/18:1(11Z))
TG(18:1(11Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PI(22:4(10Z,13Z,16Z,19Z)/18:0)
Vitamin D3
TG(18:1(9Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
6-Thioguanosine monophosphate An organic molecule that has formula C10H14N5O7PS.
PC(20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
DG(24:1n9/0:0/18:3n6)
Arsenic A pnictogen that has formula As.
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(22:0/18:3(9Z,12Z,15Z)/20:3n6)
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
Norgestimate
TG(15:0/15:0/14:1(9Z))
PE(P-18:1(11Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/20:1(11Z))
Clonazepam 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
TG(22:0/22:0/22:1(13Z))
TG(20:2n6/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PS(18:0/18:3(9Z,12Z,15Z))
Melanin
PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
Galabiosylceramide (d18:1/20:0)
Dexmedetomidine
TG(15:0/20:3(5Z,8Z,11Z)/18:1(9Z))
TG(18:0/18:1(11Z)/o-18:0)
1a,11b-Dihydro-4,9-dimethylbenz[a]anthra[3,4-b]oxirene A phenanthrene that has formula C20H16O.
Pentacarboxylporphyrin I
TG(22:0/15:0/24:0)
TG(18:2(9Z,12Z)/20:0/20:3n6)
Malathion A diester that is butanedioate substituted by a (dimethoxyphosphorothioyl)sulfanediyl group at position 2.
TG(14:1(9Z)/20:0/22:4(7Z,10Z,13Z,16Z))
Ecgonine A tropane alkaloid that consists of tropane bearing carboxy and hydroxy substituents at positions 2 and 3 respectively and having (1R,2R,3S,5S)-configuration. It is both a metabolite of and a precursor to cocaine.
L-Fucose Any form of fucose having L configuration.
DG(18:0/16:1(9Z)/0:0)
TG(18:2(9Z,12Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
DG(18:3n6/0:0/22:5n3)
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/16:0/o-18:0)
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:1(9Z)/24:0)
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)
TG(16:0/15:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
Maraviroc
Ganglioside GT2 (d18:1/22:0)
Galactan Polysaccharides composed of galactose residues.
PG(16:0/18:1(9Z)) A phosphatidylglycerol(1-) that is the conjugate base of 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) obtained by deprotonation of the phosphate hydroxy group; major species at pH 7.3.
TG(22:1(13Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/20:2n6/22:1(13Z))
Phosphoribosylformylglycineamidine
MG(16:1(9Z)/0:0/0:0)
TG(20:2n6/15:0/20:4(8Z,11Z,14Z,17Z))
DG(14:0/0:0/20:4n3)
PE(20:1(11Z)/20:3(8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(15:0/18:1(11Z)/18:0)
TG(20:1(11Z)/18:2(9Z,12Z)/20:1(11Z))
PC(16:1(9Z)/24:1(15Z))
TG(18:0/o-18:0/18:1(11Z))
3-Oxohexanoyl-CoA An oxo-fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxylic acid group of 3-oxohexanoic acid.
TG(14:1(9Z)/14:0/20:3(5Z,8Z,11Z))
DG(22:5n3/0:0/22:5n3)
TG(18:1(11Z)/24:0/20:3n6)
Ethylene oxide/propylene oxide copolymer (avg m w 9,760 - 13,200)
TG(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(dm18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/18:0/20:0)
TG(22:1(13Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/18:2(9Z,12Z)/18:1(9Z))
TG(18:0/22:1(13Z)/20:0)
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
PC(22:0/22:4(7Z,10Z,13Z,16Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]
TG(15:0/14:1(9Z)/20:3(5Z,8Z,11Z))
TG(22:0/20:2n6/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(18:0/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PI(16:0/22:2(13Z,16Z))
DG(20:1(11Z)/20:0/0:0)
TG(16:1(9Z)/24:0/18:1(9Z))
5-Acetylamino-6-formylamino-3-methyluracil
TG(18:1(9Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
Pyridine An azaarene comprising a benzene core in which one -CH group is replaced by a nitrogen atom. It is the parent compound of the class pyridines.
Ganglioside GA2 (d18:1/26:0)
TG(20:2n6/18:3(6Z,9Z,12Z)/o-18:0)
TG(20:4(8Z,11Z,14Z,17Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PS(16:1(9Z)/18:0)
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
PE(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(18:0/24:0/18:1(9Z))
TG(18:2(9Z,12Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
PC(20:0/24:0)
TG(18:1(11Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
PE(P-16:0/18:3(6Z,9Z,12Z))
TG(22:0/20:0/20:3n6)
DG(18:0/20:3(5Z,8Z,11Z)/0:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(18:1(9Z)/18:1(11Z)/20:3n6)
DG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:3(6Z,9Z,12Z)/14:0/o-18:0)
PC(o-16:1(9Z)/22:0)
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(15:0/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Galactosylceramide (d18:1/22:0)
TG(18:2(9Z,12Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
MG(0:0/20:2(11Z,14Z)/0:0)
TG(24:0/20:1(11Z)/24:0)
PE(22:2(13Z,16Z)/P-18:1(11Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
TG(14:1(9Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/20:1(11Z)/18:1(9Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
TG(15:0/20:3n6/16:0)
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(22:0/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:0/18:1(9Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(16:1(9Z)/22:0/20:4(5Z,8Z,11Z,14Z))
Hyocholic acid A bile acid that has formula C24H40O5.
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(16:0/18:1(11Z)/18:0)
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/15:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
Ketoprofen glucuronide
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)/0:0)
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Inositol phosphate
TG(18:2(9Z,12Z)/14:1(9Z)/22:2(13Z,16Z))
(2R,3R)-2,3-Butanediol
TG(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
Nandrolone phenpropionate A 3-phenylpropionate ester that has formula C27H34O3.
TG(24:0/16:1(9Z)/20:2n6)
PIP(18:1(9Z)/20:3(5Z,8Z,11Z))
Sulfathiazole A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position.
trans-3-Decenoyl-CoA
TG(24:0/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
cis-beta-D-Glucosyl-2-hydroxycinnamate
TG(16:0/20:0/14:1(9Z))
Ganglioside GD1b (d18:1/12:0)
TG(18:1(11Z)/22:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/14:0/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(20:0/14:1(9Z)/20:0)
CE(24:1(15Z))
N-Stearoylsphingosine
TG(18:1(9Z)/18:1(9Z)/18:3(6Z,9Z,12Z))[iso6]
Ganglioside GD1b (d18:1/14:0)
TG(16:0/20:1(11Z)/18:0)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
DG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/0:0)
TG(16:1(9Z)/16:0/16:1(9Z))
PC(20:4(5Z,8Z,11Z,14Z)/22:0)
TG(20:0/14:0/20:2n6)
L-erythro-tetrahydrobiopterin
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/18:1(9Z))
TG(20:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(24:0/20:3(8Z,11Z,14Z)/0:0)
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/20:3n6)
TG(16:0/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(18:1(9Z)/14:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/20:0/20:1(11Z))[iso6]
TG(18:0/24:0/22:4(7Z,10Z,13Z,16Z))
N6,N6,N6-Trimethyl-L-lysine An alpha-amino-acid cation that is the N(6)-trimethyl derivative of L-lysine.
TG(15:0/18:1(11Z)/14:1(9Z))
TG(20:2n6/18:1(11Z)/o-18:0)
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(16:0/18:2(9Z,12Z)/24:0)
TG(22:0/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
TG(16:0/20:0/18:1(9Z))
TG(20:3n6/18:1(9Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
PE(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
PG(18:2(9Z,12Z)/18:2(9Z,12Z))
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
D-Tagatose 6-phosphate
PE(18:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:1(9Z)/14:0)
PE(18:3(6Z,9Z,12Z)/18:0)
TG(14:1(9Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0/o-18:0)
PC(20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(14:0/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/15:0/16:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PC(24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
Anisindione
TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/20:1(11Z)/20:3n6)
TG(18:0/20:3n6/18:1(9Z))
TG(16:0/18:2(9Z,12Z)/22:0)
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
Quinestrol
PC(24:0/22:2(13Z,16Z))
Nutriacholic acid
TG(18:4(6Z,9Z,12Z,15Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
PG(18:3(6Z,9Z,12Z)/18:1(11Z))
Finasteride e
TG(16:1(9Z)/20:1(11Z)/20:3n6)
TG(24:0/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
L-Serine The L-enantiomer of serine.
Hydroxychloroquine
TG(14:0/18:1(9Z)/16:0)
TG(14:0/20:0/20:1(11Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/15:0/24:1(15Z))
TG(16:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/24:1(15Z)/18:0)
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
15-Hydroxynorandrostene-3,17-dione glucuronide
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Isovaleryl-CoA A short-chain, methyl-branched fatty acyl-CoA that is the S-isovaleryl derivative of coenzyme A.
7a-Hydroxy-5b-cholanic acid
PI(18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
cis,trans-5'-Hydroxythalidomide
TG(20:0/20:3n6/20:1(11Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(24:0/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:2(13Z,16Z)/18:1(11Z))
TG(18:3(6Z,9Z,12Z)/20:0/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/o-18:0/24:1(15Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(24:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/o-18:0/20:0)
TG(20:0/18:3(6Z,9Z,12Z)/18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Primidone A pyrimidone that is dihydropyrimidine-4,6(1H,5H)-dione substituted by an ethyl and a phenyl group at position 5. It is used as an anticonvulsant for treatment of various types of seizures.
TG(15:0/16:0/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:0/18:3(9Z,12Z,15Z))
Ganglioside GM3 (d18:1/25:0)
1-Piperidinecarboxaldehyde
Ganglioside GT1c (d18:0/12:0)
PE(22:2(13Z,16Z)/18:1(9Z))
TG(20:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/24:0/20:3n6)
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
PC(dm16:0/dm18:1(9Z))
TG(24:0/18:0/24:0)
TG(20:0/14:1(9Z)/22:0)
TG(20:2n6/14:0/22:4(7Z,10Z,13Z,16Z))
7,8-Dihydro-7-hydroxy-8-S-glutathionyl-benzo[a]pyrene A glutathione derivative in which the hydrogen of the side-chain thiol function of glutathione is substituted by a 7-hydroxy-7,8-dihydrobenzo[pqr]tetraphen-8-yl group.
Cefotiam
PC(20:0/22:2(13Z,16Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:1(13Z)/24:0)
TG(15:0/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:1(9Z)/18:1(9Z))[iso3]
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
DG(16:1n7/0:0/22:2n6)
PC(o-20:0/20:0)
TG(14:0/14:0/18:3(9Z,12Z,15Z))
TG(20:0/16:0/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Chlorprothixene
TG(18:2(9Z,12Z)/16:0/20:2(11Z,14Z))[iso6]
TG(14:1(9Z)/20:0/20:4(5Z,8Z,11Z,14Z))
TG(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(18:0/24:1(15Z)/16:1(9Z))
Miglustat
TG(22:2(13Z,16Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3n6/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:0/0:0/16:1n7)
TG(18:0/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/18:1(9Z)/20:3n6)
PC(16:0/P-18:1(9Z))
PE(18:3(9Z,12Z,15Z)/14:0)
Cefuroxime A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
TG(18:2(9Z,12Z)/o-18:0/22:2(13Z,16Z))
TG(24:1(15Z)/14:1(9Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
Travoprost
Hydroxyurea A member of the class of ureas that is urea in which one of the hydrogens is replaced by a hydroxy group. An antineoplastic used in the treatment of chronic myeloid leukaemia as well as for sickle-cell disease.
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
TG(18:0/14:1(9Z)/20:3n6)
TG(20:3(5Z,8Z,11Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/18:1(9Z)/22:1(13Z))
TG(14:1(9Z)/14:1(9Z)/22:2(13Z,16Z))
PE(22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/20:2n6)
PE(18:2(9Z,12Z)/18:2(9Z,12Z))
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(20:1(11Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Gamma-Aminobutyric acid A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Hexane An unbranched alkane containing six carbon atoms.
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(P-18:0/20:1(11Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/20:0/20:3(5Z,8Z,11Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
PC(24:1(15Z)/18:2(9Z,12Z))
TG(18:1(11Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(20:3n6/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
PC(22:2(13Z,16Z)/24:0)
DG(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(20:3n6/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Dihydroxyacetone phosphate
TG(14:0/22:4(7Z,10Z,13Z,16Z)/15:0)
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PC(22:2(13Z,16Z)/22:0)
PIP(16:1(9Z)/18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Anastrozole A 1,2,4-triazole compound having a 3,5-bis(2-cyano-2-propyl)benzyl group at the 1-position.
Fenoterol
TG(14:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
Rasagiline
LysoPE(0:0/20:3(11Z,14Z,17Z))
PI(18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(14:1(9Z)/20:3(8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/24:0/20:3n6)
L-Cystathionine A modified amino acid generated by enzymic means from L-homocysteine and L-serine.
PS(18:3(9Z,12Z,15Z)/16:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Cilastatin
PG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
TG(14:1(9Z)/18:2(9Z,12Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
Triazolam A triazolobenzodiazepine that has formula C17H12Cl2N4.
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:4(5Z,8Z,11Z,14Z)/18:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
DG(24:1(15Z)/22:1(13Z)/0:0)
TG(22:2(13Z,16Z)/14:0/20:4(8Z,11Z,14Z,17Z))
TG(14:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
Androsterone An androstanoid that is 5alpha-androstane having a hydroxy substituent at the 3alpha-position and an oxo group at the 17-position. It is a metabolite of dehydroepiandrosterone .
TG(16:0/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/o-18:0)
Dihydrofolic acid A folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid. It interacts with bacteria during cell division and is targeted by various drugs to prevent nucleic acid synthesis.
TG(18:0/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
gamma-Glutamyl-beta-cyanoalanine A dipeptide composed of 3-cyano-L-alanine and L-glutamine joined by a peptide linkage formed from the side-chain of glutamine.
TG(16:1(9Z)/16:0/22:2(13Z,16Z))
1-Methylhistidine A histidine derivative in which the methyl group is located at N-1.
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/16:0/20:3n6)
TG(22:0/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
dGDP A purine 2'-deoxyribonucleoside 5'-diphosphate having guanine as the nucleobase.
PE(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))
Neostigmine A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
TG(24:0/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
DG(20:3n6/0:0/22:4n6)
TG(15:0/18:1(11Z)/18:3(9Z,12Z,15Z))
Ganglioside GM2 (d18:1/18:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/20:2n6/18:4(6Z,9Z,12Z,15Z))
3-Phosphoglyceric acid A monophosphoglyceric acid having the phospho group at the 3-position. It is an intermediate in metabolic pathways like glycolysis and calvin cycle.
Isoetharine
PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:2n6/18:1(11Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
TG(18:1(9Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/18:3(9Z,12Z,15Z))
Orciprenaline A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
Pseudouridine A C-glycosyl pyrimidine that consists of uracil having a beta-D-ribofuranosyl residue attached at position 5. The C-glycosyl isomer of the nucleoside uridine.
PE(24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
18-Hydroxycorticosterone A 18-hydroxy steroid that is corticosterone substituted by a hydroxy group at position 18.
Dihydrothymine
TG(14:1(9Z)/18:1(11Z)/14:1(9Z))
TG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/20:1(11Z)/20:3n6)
TG(20:4(8Z,11Z,14Z,17Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:1(11Z)/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/16:0/24:0)
3-beta-Hydroxy-4-beta-methyl-5-alpha-cholest-7-ene-4-alpha-carboxylate A steroid acid anion that is the conjugate base of 3beta-hydroxy-4beta-methyl-5alpha-cholest-7-ene-4alpha-carboxylic acid, obtained via deprotonation of the carboxy group; major species at pH 7.3.
TG(14:0/22:0/20:3n6)
PE(18:3(9Z,12Z,15Z)/18:1(9Z))
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(22:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
DG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/0:0)
TG(16:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
Indan-1-ol An alcohol that has formula C9H10O.
PIP2(18:0/18:3(6Z,9Z,12Z))
TG(24:0/14:1(9Z)/22:1(13Z))
Ganglioside GD3 (d18:1/25:0)
TG(20:2n6/20:3(5Z,8Z,11Z)/20:3n6)
TG(16:0/o-18:0/20:2n6)
Hydroquinone A benzenediol comprising benzene core carrying two hydroxy substituents para to each other.
TG(16:1(9Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(18:0/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/14:1(9Z)/18:1(11Z))
2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate A hydroxy monocarboxylic acid anion that is the conjugate base of 2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid.
TG(20:0/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
Dimethylamine A secondary aliphatic amine where both N-substituents are methyl.
PE(18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(18:0/22:1(13Z)/18:1(9Z))
2-(S-Glutathionyl)acetyl chloride A peptide that has formula C12H18ClN3O7S.
Molybdopterin A molybdopterin that is the O-phospho derivative of [(5aR,8R,9aR)-2-amino-4-oxo-6,7-disulfanyl-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methanol.
TG(20:3n6/16:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/18:1(11Z)/24:1(15Z))
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/20:2n6)
TG(18:1(11Z)/20:2n6/22:2(13Z,16Z))
6-Lactoyltetrahydropterin
DG(16:0/18:1(9Z)/0:0)
Flunisolide A cyclic ketal that has formula C24H31FO6.
TG(18:3(9Z,12Z,15Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:3n6/18:1(11Z))
DG(18:1(11Z)/20:3(8Z,11Z,14Z)/0:0)
TG(22:0/22:2(13Z,16Z)/14:1(9Z))
TG(15:0/14:1(9Z)/18:2(9Z,12Z))
Trilostane
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z)/o-18:0)
TG(20:1(11Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
N1-Acetylspermine An acetylspermine carrying an acetyl group at position N(1).
PIP(20:4(5Z,8Z,11Z,14Z)/18:0)
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Oleamide A fatty amide derived from oleic acid.
4,8 Dimethylnonanoyl carnitine
DG(20:3(5Z,8Z,11Z)/14:0/0:0)
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PS(18:0/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Ganglioside GM1 (d18:1/24:1(15Z))
Ritonavir A L-valine derivative in which the alpha-nitrogen of L-valinamide is substituted with a methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl group and the amide nitrogen by a (2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl group. An antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS, it is often used as a fixed-dose combination with another protease inhibitor, lopinavir.
TG(24:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
17a-Hydroxypregnenolone
TG(22:0/18:3(9Z,12Z,15Z)/20:1(11Z))
Ganglioside GM1 (d18:0/22:1(13Z))
TG(15:0/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
Octanoyl-CoA A medium-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of octanoic acid.
CL(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/18:1(11Z))
TG(24:1(15Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(15:0/20:3n6/22:1(13Z))
Lomefloxacin
Udenafil
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z))
L-Dopachrome The L-enantiomer of dopachrome.
Phosphoribosyl formamidocarboxamide
PE(18:0/18:3(6Z,9Z,12Z))
TG(15:0/15:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(20:3(5Z,8Z,11Z)/15:0)
PC(24:1(15Z)/P-18:1(9Z))
DG(22:4n6/0:0/22:5n6)
N6-Acetyl-L-lysine An N(6)-acyl-L-lysine where the N(6)-acyl group is acetyl.
Ganglioside GA1 (d18:1/16:0)
TG(22:0/20:3n6/16:1(9Z))
TG(20:1(11Z)/20:0/22:2(13Z,16Z))
Diphenidol
TG(18:0/24:1(15Z)/20:1(11Z))
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(20:2n6/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Deoxyadenosine
Lucanthone A thioxanthen-9-one compound having a methyl substituent at the 1-position and a 2-[(diethylamino)ethyl]amino substituent at the 4-position. Formerly used for the treatment of schistosomiasis. It is a prodrug, being metabolised to hycanthone.
Serotonin A primary amino compound that is the 5-hydroxy derivative of tryptamine.
PE(15:0/18:3(9Z,12Z,15Z))
DG(24:1(15Z)/18:1(11Z)/0:0)
TG(14:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
Trichloroacetic acid A monocarboxylic acid that is acetic acid in which all three methyl hydrogens are substituted by chlorine.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)/o-18:0)
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
PE(P-18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:1(13Z)/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/24:0/20:2n6)
Flupenthixol
TG(24:0/15:0/18:1(9Z))
DG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
Doxycycline Tetracycline in which the 5beta-hydrogen is replaced by a hydroxy group, while the 6alpha-hydroxy group is replaced by hydrogen. A semi-synthetic tetracycline antibiotic, it is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with chronic obstructive pulmonary disease (COPD), and adult periodontitis.
TG(14:1(9Z)/24:1(15Z)/18:1(11Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
TG(16:0/22:1(13Z)/22:1(13Z))
Nicotinic acid adenine dinucleotide
TG(24:0/20:4(5Z,8Z,11Z,14Z)/24:0)
TG(18:1(9Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
Ganglioside GM3 (d18:0/18:1(9Z))
Galabiosylceramide (d18:1/18:0)
PG(18:1(9Z)/18:3(9Z,12Z,15Z))
TG(16:0/14:0/20:1(11Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/0:0)
TG(18:0/20:4(5Z,8Z,11Z,14Z)/18:0)
TG(22:2(13Z,16Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Tripelennamine
TG(18:0/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
DG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
PC(P-16:0/22:0)
TG(22:1(13Z)/22:1(13Z)/20:2n6)
TG(22:0/14:0/18:3(9Z,12Z,15Z))
TG(18:0/20:1(11Z)/22:0)
TG(16:0/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(14:0/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/15:0/20:4(5Z,8Z,11Z,14Z))
TG(14:0/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(22:0/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/14:1(9Z)/22:1(13Z))
Pristanal A 2-methyl-branched fatty aldehyde that has formula C19H38O.
TG(18:3(9Z,12Z,15Z)/20:0/18:4(6Z,9Z,12Z,15Z))
TG(14:0/24:0/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Taurohyocholate Conjugate base of taurohyocholic acid.
Sufentanil An anilide resulting from the formal condensation of the aryl amino group of 4-(methoxymethyl)-N-phenyl-1-[2-(2-thienyl)ethyl]piperidin-4-amine with propanoic acid.
PE(P-16:0e/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:0/18:2(9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/20:3n6/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:2n6/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
2,5-Dichloro-4-oxohex-2-enedioate An oxo dicarboxylate obtained by deprotonation of both carboxy groups of 2,5-dichloro-4-oxohex-2-enedioic acid.
D-Ornithine The D-enantiomer of ornithine. It is an intermediate metabolite produced in the urea cycle.
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/o-18:0)
3-trans,5-cis-Octadienoyl-CoA
PC(P-18:1(11Z)/22:2(13Z,16Z))
Adapalene An adamantane that has formula C28H28O3.
TG(24:0/18:1(11Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Arbutamine
TG(15:0/16:1(9Z)/22:0)
TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(22:1n9/0:0/20:2n6)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(14:0/o-18:0/14:1(9Z))
PE(18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
Hyodeoxycholic acid A member of the class of 5beta-cholanic acids that is (5beta)-cholan-24-oic acid substituted by alpha-hydroxy groups at positions 3 and 6.
PE(14:1(9Z)/18:3(6Z,9Z,12Z))
TG(24:0/18:2(9Z,12Z)/20:1(11Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/18:0/o-18:0)
D-Alanine The D-enantiomer of alanine.
TG(15:0/15:0/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
Glyoxylic acid A 2-oxo monocarboxylic acid that is acetic acid bearing an oxo group at the alpha carbon atom.
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
TG(20:0/18:3(6Z,9Z,12Z)/14:1(9Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
Hydrochlorothiazide
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(15:0/0:0/24:1n9)
TG(18:1(11Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(22:0/14:0/20:3(5Z,8Z,11Z))
DG(22:1n9/0:0/18:2n6)
TG(16:1(9Z)/24:1(15Z)/18:1(11Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
Sulfamoxole
Cefixime
TG(16:1(9Z)/24:0/22:1(13Z))
Amyl Nitrite A nitrite ester having n-pentyl as the alkyl group.
DG(20:2(11Z,14Z)/18:2(9Z,12Z)/0:0)
DG(20:0/0:0/18:1n7)
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PI(18:2(9Z,12Z)/22:2(13Z,16Z))
DG(20:2(11Z,14Z)/22:1(13Z)/0:0)
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:0/20:0/16:1(9Z))
7-a,25-Dihydroxycholesterol
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
1-Methyluric acid An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by a methyl group at N-1. It is one of the metabolites of caffeine found in human urine.
DG(20:0/22:2(13Z,16Z)/0:0)
TG(22:2(13Z,16Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(24:0/18:2(9Z,12Z)/o-18:0)
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
Substance P
Propionic acid
PE(16:1(9Z)/P-16:0)
Ganglioside GT2 (d18:1/16:0)
TG(16:1(9Z)/18:1(11Z)/18:1(11Z))
TG(18:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/14:1(9Z)/o-18:0)
PC(14:1(9Z)/20:0)
PS(14:1(9Z)/18:1(9Z))
Ganglioside GD2 (d18:1/22:1(13Z))
TG(14:0/16:1(9Z)/20:1(11Z))
TG(14:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
DG(14:1(9Z)/18:3(9Z,12Z,15Z)/0:0)
TG(22:2(13Z,16Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/20:1(11Z)/22:1(13Z))
TG(22:2(13Z,16Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:2n6/24:1(15Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
PC(20:4(5Z,8Z,11Z,14Z)/P-18:0)
Flecainide
TG(24:0/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Azacitidine
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
PC(P-18:0/20:1(11Z))
Ganglioside GM2 (d18:0/26:0)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))
PC(16:0/14:0)
PE(22:2(13Z,16Z)/18:1(11Z))
TG(20:0/14:1(9Z)/20:1(11Z))
TG(15:0/20:2n6/18:1(11Z))
TG(22:0/22:0/18:2(9Z,12Z))
DG(20:2n6/0:0/22:4n6)
PE(24:0/20:3(5Z,8Z,11Z))
PC(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
PC(16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/24:0/18:2(9Z,12Z))
TG(18:1(9Z)/16:0/20:2n6)
TG(14:0/o-18:0/22:0)
TG(24:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
TG(24:0/22:0/24:0)
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/24:0/22:2(13Z,16Z))
Glucosamine
TG(20:3n6/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
1-Phenylethylamine A phenylethylamine that is ethylamine substituted by a phenyl group at position 1.
TG(24:1(15Z)/14:0/18:2(9Z,12Z))
TG(24:0/16:0/20:2n6)
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
DG(20:1n9/0:0/22:5n6)
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/20:0/20:1(11Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
TG(14:0/18:2(9Z,12Z)/o-18:0)
TG(20:1(11Z)/20:1(11Z)/24:1(15Z))
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(18:1(9Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:1(13Z)/20:1(11Z))
DG(18:1n9/0:0/20:2n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/22:0/20:4(8Z,11Z,14Z,17Z))
Codeine A morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties.
N-Acetyl-L-tyrosine The N-acetyl derivative of L-tyrosine.
Quinidine A cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy.
TG(20:1(11Z)/14:1(9Z)/20:1(11Z))
Ganglioside GM2 (d18:1/25:0)
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/24:0)
Tetrahexosylceramide (d18:1/24:0)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/15:0/20:1(11Z))
Glutaconyl-CoA
TG(22:0/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
PC(20:0/16:1(9Z))
PE(24:1(15Z)/18:0)
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:1(13Z)/20:3n6)
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(15:0/18:3(6Z,9Z,12Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
(S)-2-Methylbutanoyl-CoA An organic molecule that has formula C26H44N7O17P3S.
Ganglioside GQ1c (d18:0/23:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:0/20:4(8Z,11Z,14Z,17Z))
PE(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
PC(18:1(9Z)e/2:0)
TG(22:1(13Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(22:0/20:3(5Z,8Z,11Z)/20:2n6)
Ganglioside GD1b (d18:1/26:1(17Z))
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(20:3n6/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Apomorphine
TG(14:1(9Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(20:2n6/20:1(11Z)/22:2(13Z,16Z))
DL-Dopa
Balsalazide A monohydroxybenzoic acid consisting of 5-aminosalicylic acid (mesalazine) linked to 4-aminobenzoyl-beta-alanine via an azo bond.
TG(18:3(6Z,9Z,12Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(16:0/24:1(15Z))
CMP-N-glycoloylneuraminate
TG(22:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:3(8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(16:0/18:1(11Z)/20:0)
PS(16:1(9Z)/18:2(9Z,12Z))
TG(24:1(15Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(22:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:3n6/24:1(15Z))
Hydroxycobalamin
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
DG(14:1n5/0:0/20:4n3)
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/15:0)
cis-Aconitic acid The cis-isomer of aconitic acid.
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Aminopropylcadaverine A polyazaalkane that is the 1,4,11-triaza derivative of undecane.
TG(15:0/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PIP(16:2(9Z,12Z)/18:0)
p-Hydroxyphenylacetic acid
TG(18:0/20:0/20:1(11Z))[iso6]
DG(22:5n6/0:0/20:5n3)
PC(20:2(11Z,14Z)/16:0)
Ganglioside GD1b (d18:1/22:0)
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
TG(22:0/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/15:0/20:3n6)
TG(16:0/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
3a,6b,7a,12a-Tetrahydroxy-5b-cholanoic acid
PC(20:1(11Z)/16:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(16:0/18:1(11Z)/22:0)
TG(24:0/18:1(11Z)/20:3n6)
PC(18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Micafungin
TG(14:0/14:0/16:1(9Z))
TG(14:0/18:3(6Z,9Z,12Z)/16:1(9Z))
PC(22:0/P-18:1(9Z))
TG(18:0/20:0/o-18:0)
TG(18:0/15:0/20:0)
PE(22:5(4Z,7Z,10Z,13Z,16Z)/P-16:0)
TG(22:2(13Z,16Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:1(13Z)/24:1(15Z))
PE(20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/20:0/o-18:0)
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:0)
Sulindac A monocarboxylic acid that is 1-benzylidene-1H-indene which is substituted at positions 2, 3, and 5 by methyl, carboxymethyl, and fluorine respectively, and in which the phenyl group of the benzylidene moiety is substituted at the para position by a methylsulfinyl group. It is a prodrug for the corresponding sulfide, a non-steroidal anti-inflammatory drug, used particularly in the treatment of acute and chronic inflammatory conditions.
TG(24:0/14:0/18:1(11Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:0)
PC(16:0/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/20:2n6)
5-Methylthioribose 1-phosphate
TG(16:1(9Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/o-18:0)
Mimosine
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/16:0/20:1(11Z))
PE(22:0/22:1(13Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
3a,7a-Dihydroxy-5b-cholestanate
L-2-Aminoadipate adenylate A dicarboxylic acid that has formula C16H23N6O10P.
DG(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/0:0)
TG(22:0/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(16:0/14:0/18:1(9Z))[iso6]
TG(20:0/16:0/22:0)
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:0/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(20:4(8Z,11Z,14Z,17Z)/20:2(11Z,14Z)/0:0)
TG(14:0/18:3(6Z,9Z,12Z)/22:1(13Z))
TG(18:3(9Z,12Z,15Z)/18:0/18:4(6Z,9Z,12Z,15Z))
Mestranol
PC(24:1(15Z)/18:1(9Z))
TG(15:0/18:2(9Z,12Z)/22:1(13Z))
DG(20:4(8Z,11Z,14Z,17Z)/15:0/0:0)
S-Formylglutathione A S-acylglutathione in which the acyl group specified is formyl.
TG(15:0/20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(16:1(9Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
PC(18:1(11Z)/14:0)
PC(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
5-Androstenediol
TG(22:0/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/24:0/18:4(6Z,9Z,12Z,15Z))
Carbamoyl phosphate An acyl monophosphate that has formula CH4NO5P.
TG(22:1(13Z)/16:1(9Z)/20:3n6)
TG(22:0/15:0/24:1(15Z))
TG(20:0/22:0/18:3(9Z,12Z,15Z))
PE(24:1(15Z)/18:3(6Z,9Z,12Z))
Methoxamine
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/24:1(15Z))
TG(18:1(9Z)/18:1(11Z)/24:1(15Z))
Tridecanoic acid A C13 straight-chain saturated fatty acid.
TG(20:0/18:1(9Z)/18:2(9Z,12Z))
TG(22:2(13Z,16Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/16:0/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:1(11Z))[iso3]
TG(16:1(9Z)/20:0/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
PE(20:4(8Z,11Z,14Z,17Z)/P-18:0)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))
TG(20:3n6/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/20:2n6/o-18:0)
PE(22:0/18:4(6Z,9Z,12Z,15Z))
Ganglioside GD1b (d18:0/24:0)
N,N'-Diacetylchitobiosyldiphosphodolichol
DG(24:1(15Z)/20:1(11Z)/0:0)
Voglibose
PC(20:3(8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/16:1(9Z)/22:2(13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
PC(18:3(6Z,9Z,12Z)/18:1(11Z))
TG(22:0/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/20:2n6)
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
DG(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/0:0)
PC(22:0/20:3(8Z,11Z,14Z))
TG(18:1(9Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/18:2(9Z,12Z)/o-18:0)
TG(18:1(9Z)/18:1(11Z)/20:2n6)
DG(18:2(9Z,12Z)/22:1(13Z)/0:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:0/o-18:0)
TG(16:0/18:0/20:3(5Z,8Z,11Z))
Glucosylceramide (d18:1/26:0)
TG(24:0/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PC(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
Zalcitabine
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
DG(18:3n6/0:0/20:3n6)
TG(20:3n6/o-18:0/18:4(6Z,9Z,12Z,15Z))
Glucosylceramide (d18:1/24:0)
Eicosapentaenoic acid
TG(15:0/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
TG(16:0/18:3(6Z,9Z,12Z)/14:1(9Z))
Ganglioside GD1b (d18:0/22:0)
TG(18:2(9Z,12Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:3(9Z,12Z,15Z)/14:0)
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PIP2(20:3(5Z,8Z,11Z)/16:0)
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/24:1(15Z))
DG(22:4(7Z,10Z,13Z,16Z)/16:0/0:0)
TG(14:1(9Z)/18:0/18:3(9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Alpha-D-Glucose 1,6-bisphosphate A D-glucose 1,6-bisphosphate in which both phosphate groups are monophosphates.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GT1b (d18:0/18:1(9Z))
TG(15:0/14:1(9Z)/22:2(13Z,16Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
TG(14:0/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
Fluorescein
TG(22:1(13Z)/15:0/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/20:1(11Z)/o-18:0)
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
3a,7b,12b-Trihydroxy-5b-cholanoic acid
DG(20:1(11Z)/20:3(8Z,11Z,14Z)/0:0)
TG(15:0/16:1(9Z)/18:1(11Z))
Pantothenic acid A member of the class of pantothenic acids that is an amide formed from pantoic acid and beta-alanine.
TG(24:1(15Z)/16:0/18:3(9Z,12Z,15Z))
TG(15:0/o-18:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/22:1(13Z)/o-18:0)
TG(18:1(11Z)/o-18:0/18:1(9Z))
PE(20:0/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(14:0/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:0/18:4(6Z,9Z,12Z,15Z))
TG(18:0/20:0/18:0)
TG(18:0/18:3(6Z,9Z,12Z)/24:0)
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/16:1(9Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/14:0/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/24:0/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(16:0/20:3(5Z,8Z,11Z)/20:3n6)
2,3,5-Trichloromaleylacetate
TG(24:1(15Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/20:0)
PC(18:1(9Z)/18:3(6Z,9Z,12Z))
2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
3-Butyn-1-al
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6/o-18:0)
TG(16:0/18:2(9Z,12Z)/20:2n6)
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
Silenoside A
Silenoside C
Silenoside B
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:0)
TG(20:0/18:1(11Z)/22:2(13Z,16Z))
Azithromycin A macrolide antibiotic useful for the treatment of bacterial infections.
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
PIP(18:3(6Z,9Z,12Z)/18:1(9Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
TG(24:1(15Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Cer(d18:0/18:0)
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:0)
PI(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))
TG(22:0/22:2(13Z,16Z)/18:1(9Z))
Bicalutamide A sulfone that is an oral non-steroidal antiandrogen used in the treatment of prostate cancer and hirsutism.
TG(15:0/20:2n6/16:1(9Z))
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(18:1(9Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
Vilazodone
PE(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:3(5Z,8Z,11Z)/20:3n6)
PC(20:0/18:3(9Z,12Z,15Z))
TG(22:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(22:0/24:1(15Z)/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/15:0/20:4(8Z,11Z,14Z,17Z))
Propionylglycine
TG(20:0/14:0/20:3(5Z,8Z,11Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/14:0/22:4(7Z,10Z,13Z,16Z))
DG(18:1(11Z)/24:0/0:0)
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GQ1c (d18:0/18:0)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/o-18:0/24:1(15Z))
2-Polyprenyl-6-methoxyphenol
Flumazenil A 1,4-benzodiazepine that has formula C15H14FN3O3.
TG(15:0/20:3n6/24:0)
3-Hydroxybutyric acid A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
LPA(0:0/18:2(9Z,12Z))
TG(18:1(9Z)/22:1(13Z)/18:2(9Z,12Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
PE(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/o-18:0/22:2(13Z,16Z))
TG(16:1(9Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/15:0/20:2n6)
DG(20:0/0:0/18:3n6)
TG(20:2n6/24:0/18:3(9Z,12Z,15Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/24:0/20:4(8Z,11Z,14Z,17Z))
PE(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
TG(24:0/20:0/18:4(6Z,9Z,12Z,15Z))
PE(22:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:0)
PE(20:1(11Z)/18:3(6Z,9Z,12Z))
TG(20:3n6/18:1(11Z)/o-18:0)
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(18:0/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(16:0/o-18:0/22:2(13Z,16Z))
PC(14:1(9Z)/P-18:0)
PE(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(16:0/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/16:0/18:4(6Z,9Z,12Z,15Z))
PE(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:0/20:3n6/20:1(11Z))
PC(14:1(9Z)/P-16:0)
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Jaceidin 4'-glucuronide
PC(18:1(11Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
Ibandronate
TG(20:1(11Z)/16:0/24:1(15Z))
TG(18:1(9Z)/18:0/18:3(6Z,9Z,12Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/o-18:0)
LysoPE(0:0/18:3(9Z,12Z,15Z))
TG(22:0/24:0/20:3n6)
TG(20:3n6/20:0/18:3(9Z,12Z,15Z))
Pyridoxamine A monohydroxypyridine that is pyridine substituted by a hydroxy group at position 3, an aminomethyl group at position 4, a hydroxymethyl group at position 5 and a methyl group at position 2.
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PC(24:0/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
TG(20:1(11Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(20:0/24:0/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:4(6Z,9Z,12Z,15Z)/18:0/0:0)
Ganglioside GD3 (d18:0/18:1(11Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
Pristanic acid A branched, long-chain saturated fatty acid composed of pentadecanoic acid having methyl substituents at the 2-, 6-, 10- and 14-positions.
PE(P-18:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PIP2(20:3(5Z,8Z,11Z)/18:0)
Inosine 2'-phosphate
TG(24:0/20:3n6/18:3(9Z,12Z,15Z))
PIP3(18:0/18:1(9Z))
Dolichyl b-D-glucosyl phosphate
TG(22:0/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
SM(d18:0/22:1(13Z))
TG(18:1(9Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/18:1(9Z)/18:1(11Z))
PC(22:2(13Z,16Z)/22:1(13Z))
TG(16:0/16:0/22:4(7Z,10Z,13Z,16Z))
Hyoscyamine
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(18:3(9Z,12Z,15Z)/18:1(11Z))
TG(18:2(9Z,12Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/14:1(9Z)/20:2n6)
TG(16:1(9Z)/24:1(15Z)/22:2(13Z,16Z))
Inositol 1,3,4,5-tetraphosphate
TG(24:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(20:2n6/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/16:1(9Z)/22:1(13Z))
PC(20:1(11Z)/P-18:0)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z)/0:0)
TG(15:0/24:0/22:1(13Z))
Propiomazine
PIP2(20:3(8Z,11Z,14Z)/16:0)
O-Desmethylnaproxen
TG(14:0/18:1(9Z)/24:0)
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/16:0/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:3n6/o-18:0)
TG(16:0/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(14:1(9Z)/22:0/18:4(6Z,9Z,12Z,15Z))
PI(18:3(6Z,9Z,12Z)/18:0)
PC(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
PC(P-18:0/24:0)
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
Everolimus
PI(18:1(9Z)/18:1(9Z))
TG(18:1(11Z)/14:0/18:2(9Z,12Z))[iso3]
TG(22:0/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(16:0/14:0/22:1(13Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(24:0/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
TG(22:0/15:0/22:2(13Z,16Z))
TG(14:0/20:3n6/18:3(6Z,9Z,12Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
PC(24:1(15Z)/20:1(11Z))
TG(18:1(9Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Bisoprolol A secondary amine that has formula C18H31NO4.
Ganglioside GT3 (d18:1/26:1(17Z))
Estriol-16-Glucuronide
PIP2(20:4(8Z,11Z,14Z,17Z)/16:0)
TG(20:2n6/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/24:1(15Z)/20:2n6)
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/16:0/22:2(13Z,16Z))
DG(24:0/0:0/24:0)
Ganglioside GM2 (d18:0/18:0)
TG(18:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/24:1(15Z))
TG(22:1(13Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(P-18:0/18:1(11Z))
TG(18:2(9Z,12Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:4(6Z,9Z,12Z,15Z)/24:0/o-18:0)
PC(o-22:0/18:3(9Z,12Z,15Z))
Paramethadione
TG(24:0/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
PE(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:2n6/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
Doxacurium chloride The dichloride salt of doxacurium. It is a mixture of the (1R,2S,1'S,2'R), (1R,2S,1'R,2'S) and (1S,2R,1'S,2'R) stereoisomers (a meso isomer and two enantiomers, respectively) of 2,2'-[(1,4-dioxobutane-1,4-diyl)bis(oxypropane-3,1-diyl)]bis[6,7,8-trimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolinium] dichloride, all of which are in a trans configuration at the 1 and 2 positions of the tetrahydroisoquinolinium rings. A competitive neuromuscular blocker, it is used to provide muscle relaxation in general anaesthesia and to facilitate mechanical ventilation in patients in intensive care.
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/o-18:0/18:1(11Z))
4a-Methyl-5a-cholesta-8,24-dien-3-one
PC(22:2(13Z,16Z)/18:2(9Z,12Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:0)
TG(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/22:0/15:0)
PE(18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(18:2n6/0:0/18:2n6)
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/20:3n6)
TG(22:0/18:2(9Z,12Z)/18:1(9Z))
TG(20:2n6/18:0/20:3n6)
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
Delphinidin 3-rhamnoside 5-glucoside
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
Cyclic GMP
TG(20:0/18:2(9Z,12Z)/24:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:0/18:3(9Z,12Z,15Z))
Capecitabine
TG(15:0/14:0/20:4(5Z,8Z,11Z,14Z))
DG(22:0/0:0/22:0)
TG(18:2(9Z,12Z)/24:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:2(9Z,12Z)/24:1(15Z))
DG(14:0/20:3(5Z,8Z,11Z)/0:0)
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
MG(0:0/24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0)
TG(14:1(9Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:3n6/20:2n6)
Paraxanthine
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/16:0)
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/16:0/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(18:1(11Z)/18:0/20:4(8Z,11Z,14Z,17Z))
DG(18:1(11Z)/20:2(11Z,14Z)/0:0)
S-(3-Methylbutanoyl)-dihydrolipoamide-E
TG(18:3(9Z,12Z,15Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
PC(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(15:0/20:1(11Z)/16:1(9Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
L-3-Cyanoalanine
TG(18:2(9Z,12Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/24:0/20:1(11Z))
TG(18:3(6Z,9Z,12Z)/20:2n6/18:3(6Z,9Z,12Z))
2-Acetolactate
TG(14:0/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(14:1(9Z)/22:1(13Z)/22:1(13Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:0/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
LysoPE(20:3(5Z,8Z,11Z)/0:0)
L-Cystine The L-enantiomer of the sulfur-containing amino acid cystine.
TG(18:4(6Z,9Z,12Z,15Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/16:1(9Z)/18:1(9Z))
PE(14:0/16:1(9Z))
TG(18:1(9Z)/15:0/24:1(15Z))
TG(24:1(15Z)/16:1(9Z)/18:2(9Z,12Z))
TG(22:0/22:2(13Z,16Z)/18:2(9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/24:0/o-18:0)
PG(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z))
TG(24:0/18:2(9Z,12Z)/22:1(13Z))
TG(14:1(9Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
PE(18:1(9Z)/20:3(8Z,11Z,14Z))
TG(15:0/16:0/24:0)
TG(15:0/18:1(9Z)/22:2(13Z,16Z))
TG(18:1(9Z)/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
Melibiitol An alditol that has formula C12H24O11.
TG(14:0/20:1(11Z)/20:0)
8,9-DiHETrE
PC(o-18:2(9Z,12Z)/24:0)
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
(7R)-7-(5-Carboxy-5-oxopentanoyl)aminocephalosporinate
TG(16:0/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
Ovalicin
TG(18:1(11Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/16:0/20:2n6)
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
Imidazoleacetic acid
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
Ganglioside GD3 (d18:1/22:1(13Z))
TG(18:1(9Z)/14:0/24:1(15Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(18:1(11Z)/16:1(9Z)/24:1(15Z))
PE(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Fulvestrant
Isoniazid
DG(18:0/0:0/18:2n6)
PE(P-16:0/16:1(9Z))
Oxalosuccinic acid A tricarboxylic acid consisting of 2-oxoglutaric acid having a further carboxy group at the 3-position. It is a substrate of the citric acid cycle.
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
PC(18:2(9Z,12Z)/16:0)
TG(16:1(9Z)/24:1(15Z)/16:1(9Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
TG(16:0/18:0/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:1(13Z)/24:1(15Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:0)
6-Carboxy-5,6,7,8-tetrahydropterin
Pantetheine An amide obtained by formal condensation of the carboxy group of pantothenic acid and the maino group of cysteamine.
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(14:1(9Z)/22:0/20:3n6)
PIP(18:1(9Z)/16:1(9Z))
TG(14:0/20:0/20:0)
TG(18:0/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(24:0/20:0/22:1(13Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/20:3n6)
PE(20:3(8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Pargyline
TG(24:0/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/24:0/18:4(6Z,9Z,12Z,15Z))
Coproporphyrinogen III A coproporphyrinogen that has formula C36H44N4O8.
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
PE(20:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:0)
TG(24:0/18:0/18:1(11Z))
TG(22:0/15:0/20:2n6)
TG(24:1(15Z)/16:1(9Z)/24:1(15Z))
PG(18:0/22:4(7Z,10Z,13Z,16Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
PE(24:1(15Z)/15:0)
DG(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z)/0:0)
1D-Myo-inositol 1,3,4,6-tetrakisphosphate
TG(18:1(11Z)/18:0/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
(2E)-Octenoyl-CoA A trans-2,3-didehydroacyl-CoA(4-) arising from deprotonation of the phosphate and diphosphate OH groups of trans-oct-2-enoyl-CoA; major species at pH 7.3.
TG(16:0/14:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/18:0/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Phosphoadenosine phosphosulfate
Ureidosuccinic acid
TG(18:0/22:0/20:3n6)
TG(18:2(9Z,12Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/16:1(9Z)/20:2n6)
TG(22:1(13Z)/14:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(14:0/24:1(15Z)/18:3(6Z,9Z,12Z))
beta-Ionone An ionone that is but-3-en-2-one substituted by a 2,6,6-trimethylcyclohex-1-en-1-yl group at position 4.
TG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/o-18:0)
TG(20:3n6/18:0/22:2(13Z,16Z))
PC(20:4(5Z,8Z,11Z,14Z)/16:0)
TG(24:0/24:0/20:1(11Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
3-Hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl-CoA The S-3-hydroxy-3-(4-methylpent-3-en-1-yl)glutaryl derivative of CoA.
TG(20:3(5Z,8Z,11Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(20:0/20:1(11Z)/20:3(5Z,8Z,11Z))
(R)-3-Hydroxy-Octadecanoic acid
PC(20:1(11Z)/20:3(8Z,11Z,14Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/20:3n6/20:1(11Z))
TG(18:2(9Z,12Z)/22:0/18:3(6Z,9Z,12Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/22:0)
TG(20:2n6/16:0/20:2n6)
E-3179
TG(20:0/14:0/18:3(6Z,9Z,12Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(20:0/18:1(9Z)/22:2(13Z,16Z))
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:2(9Z,12Z)/24:1(15Z))
TG(20:1(11Z)/16:1(9Z)/o-18:0)
CL(18:2(9Z,12Z)/18:1(9Z)/18:1(11Z)/16:0)
PE(14:1(9Z)/20:3(5Z,8Z,11Z))
PC(18:3(6Z,9Z,12Z)/15:0)
MG(0:0/22:0/0:0)
PE(P-18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:0/18:4(6Z,9Z,12Z,15Z))
TG(18:0/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/22:0/18:4(6Z,9Z,12Z,15Z))
DG(14:1n5/0:0/22:4n6)
PE(18:1(11Z)/18:0)
TG(24:0/14:1(9Z)/18:1(11Z))
TG(15:0/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
TG(14:0/22:1(13Z)/16:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
LPA(0:0/18:0)
Isohomovanillic acid A monocarboxylic acid that is the 4-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid.
TG(22:4(7Z,10Z,13Z,16Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:1(13Z)/22:2(13Z,16Z))
TG(24:0/24:1(15Z)/20:3n6)
TG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/24:0/20:3(5Z,8Z,11Z))
TG(22:0/14:1(9Z)/22:1(13Z))
TG(15:0/20:0/15:0)
TG(20:0/22:2(13Z,16Z)/14:1(9Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/22:0)
TG(16:0/16:0/22:0)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
DG(18:2(9Z,12Z)/22:0/0:0)
TG(24:0/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Retinal An enal that consists of 3,7-dimethyl-9-nona-2,4,6,8-tetraenal (double bond geometry unspecified) carrying a 2,6,6-trimethylcyclohex-1-en-1-yl group at the 9-position.
TG(24:1(15Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(15:0/16:1(9Z)/22:2(13Z,16Z))
TG(14:0/14:0/20:1(11Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/20:0)
3b,7a-Dihydroxy-5b-cholanoic acid
TG(14:0/18:4(6Z,9Z,12Z,15Z)/16:0)
TG(18:2(9Z,12Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
Trihexosylceramide (d18:1/26:1(17Z))
Ganglioside GT1c (d18:0/18:1(9Z))
Sertraline A member of the class of tetralins that is tetralin which is substituted at positions 1 and 4 by a methylamino and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as the hydrochloride salt as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder.
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PC(15:0/22:2(13Z,16Z))
TG(22:1(13Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
PI(16:0/20:4(8Z,11Z,14Z,17Z))
Ganglioside GM1 (d18:0/18:0)
PIP(18:1(11Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/14:0/22:1(13Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
Propylene glycol
TG(16:1(9Z)/15:0/20:3n6)
TG(16:0/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
CDP-DG(18:1(11Z)/18:1(9Z))
2-hydroxy-dATP A purine 2'-deoxyribonucleoside 5'-triphosphate in which the 2'-deoxyribonucleoside moiety is 2'-deoxy-2-hydroxyadenosine.
DG(15:0/0:0/14:1n5)
DG(22:2(13Z,16Z)/15:0/0:0)
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
4-alpha-Methyl-5-alpha-cholest-7-en-3-beta-ol A 3beta-hydroxy steroid that has formula C28H48O.
TG(18:1(11Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(24:0/22:2(13Z,16Z)/20:3n6)
TG(20:1(11Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
hexadecanoyl-CoA
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/20:3(5Z,8Z,11Z)/24:0)
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(14:1(9Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(18:1(9Z)/18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/24:1(15Z))
TG(22:1(13Z)/18:0/24:1(15Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/15:0)
TG(24:0/15:0/20:1(11Z))
Ceramide (d18:1/18:0)
TG(16:0/24:1(15Z)/24:1(15Z))
PE(18:1(9Z)/P-16:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:0/18:0/18:1(11Z))
DG(20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
Dihydroxyacetone
TG(16:0/20:3(5Z,8Z,11Z)/24:0)
TG(20:0/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
4-Methylumbelliferone A hydroxycoumarin that is umbelliferone substituted by a methyl group at position 4.
TG(20:1(11Z)/18:0/18:2(9Z,12Z))
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
Pefloxacin
TG(22:1(13Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Roxithromycin
TG(14:1(9Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:3(5Z,8Z,11Z)/22:0)
PC(18:0/16:1(9Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(14:0/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(18:1(9Z)/18:0/18:3(9Z,12Z,15Z))[iso6]
DG(20:1n9/0:0/20:2n6)
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
PIP2(16:0/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/20:0/20:1(11Z))
Gamma-Glutamylcysteine
PE(20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/18:0)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
DG(22:0/0:0/18:3n6)
TG(16:1(9Z)/18:1(9Z)/20:0)[iso6]
Itaconic acid A dicarboxylic acid that is methacrylic acid in which one of the methyl hydrogens is substituted by a carboxylic acid group.
DG(20:3n6/0:0/20:4n6)
Warfarin A hydroxycoumarin that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenyl-3-oxo-1-butyl group.
Guanine A 2-aminopurine carrying a 6-oxo substituent.
Finasteride An aza-steroid that is a synthetic drug for the treatment of benign prostatic hyperplasia.
TG(20:4(5Z,8Z,11Z,14Z)/20:0/18:3(9Z,12Z,15Z))
5-Phenyl-1,3-oxazinane-2,4-dione A benzene that has formula C10H9NO3.
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(24:1(15Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
PIP(20:1(11Z)/18:2(9Z,12Z))
TG(20:0/20:0/20:2n6)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0)
Ganglioside GM3 (d18:0/16:0)
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/20:2n6)
TG(24:1(15Z)/22:0/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/18:1(11Z)/20:2n6)
TG(18:0/20:2n6/24:1(15Z))
DG(20:3n6/0:0/22:5n3)
2-Methyl-3-hydroxybutyryl-CoA
TG(14:0/22:0/24:0)
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(24:0/18:3(6Z,9Z,12Z)/o-18:0)
TG(24:1(15Z)/18:1(9Z)/18:3(6Z,9Z,12Z))
DG(18:3(9Z,12Z,15Z)/24:1(15Z)/0:0)
Simvastatin A fatty acid ester comprising a dihydroxyheptanoic acid unit condensed into a lactone; a partially reduced naphthalene structure; and a 2,2-dimethylbutyric acyl substituent at C17. It is used as a cholesterol-lowering and anti-cardiovascular disease drug.
1-Pyrroline-5-carboxylic acid A 1-pyrrolinecarboxylic acid that is 1-pyrroline in which one of the hydrogens at position 5 is replaced by a carboxy group.
Darifenacin
TG(16:0/14:0/o-18:0)
TG(18:0/20:3n6/18:3(9Z,12Z,15Z))
TG(15:0/18:3(9Z,12Z,15Z)/18:1(9Z))
PE(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:0/20:4(8Z,11Z,14Z,17Z))
1D-myo-Inositol 3-phosphate A myo-inositol monophosphate that has formula C6H13O9P.
TG(15:0/18:1(11Z)/15:0)
TG(16:1(9Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:1(13Z)/22:2(13Z,16Z))
TG(20:3n6/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
PG(18:1(9Z)/18:1(11Z))
TG(14:0/24:0/20:4(5Z,8Z,11Z,14Z))
PE(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/20:3(5Z,8Z,11Z)/14:1(9Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
PC(18:1(11Z)/18:1(11Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
Phylloquinol
PI(16:1(9Z)/18:0)
TG(24:1(15Z)/22:0/20:3n6)
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(dm18:1(9Z)/dm16:0)
PG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:2(9Z,12Z)/15:0)
DG(18:0/0:0/20:3n9)
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/14:0/20:4(8Z,11Z,14Z,17Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:0/20:1(11Z))
PC(18:2(9Z,12Z)/P-16:0)
TG(22:2(13Z,16Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:1(9Z)/20:3(8Z,11Z,14Z))[iso6]
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
PC(P-18:0/24:1(15Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(20:1(11Z)/16:0/18:3(9Z,12Z,15Z))
Fenoldopam A benzazepine that has formula C16H16ClNO3.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GT3 (d18:1/20:0)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
PE(22:1(13Z)/16:0)
TG(14:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(16:0/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GT3 (d18:1/22:0)
PE(22:1(13Z)/14:0)
TG(20:4(8Z,11Z,14Z,17Z)/14:0/20:4(8Z,11Z,14Z,17Z))
DG(18:3n3/0:0/20:5n3)
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/o-18:0)
DG(16:1n7/0:0/22:5n6)
Ganglioside GA2 (d18:1/9Z-18:1)
TG(14:1(9Z)/14:0/22:2(13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
DG(20:1(11Z)/22:1(13Z)/0:0)
Metocurine
PE(20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
Atropine A racemate composed of equimolar concentrations of (S)- and (R)-atropine . It is obtained from deadly nightshade (Atropa belladonna) and other plants of the family Solanaceae.
PE(P-18:1(11Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/22:1(13Z)/20:3n6)
PC(22:0/18:1(9Z))
Cephalexin A semisynthetic first-generation cephalosporin antibiotic having methyl and beta-(2R)-2-amino-2-phenylacetamido groups at the 3- and 7- of the cephem skeleton, respectively. It is effective against both Gram-negative and Gram-positive organisms, and is used for treatment of infections of the skin, respiratory tract and urinary tract.
TG(16:1(9Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:0/18:3(9Z,12Z,15Z)/0:0)
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:0)[iso3]
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
Zidovudine A pyrimidine 2',3'-dideoxyribonucleoside compound having a 3'-azido substituent and thymine as the nucleobase.
TG(16:0/22:1(13Z)/o-18:0)
PC(24:0/20:0)
DG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
Dimethylglycine
TG(22:0/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:3(9Z,12Z,15Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(20:1(11Z)/14:0/22:4(7Z,10Z,13Z,16Z))
TG(20:2n6/18:2(9Z,12Z)/o-18:0)
DG(16:0/18:2(9Z,12Z)/0:0)
PIP2(18:2(9Z,12Z)/20:0)
Urea A carbonyl group with two C-bound amine groups.
TG(18:4(6Z,9Z,12Z,15Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
Heme A heme is any tetrapyrrolic chelate of iron.
TG(18:1(11Z)/18:1(9Z)/20:3(5Z,8Z,11Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PIP2(16:0/16:2(9Z,12Z))
TG(18:2(9Z,12Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/22:1(13Z))
TG(20:1(11Z)/24:0/20:1(11Z))
TG(15:0/24:1(15Z)/20:0)
SR 49498
TG(24:1(15Z)/16:0/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
PE(18:4(6Z,9Z,12Z,15Z)/P-18:1(9Z))
Ganglioside GA1 (d18:1/25:0)
TG(18:1(11Z)/24:1(15Z)/20:2n6)
Mivacurium
TG(18:2(9Z,12Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]
xi-Norepinephrine
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(22:0/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(20:3n6/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/14:0/22:2(13Z,16Z))
MG(22:5(4Z,7Z,10Z,13Z,16Z)/0:0/0:0)
TG(18:1(9Z)/16:0/20:1(11Z))
TG(20:1(11Z)/20:0/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/16:0)
TG(18:4(6Z,9Z,12Z,15Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:3n6/o-18:0)
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(20:0/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
PC(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/18:1(11Z))
TG(24:0/16:1(9Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/18:1(11Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/20:1(11Z)/16:1(9Z))
TG(20:0/18:0/22:4(7Z,10Z,13Z,16Z))
Lubiprostone
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/14:0/16:1(9Z))
TG(20:0/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(15:0/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/15:0/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(22:1(13Z)/20:0/20:3n6)
TG(18:1(11Z)/14:0/18:3(6Z,9Z,12Z))
(+)-(1R,2R)-1,2-Diphenylethane-1,2-diol A hydrobenzoin that has formula C14H14O2.
TG(14:0/o-18:0/20:3n6)
Cer(d18:0/23:0)
3-Sulfinylpyruvic acid A pyruvic acid compound having a 3-sulfinyl substituent.
TG(20:0/22:2(13Z,16Z)/20:1(11Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/o-18:0/18:4(6Z,9Z,12Z,15Z))
Teniposide
TG(20:3(5Z,8Z,11Z)/18:0/o-18:0)
DG(20:3(8Z,11Z,14Z)/14:0/0:0)
TG(24:1(15Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:4n6/0:0/20:5n3)
TG(22:1(13Z)/16:1(9Z)/20:2n6)
PI(18:3(9Z,12Z,15Z)/18:0)
TG(20:1(11Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/14:0/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/20:0/o-18:0)
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/22:1(13Z)/o-18:0)
TG(18:3(9Z,12Z,15Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/20:3n6)
TG(24:1(15Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z)/o-18:0)
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
TG(20:0/14:0/20:0)
TG(18:1(11Z)/24:1(15Z)/18:1(9Z))
PI(16:0/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
PE(P-16:0/22:5(4Z,7Z,10Z,13Z,16Z))
1-Nitro-5-glutathionyl-6-hydroxy-5,6-dihydronaphthalene A peptide that has formula C20H24N4O9S.
DG(20:1(11Z)/18:3(6Z,9Z,12Z)/0:0)
TG(16:0/20:2n6/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
LysoPE(0:0/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/20:3n6/o-18:0)
PIP2(22:4(7Z,10Z,13Z,16Z)/16:0)
trans-Dec-2-enoic acid
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)
PC(16:1(9Z)/18:2(9Z,12Z))
trans,cis-Lauro-2,6-dienoyl-CoA
TG(16:1(9Z)/24:0/18:1(11Z))
TG(20:3n6/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:4(6Z,9Z,12Z,15Z)/P-18:1(11Z))
TG(22:1(13Z)/16:0/20:2n6)
DG(18:0/0:0/22:0)
PI(18:2(9Z,12Z)/18:2(9Z,12Z))
TG(18:1(11Z)/22:0/18:2(9Z,12Z))
TG(16:0/24:0/20:3(5Z,8Z,11Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
2,2,2-Trichloroethanol A chloroethanol that has formula C2H3Cl3O.
TG(22:0/14:0/20:2n6)
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
Cinalukast 2,2-Diethylsuccinanilic acid substituted at a meta- position by an (E)-2-(4-cyclobutyl-1,3-thiazol-2-yl)ethenyl group. It selectively antagonizes leukotriene D4 at the cysteinyl leukotriene receptor, in the human airway, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus. It is used in the treatment of asthma.
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))[iso6]
TG(18:0/18:2(9Z,12Z)/24:1(15Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
Ganglioside GD1a (d18:0/16:0)
TG(15:0/20:3(5Z,8Z,11Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/24:0/20:0)
TG(20:0/22:0/20:0)
Cladribine 2'-Deoxyadenosine in which the hydrogen at position 2 on the purine ring has been substituted by chlorine. It inhibits the synthesis and repair of DNA, particularly in lymphocytes and monocytes, and is used as an antimetabolite antineoplastic drug for the treatment of lymphoid malignancies including hairy-cell leukaemia and chronic lymphocytic leukaemia.
TG(20:0/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PE(24:1(15Z)/18:1(11Z))
TG(18:1(9Z)/14:0/18:3(6Z,9Z,12Z))
TG(18:0/18:2(9Z,12Z)/16:1(9Z))
PC(18:2(9Z,12Z)/P-18:0)
TG(18:0/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
DG(24:0/20:1(11Z)/0:0)
PE(22:1(13Z)/20:2(11Z,14Z))
2-Methyl-3-oxopropanoic acid The 2-methyl-3-oxo derivative of propanoic acid.
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
Oxcarbazepine A dibenzoazepine derivative, having a carbamoyl group at the ring nitrogen, substituted with an oxo group at C-4 of the azepeine ring which is also hydrogenated at C-4 and C-5. It is a anticholinergic anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy.
PC(22:0/18:1(11Z))
TG(18:1(11Z)/15:0/22:1(13Z))
TG(18:1(11Z)/22:1(13Z)/20:3n6)
TG(22:0/o-18:0/22:2(13Z,16Z))
TG(18:1(9Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(14:0/16:1(9Z)/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/15:0/22:4(7Z,10Z,13Z,16Z))
(3S)-2,3-epoxy-2,3-dihydrosqualene
Cefoperazone
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
Emtricitabine
DG(18:0/0:0/24:0)
TG(18:1(9Z)/20:3n6/24:1(15Z))
MG(0:0/22:1(13Z)/0:0)
PE(20:0/15:0)
TG(15:0/14:0/16:1(9Z))
Ganglioside GD1b (d18:1/18:0)
Inositol 1,3,4,5,6-pentakisphosphate
3-Oxo-OPC8-CoA An organic molecule that has formula C39H62N7O19P3S.
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/o-18:0/18:2(9Z,12Z))
TG(18:1(9Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
N4-Acetylaminobutanal
TG(20:0/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/14:1(9Z)/o-18:0)
Antrafenine
Midazolam
TG(20:0/22:0/18:2(9Z,12Z))
Myo-inositol hexakisphosphate A myo-inositol hexakisphosphate in which each hydroxy group of myo-inositol is monophosphorylated.
Fructose 1,6-bisphosphate
Pramipexole A member of the class of benzothiazoles that is 4,5,6,7-tetrahydro-1,3-benzothiazole in which the hydrogens at the 2 and 6-pro-S-positions are substituted by amino and propylamino groups, respectively.
TG(15:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/14:1(9Z)/20:2n6)
PE(14:1(9Z)/24:1(15Z))
TG(18:1(9Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
Geranyl-PP
TG(18:3(9Z,12Z,15Z)/18:0/18:3(9Z,12Z,15Z))[iso3]
TG(20:0/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
PC(P-18:1(9Z)/20:2(11Z,14Z))
TG(20:3n6/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:1(9Z)/20:1(11Z)/0:0)
TG(22:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
Trifluoperazine A member of the class of phenothiazines that is phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.
Pyrocatechol
TG(22:0/14:0/18:2(9Z,12Z))
TG(20:0/20:1(11Z)/24:0)
PC(18:2(9Z,12Z)/15:0)
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
DG(20:2n6/0:0/22:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(16:0/18:1(11Z))
11-beta-Hydroxyandrosterone-3-glucuronide
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:0/18:4(6Z,9Z,12Z,15Z))
Nicotinamide riboside
TG(15:0/14:0/22:4(7Z,10Z,13Z,16Z))
PC(20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/15:0/20:4(8Z,11Z,14Z,17Z))
PC(22:4(7Z,10Z,13Z,16Z)/P-18:1(11Z))
DG(22:1(13Z)/18:0/0:0)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z)/0:0)
3-Hexaprenyl-4,5-Dihydroxybenzoic acid A dihydroxybenzoic acid where the hydroxy groups are at the 4- and 5-positions together with a hexaprenyl group at the 3-position.
TG(16:1(9Z)/18:0/20:3(5Z,8Z,11Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
PC(22:2(13Z,16Z)/P-18:0)
TG(18:1(11Z)/16:1(9Z)/20:3n6)
PE(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Levetiracetam
PC(20:3(5Z,8Z,11Z)/18:1(9Z))
PE(20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
PE(24:0/24:0)
TG(22:0/20:2n6/20:1(11Z))
DG(14:0/24:0/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
PE(24:0/22:0)
TG(20:2n6/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(24:0/14:1(9Z)/16:1(9Z))
TG(24:0/o-18:0/20:3n6)
TG(20:0/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
DG(24:0/20:3(5Z,8Z,11Z)/0:0)
TG(20:0/20:3(5Z,8Z,11Z)/18:1(11Z))
3-Hydroxyquinine A cinchona alkaloid that has formula C20H24N2O3.
TG(18:0/24:0/20:0)
TG(14:0/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
PC(18:1(9Z)/18:1(11Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(14:0/14:0/22:2(13Z,16Z))
PIP2(16:0/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/20:1(11Z)/22:1(13Z))
TG(14:1(9Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
TG(20:3n6/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:1(9Z)/20:3(5Z,8Z,11Z))
Methantheline
Progabide
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/22:0/20:3(5Z,8Z,11Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(14:1(9Z)/18:1(11Z)/20:1(11Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
TG(16:0/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/16:1(9Z)/o-18:0)
TG(15:0/14:0/18:1(11Z))
TG(18:2(9Z,12Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GT1b (d18:1/16:0)
PS(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/14:1(9Z)/20:2n6)
TG(14:1(9Z)/16:0/o-18:0)
PIP3(18:1(11Z)/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(24:0/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
3-Methylglutaconyl-CoA
TG(20:1(11Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:1(9Z)/18:2(9Z,12Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(24:0/16:0/20:1(11Z))
TG(18:2(9Z,12Z)/24:1(15Z)/o-18:0)
Allopregnanolone
TG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(15:0/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
Formiminoglutamic acid
SM(d18:1/24:1(15Z))
TG(22:1(13Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/15:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/18:1(9Z)/20:2n6)
TG(16:1(9Z)/20:3n6/20:2n6)
Betavulgaroside IV
Heptacarboxylporphyrin I
TG(20:3n6/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
PC(22:0/24:0)
DG(18:2(9Z,12Z)/14:1(9Z)/0:0)
TG(18:2(9Z,12Z)/20:1(11Z)/22:2(13Z,16Z))
Rotigotine
TG(24:1(15Z)/16:1(9Z)/20:2n6)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z)/0:0)
TG(18:4(6Z,9Z,12Z,15Z)/15:0/20:4(8Z,11Z,14Z,17Z))
Selenocysteine An alpha-amino acid that consists of alanine where one of the methyl hydrogens is substituted with a seleno group.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:1(13Z)/22:1(13Z))
TG(20:1(11Z)/20:3n6/18:2(9Z,12Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/22:0)
DG(22:1(13Z)/22:0/0:0)
TG(14:1(9Z)/15:0/22:4(7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(22:0/18:1(9Z)/18:2(9Z,12Z))
TG(16:0/18:0/20:4(5Z,8Z,11Z,14Z))[iso6]
CE(22:1(13Z))
TG(20:1(11Z)/16:0/20:2n6)
2-Hexaprenyl-6-methoxyphenol A monomethoxybenzene that is 6-methoxyphenol substituted by a (all-trans)-hexaprenyl group at position 2.
(9S,10S)-10-hydroxy-9-(phosphonooxy)octadecanoate Trianion of (9S,10S)-10-hydroxy-9-(phosphonooxy)octadecanoic acid arising from deprotonation of carboxylic acid and phosphate functions.
TG(16:1(9Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/24:1(15Z)/20:2n6)
TG(18:0/18:3(9Z,12Z,15Z)/18:1(9Z))
TG(22:0/20:0/24:0)
PIP2(18:1(9Z)/18:1(11Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
LysoPE(15:0/0:0)
DG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
Hexanoyl-CoA A medium-chain fatty acyl-CoA having hexanoyl as the S-acyl group.
PI(18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:0/20:0/0:0)
TG(20:0/18:1(11Z)/18:2(9Z,12Z))
TG(20:1(11Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/20:3n6/22:1(13Z))
Cadaverine An alkane-alpha,omega-diamine comprising a straight-chain pentane core with amino substitutents at positions 1 and 5. A colourless syrupy liquid diamine with a distinctive unpleasant odour, it is a homologue of putresceine and is formed by the bacterial decarboxylation of lysine that occurs during protein hydrolysis during putrefaction of animal tissue. It is also found in plants such as soyabean.
TG(16:1(9Z)/22:1(13Z)/22:1(13Z))
DG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/0:0)
PC(20:3(5Z,8Z,11Z)/22:0)
TG(22:0/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(20:2n6/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/14:0/20:1(11Z))
TG(20:3(5Z,8Z,11Z)/15:0/22:1(13Z))
TG(18:1(9Z)/14:1(9Z)/20:2n6)
Nizatidine
PIP2(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
DG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
4a-Methylzymosterol
Deoxycorticosterone
TG(14:0/22:1(13Z)/20:2n6)
Nefazodone A triazole that has formula C25H32ClN5O2.
TG(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:1(13Z)/24:1(15Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
(1S,2R)-Naphthalene 1,2-oxide A naphthalene that has formula C10H8O.
TG(22:0/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
LysoSM(d18:0)
PC(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:0/0:0/20:3n9)
4-Trimethylammoniobutanal A butanal that has formula C7H16NO.
PC(20:3(5Z,8Z,11Z)/20:0)
PC(24:1(15Z)/14:1(9Z))
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
DG(20:0/0:0/20:1n9)
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
(N-acetylneuraminosyl(a2-6)lactosamine)
DG(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/22:2(13Z,16Z)/20:3n6)
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/15:0/18:3(9Z,12Z,15Z))
CL(18:2(9Z,12Z)/18:1(11Z)/18:1(11Z)/16:1(9Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
TG(16:1(9Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
Ganglioside GM2 (d18:1/9Z-18:1)
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
TG(20:3n6/14:1(9Z)/18:3(9Z,12Z,15Z))
PE(16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
PI(18:2(9Z,12Z)/22:3(10Z,13Z,16Z))
Sinapyl alcohol A primary alcohol, being cinnamyl alcohol hydroxylated at C-4 and methoxylated at C-3 and -5.
TG(16:1(9Z)/15:0/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/20:3n6/20:3n6)
TG(22:0/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Mesoxalic acid
7a-Hydroxydehydroepiandrosterone
DG(18:1(11Z)/22:0/0:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/o-18:0)
TG(20:0/18:1(9Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/20:2n6/18:2(9Z,12Z))
TG(20:0/14:1(9Z)/16:1(9Z))
TG(20:3(5Z,8Z,11Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:1(11Z)/15:0)
TG(15:0/18:1(11Z)/20:2n6)
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:0/P-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z)/0:0)
TG(20:3(5Z,8Z,11Z)/16:0/20:3(5Z,8Z,11Z))
DG(18:2n6/0:0/20:3n6)
TG(16:0/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/15:0/20:3n6)
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:0/18:3(6Z,9Z,12Z))
Pantetheine 4'-phosphate A phosphopantetheine that has formula C11H23N2O7PS.
DG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(14:1(9Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PG(16:0/16:0)
TG(24:1(15Z)/14:1(9Z)/20:2n6)
TG(22:1(13Z)/20:1(11Z)/20:3n6)
TG(15:0/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
TG(24:1(15Z)/18:0/20:3n6)
TG(18:1(11Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/22:0/18:3(6Z,9Z,12Z))
Ganglioside GD2 (d18:0/22:1(13Z))
TG(18:2(9Z,12Z)/24:1(15Z)/18:2(9Z,12Z))
PE(14:0/P-18:1(11Z))
TG(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Nebivolol
PS(20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z))
TG(15:0/18:0/24:0)
DG(16:0/0:0/22:5n3)
TG(20:4(8Z,11Z,14Z,17Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
PG(16:0/18:0)
PE(18:1(9Z)/20:2(11Z,14Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
PE(16:0/18:3(9Z,12Z,15Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/18:0/20:2n6)
TG(20:0/24:0/16:1(9Z))
TG(15:0/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
Succinic acid
TG(24:0/16:1(9Z)/18:2(9Z,12Z))
TG(20:0/16:0/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
PIP3(18:1(9Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
Butyric acid A four-carbon straight-chain saturated fatty acid.
TG(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
PC(15:0/14:1(9Z))
TG(14:0/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:1(11Z)/14:1(9Z))
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(15:0/0:0/20:5n3)
TG(24:0/15:0/22:1(13Z))
Cob(I)alamin A cobalamin in which the central cobalt atom has an oxidation state of +1.
TG(16:1(9Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/20:3n6/20:3n6)
TG(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(15:0/14:1(9Z)/22:1(13Z))
PE(16:1(9Z)/16:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:0/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(22:0/18:3(6Z,9Z,12Z)/16:1(9Z))
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/18:2(9Z,12Z)/14:1(9Z))
Letrozole A triazole that has formula C17H11N5.
TG(22:1(13Z)/16:0/18:2(9Z,12Z))
TG(20:1(11Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))
PC(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
PIP2(18:0/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/20:2n6)
PS(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(14:0/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Azatadine
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(20:0/18:3(6Z,9Z,12Z)/18:1(9Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
MG(24:0/0:0/0:0)
DG(18:4(6Z,9Z,12Z,15Z)/24:0/0:0)
PC(O-16:0/18:2(9Z,12Z))
CL(20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
PC(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(15:0/o-18:0/20:0)
DG(14:1(9Z)/14:0/0:0)
TG(20:1(11Z)/22:0/20:3n6)
PE(18:2(9Z,12Z)/24:0)
TG(18:3(9Z,12Z,15Z)/22:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
TG(18:0/18:2(9Z,12Z)/20:3n6)
PC(18:1(9Z)/P-18:1(9Z))
Fosinopril A phosphinate ester-containing N-acyl derivative of (4S)-cyclohexyl-L-proline. It is used for the treatment of hypertension and heart failure. A pro-drug, it is hydrolysed in vivo to the corresponding phosphininc acid, fosinoprilat, which is the active metabolite.
TG(22:1(13Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:0/20:3(5Z,8Z,11Z))
TG(18:0/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(9Z)/18:1(9Z)/20:1(11Z))[iso3]
TG(20:0/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(14:0/18:0/14:0)
TG(18:0/18:2(9Z,12Z)/18:0)
PE(22:1(13Z)/P-18:1(11Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Proparacaine
5'-Deoxy-5-fluorouridine A pyrimidine 5'-deoxyribonucleoside that is 5-fluorouridine in which the hydroxy group at the 5' position is replaced by a hydrogen. It is an oral prodrug of the antineoplastic agent 5-fluorouracil. Designed to circumvent the rapid degradation of 5-fluorouracil by dihydropyrimidine dehydrogenase in the gut wall, it is converted into 5-fluorouracil in the presence of pyrimidine nucleoside phosphorylase.
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/20:2n6/20:3n6)
Perindopril An alpha-amino acid ester that is the ethyl ester of N-{(2S)-1-[(2S,3aS,7aS)-2-carboxyoctahydro-1H-indol-1-yl]-1-oxopropan-2-yl}-L-norvaline
PC(18:3(9Z,12Z,15Z)/18:1(11Z))
CE(18:3(6Z,9Z,12Z))
TG(18:1(9Z)/20:0/20:2n6)
Aminoglutethimide
TG(18:1(9Z)/20:2n6/o-18:0)
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
Trihexosylceramide (d18:1/24:0)
PC(16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
PC(P-18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(24:0/22:2(13Z,16Z))
TG(14:0/20:3n6/24:1(15Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(18:0/0:0/18:3n6)
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:0/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3n6/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
Ganglioside GM3 (d18:0/24:1(15Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(22:1(13Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/16:0/18:3(9Z,12Z,15Z))[iso6]
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/18:1(11Z)/22:2(13Z,16Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:1(9Z)/18:1(9Z))
TG(18:1(9Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/15:0/18:2(9Z,12Z))
3-(3,5-Diiodo-4-hydroxyphenyl)pyruvate
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(22:1(13Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(18:3(9Z,12Z,15Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Diethylstilbestrol
TG(20:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
Varanic acid
TG(18:2(9Z,12Z)/24:0/18:2(9Z,12Z))
CL(20:2(11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z))
TG(16:1(9Z)/22:1(13Z)/16:1(9Z))
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/18:0/20:4(5Z,8Z,11Z,14Z))
DG(18:1(11Z)/14:1(9Z)/0:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
4,4-Dimethyl-5a-cholesta-8-en-3b-ol
Cycloserine
PG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:0/18:3(9Z,12Z,15Z)/22:1(13Z))
PC(o-18:0/22:0)
TG(14:0/22:0/14:0)
TG(22:0/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/20:1(11Z)/22:2(13Z,16Z))
PC(o-18:0/20:0)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
Squalene
TG(22:1(13Z)/18:0/22:2(13Z,16Z))
TG(16:0/20:3(5Z,8Z,11Z)/18:1(11Z))
TG(22:0/18:3(6Z,9Z,12Z)/22:0)
DG(16:0/0:0/20:4n3)
TG(20:0/14:1(9Z)/o-18:0)
TG(18:0/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
PC(20:0/18:0)
TG(15:0/20:3(5Z,8Z,11Z)/14:1(9Z))
TG(16:0/20:3(5Z,8Z,11Z)/20:1(11Z))
Methadyl Acetate
TG(24:0/14:0/20:4(5Z,8Z,11Z,14Z))
TG(20:0/16:1(9Z)/18:1(11Z))
TG(22:0/18:3(6Z,9Z,12Z)/24:0)
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
Diguanosine tetraphosphate
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PE(14:0/24:1(15Z))
Hypotaurine An aminosulfinic acid comprising ethylamine having the sulfo group at the 2-position.
TG(22:0/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/14:1(9Z)/14:1(9Z))
PE(18:2(9Z,12Z)/P-18:1(11Z))
Deoxyadenosine monophosphate
TG(22:0/18:1(11Z)/o-18:0)
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(16:0/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/18:3(6Z,9Z,12Z))
PE(16:0/18:2(9Z,12Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(16:1(9Z)/18:1(11Z)/24:1(15Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
Ganglioside GD1a (d18:1/26:1(17Z))
Cervonyl coenzyme A
TG(14:0/22:4(7Z,10Z,13Z,16Z)/22:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
DG(18:0/0:0/18:1n9)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/24:0/18:1(9Z))
N-Butyrylglycine
TG(14:1(9Z)/24:1(15Z)/18:2(9Z,12Z))
TG(16:0/16:1(9Z)/22:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0/o-18:0)
TG(15:0/24:0/24:0)
Oxybuprocaine A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester caine) used especially in ophthalmology and otolaryngology.
Trimipramine A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)-2-methylpropyl group at the nitrogen atom. It is used as an antidepressant.
TG(14:0/22:4(7Z,10Z,13Z,16Z)/24:0)
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/o-18:0)
3-Chloro-2-methyldienelactone A halo fatty acid that has formula C7H5ClO4.
TG(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(14:0/14:1(9Z))
PC(15:0/20:0)
TG(16:0/22:2(13Z,16Z)/22:0)
PIP2(16:0/20:1(11Z))
Bepridil
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
PC(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
Histamine A 1H-imidazol-4-yl group substituted at position C-4 by a 2-aminoethyl group.
TG(18:3(6Z,9Z,12Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(15:0/o-18:0/22:4(7Z,10Z,13Z,16Z))
DG(22:1(13Z)/18:2(9Z,12Z)/0:0)
TG(18:0/18:1(11Z)/16:1(9Z))
PE(20:1(11Z)/22:2(13Z,16Z))
TG(16:1(9Z)/14:1(9Z)/24:1(15Z))
PC(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(P-16:0/20:2(11Z,14Z))
TG(14:1(9Z)/20:0/16:1(9Z))
Oxymorphone
DG(20:1n9/0:0/18:3n3)
Oxidized dithiothreitol
TG(22:1(13Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:3n6/14:0)
3-Hydroxy-3-methylglutaryl-CoA An alpha,omega dicarboxyacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with one of the carboxy groups of 3-hydroxy-3-methylglutaric acid.
TG(20:0/22:2(13Z,16Z)/22:0)
Sulfolithocholylglycine
TG(20:0/18:3(9Z,12Z,15Z)/20:0)
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(15:0/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/16:0/20:2n6)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/14:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
3a,7a,12a,24-Tetrahydroxy-5b-cholestanoyl-CoA
TG(20:0/22:2(13Z,16Z)/20:0)
TG(20:3n6/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PI(22:2(13Z,16Z)/18:2(9Z,12Z))
PC(20:3(8Z,11Z,14Z)/14:1(9Z))
TG(18:2(9Z,12Z)/18:0/20:3n6)
TG(14:0/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:2n6/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:2n6/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
PE(20:1(11Z)/20:0)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/16:0)
Monobenzone
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
Methylprednisolone
17-Hydroxyandrostane-3-glucuronide
D-fructose 1-phosphate The D-enantiomer of fructose 1-phosphate.
TG(18:3(9Z,12Z,15Z)/18:0/20:4(8Z,11Z,14Z,17Z))
PE(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:1(11Z)/20:1(11Z))
Sulfapyridine
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:1(9Z)/20:2n6)
Delta 8,14 -Sterol
3-Dehydrosphinganine A 2-amino-1-hydroxyoctadecan-3-one that has S-configuration.
TG(18:0/15:0/18:3(9Z,12Z,15Z))
PG(18:3(6Z,9Z,12Z)/18:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Bupranolol
Paroxetine A benzodioxole that consists of piperidine bearing 1,3-benzodioxol-5-yloxy)methyl and 4-fluorophenyl substituents at positions 3 and 4 respectively; the (3S,4R)-diastereomer. Highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki values are 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Displays minimal affinity for alpha1-, alpha2- or beta-adrenoceptors, 5-HT2A, 5-HT1A, D2 or H1 receptors at concentrations below 1000 nM, however displays weak affinity for muscarinic ACh receptors (Ki = 42 nM). Antidepressant and anxiolytic in vivo.
PE(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/14:0/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:2n6/18:3(9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
DG(14:1(9Z)/22:1(13Z)/0:0)
TG(18:0/18:3(6Z,9Z,12Z)/20:3n6)
PE(P-18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(14:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
MG(20:0/0:0/0:0)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/22:2(13Z,16Z))
CDP-DG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
PIP3(16:0/18:1(11Z))
CDP-DG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(20:4(8Z,11Z,14Z,17Z)/20:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
LysoPE(22:2(13Z,16Z)/0:0)
Morphine-3-glucuronide A morphinane alkaloid that has formula C23H27NO9.
PE(18:0/14:1(9Z))
7a-Hydroxytestosterone
Ganglioside GT1b (d18:0/26:1(17Z))
TG(24:1(15Z)/24:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/16:1(9Z)/20:1(11Z))
TG(16:0/20:2n6/18:3(6Z,9Z,12Z))
PI(20:3(5Z,8Z,11Z)/18:1(11Z))
TG(20:0/14:0/18:3(9Z,12Z,15Z))
TG(14:0/16:0/14:1(9Z))
PS(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))
Ganglioside GQ1c (d18:1/23:0)
TG(16:1(9Z)/o-18:0/20:3(5Z,8Z,11Z))
Nabumetone
Coenzyme A A thiol comprising a panthothenate unit in phosphoric anhydride linkage with a 3',5'-adenosine diphosphate unit; and an aminoethanethiol unit.
11,12-DiHETrE
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/20:2n6)
DG(16:0e/18:0/0:0)
TG(16:1(9Z)/14:0/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:1(9Z)/18:2(9Z,12Z))[iso6]
PI(18:0/20:4(5Z,8Z,11Z,14Z)) is_a CHEBI:65055, is_a CHEBI:74240
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:0/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/20:0/18:4(6Z,9Z,12Z,15Z))
PC(P-18:0/14:1(9Z))
TG(20:3(5Z,8Z,11Z)/14:0/18:3(9Z,12Z,15Z))
Ganglioside GD1b (d18:0/18:0)
PS(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
Tetrahydrodeoxycorticosterone
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
Amlexanox
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(22:2(13Z,16Z)/20:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(18:2(9Z,12Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Chlordecone alcohol An organochlorine compound that has formula C10H2Cl10O.
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(20:2n6/14:1(9Z)/22:2(13Z,16Z))
DG(24:0/0:0/20:3n9)
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PI(16:0/16:2(9Z,12Z))
Aflatoxin B1 An aflatoxin having a tetrahydrocyclopenta[c]furo[3',2':4,5]furo[2,3-h]chromene skeleton with oxygen functionality at positions 1, 4 and 11.
DG(24:0/0:0/20:1n9)
Fructose 6-phosphate
PC(14:0/18:2(9Z,12Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:0)
TG(18:3(9Z,12Z,15Z)/14:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
2-Aminoacrylic acid A dehydroamino acid that is the 2,3-didehydro derivative of alanine.
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Felbamate
TG(18:0/15:0/18:4(6Z,9Z,12Z,15Z))
TG(18:0/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/24:0/0:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:2n6/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
LysoPE(0:0/20:1(11Z))
TG(24:1(15Z)/24:0/20:2n6)
PE(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Acetyl adenylate
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
N-Sulfo-D-glucosamine The N-sulfoglucosamine formed by sulfating the amino group of D-glucosamine.
TG(24:0/20:3(5Z,8Z,11Z)/20:3n6)
TG(14:0/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
PS(18:2(9Z,12Z)/18:1(9Z))
DG(20:2(11Z,14Z)/14:1(9Z)/0:0)
DG(24:1n9/0:0/18:2n6)
(S)-2-Aceto-2-hydroxybutanoic acid
PE(P-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/18:0/20:1(11Z))
TG(16:0/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:0/18:1(11Z)/18:1(11Z))
PC(18:3(9Z,12Z,15Z)/16:1(9Z))
TG(22:0/20:2n6/22:1(13Z))
TG(20:1(11Z)/15:0/18:3(6Z,9Z,12Z))
DG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
DG(16:1n7/0:0/22:4n6)
TG(22:0/24:1(15Z)/22:2(13Z,16Z))
TG(14:1(9Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
1-Nitro-7-glutathionyl-8-hydroxy-7,8-dihydronaphthalene A peptide that has formula C20H24N4O9S.
TG(18:1(9Z)/15:0/o-18:0)
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
PE(22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
DG(18:0/0:0/20:4n6)
TG(15:0/22:0/20:1(11Z))
PC(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))
TG(18:1(9Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
DG(22:2(13Z,16Z)/20:3(8Z,11Z,14Z)/0:0)
TG(22:0/18:3(9Z,12Z,15Z)/20:2n6)
TG(16:0/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:0/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
DG(18:1(9Z)/16:0/0:0)
TG(20:2n6/18:3(9Z,12Z,15Z)/o-18:0)
TG(24:0/22:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:3n6/22:1(13Z))
Lactosylceramide (d18:1/16:0)
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
PC(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(15:0/22:2(13Z,16Z)/24:0)
TG(22:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Rifaximin
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(20:1(11Z)/20:3n6/20:3(5Z,8Z,11Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
Ergonovine
TG(22:4(7Z,10Z,13Z,16Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:2n6/22:2(13Z,16Z))
TG(15:0/24:0/18:0)
N-Acetylserine
TG(16:0/o-18:0/18:1(11Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
N-Acetyldapsone
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/16:1(9Z)/16:1(9Z))
TG(16:0/22:0/18:1(9Z))
TG(18:3(9Z,12Z,15Z)/14:0/18:4(6Z,9Z,12Z,15Z))
DG(18:4n3/0:0/20:5n3)
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
L-Dopa An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease
TG(18:1(9Z)/22:0/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))[iso3]
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
3-Hydroxymethylglutaric acid
PIP3(18:1(11Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/20:2n6/18:1(9Z))
PC(14:0/15:0)
Ganglioside GM1 (d18:1/23:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/24:0/0:0)
PG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/0:0)
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
Cilostazol A lactam that is 3,4-dihydroquinolin-2(1H)-one in which the hydrogen at position 6 is substiuted by a 4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy group.
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(16:1(9Z)/15:0/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/20:1(11Z)/14:1(9Z))
Uridine 2',3'-cyclic phosphate
Perillyl aldehyde An aldehyde that has formula C10H14O.
TG(18:1(11Z)/22:1(13Z)/22:1(13Z))
Acetaldehyde The aldehyde formed from acetic acid by reduction of the carboxy group. It is the most abundant carcinogen in tobacco smoke.
PE(22:1(13Z)/16:1(9Z))
Ivermectin A mixture consisting of >= 90% 22,23-dihydroavermectin B1a (R = Me) and <= 10% 22,23-dihydroavermectin B1b (R = H). A semi-synthetic derivative of abamectin, it is used as a broad-spectrum antiparasite medication, particularly against worms (except tapeworms), although it is also effective against most mites and some lice.
PIP(20:2(11Z,14Z)/18:0)
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
LysoPE(0:0/20:3(8Z,11Z,14Z))
Cyclopentolate A carboxylic ester resulting from the formal condensation of (1-hydroxycyclopentyl)(phenyl)acetic acid with N,N-dimethylethanolamine. A tertiary amine antimuscarinic with actions similar to atropine, it is used as its hydrochloride salt to produce mydriasis (excessive dilation of the pupil) and cycloplegia (paralysis of the ciliary muscle of the eye) for opthalmic diagnostic procedures. It acts more quickly than atropine and has a shorter duration of action.
TG(15:0/16:0/20:3n6)
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/16:0/22:4(7Z,10Z,13Z,16Z))
Ganglioside GT1c (d18:0/24:0)
N-Acetyl-D-glucosaminyldiphosphodolichol
PE(15:0/P-18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:0/18:4(6Z,9Z,12Z,15Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
DG(20:3(5Z,8Z,11Z)/22:1(13Z)/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/15:0/18:3(9Z,12Z,15Z))
TG(16:0/18:1(9Z)/18:2(9Z,12Z))[iso6]
16a-Hydroxyandrost-4-ene-3,17-dione
TG(18:1(11Z)/24:1(15Z)/o-18:0)
TG(14:1(9Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/16:1(9Z)/20:2n6)
DG(20:3n9/0:0/22:4n6)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
PI(20:3(5Z,8Z,11Z)/18:0)
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
17-alpha-Estradiol-3-glucuronide
PC(22:2(13Z,16Z)/18:1(11Z))
TG(14:0/20:3(5Z,8Z,11Z)/18:1(9Z))
TG(22:2(13Z,16Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(24:0/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:2(9Z,12Z)/24:1(15Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/24:1(15Z)/22:1(13Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/o-18:0/20:3(5Z,8Z,11Z))
PI(22:3(10Z,13Z,16Z)/18:2(9Z,12Z))
PE(22:4(7Z,10Z,13Z,16Z)/22:0)
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/14:0/o-18:0)
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
D-Glutamine The D-enantiomer of glutamine.
TG(18:0/20:2n6/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/16:0/18:4(6Z,9Z,12Z,15Z))
TG(18:0/18:0/22:2(13Z,16Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
DG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/0:0)
Isopentenyl pyrophosphate
TG(18:1(9Z)/20:0/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Sertindole
TG(16:0/18:4(6Z,9Z,12Z,15Z)/16:0)
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(22:1(13Z)/o-18:0/22:2(13Z,16Z))
TG(15:0/18:2(9Z,12Z)/18:1(9Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
Latanoprost A prostaglandin Falpha that is the isopropyl ester prodrug of latanoprost free acid. Used in the treatment of open-angle glaucoma and ocular hypertension.
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(20:2n6/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
DG(18:3(6Z,9Z,12Z)/16:1(9Z)/0:0)
TG(18:0/16:0/14:1(9Z))
TG(20:0/18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:0/20:2n6/o-18:0)
TG(24:0/24:1(15Z)/18:3(6Z,9Z,12Z))
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(22:0/20:3n6/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
Hippuric acid
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:2n6/16:0)
TG(18:2(9Z,12Z)/24:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/18:0/18:4(6Z,9Z,12Z,15Z))
1-Methoxyphenanthrene A phenanthrene that has formula C15H12O.
TG(15:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/22:0)
ADP A purine ribonucleoside 5'-diphosphate having adenine as the nucleobase.
TG(20:2n6/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Glycocholic acid A bile acid glycine conjugate having cholic acid as the bile acid component.
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/20:3n6)
TG(14:0/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
CL(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
SM(d18:0/22:0)
TG(24:1(15Z)/22:0/24:1(15Z))
PC(18:3(6Z,9Z,12Z)/22:0)
TG(16:1(9Z)/24:1(15Z)/18:2(9Z,12Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
Leukotriene A4 A leukotriene that is the (5S,6S)-epoxy derivative of (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid.
TG(20:0/16:1(9Z)/20:3n6)
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/24:0/16:1(9Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:5n3/0:0/22:6n3)
Paclitaxel A tetracyclic diterpenoid isolated originally from the bark of the Pacific yew tree, Taxus brevifolia. It is a mitotic inhibitor used in cancer chemotherapy. Note that the use of the former generic name 'taxol' is now limited, as Taxol is a registered trade mark.
TG(22:2(13Z,16Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/14:1(9Z)/24:1(15Z))
TG(24:0/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Chitobiose
TG(15:0/18:0/16:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/14:1(9Z)/18:1(9Z))
TG(14:1(9Z)/18:1(11Z)/18:1(9Z))
DG(20:3n6/0:0/20:5n3)
TG(24:0/18:3(9Z,12Z,15Z)/24:0)
5-HPETE
TG(20:5(5Z,8Z,11Z,14Z,17Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
Valdecoxib
DG(20:4n3/0:0/20:4n3)
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
LysoPE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)/o-18:0)
TG(20:1(11Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
PC(18:3(6Z,9Z,12Z)/20:0)
DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/0:0)
TG(15:0/16:0/14:1(9Z))
TG(18:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:0/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(24:0/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
3-Oxo-4,6-choladienoic acid
TG(14:0/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GQ1c (d18:0/18:1(9Z))
TG(15:0/22:2(13Z,16Z)/o-18:0)
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
PE(20:3(8Z,11Z,14Z)/24:1(15Z))
PE(14:0/14:0)
Benzonatate The ester obtained by formal condensation of 4-butylaminobenzoic acid with nonaethylene glycol monomethyl ether. Structurally related to procaine and benzocaine, it has an anaesthetic effect on the stretch sensors in the lungs, and is used as a non-narcotic cough suppressant.
TG(20:0/22:1(13Z)/18:3(9Z,12Z,15Z))
Carbonic acid A chalcocarbonic acid that has formula CH2O3.
TG(14:0/18:0/18:2(9Z,12Z))
PC(24:0/22:5(4Z,7Z,10Z,13Z,16Z))
Hydroflumethiazide
N1-(alpha-D-ribosyl)-5,6-dimethyl-benzimidazole
TG(20:0/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
PIP2(18:3(6Z,9Z,12Z)/18:0)
PC(24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
DG(14:1(9Z)/20:1(11Z)/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/16:0/18:1(11Z))
TG(16:0/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/20:2n6/16:0)
TG(20:4(5Z,8Z,11Z,14Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
PS(16:1(9Z)/14:0)
Glycerylphosphorylethanolamine
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/16:0/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/24:1(15Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:0)
TG(16:0/o-18:0/24:1(15Z))
PS(18:2(9Z,12Z)/16:0)
TG(20:1(11Z)/14:0/22:2(13Z,16Z))
TG(20:2n6/20:2n6/o-18:0)
PS(16:1(9Z)/14:1(9Z))
TG(18:0/20:0/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:0/18:1(9Z))
TG(24:0/18:3(6Z,9Z,12Z)/24:0)
TG(20:1(11Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
(E)-but-2-enoyl-CoA
PS(18:2(9Z,12Z)/14:0)
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(24:0/o-18:0/20:2n6)
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/o-18:0)
PE(18:1(9Z)/20:0)
TG(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(18:2(9Z,12Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:0/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Dihydrocortisol
PS(16:1(9Z)/16:0)
5,6-Dihydroxyindole-2-carboxylic acid A dihydroxyindole that is indole-2-carboxylic acid substituted by hydroxy groups at positions 5 and 6.
PI(22:5(7Z,10Z,13Z,16Z,19Z)/16:0)
TG(22:0/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
PI(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))
TG(16:0/18:0/20:2n6)
Vecuronium A 5alpha-androstane compound having 3alpha-acetoxy-, 17beta-acetoxy-, 2beta-piperidino- and 16beta-N-methylpiperidinium substituents.
Amlodipine A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
TG(16:0/16:0/18:3(9Z,12Z,15Z))[iso3]
TG(22:0/20:2n6/18:1(9Z))
TG(20:3n6/18:0/18:3(9Z,12Z,15Z))
PI(20:3(5Z,8Z,11Z)/16:0)
TG(20:3n6/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
DG(16:1(9Z)/22:1(13Z)/0:0)
TG(18:0/22:1(13Z)/16:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/o-18:0/18:1(9Z))
Iodine A monoatomic iodine that has formula I.
DG(18:3(9Z,12Z,15Z)/18:1(9Z)/0:0)
TG(18:2(9Z,12Z)/14:1(9Z)/20:3n6)
Terazosin A piperazine that has formula C19H25N5O4.
TG(20:1(11Z)/16:0/20:3n6)
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/20:3n6)
PIP2(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/15:0/20:2n6)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Acepromazine A member of the class of phenothiazines that is 10H-phenothiazine substituted by an acetyl group at position 2 and a 3-(dimethylamino)propyl group at position 10.
TG(20:0/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
PS(20:3(8Z,11Z,14Z)/14:0)
PC(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(18:1(9Z)/16:0/20:4(5Z,8Z,11Z,14Z))
Anisotropine Methylbromide A quaternary ammonium salt resulting from the reaction of the amino group of anisotropine with methyl bromide.
PE(20:3(8Z,11Z,14Z)/24:0)
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/18:1(9Z))
TG(18:0/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
Amsacrine
PE(18:1(9Z)/24:0)
TG(8:0/8:0/8:0)
TG(24:1(15Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/20:2n6/14:1(9Z))
PC(15:0/22:1(13Z))
TG(20:3n6/20:2n6/20:3n6)
TG(18:1(9Z)/24:1(15Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
Demecarium
Tenofovir
TG(16:0/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PIP(18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Mycophenolic acid
DG(18:1(9Z)/20:3(5Z,8Z,11Z)/0:0)
Noradrenochrome
TG(20:0/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
PE(24:0/18:1(9Z))
TG(18:1(9Z)/18:1(11Z)/22:2(13Z,16Z))
TG(20:0/16:0/24:1(15Z))
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
Xanthine A purine nucleobase found in humans and other organisms.
Linoleic acid An octadecadienoic acid in which the two double bonds are at positions 9 and 12 and have Z (cis) steeochemistry.
TG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
Cinacalcet
TG(24:0/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/18:0/16:1(9Z))
SM(d18:1/18:1(9Z)) A sphingomyelin d18:1 in which the acyl group specified is 9Z-octadecenoyl.
Atracurium A diester compound consisting of pentane-1,5-diol with both hydroxyls bearing 3-[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-3,4-dihydroisoquinolinium-2(1H)-yl]propanoyl groups.
TG(18:2(9Z,12Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:1(11Z)/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
(24R)-Cholest-5-ene-3-beta,24-diol A 24-hydroxycholesterol that has formula C27H46O2.
Iminoaspartic acid A succinic acid derivative having an imino group at the 2-position.
DG(18:1n9/0:0/18:2n6)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(16:0/20:0/16:0)
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
DG(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/0:0)
PG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
PI(20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(14:0/18:0/24:1(15Z))
DG(16:1n7/0:0/20:2n6)
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/20:1(11Z))
PC(20:3(8Z,11Z,14Z)/22:0)
TG(18:1(9Z)/20:0/22:4(7Z,10Z,13Z,16Z))
TG(16:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Zopiclone
TG(20:3n6/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:3(8Z,11Z,14Z)/20:0)
TG(16:0/22:1(13Z)/16:0)
Putrescine A four-carbon alkane-alpha,omega-diamine. It is obtained by the breakdown of amino acids and is responsible for the foul odour of putrefying flesh.
TG(18:1(9Z)/o-18:0/22:2(13Z,16Z))
TG(24:0/16:0/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/18:1(11Z)/o-18:0)
TG(20:4(8Z,11Z,14Z,17Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:3(5Z,8Z,11Z)/18:0)
Physostigmine An indole alkaloid that has formula C15H21N3O2.
PA(16:0/18:1(9Z))
PC(P-18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/20:1(11Z)/20:1(11Z))[iso3]
TG(18:0/20:0/24:1(15Z))
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(20:0/22:2(13Z,16Z)/20:2n6)
TG(20:0/24:0/18:4(6Z,9Z,12Z,15Z))
PE(20:2(11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/20:1(11Z)/20:3n6)
TG(18:1(9Z)/22:2(13Z,16Z)/o-18:0)
DG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/0:0)
TG(20:0/18:1(11Z)/18:1(9Z))
TG(18:3(6Z,9Z,12Z)/24:0/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
HClO
TG(18:0/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/22:1(13Z)/24:1(15Z))
TG(16:0/18:1(11Z)/18:1(9Z))
D-Glucuronic acid The D-enantiomer of glucuronic acid.
TG(24:1(15Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Cyclohexane An alicyclic hydrocarbon comprising a ring of six carbon atoms; the cyclic form of hexane, used as a raw material in the manufacture of nylon.
Tetrahexosylceramide (d18:1/22:0)
TG(24:0/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
PC(22:0/P-16:0)
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(16:1(9Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/18:2(9Z,12Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GT3 (d18:0/26:1(17Z))
TG(15:0/24:1(15Z)/20:1(11Z))
Gabapentin
Ganglioside GD2 (d18:0/26:1(17Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(18:2(9Z,12Z)/18:0/20:4(5Z,8Z,11Z,14Z))
TG(20:0/18:1(9Z)/20:1(11Z))
Phenylephrine A member of the class of the class of phenylethanolamines that is 2-(methylamino)ethanol substituted by a 3-hydroxyphenyl group at position 1.
Tetracosanoic acid A C24 straight-chain saturated fatty acid.
TG(18:0/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
PE(14:1(9Z)/18:0)
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(22:0/15:0/20:4(5Z,8Z,11Z,14Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(P-18:1(9Z)/14:0)
Tamsulosin A sulfonamide that has formula C20H28N2O5S.
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
DG(22:1(13Z)/14:1(9Z)/0:0)
TG(18:2(9Z,12Z)/15:0/18:3(9Z,12Z,15Z))
PI(18:0/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/22:1(13Z)/o-18:0)
TG(14:0/22:1(13Z)/22:2(13Z,16Z))
TG(20:3n6/16:0/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
PE(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:0/18:3(6Z,9Z,12Z))
TG(20:0/15:0/24:1(15Z))
TG(22:2(13Z,16Z)/22:0/22:2(13Z,16Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/22:1(13Z))
TG(15:0/22:0/20:2n6)
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:0/18:2(9Z,12Z))[iso6]
TG(14:1(9Z)/20:0/20:1(11Z))
5-Hydroxypyrazinamide
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
TG(22:1(13Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/22:2(13Z,16Z)/o-18:0)
N-Acetyl-b-D-galactosamine
Tolbutamide An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
TG(24:1(15Z)/18:0/20:2n6)
PE(P-16:0e/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/20:3n6)
DG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/o-18:0)
PE(14:0/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:0/o-18:0)
TG(14:1(9Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
PC(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(18:0/18:1(11Z)/20:3n6)
TG(20:0/18:1(9Z)/20:2n6)
TG(20:2n6/15:0/20:2n6)
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/15:0/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
PIP2(18:1(9Z)/20:3(5Z,8Z,11Z))
CL(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/18:1(11Z)/18:1(11Z))
TG(22:2(13Z,16Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
7-Dehydrodesmosterol A 3beta-sterol having the structure of desmosterol with an extra double bond at C-7--C-8.
TG(24:1(15Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
Sertaconazole
TG(16:0/14:0/20:3n6)
TG(15:0/18:0/18:4(6Z,9Z,12Z,15Z))
TG(15:0/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(14:1n5/0:0/22:6n3)
trans-3-Hydroxycotinine glucuronide
DG(18:0/0:0/22:1n9)
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:1(9Z)/15:0/0:0)
PE(P-18:1(9Z)/14:0)
PC(20:1(11Z)/22:1(13Z))
TG(18:1(9Z)/14:0/20:3(5Z,8Z,11Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:0/20:4(5Z,8Z,11Z,14Z))
PE(20:2(11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
Thiocysteine
N-Acetyl-glucosamine 1-phosphate
DG(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/15:0/18:2(9Z,12Z))
Oxazepam A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5.
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
DG(20:2(11Z,14Z)/22:0/0:0)
(R)-3-Hydroxybutyric acid The R-enantiomer of 3-hydroxybutyric acid. Involved in the synthesis and degradation of ketone bodies, it can be used as an energy source by the brain during hypoglycaemia, and for the synthesis of biodegradable plastics.
DG(16:1(9Z)/20:2(11Z,14Z)/0:0)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
DG(18:0/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(22:2(13Z,16Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
TG(20:1(11Z)/14:1(9Z)/22:1(13Z))
Ganglioside GT1b (d18:0/12:0)
Guaiacol
TG(22:0/24:0/18:3(9Z,12Z,15Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
PE(20:3(5Z,8Z,11Z)/P-18:1(11Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:1(13Z)/14:1(9Z))
DG(20:2(11Z,14Z)/20:2(11Z,14Z)/0:0)
TG(24:0/18:0/o-18:0)
TG(18:1(11Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
Ethyl carbamate A carbamate ester obtained by the formal condensation of ethanol with carbamic acid. It has been found in alcoholic beverages.
TG(22:0/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(15:0/15:0/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/20:2n6/20:2n6)
DG(24:0/18:1(11Z)/0:0)
DG(20:4n6/0:0/18:4n3)
TG(20:4(8Z,11Z,14Z,17Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/o-18:0)
PG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:3n9/0:0/22:1n9)
TG(20:0/20:3(5Z,8Z,11Z)/24:1(15Z))
TG(14:0/16:1(9Z)/22:2(13Z,16Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
(2E)-Dodecenoyl-CoA
PE(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Dorzolamide 5,6-Dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide in which hydrogens at the 4 and 6 positions are substituted by ethylamino and methyl groups, respectively (4S, trans-configuration). A carbonic anhydrase inhibitor, it is used as the hydrochloride in ophthalmic solutions to lower increased intraocular pressure in the treatment of open-angle glaucoma and ocular hypertension.
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
SM(d18:0/26:1(17Z))
Picrotoxin
N-Lignoceroylsphingosine
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
3'-Ketolactose A keto-disaccharide that is beta-D-galactosyl-(1->4)-beta-D-glucose in which the hydroxy group at position 3 of the galactosyl moiety has been oxidised to the corresponding ketone.
TG(14:0/24:1(15Z)/16:1(9Z))
DG(24:0/0:0/18:3n6)
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/18:0/22:4(7Z,10Z,13Z,16Z))
TG(14:0/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Triamterene
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/14:1(9Z)/16:1(9Z))
TG(16:1(9Z)/16:0/20:3n6)
Miconazole A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes.
TG(16:1(9Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
Isolithocholic acid A bile acid that has formula C24H40O3.
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
Amisulpride
DG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
Ganglioside GD3 (d18:1/20:0)
Ergocalciferol
PC(22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
Ramelteon
DG(20:0/22:0/0:0)
TG(20:0/20:0/24:1(15Z))
Ganglioside GD3 (d18:1/22:0)
TG(15:0/20:3(5Z,8Z,11Z)/22:0)
TG(22:0/20:0/18:4(6Z,9Z,12Z,15Z))
PC(20:3(5Z,8Z,11Z)/22:1(13Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(20:0/20:1(11Z)/24:1(15Z))
PE(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(18:1(11Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PC(22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:3(6Z,9Z,12Z)/18:1(11Z))
TG(16:0/24:0/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/18:1(11Z)/16:1(9Z))
TG(18:2(9Z,12Z)/20:3n6/20:3n6)
Atorvastatin A dihydroxy monocarboxylic acid that is a member of the drug class known as statins, used primarily for lowering blood cholesterol and for preventing cardiovascular diseases.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Cer(t18:0/16:0)
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/20:1(11Z))
TG(18:2(9Z,12Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/14:1(9Z)/20:2n6)
TG(20:3(5Z,8Z,11Z)/24:0/20:3n6)
TG(24:0/18:0/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/14:0/o-18:0)
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
(S)-Ureidoglycolic acid
TG(20:3n6/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
DG(16:0/0:0/18:4n3)
TG(22:1(13Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
Clofibrate A carboxylic ester that is the ethyl ester of clofibric acid.
Inosinic acid
TG(24:0/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Cer(d18:0/26:1(17Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GT1c (d18:1/26:0)
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(20:3n6/22:1(13Z)/20:3n6)
TG(20:0/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:0/22:1(13Z))
Ganglioside GT1c (d18:1/20:0)
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GD3 (d18:0/23:0)
Bromodiphenhydramine
PI(22:5(4Z,7Z,10Z,13Z,16Z)/16:0)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
PE(20:2(11Z,14Z)/20:2(11Z,14Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/20:1(11Z))
TG(20:0/18:2(9Z,12Z)/24:1(15Z))
PC(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(22:2(13Z,16Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
Acetone cyanohydrin
DG(20:0/0:0/20:4n3)
PC(18:0/18:2(9Z,12Z))
PE(20:2(11Z,14Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/o-18:0)
Tafluprost free acid
MG(18:2(9Z,12Z)/0:0/0:0)
TG(18:0/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/18:1(11Z)/24:1(15Z))
Azelaic acid An alpha,omega-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups.
TG(16:0/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/20:2n6/16:1(9Z))
PC(22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
5-alpha-Cholesta-7,24-dien-3-beta-ol A 3beta-sterol that has formula C27H44O.
TG(22:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/o-18:0/22:1(13Z))
TG(16:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(20:0/16:1(9Z)/22:2(13Z,16Z))
TG(24:1(15Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Levobupivacaine
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
DG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(24:0/22:0/16:1(9Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/20:1(11Z)/18:2(9Z,12Z))
TG(20:1(11Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/20:3n6/o-18:0)
DG(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(14:1(9Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
Deserpidine
DG(20:3(5Z,8Z,11Z)/20:2(11Z,14Z)/0:0)
DG(20:3(8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(18:1(11Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/20:2n6/20:0)
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Carbon monoxide A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
TG(20:0/20:2n6/22:0)
TG(18:2(9Z,12Z)/18:1(11Z)/20:2n6)
TG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
Idarubicin An anthracycline antibiotic that has formula C26H27NO9.
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/o-18:0/24:1(15Z))
DG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/0:0)
Prazosin A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/16:0/22:2(13Z,16Z))
Tetrahydropteridine
TG(20:2n6/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/18:2(9Z,12Z)/16:0)
TG(18:1(9Z)/15:0/18:1(9Z))
TG(24:0/18:3(9Z,12Z,15Z)/16:1(9Z))
DG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
Enoxaparin
TG(20:2n6/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
CL(20:4(8Z,11Z,14Z,17Z)/20:2(11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
PE(20:3(8Z,11Z,14Z)/15:0)
PC(P-18:0/18:1(9Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
PE(18:0/20:0)
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(14:1(9Z)/20:2n6/22:1(13Z))
PE(18:0/22:0)
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:3(8Z,11Z,14Z)/16:0/0:0)
PC(18:1(9Z)/20:0)
TG(16:0/20:1(11Z)/14:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(20:0/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
PE(22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
DG(18:0/18:1(11Z)/0:0)
Cinnarizine
TG(18:0/20:3(5Z,8Z,11Z)/18:0)
TG(16:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
N-Glycolylneuraminic acid
PG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
PC(20:3(5Z,8Z,11Z)/16:0)
TG(15:0/22:0/20:4(5Z,8Z,11Z,14Z))
TG(22:0/18:0/18:1(9Z))
LysoPE(0:0/24:6(6Z,9Z,12Z,15Z,18Z,21Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Dipyridamole A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
TG(22:0/18:3(9Z,12Z,15Z)/24:1(15Z))
Stearic acid A C18 straight-chain saturated fatty acid component of many animal and vegetable lipids. As well as in the diet, it is used in hardening soaps, softening plastics and in making cosmetics, candles and plastics.
S-Adenosylmethioninamine The S-adenosyl derivative of methioninamine.
Lamivudine
TG(24:1(15Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(15:0/0:0/20:4n6)
DG(20:3n9/0:0/20:4n3)
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/20:3n6)
DG(18:1n7/0:0/22:1n9)
PC(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/18:2(9Z,12Z)/24:0)
Fencamfamine
TG(24:0/20:0/20:2n6)
PC(P-18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Polythiazide
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Myo-inositol 1-phosphate
PE(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
Bumetanide A member of the class of benzoic acids that is 4-phenoxybenzoic acid in which the hydrogens ortho to the phenoxy group are substituted by butylamino and sulfamoyl groups. Bumetanide is a diuretic, and is used for treatment of oedema associated with congestive heart failure, hepatic and renal disease.
Cefaclor A cephalosporin bearing chloro and (R)-2-amino-2-phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton.
TG(22:0/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2(11Z,14Z)/0:0)
DG(20:0/0:0/18:2n6)
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:0)
TG(18:1(9Z)/20:0/22:2(13Z,16Z))
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:1(11Z)/15:0)
TG(20:2n6/18:1(11Z)/20:2n6)
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(18:0/16:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(24:0/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:2(9Z,12Z)/20:2n6)
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(24:0/18:0/24:1(15Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
Dihydroneopterin phosphate
PS(18:1(9Z)/18:1(9Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
Ganglioside GD2 (d18:1/26:0)
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:1n9/0:0/22:6n3)
TG(22:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/16:0/18:3(9Z,12Z,15Z))
(R)-3-Hydroxydecanoic acid
TG(20:0/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/24:0/18:1(11Z))
TG(16:1(9Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/16:0/18:1(9Z))
Heptacarboxylporphyrin III
Ganglioside GD2 (d18:1/20:0)
DG(18:1(11Z)/20:1(11Z)/0:0)
PIP2(20:3(5Z,8Z,11Z)/18:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:0/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(20:0/18:0/18:4(6Z,9Z,12Z,15Z))
PE(18:1(9Z)/18:0)
TG(22:4(7Z,10Z,13Z,16Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(18:0/16:0/20:2n6)
DG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/0:0)
TG(18:1(11Z)/24:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(22:0/22:0/24:0)
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(18:1(11Z)/20:0/20:3n6)
TG(16:1(9Z)/20:0/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
PI(22:4(7Z,10Z,13Z,16Z)/18:0)
TG(22:1(13Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/20:0/18:3(6Z,9Z,12Z))
TG(20:3n6/14:1(9Z)/20:3n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
Chlorpheniramine
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/o-18:0/14:0)
PA(18:1(9Z)/18:1(9Z))
TG(18:0/16:0/20:0)
PC(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
CDP-DG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(20:0/22:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(14:1(9Z)/20:3n6/18:2(9Z,12Z))
TG(20:1(11Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/22:0/o-18:0)
TG(20:0/o-18:0/20:1(11Z))
TG(22:0/20:3n6/18:2(9Z,12Z))
TG(20:0/18:1(11Z)/24:0)
Methylamine The simplest of the methylamines, consisting of ammonia bearing a single methyl substituent.
TG(18:1(9Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
PC(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
PC(18:0/P-16:0)
TG(20:4(5Z,8Z,11Z,14Z)/15:0/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(18:1(11Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/o-18:0)
CE(18:2(9Z,12Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(18:0/20:1(11Z)/18:1(11Z))
PI(18:1(11Z)/20:3(8Z,11Z,14Z))
L-Histidine The L-enantiomer of the amino acid histidine.
TG(22:1(13Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:0/16:0/18:0)
TG(14:0/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
Indanone An ortho-fused bicyclic compound consisting of a benzene ring fused to a cyclopentanone.
TG(16:1(9Z)/18:2(9Z,12Z)/20:0)[iso6]
Morphine A morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug. Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly. Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy).
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:0/o-18:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(16:0/20:3(5Z,8Z,11Z)/0:0)
TG(20:2n6/20:0/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/24:1(15Z)/18:1(9Z))
DG(22:0/20:3(8Z,11Z,14Z)/0:0)
TG(14:1(9Z)/22:1(13Z)/20:3(5Z,8Z,11Z))
PE(14:0/24:0)
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(18:1(11Z)/18:1(11Z)/18:1(11Z))
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))[iso3]
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/16:1(9Z)/20:0)
TG(15:0/14:0/18:4(6Z,9Z,12Z,15Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/18:1(11Z))
TG(18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(18:1(9Z)/18:2(9Z,12Z)/20:0)[iso6]
Glucosylceramide (d18:1/26:1(17Z))
TG(20:3n6/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
DG(20:2(11Z,14Z)/24:1(15Z)/0:0)
TG(14:0/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
PE(22:2(13Z,16Z)/P-18:0)
TG(14:0/20:3(5Z,8Z,11Z)/16:0)
TG(15:0/16:0/20:2n6)
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:0/24:0/20:3(5Z,8Z,11Z))
TG(20:0/15:0/18:1(9Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/22:0)
TG(18:2(9Z,12Z)/o-18:0/18:3(6Z,9Z,12Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GM3 (d18:1/26:0)
TG(16:1(9Z)/22:1(13Z)/20:2n6)
TG(18:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
Ganglioside GT1c (d18:0/24:1(15Z))
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso3]
Xanthurenic acid A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by hydroxy groups at C-4 and C-8.
TG(16:0/18:2(9Z,12Z)/16:1(9Z))
DG(20:0/18:3(6Z,9Z,12Z)/0:0)
TG(24:1(15Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:0/18:4(6Z,9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
PE(18:3(6Z,9Z,12Z)/18:1(9Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
DG(22:4n6/0:0/22:4n6)
TG(22:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(18:0/20:3n6/24:1(15Z))
DG(20:3n9/0:0/22:5n6)
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/20:3n6)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
DG(18:1n7/0:0/20:2n6)
TG(18:2(9Z,12Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
PS(18:3(9Z,12Z,15Z)/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:0/o-18:0)
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
PE(20:3(8Z,11Z,14Z)/16:1(9Z))
Mepenzolate
TG(20:1(11Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:2(9Z,12Z)/16:0/20:3n6)
TG(24:0/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(24:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Glycineamideribotide
TG(20:3(5Z,8Z,11Z)/15:0/20:3n6)
Ganglioside GM3 (d18:1/20:0)
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/20:2n6)
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/24:1(15Z)/18:2(9Z,12Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:2(13Z,16Z)/18:1(9Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/16:0)
TG(15:0/20:1(11Z)/20:1(11Z))
Folic acid An N-acyl-amino acid that is a form of the water-soluble vitamin B9. Its biologically active forms (tetrahydrofolate and others) are essential for nucleotide biosynthesis and homocysteine remethylation.
MG(0:0/24:0/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:2(9Z,12Z)/24:1(15Z))
PC(18:3(9Z,12Z,15Z)/20:0)
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:4(6Z,9Z,12Z,15Z)/24:0)
TG(20:2n6/20:3(5Z,8Z,11Z)/o-18:0)
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
TG(20:1(11Z)/18:1(9Z)/22:2(13Z,16Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(o-22:0/22:3(10Z,13Z,16Z))
PE(18:4(6Z,9Z,12Z,15Z)/22:0)
PE(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
Pilocarpine
3-Oxo-OPC6-CoA An organic molecule that has formula C37H58N7O19P3S.
TG(20:4(5Z,8Z,11Z,14Z)/16:0/20:4(5Z,8Z,11Z,14Z))
PC(P-18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
3a,7a,12a-Trihydroxy-5b-cholestanoyl-CoA
PE(20:3(8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
Ondansetron
TG(16:0/18:0/24:1(15Z))
PC(P-16:0/22:2(13Z,16Z))
TG(14:1(9Z)/22:0/20:4(5Z,8Z,11Z,14Z))
TG(14:0/24:0/18:1(11Z))
TG(22:1(13Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
Biliverdin A linear tetrapyrrole produced in the reticuloendothelial system by the first step of heme degradation, catalysed by heme oxygenase.
TG(24:0/15:0/18:1(11Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(22:1(13Z)/16:1(9Z)/22:1(13Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
PIP(16:0/22:4(10Z,13Z,16Z,19Z))
TG(15:0/18:3(6Z,9Z,12Z)/20:1(11Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(15:0/15:0/18:1(9Z))
TG(16:1(9Z)/18:1(11Z)/20:3n6)
TG(14:1(9Z)/16:0/18:2(9Z,12Z))
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Methocarbamol
TG(15:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/20:3n6/20:1(11Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(15:0/24:0/22:4(7Z,10Z,13Z,16Z))
TG(14:0/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/24:1(15Z)/22:1(13Z))
PE(20:2(11Z,14Z)/18:3(6Z,9Z,12Z))
TG(18:3(9Z,12Z,15Z)/22:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/18:2(9Z,12Z)/20:3n6)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
All-trans-hexaprenyl diphosphate A hexaprenyl diphosphate that has formula C30H52O7P2.
TG(16:0/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/22:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
13-L-Hydroperoxylinoleic acid
CL(18:2(9Z,12Z)/18:1(9Z)/18:1(11Z)/16:1(9Z))
TG(20:1(11Z)/18:1(11Z)/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
Dextrorphan O-glucuronide
TG(20:3(5Z,8Z,11Z)/20:2n6/22:1(13Z))
PC(24:1(15Z)/22:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:3n6/18:1(9Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6/o-18:0)
TG(18:1(11Z)/18:0/22:2(13Z,16Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
Phenol An organic hydroxy compound that consists of benzene bearing a single hydroxy substituent. The parent of the class of phenols.
PC(24:1(15Z)/24:0)
Amodiaquine
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)/0:0)
DG(15:0/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(16:0/15:0/14:1(9Z))
TG(18:1(11Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
PC(20:2(11Z,14Z)/P-18:1(11Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/18:2(9Z,12Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z))
Mitotane
TG(16:0/22:0/o-18:0)
PC(14:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(14:0/22:1(13Z)/20:1(11Z))
TG(20:0/22:1(13Z)/14:1(9Z))
TG(15:0/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(16:0/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/20:3(5Z,8Z,11Z))
TG(18:3(9Z,12Z,15Z)/24:0/o-18:0)
TG(18:0/o-18:0/22:2(13Z,16Z))
TG(15:0/20:1(11Z)/20:3(5Z,8Z,11Z))
Ganglioside GD2 (d18:0/24:1(15Z))
TG(16:0/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(14:1(9Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
Chlophedianol
N-Acetylornithine
TG(18:0/18:1(9Z)/o-18:0)
PI(22:2(13Z,16Z)/16:0)
Adenosine phosphosulfate
TG(14:1(9Z)/15:0/18:3(9Z,12Z,15Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
Acebutolol An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0)
TG(24:1(15Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PG(18:1(9Z)/16:0)
PE(15:0/18:2(9Z,12Z))
TG(20:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/15:0/o-18:0)
N-Acryloylglycine
PC(14:1(9Z)/16:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
PC(P-18:1(9Z)/24:0)
PE(20:1(11Z)/16:0)
TG(15:0/15:0/20:1(11Z))
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
Cortisone acetate A corticosteroid hormone that has formula C23H30O6.
TG(15:0/18:1(11Z)/18:3(6Z,9Z,12Z))
D-Fructose 2,6-bisphosphate
PC(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/24:1(15Z))
4-(2-Aminophenyl)-2,4-dioxobutanoic acid A 4-oxo monocarboxylic acid that has formula C10H9NO4.
DG(20:0/20:4(8Z,11Z,14Z,17Z)/0:0)
Proguanil
TG(20:3n6/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/22:0/24:1(15Z))
TG(14:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(14:0/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Docosa-4,7,10,13,16-pentaenoyl CoA
MG(15:0/0:0/0:0)
TG(15:0/18:1(11Z)/20:1(11Z))
TG(22:2(13Z,16Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:0/22:2(13Z,16Z))
3-Oxododecanoic acid A 3-oxo monocarboxylic acid that has formula C12H22O3.
Pamidronate
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
Undecaprenyl diphosphate A polyprenol diphosphate compound having eleven prenyl units with undefined stereochemistry about the double bonds.
TG(22:1(13Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(15:0/24:1(15Z)/14:1(9Z))
TG(20:3n6/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
PE(20:1(11Z)/14:0)
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/20:1(11Z)/22:1(13Z))
TG(16:1(9Z)/18:2(9Z,12Z)/18:1(9Z))
Ciliatine
Atazanavir
Ganglioside GD2 (d18:0/18:0)
TG(18:1(9Z)/14:0/20:2n6)
L-Phenylalanine The L-enantiomer of phenylalanine.
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/o-18:0)
DG(18:3(9Z,12Z,15Z)/22:0/0:0)
Ganglioside GT2 (d18:0/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
PE(P-18:1(11Z)/18:0)
SM(d18:0/22:3(10Z,13Z,16Z))
DG(18:1(11Z)/15:0/0:0)
TG(15:0/18:2(9Z,12Z)/18:1(11Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:0)
PC(16:0/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/20:0/18:2(9Z,12Z))
Lactose 6-phosphate A lactose phosphate in which a single monophosphate substituent is placed at position 6 on the galactose ring of lactose.
DG(22:5(7Z,10Z,13Z,16Z,19Z)/24:0/0:0)
PIP(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:1n9/0:0/20:3n6)
TG(20:2n6/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(18:1(11Z)/14:1(9Z))
TG(24:1(15Z)/20:3n6/o-18:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-16:0)
TG(20:0/18:2(9Z,12Z)/18:1(11Z))
LysoPE(0:0/22:2(13Z,16Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:3n6/18:1(11Z))
TG(20:0/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/24:1(15Z))
Amobarbital
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/22:1(13Z))
TG(22:2(13Z,16Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/24:0/20:3n6)
TG(24:0/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:3(9Z,12Z,15Z)/14:0/0:0)
TG(16:0/20:0/22:2(13Z,16Z))
TG(16:0/18:0/14:1(9Z))
TG(24:0/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(20:1(11Z)/20:2n6/20:3(5Z,8Z,11Z))
TG(14:0/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
Muricholic acid
PE(20:2(11Z,14Z)/18:0)
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0)
3-Dehydroquinate A hydroxy monocarboxylic acid anion that is obtained by removal of a proton from the carboxylic acid group of 3-dehydroquinic acid.
TG(22:1(13Z)/24:1(15Z)/20:3n6)
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
PIP2(18:3(9Z,12Z,15Z)/18:0)
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
DG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/0:0)
TG(24:0/24:1(15Z)/14:1(9Z))
TG(14:0/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
TG(18:0/18:0/22:1(13Z))
PC(14:1(9Z)/22:1(13Z))
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(14:1(9Z)/o-18:0/20:1(11Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/16:0)
TG(14:1(9Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(15:0/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:2n6/20:3n6)
Pregabalin
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/18:2(9Z,12Z))
Carbinoxamine An organochlorine compound that is 2-(4-chlorobenzyl)pyridine in which one of the benzylic hydrogens is substituted by 2-(dimethylamino)ethoxy group. It is an ethanolamine-type antihistamine, used as its maleate salt for treating hay fever, as well as mild cases of Parkinson's disease.
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/14:1(9Z)/o-18:0)
TG(20:2n6/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/14:0)
Arachidyl alcohol
TG(15:0/20:2n6/18:1(9Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)
TG(16:0/14:1(9Z)/20:0)
TG(15:0/20:0/20:3(5Z,8Z,11Z))
TG(22:0/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:1(11Z)/20:3n6)
TG(15:0/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
Gadopentetate dimeglumine
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Lactosylceramide (d18:1/24:0)
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:0)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(18:0/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Lactosylceramide (d18:1/22:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
Duloxetine
PC(18:1(11Z)/20:1(11Z))
TG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/o-18:0)
N-[(3a,5b,7a,12a)-3,12-dihydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]-Glycine
TG(22:0/22:0/18:1(9Z))
DG(20:4(5Z,8Z,11Z,14Z)/24:0/0:0)
Cabergoline An N-acylurea that is (8R)-ergoline-8-carboxamide in which the hydrogen attached to the piperidine nitrogen (position 6) is substituted by an allyl group and the hydrogens attached to the carboxamide nitrogen are substituted by a 3-(dimethylamino)propyl group and an N-ethylcarbamoyl group. A dopamine D2 receptor agonist, cabergoline is used in the management of Parkinson's disease and of disorders associated with hyperprolactinaemia.
7alpha-Hydroxypregnenolone A corticosteroid hormone that has formula C21H32O3.
TG(16:0/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:0)
TG(18:0/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:0/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(20:1(11Z)/22:0/22:2(13Z,16Z))
TG(22:1(13Z)/16:0/22:1(13Z))
TG(24:1(15Z)/22:0/20:4(5Z,8Z,11Z,14Z))
DG(14:1n5/0:0/20:3n9)
TG(18:2(9Z,12Z)/20:2n6/20:3n6)
PC(22:1(13Z)/20:3(8Z,11Z,14Z))
PC(dm18:0/dm18:1(11Z))
Chenodeoxyglycocholic acid
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/18:3(9Z,12Z,15Z)/24:0)
Etomidate The ethyl ester of 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylic acid. It is an intravenous general anaesthetic with no analgesic activity.
TG(24:1(15Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/15:0/20:2n6)
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
PE(20:0/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
ADP-ribose 2'-phosphate
TG(18:0/18:3(9Z,12Z,15Z)/18:0)
DG(20:0/0:0/20:2n6)
DG(14:1n5/0:0/18:1n9)
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
DG(22:0/0:0/22:1n9)
PC(18:2(9Z,12Z)/18:2(9Z,12Z))
TG(22:1(13Z)/20:0/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/22:0/18:3(6Z,9Z,12Z))
PE(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:0/20:3(5Z,8Z,11Z))
TG(20:0/18:1(9Z)/20:3n6)
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/16:1(9Z)/20:1(11Z))
TG(20:3n6/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/20:2n6/22:2(13Z,16Z))
CL(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z))
5,6-Dihydro-5-fluorouracil A 9,11,15-octadecatrienoic acid that has formula C4H5FN2O2.
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/24:1(15Z)/20:2n6)
TG(18:3(9Z,12Z,15Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
PC(14:0/20:0)
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
Ganglioside GA1 (d18:1/26:1(17Z))
TG(24:0/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(24:0/14:0)
TG(16:0/22:0/22:2(13Z,16Z))
TG(24:0/o-18:0/16:1(9Z))
PC(20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z))
PC(24:0/16:0)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/18:2(9Z,12Z)/20:3n6)
PS(14:0/14:1(9Z))
PE(18:3(9Z,12Z,15Z)/14:1(9Z))
PC(o-18:1(9Z)/22:0)
TG(18:0/20:3(5Z,8Z,11Z)/20:0)
TG(14:1(9Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:0/24:1(15Z))
MG(18:1(11Z)/0:0/0:0)
DG(15:0/16:0/0:0)
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:0)
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/0:0)
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PI(18:1(9Z)/20:1(11Z))
TG(20:3(5Z,8Z,11Z)/16:0/20:3n6)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PC(P-16:0/18:2(9Z,12Z))
(S)-5-Diphosphomevalonic acid
Erlotinib
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/18:1(11Z))
TG(22:0/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:0/20:4(5Z,8Z,11Z,14Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/14:0/0:0)
TG(18:0/16:1(9Z)/20:0)
TG(18:0/24:0/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:2(11Z,14Z)/20:3(5Z,8Z,11Z)/0:0)
TG(14:1(9Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GD1a (d18:0/23:0)
TG(20:0/14:1(9Z)/24:1(15Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:2n6/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
13-OxoODE
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(20:1(11Z)/18:1(11Z)/22:2(13Z,16Z))
TG(16:0/18:1(9Z)/18:1(11Z))
TG(15:0/18:3(9Z,12Z,15Z)/16:1(9Z))
1-Methylnicotinamide A pyridinium ion comprising nicotinamide having a methyl group at the 1-position.
TG(15:0/20:3(5Z,8Z,11Z)/20:1(11Z))
TG(18:2(9Z,12Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
DG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
PS(14:1(9Z)/18:3(9Z,12Z,15Z))
TG(22:0/20:2n6/18:1(11Z))
7-Aminomethyl-7-carbaguanine
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
2-Methyl-1-hydroxypropyl-ThPP
TG(24:0/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Alpha-hydroxyalprazolam
Remifentanil A piperidinecarboxylate ester that is methyl piperidine-4-carboxylate in which the hydrogen attached to the nitrogen is substituted by a 3-methoxy-3-oxopropyl group and the hydrogen at position 4 is substituted the nitrogen of N-propanoylaniline.
2-Furoylglycine
1-Nitro-5-hydroxy-6-glutathionyl-5,6-dihydronaphthalene A peptide that has formula C20H24N4O9S.
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
CE(16:1(9Z))
TG(22:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:2(9Z,12Z)/16:1(9Z))
DG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(15:0/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:0/22:4(7Z,10Z,13Z,16Z))
TG(22:0/16:0/22:0)
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
PE(18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
Morphine-6-glucuronide A morphinane alkaloid that has formula C23H27NO9.
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:1(11Z))
Ganglioside GT2 (d18:1/12:0)
TG(24:1(15Z)/24:1(15Z)/o-18:0)
TG(14:0/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/24:1(15Z)/24:0)
Calenduloside H
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
Ganglioside GD1a (d18:0/25:0)
Ampicillin A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group.
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
Dibucaine
Ganglioside GQ1c (d18:1/24:1(15Z))
TG(18:1(11Z)/14:0/22:1(13Z))
Pindolol A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Fluconazole A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It has been shown to exhibit antifungal activity.
3'-Hydroxyhexobarbital A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a cyclohex-1-en-1-yl group at position 5, a hydroxy group at position 1 and methyl groups at positions 3 and 5.
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
PIP(18:0/18:2(9Z,12Z))
TG(22:1(13Z)/18:1(9Z)/18:2(9Z,12Z))
TG(22:0/22:1(13Z)/18:3(6Z,9Z,12Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganciclovir An oxopurine that is guanine substituted by a [(1,3-dihydroxypropan-2-yl)oxy]methyl group at position 9. Ganciclovir is an antiviral drug used to treat or prevent AIDS-related cytomegalovirus infections.
PE(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
3-Carbamoyl-2-phenylpropionic acid A monocarboxylic acid that has formula C10H11NO4.
TG(24:0/18:3(6Z,9Z,12Z)/24:1(15Z))
TG(14:0/o-18:0/24:0)
TG(18:1(11Z)/o-18:0/18:2(9Z,12Z))
PIP(18:1(9Z)/18:0)
TG(14:0/18:4(6Z,9Z,12Z,15Z)/20:3n6)
TG(16:0/14:1(9Z)/18:2(9Z,12Z))
TG(20:3n6/16:1(9Z)/22:2(13Z,16Z))
TG(16:0/18:0/18:3(9Z,12Z,15Z))
Estrone sulfate
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/24:1(15Z))
TG(18:0/18:3(9Z,12Z,15Z)/20:3n6)
TG(15:0/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:2(13Z,16Z)/16:1(9Z)/0:0)
DG(20:2n6/0:0/20:5n3)
DG(14:0/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/16:0/24:0)
Ganglioside GT2 (d18:0/16:0)
TG(14:0/16:0/24:0)
Linamarin A beta-D-glucoside that has formula C10H17NO6.
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
PC(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
D-Glucosaminide
PE(20:4(8Z,11Z,14Z,17Z)/P-18:1(11Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/o-18:0)
PE(20:0/20:4(8Z,11Z,14Z,17Z))
4-Nitrocatechol A member of the class of catechols that is benzene-1,2-diol substituted by a nitro group at position 4.It is the by-product of the hydroxylation of p-nitrophenol.
Epinephrine glucuronide
Ephedrine A phenethylamine alkaloid that is 2-phenylethanamine substituted by a methyl group at the amino nitrogen and a methyl and a hydroxy group at position 2 and 1 respectively.
TG(24:1(15Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(20:2n6/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/o-18:0/22:2(13Z,16Z))
Ganglioside GD3 (d18:1/18:1(11Z))
TG(16:0/24:1(15Z)/22:0)
PE(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
4-Pyridoxic acid A methylpyridine that is 2-methylpyridine substituted by a hydroxy group at C-3, a carboxy group at C-4, and a hydroxymethyl group at C-5.
TG(24:1(15Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/14:0/20:2n6)
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/18:3(6Z,9Z,12Z)/18:0)
PE(24:0/14:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/o-18:0)
PE(20:0/18:2(9Z,12Z))
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(24:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/24:0/24:1(15Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(22:0/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:0)
TG(24:0/18:3(6Z,9Z,12Z)/14:1(9Z))
TG(14:0/15:0/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/24:0/20:2n6)
TG(18:2(9Z,12Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:1(11Z)/20:3(5Z,8Z,11Z))
PC(18:1(9Z)/18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:0/22:4(7Z,10Z,13Z,16Z))
DG(22:4(7Z,10Z,13Z,16Z)/20:0/0:0)
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
Ganglioside GM3 (d18:1/18:1(11Z))
DG(20:1(11Z)/22:2(13Z,16Z)/0:0)
PE(22:5(7Z,10Z,13Z,16Z,19Z)/16:0)
TG(18:1(11Z)/15:0/22:2(13Z,16Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z)/o-18:0)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/15:0)
Guanethidine
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/22:2(13Z,16Z))
2-Methyl-1-hydroxybutyl-ThPP A thiamine phosphate that has formula C17H29N4O8P2S.
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PIP(18:1(11Z)/18:0)
TG(10:0/10:0/10:0)[iso]
DG(20:1(11Z)/18:1(9Z)/0:0)
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
TG(18:2(9Z,12Z)/20:0/22:2(13Z,16Z))
PE(16:1(9Z)/14:1(9Z))
TG(15:0/18:3(6Z,9Z,12Z)/24:1(15Z))
TG(18:3(6Z,9Z,12Z)/18:0/18:3(9Z,12Z,15Z))
PG(18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(14:0/14:0/14:1(9Z))
TG(18:1(11Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/24:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
DG(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
DG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(18:0/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
Dasatinib
PC(14:0/18:4(6Z,9Z,12Z,15Z))
PE(P-16:0/24:1(15Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/24:1(15Z))
LysoPC(18:0) A lysophosphatidylcholine in which the acyl group has a fully saturated C18 chain and is attached to the glycero moiety at either position 1 or 2.
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:2n6/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
7-Methyluric acid An oxopurine that has formula C6H6N4O3.
Levonorgestrel A 17beta-hydroxy steroid that has formula C21H28O2.
TG(16:1(9Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/20:2n6/20:2n6)
TG(24:1(15Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/16:0/18:2(9Z,12Z))
Nilotinib
TG(16:0/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:0/18:1(9Z))
TG(22:1(13Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/0:0)
TG(22:0/24:0/20:2n6)
TG(18:0/20:0/24:0)
DG(18:3n6/0:0/18:4n3)
TG(24:1(15Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Propantheline
PE(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3n6/20:2n6/o-18:0)
DG(22:5(4Z,7Z,10Z,13Z,16Z)/22:0/0:0)
LPA(0:0/16:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Campest-4-en-3-one A 3-oxo steroid that has formula C28H46O.
Dhurrin
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:1(11Z)/18:1(11Z))
TG(20:2n6/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/14:0/18:0)[iso3]
Ganglioside GT3 (d18:0/18:1(11Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
PIP(20:3(5Z,8Z,11Z)/18:1(11Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
MG(0:0/24:1(15Z)/0:0)
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
Mitomycin
Dexmethylphenidate
TG(18:4(6Z,9Z,12Z,15Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
DG(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)/0:0)
TG(24:0/18:1(11Z)/22:2(13Z,16Z))
TG(20:0/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/24:0/18:3(6Z,9Z,12Z))
TG(14:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PC(22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
Cer(d18:0/24:0)
Mandelonitrile A cyanohydrin that has formula C8H7NO.
DG(20:1(11Z)/14:1(9Z)/0:0)
TG(20:3n6/o-18:0/22:2(13Z,16Z))
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/15:0/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/24:0/22:2(13Z,16Z))
TG(24:0/15:0/14:1(9Z))
TG(20:1(11Z)/14:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:3(9Z,12Z,15Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(20:3n9/0:0/24:1n9)
TG(22:0/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:0/18:3(9Z,12Z,15Z)) A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and alpha-linolenoyl respectively.
DG(22:0/18:3(6Z,9Z,12Z)/0:0)
TG(16:1(9Z)/15:0/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/18:1(11Z)/20:3n6)
DG(24:0/14:0/0:0)
TG(18:0/16:1(9Z)/20:3n6)
TG(16:0/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
9,10-Epoxyoctadecenoic acid
TG(16:0/18:0/22:2(13Z,16Z))
TG(16:0/24:1(15Z)/16:1(9Z))
TG(16:0/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
PE(18:1(11Z)/15:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(18:0/22:0/22:2(13Z,16Z))
PC(14:1(9Z)/15:0)
PG(18:1(11Z)/18:1(9Z))
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
LysoPE(0:0/18:3(6Z,9Z,12Z))
PIP2(18:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
PE(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/14:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/15:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
Daunorubicin A natural product found in Actinomadura roseola.
Ibutilide
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/18:3(9Z,12Z,15Z)/18:1(11Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:0/18:3(9Z,12Z,15Z))
Ganglioside GT1b (d18:1/24:1(15Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
PE(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/24:1(15Z)/18:2(9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/15:0/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
LysoPE(0:0/24:0)
(S)-2,3,4,5-tetrahydropyridine-2-carboxylate
Ouabain
PE(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/18:0/20:2n6)
TG(20:0/24:0/18:1(9Z))
4-Trimethylammoniobutanoic acid A quaternary ammonium ion that is the conjugate acid of 4-(trimethylammonio)butanoate.
PIP2(16:0/18:0)
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
PG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/20:2n6)
TG(14:0/16:0/18:0)
TG(24:1(15Z)/18:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(15:0/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
Prostaglandin D2 A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- stereoisomer).
TG(14:0/15:0/20:2n6)
Ganglioside GD2 (d18:1/18:1(11Z))
TG(16:0/15:0/20:2n6)
N-Palmitoylsphingosine
TG(18:1(11Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Sulfate A sulfur oxoanion obtained by deprotonation of both OH groups of sulfuric acid.
DG(20:0/20:3(8Z,11Z,14Z)/0:0)
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))
Ganglioside GD1b (d18:0/24:1(15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/14:0/18:1(11Z))[iso3]
TG(18:1(9Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
PE(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(15:0/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/15:0/20:2n6)
TG(22:1(13Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/16:1(9Z)/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/o-18:0/20:3n6)
PS(14:0/18:2(9Z,12Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
DG(18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
PC(20:1(11Z)/14:1(9Z))
PC(20:3(5Z,8Z,11Z)/18:1(11Z))
Ganglioside GT2 (d18:1/26:0)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:1(11Z)/20:3(5Z,8Z,11Z)/0:0)
Acetoacetyl-CoA A 3-oxoacyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of acetoacetic acid.
PE(22:2(13Z,16Z)/20:1(11Z))
DG(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/0:0)
TG(24:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:1n9/0:0/22:5n3)
TG(18:3(6Z,9Z,12Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
TG(16:0/22:0/18:3(9Z,12Z,15Z))
TG(14:0/20:3n6/18:4(6Z,9Z,12Z,15Z))
Ganglioside GT2 (d18:1/20:0)
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
PC(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
3-alpha-hydroxy-5-alpha-androstane-17-one 3-D-glucuronide
TG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene A peptide that has formula C20H25N3O7S.
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/18:3(9Z,12Z,15Z)/o-18:0)
TG(24:0/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
N-Acetylneuraminate 9-phosphate
TG(18:0/20:3n6/18:2(9Z,12Z))
TG(18:1(9Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
Lapatinib
TG(14:0/24:1(15Z)/20:3n6)
TG(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Trimethylamine A tertiary amine that is ammonia in which each hydrogen atom is substituted by an methyl group.
TG(18:0/22:4(7Z,10Z,13Z,16Z)/o-18:0)
Trypanothione A glutathione derivative that has formula C27H49N9O10S2.
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
PE(16:1(9Z)/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
Melatonin A member of the class of acetamides that is acetamide in which one of the hydrogens attached to the nitrogen atom is replaced by a 2-(5-methoxy-1H-indol-3-yl)ethyl group. It is a hormone secreted by the pineal gland in humans.
DG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/0:0)
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/24:1(15Z))
PE(22:0/18:3(9Z,12Z,15Z))
TG(14:0/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:1(13Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:0/0:0/24:1n9)
TG(24:0/14:1(9Z)/18:2(9Z,12Z))
TG(18:0/22:1(13Z)/24:0)
Tetrahydrobiopterin
TG(24:0/18:3(6Z,9Z,12Z)/22:1(13Z))
PC(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
7-Ketodeoxycholic acid
3-Methylcrotonyl-CoA
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/22:1(13Z)/22:0)
TG(18:4(6Z,9Z,12Z,15Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(16:1n7/0:0/18:4n3)
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/22:2(13Z,16Z)/20:2n6)
TG(15:0/o-18:0/14:1(9Z))
TG(18:1(11Z)/24:0/18:1(11Z))
Ganglioside GT3 (d18:1/12:0)
TG(20:1(11Z)/15:0/22:2(13Z,16Z))
Clomipramine A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
1-Phosphatidyl-D-myo-inositol
TG(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/o-18:0/20:3n6)
PE(16:0/22:5(7Z,10Z,13Z,16Z,19Z))
PE(P-18:1(11Z)/15:0)
DG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
Guanosine 2',3'-cyclic phosphate
DG(20:3(8Z,11Z,14Z)/18:0/0:0)
TG(18:1(9Z)/18:0/20:2n6)
TG(20:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Androstanediol
PC(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
DG(18:1n7/0:0/20:3n6)
TG(24:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
PC(14:0/24:1(15Z))
PE(24:0/20:1(11Z))
TG(22:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(16:0/18:3(9Z,12Z,15Z)/16:0)
Caspofungin
TG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:3(5Z,8Z,11Z)/24:1(15Z))
5-Methyltetrahydropteroyltri-L-glutamate A peptide anion arising from deprotonation of all four carboxy groups of 5-methyltetrahydropteroyltri-L-glutamic acid; major species at pH 7.3.
Ganglioside GT3 (d18:1/14:0)
Clofarabine
PC(24:1(15Z)/20:2(11Z,14Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/24:1(15Z)/18:1(9Z))
Tetrahexosylceramide (d18:1/26:0)
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/o-18:0/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/24:0/18:3(9Z,12Z,15Z))
TG(24:0/14:0/18:1(9Z))
TG(18:2(9Z,12Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
3-Oxooctanoyl-CoA An oxo-fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxylic acid group of 3-oxooctanoic acid.
Ganglioside GD3 (d18:0/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/20:0/24:1(15Z))
Adenylsuccinic acid
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
Yohimbine An indole alkaloid with alpha2-adrenoceptor antagonist activity. It is produced by Corynanthe johimbe and Rauwolfia serpentina.
TG(14:1(9Z)/22:0/20:2n6)
7a-Hydroxycholesterol
PE(P-16:0/18:1(9Z))
PC(P-18:1(11Z)/20:1(11Z))
TG(18:1(11Z)/18:0/20:1(11Z))
TG(15:0/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
Gallium nitrate
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
PE(16:0/P-18:0)
TG(20:0/18:0/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/22:2(13Z,16Z)/18:1(11Z))
TG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
PE(O-18:1(1Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:1(11Z)/22:1(13Z))
PIP2(16:0/16:0)
TG(22:0/o-18:0/22:0)
Acetyl-CoA An acyl-CoA having acetyl as its S-acetyl component.
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
LysoPC(18:4(6Z,9Z,12Z,15Z))
TG(14:0/24:0/24:1(15Z))
TG(18:2(9Z,12Z)/18:1(9Z)/18:2(9Z,12Z))
TG(16:0/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(15:0/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:0/18:3(6Z,9Z,12Z))
MG(0:0/22:4(7Z,10Z,13Z,16Z)/0:0)
PE(18:2(9Z,12Z)/18:0)
TG(24:1(15Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/24:0/o-18:0)
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:2(9Z,12Z)/20:1(11Z))
PE(20:2(11Z,14Z)/20:1(11Z))
Piperazine An azacycloalkane that consists of a six-membered ring containing two nitrogen atoms at opposite positions.
5-Hydroxyomeprazole A sulfoxide that is omeprazole in which one of the methyl hydrogens at position 5 on the pyridine ring is substituted by a hydroxy group.
TG(18:1(11Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/16:0/16:0)
Carbimazole
DG(22:5n6/0:0/22:6n3)
TG(24:1(15Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:2(13Z,16Z)/16:1(9Z))
TG(14:0/18:3(9Z,12Z,15Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/15:0/20:2n6)
TG(20:3n6/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/24:1(15Z)/20:3n6)
TG(16:1(9Z)/20:2n6/18:1(9Z))
TG(18:3(9Z,12Z,15Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
12(S)-Leukotriene B4
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/o-18:0)
TG(22:0/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/22:2(13Z,16Z)/22:1(13Z))
TG(16:1(9Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
Tetracosanoyl-CoA A very long-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of tetracosanoic (lignoceric) acid. It is an intermediate in the biosynthesis of unsaturated fatty acids.
TG(22:1(13Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(15:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Phosphoric acid A phosphorus oxoacid that consits of one oxo and three hydroxy groups joined covalently to a central phosphorus atom.
Ganglioside GA2 (d18:1/24:0)
TG(14:1(9Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:0/15:0)
1,2-Di-(9Z,12Z,15Z-octadecatrienoyl)-3-(Galactosyl-alpha-1-6-Galactosyl-beta-1)-glycerol
TG(15:0/20:1(11Z)/24:1(15Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/18:1(11Z)/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/o-18:0)
PE(24:0/P-16:0)
TG(22:0/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:0/22:1(13Z))
TG(18:1(9Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(20:0/o-18:0/22:4(7Z,10Z,13Z,16Z))
PC(P-18:1(9Z)/24:1(15Z))
TG(14:0/o-18:0/15:0)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:0)
TG(20:4(5Z,8Z,11Z,14Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
Cetirizine A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
TG(20:0/15:0/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/14:1(9Z)/o-18:0)
DG(20:4n6/0:0/18:3n3)
TG(15:0/14:0/18:3(6Z,9Z,12Z))
TG(14:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(8Z,11Z,14Z,17Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:0/20:3(5Z,8Z,11Z))
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
Lithocholic acid glycine conjugate
TG(18:0/16:0/20:4(8Z,11Z,14Z,17Z))
PE(16:0/16:1(9Z))
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(20:2n6/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
1,3-Diaminopropane
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/24:1(15Z))
Paraoxon An aryl dialkyl phosphate where both the alkyl groups are ethyl and the aryl group is 4-nitrophenyl.
PE(20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:0/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(15:0/15:0)
TG(18:0/22:2(13Z,16Z)/22:0)
TG(18:2(9Z,12Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(24:0/18:1(11Z)/18:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
Iduronic acid A member of the class of iduronic acids that is the major uronic acid component of the dermatan sulfate and heparin.
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
DG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/22:0)
TG(14:0/16:0/18:2(9Z,12Z))
PE(24:1(15Z)/18:2(9Z,12Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:2(13Z,16Z)/18:1(11Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
Naphthalene epoxide
TG(18:1(11Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
Thyroxine sulfate An iodothyronine having iodo substituents in the 3-, 3'-, 5- and 5'-positions and a sulfate group attached to the phenol function.
TG(22:0/16:0/o-18:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/20:0/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/20:3(5Z,8Z,11Z)/18:0)
PIP(16:0/18:1(11Z))
PC(18:1(11Z)/22:1(13Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(18:3(9Z,12Z,15Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(22:1(13Z)/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:0)
TG(18:2(9Z,12Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Pyridostigmine
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/22:1(13Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
Aprepitant
PE(P-18:0/22:0)
DG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(18:0/20:3n6/20:4(8Z,11Z,14Z,17Z))
Trifluridine
TG(22:0/16:0/18:3(9Z,12Z,15Z))
TG(22:0/20:3n6/18:3(6Z,9Z,12Z))
TG(24:0/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
Ganglioside GD1a (d18:0/14:0)
PC(P-18:0/20:4(5Z,8Z,11Z,14Z))
4-Nitrophenol A mononitrophenol having the nitro group placed at the 4-position.
LysoPC(18:1(9Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/18:1(11Z)/22:0)
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
Phosphoglycolic acid
TG(20:3(5Z,8Z,11Z)/22:0/20:3(5Z,8Z,11Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
Deferasirox
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
11-Epi-PGF2a
TG(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/16:0/18:1(11Z))
PE(22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
Omeprazole A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
DG(18:3(9Z,12Z,15Z)/18:1(11Z)/0:0)
TG(18:1(9Z)/16:1(9Z)/22:1(13Z))
TG(18:0/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(24:0/24:0/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/24:0/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
PC(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
DG(22:0/0:0/20:3n6)
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/20:3n6)
TG(16:1(9Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:0/22:2(13Z,16Z))
PIP2(20:3(5Z,8Z,11Z)/18:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:2(11Z,14Z)/16:1(9Z)/0:0)
TG(16:0/22:1(13Z)/18:1(9Z))
TG(22:0/24:1(15Z)/o-18:0)
TG(22:0/22:0/o-18:0)
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(15:0/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
Bromobenzene-3,4-dihydrodiol An organic hydroxy compound that has formula C6H7BrO2.
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(16:1(9Z)/16:0/22:4(7Z,10Z,13Z,16Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(14:0/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/16:0/18:2(9Z,12Z))
TG(24:1(15Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(18:1(11Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/16:0/o-18:0)
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
PC(18:2(9Z,12Z)/18:0)
PC(18:1(9Z)/15:0)
4-Imidazolone-5-propionic acid
TG(14:1(9Z)/22:1(13Z)/24:1(15Z))
DG(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)/0:0)
TG(14:0/15:0/14:1(9Z))
TG(24:0/18:3(9Z,12Z,15Z)/o-18:0)
TG(14:1(9Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/16:1(9Z)/24:0)
Valerylglycine
(2E)-Decenoyl-CoA An acyl-CoA oxoanion arising from deprotonation of the phosphate and diphosphate OH groups of trans-dec-2-enoyl-CoA; major species at pH 7.3.
TG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
PE(14:1(9Z)/P-16:0)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:2(11Z,14Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/14:0/18:3(9Z,12Z,15Z))
3,4-Dihydro-3-hydroxy-4-S-glutathionyl bromobenzene A peptide that has formula C16H22BrN3O7S.
TG(14:1(9Z)/20:0/18:4(6Z,9Z,12Z,15Z))
PE(14:1(9Z)/P-18:0)
DG(18:1(9Z)/24:0/0:0)
TG(16:0/16:1(9Z)/20:3(5Z,8Z,11Z))
DG(20:2(11Z,14Z)/20:0/0:0)
TG(16:0/22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
PC(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(24:0/20:3(8Z,11Z,14Z))
PC(24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
Se-Adenosylselenohomocysteine
TG(20:3n6/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
4-Hydroxybutyric acid A 4-hydroxy monocarboxylic acid that is butyric acid in which one of the hydrogens at position 4 is replaced by a hydroxy group.
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Isovalerylsarcosine
TG(14:1(9Z)/24:0/20:3(5Z,8Z,11Z))
DG(20:3(5Z,8Z,11Z)/15:0/0:0)
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/24:0/22:2(13Z,16Z))
TG(24:0/20:3(5Z,8Z,11Z)/16:1(9Z))
TG(14:1(9Z)/18:0/18:3(6Z,9Z,12Z))
OPC6-CoA An organic molecule that has formula C37H60N7O18P3S.
TG(15:0/20:3n6/20:0)
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(24:0/0:0/22:6n3)
TG(24:0/20:0/18:2(9Z,12Z))
Magnesium salicylate
PE(P-18:1(9Z)/20:2(11Z,14Z))
TG(14:1(9Z)/o-18:0/18:3(6Z,9Z,12Z))
PC(18:0/16:0)
TG(20:2n6/22:1(13Z)/20:2n6)
TG(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA A polyol that has formula C31H52N7O18P3S.
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
DG(16:1n7/0:0/22:1n9)
TG(16:1(9Z)/14:0/20:4(8Z,11Z,14Z,17Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(14:0/20:2n6/18:1(11Z))
beta-Carotene-15,15'-epoxide An epoxycarotenoid obtained by epoxidation across the 15,15'-double bond of beta-carotene.
DG(18:1(11Z)/20:3(5Z,8Z,11Z)/0:0)
TG(16:1(9Z)/14:0/20:1(11Z))
PC(18:3(6Z,9Z,12Z)/16:0)
PG(18:1(9Z)/16:1(9Z))
TG(18:0/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/20:2n6/18:3(9Z,12Z,15Z))
Pranlukast
TG(18:2(9Z,12Z)/15:0/20:4(5Z,8Z,11Z,14Z))
PIP(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))
TG(14:0/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
N-Glycoloylganglioside GM2
N-Glycoloylganglioside GM1
PC(20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:3n6/22:2(13Z,16Z))
DG(18:0/24:1(15Z)/0:0)
TG(14:0/20:1(11Z)/20:2n6)
DG(16:0/0:0/16:1n7)
TG(22:0/24:0/14:1(9Z))
CDP-DG(16:0/18:1(11Z))
TG(16:1(9Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(15:0/18:2(9Z,12Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(18:1(11Z)/18:1(9Z)/22:1(13Z))
TG(16:1(9Z)/18:1(9Z)/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z)/o-18:0)
3a,7b,12a-Trihydroxy-5a-Cholanoic acid
TG(20:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:1(9Z)/P-16:0)
TG(18:0/20:2n6/18:3(9Z,12Z,15Z))
PE(18:3(6Z,9Z,12Z)/22:1(13Z))
TG(14:0/22:0/20:1(11Z))
Vinorelbine A vinca alkaloid with a norvinblastine skeleton.
Deoxycholic acid A dihydroxy-5beta-cholanic acid that has formula C24H40O4.
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:2(11Z,14Z))
TG(18:0/24:1(15Z)/22:0)
TG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
PE(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/14:0/20:3n6)
TG(15:0/18:4(6Z,9Z,12Z,15Z)/20:3n6)
Temsirolimus
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
MG(22:2(13Z,16Z)/0:0/0:0)
TG(18:0/24:1(15Z)/20:2n6)
TG(14:0/14:0/24:1(15Z))
Pyridoxal
TG(20:2n6/18:2(9Z,12Z)/20:2n6)
DG(16:1n7/0:0/18:1n7)
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
11,12,15-THETA A hydroxy fatty acid that has formula C20H34O5.
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/18:1(11Z))
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:1(13Z)/20:1(11Z)/0:0)
PC(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GM3 (d18:0/22:1(13Z))
TG(20:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/24:0/22:1(13Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
TG(20:1(11Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Saccharopine
PE(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
DG(14:0/0:0/20:0)
PE(18:3(6Z,9Z,12Z)/P-18:1(11Z))
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
3-Sulfodeoxycholic acid
TG(22:0/22:0/14:1(9Z))
TG(24:0/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/o-18:0/20:2n6)
Isoflurophate
DG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:0/18:1(11Z))
TG(18:0/14:0/14:1(9Z))
TG(15:0/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Lorazepam
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/18:1(9Z))
SM(d18:0/14:1(9Z)(OH))
TG(18:1(9Z)/o-18:0/20:3n6)
PE(24:0/24:1(15Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/20:3n6)
DG(20:1(11Z)/14:0/0:0)
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/14:1(9Z))
TG(14:1(9Z)/24:1(15Z)/20:3n6)
TG(16:0/24:0/18:1(11Z))
TG(20:2n6/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/16:0/20:3n6)
TG(14:1(9Z)/18:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/22:1(13Z)/18:1(9Z))
TG(18:0/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GM3 (d18:0/26:1(17Z))
TG(16:1(9Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
Trimethylammonioacetate The amino acid betaine derived from glycine.
TG(16:0/20:2n6/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/22:0/o-18:0)
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
DG(18:1n7/0:0/18:1n7)
TG(20:1(11Z)/14:0/18:2(9Z,12Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/o-18:0)
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
TG(22:0/20:1(11Z)/20:3(5Z,8Z,11Z))
PC(16:1(9Z)/22:2(13Z,16Z))
TG(14:1(9Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:1(11Z)/20:3(5Z,8Z,11Z))
trans-Tetra-dec-2-enoic acid
Thymidine 5'-triphosphate
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/22:1(13Z))
TG(22:0/14:0/20:3n6)
TG(22:0/20:0/20:2n6)
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
TG(24:0/22:1(13Z)/18:1(9Z))
TG(18:1(9Z)/20:0/20:3n6)
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/20:3n6)
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
LysoPE(0:0/22:5(7Z,10Z,13Z,16Z,19Z))
Nitrendipine
TG(22:4(7Z,10Z,13Z,16Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/18:1(11Z)/24:0)
TG(15:0/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/14:0/20:2n6)
PE(P-18:0/15:0)
TG(20:3n6/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:1(11Z)/20:3(8Z,11Z,14Z))
TG(20:2n6/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
trans-2-Enoyl-OPC6-CoA An organic molecule that has formula C37H58N7O18P3S.
TG(24:1(15Z)/20:3n6/20:3n6)
11b-Hydroxyprogesterone
Levobunolol A cyclic ketone that is 3,4-dihydronaphthalen-1-one substituted at position 5 by a 3-(tert-butylamino)-2-hydroxypropoxy group (the S-enantiomer). A non-selective beta-adrenergic antagonist used (as its hydrochloride salt) for treatment of glaucoma.
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GM3 (d18:1/16:0)
Se-Adenosylselenomethionine
PC(18:3(6Z,9Z,12Z)/18:1(9Z))
PC(18:0/18:0)
PC(20:1(11Z)/18:0)
TG(14:1(9Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
2,2-Dichloroacetaldehyde An organochlorine compound that has formula C2H2Cl2O.
TG(15:0/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(24:0/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Vitamin A A group of fat-soluble retinoids produced via metabolism of provitamin A carotenoids. Vitamin A is involved in immune function, vision, reproduction, and cellular communication.
PE(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GM3 (d18:1/14:0)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(16:1(9Z)/18:0/18:3(9Z,12Z,15Z))
gamma-Glutamyl-beta-aminopropiononitrile A nitrile that is L-glutamine in which one of the hydrogens attached to the amide nitrogen is replaced by a 2-cyanoethyl group.
TG(24:0/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(14:0/22:2(13Z,16Z)/16:0)
TG(18:3(9Z,12Z,15Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(20:0/14:0/20:3n6)
TG(18:2(9Z,12Z)/14:0/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(18:0/20:1(11Z)/22:2(13Z,16Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
5'-Deoxyadenosine A 5'-deoxyribonucleoside compound having adenosine as the nucleobase.
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
PG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/20:1(11Z)/o-18:0)
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GQ1c (d18:1/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Estrone-3,4-quinone
TG(24:0/18:1(11Z)/24:1(15Z))
CL(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
Sphinganine 1-phosphate A sphingoid 1-phosphate that is the monophosphorylated derivative of sphinganine.
TG(18:0/22:0/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(16:1(9Z)/20:2(11Z,14Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
Methylselenopyruvate An oxo carboxylic acid that has formula C4H6O3Se.
Allysine An alpha-amino acid consisting of lysine having an oxo group in place of the side-chain amino group.
TG(18:0/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/o-18:0/20:1(11Z))
DG(20:1n9/0:0/20:1n9)
PE(20:0/20:0)
TG(22:0/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Cobinamide A cobalt-corrinoid hexaamide that has formula C48H72CoN11O8.
Alfuzosin A tetrahydrofuranol that has formula C19H27N5O4.
PC(18:2(9Z,12Z)/18:1(11Z))
TG(16:1(9Z)/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/18:1(11Z)/16:1(9Z))
PC(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/15:0/24:1(15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/24:0/18:2(9Z,12Z))
TG(24:1(15Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Azidocillin
TG(18:1(11Z)/14:0/20:3n6)
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
PC(P-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(18:1(9Z)/20:3n6/22:1(13Z))
L-Dihydroorotic acid
DHAP(18:0e)
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CE(5:0)
Clarithromycin The 6-O-methyl ether of erythromycin A, clarithromycin is a macrolide antibiotic used in the treatment of respiratory-tract, skin and soft-tissue infections. It is also used to eradicate Helicobacter pylori in the treatment of peptic ulcer disease. It prevents bacteria from growing by interfering with their protein synthesis.
DG(22:2(13Z,16Z)/14:0/0:0)
LysoPE(0:0/18:4(6Z,9Z,12Z,15Z))
TG(14:0/18:1(9Z)/16:1(9Z))
TG(22:0/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
LysoPC(20:5(5Z,8Z,11Z,14Z,17Z))
CMP-N-trimethyl-2-aminoethylphosphonate
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(18:0/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:1n9/0:0/20:3n9)
17-beta-Estradiol-3-glucuronide
TG(24:1(15Z)/24:0/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/22:2(13Z,16Z)/o-18:0)
DG(16:1(9Z)/20:1(11Z)/0:0)
TG(14:0/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:4(6Z,9Z,12Z,15Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(P-18:1(9Z)/24:0)
TG(20:1(11Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(22:0/16:1(9Z)/18:3(9Z,12Z,15Z))
PE(20:0/20:3(5Z,8Z,11Z))
D-Glucose A glucose with D-configuration.
TG(22:1(13Z)/20:3n6/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine
PC(14:1(9Z)/24:0)
TG(18:2(9Z,12Z)/14:0/22:2(13Z,16Z))
DG(14:0/14:1(9Z)/0:0)
TG(22:2(13Z,16Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/20:1(11Z)/22:2(13Z,16Z))
D-4-Hydroxy-2-oxoglutarate
TG(18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PI(16:0/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(14:1(9Z)/22:0)
TG(14:0/16:0/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/16:0/22:1(13Z))
TG(20:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:1(9Z)/20:1(11Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
Ganglioside GA1 (d18:1/24:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
DG(18:1(11Z)/18:1(11Z)/0:0)
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
all-trans-18-Hydroxyretinoic acid A retinoid that has formula C20H28O3.
PE(18:1(11Z)/18:1(9Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(15:0/20:3n6/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GM2 (d18:0/22:0)
5a-Cholesta-7,24-dien-3b-ol
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
6-Hydroxyhexanoic acid An omega-hydroxy fatty acid comprising hexanoic acid having a hydroxy group at the 6-position.
TG(18:0/18:1(11Z)/20:3(5Z,8Z,11Z))
PC(18:4(6Z,9Z,12Z,15Z)/14:0)
TG(20:0/18:3(6Z,9Z,12Z)/22:1(13Z))
Ganglioside GM2 (d18:0/24:0)
PIP(16:0/22:4(7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/15:0/18:2(9Z,12Z))
TG(18:0/22:1(13Z)/14:1(9Z))
TG(15:0/14:0/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
PE(15:0/16:1(9Z))
PC(o-16:0/22:0)
TG(20:3n6/20:3(5Z,8Z,11Z)/o-18:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(20:3n6/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Galabiosylceramide (d18:1/9Z-18:1)
TG(16:1(9Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/18:2(9Z,12Z))
TG(22:0/o-18:0/20:1(11Z))
Acenocoumarol
TG(18:1(11Z)/o-18:0/22:2(13Z,16Z))
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
DG(20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/0:0)
TG(18:1(11Z)/18:0/o-18:0)
TG(15:0/18:2(9Z,12Z)/16:0)[iso6]
Ganglioside GA1 (d18:1/22:0)
TG(18:3(6Z,9Z,12Z)/o-18:0/20:2n6)
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(24:0/20:2n6/20:3n6)
TG(18:1(11Z)/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z)/o-18:0)
Flunitrazepam
TG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/18:1(9Z)/20:2n6)
DG(22:2(13Z,16Z)/18:1(9Z)/0:0)
PE(20:1(11Z)/18:1(11Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/20:3n6/22:0)
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/o-18:0/16:1(9Z))
Tadalafil
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(18:0/18:1(9Z)/18:0)
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
Alprenolol
TG(15:0/24:0/20:3n6)
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/24:0)
TG(18:0/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2(11Z,14Z))
TG(24:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:2n6/22:2(13Z,16Z))
PE(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/15:0/22:4(7Z,10Z,13Z,16Z))
MG(0:0/22:2(13Z,16Z)/0:0)
TG(15:0/18:4(6Z,9Z,12Z,15Z)/20:1(11Z))
TG(22:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
6-Hydroxymethyletoricoxib
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:0/22:2(13Z,16Z))
PC(22:1(13Z)/P-18:1(11Z))
Glyceric acid A trionic acid that consists of propionic acid substituted at positions 2 and 3 by hydroxy groups.
TG(20:3n6/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Gluconolactone
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
PC(14:1(9Z)/18:3(6Z,9Z,12Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/22:0)
4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one A benzene that has formula C10H11NO3.
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/15:0/20:3n6)
TG(14:0/14:1(9Z)/15:0)
PE(P-18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Magnesium Sulfate A magnesium salt having sulfate as the counterion.
TG(18:1(9Z)/18:2(9Z,12Z)/22:2(13Z,16Z))
PE(16:0/15:0)
TG(16:0/18:0/o-18:0)
Bexarotene
TG(16:1(9Z)/20:3n6/24:1(15Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
Tetradecanoyl-CoA
LysoPE(0:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z)/0:0)
TG(16:0/24:0/20:2n6)
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:0/0:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PIP2(18:0/20:3(5Z,8Z,11Z))
Oxitriptan
PE(22:2(13Z,16Z)/20:0)
Norethindrone
TG(18:2(9Z,12Z)/14:1(9Z)/o-18:0)
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:3(5Z,8Z,11Z)/20:0)
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(14:1(9Z)/16:1(9Z)/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:0/18:3(6Z,9Z,12Z))
TG(18:0/22:2(13Z,16Z)/22:2(13Z,16Z))
PC(15:0/24:0)
TG(14:0/20:0/22:1(13Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Nitisinone
DG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(20:3n6/18:2(9Z,12Z)/o-18:0)
TG(22:2(13Z,16Z)/14:0/22:2(13Z,16Z))
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
3-O-Sulfogalactosylceramide (d18:1/22:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/24:0/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/15:0/o-18:0)
DG(18:0/14:0/0:0)
dCDP A 2'-deoxycytidine phosphate that is the 2'- deoxy derivative of cytidine 5'-diphosphate (CDP).
TG(20:0/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(16:0/22:1(13Z)/20:1(11Z))
3-O-Sulfogalactosylceramide (d18:1/20:0)
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
TG(14:0/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
LysoPE(18:1(9Z)/0:0)
PIP(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(14:1(9Z)/18:1(9Z)/18:2(9Z,12Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:0)
TG(16:0/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
N-Acetylputrescine An N-monoacetylalkane-alpha,omega-diamine that is the N-monoacetyl derivative of putrescine.
1-Undecanol
Artemether
DG(20:3n6/0:0/22:5n6)
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/20:3n6)
TG(20:1(11Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
DG(22:2(13Z,16Z)/20:2(11Z,14Z)/0:0)
PE(18:2(9Z,12Z)/18:1(11Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:3n6/0:0/20:4n3)
MG(20:2(11Z,14Z)/0:0/0:0)
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:0/20:4(5Z,8Z,11Z,14Z))[iso3]
L-Threo-2-pentulose
8(S)-HPETE A HPETE in which the hydroperoxy group is located at position 8S and the four double bonds at position 5, 9, 11 and 14 (the 5Z,9E,11Z,14Z-geoisomer).
DG(24:1(15Z)/20:2(11Z,14Z)/0:0)
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/0:0)
TG(20:0/14:0/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
DG(20:3(8Z,11Z,14Z)/15:0/0:0)
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/14:0/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/15:0/20:3n6)
PG(16:1(9Z)/16:0)
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
TG(20:1(11Z)/o-18:0/20:2n6)
LysoPC(P-18:1(9Z))
TG(18:0/15:0/24:0)
DG(24:0/0:0/20:2n6)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/24:0/o-18:0)
TG(20:1(11Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PE(22:2(13Z,16Z)/22:2(13Z,16Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
3-Methylindole
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/20:3n6)
DG(14:0/20:1(11Z)/0:0)
TG(16:1(9Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/18:1(11Z)/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z))
TG(14:0/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
Naloxone A morphinane alkaloid that has formula C19H21NO4.
PG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(16:0/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
(S)-2-Acetolactate
TG(20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z)/o-18:0)
L-Formylkynurenine
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(24:0/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PIP2(16:1(9Z)/18:1(11Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PI(20:4(8Z,11Z,14Z,17Z)/18:0)
TG(20:1(11Z)/22:0/20:2n6)
TG(24:0/18:3(6Z,9Z,12Z)/18:1(9Z))
TG(14:0/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Beta-D-Fructose 6-phosphate
Thiotepa
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
3-Phenylpropionylglycine
N-Acetyl-9-O-acetylneuraminic acid A N-acetyl-O-acetylneuraminic acid that has formula C13H21NO10.
TG(22:0/24:1(15Z)/20:1(11Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
PC(20:2(11Z,14Z)/18:2(9Z,12Z))
TG(18:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(24:0/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/o-18:0/20:2n6)
TG(15:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
Procyclidine
SM(d18:0/20:2(11Z,14Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(22:2(13Z,16Z)/14:1(9Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/20:0/18:3(6Z,9Z,12Z))
Delavirdine
TG(20:1(11Z)/16:1(9Z)/20:3n6)
TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:1(9Z)/18:1(11Z))
PE(P-18:0/20:4(8Z,11Z,14Z,17Z))
PIP(22:3(10Z,13Z,16Z)/16:2(9Z,12Z))
PC(20:2(11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
PC(20:4(8Z,11Z,14Z,17Z)/15:0)
Ganglioside GT3 (d18:0/16:0)
TG(18:1(9Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
Uracil
TG(14:1(9Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/20:2n6/20:0)
PC(14:0/22:4(7Z,10Z,13Z,16Z))
DG(14:1(9Z)/22:2(13Z,16Z)/0:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
Cytidine 2',3'-cyclic phosphate
TG(16:0/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Coumaric acid
TG(18:1(11Z)/16:1(9Z)/18:2(9Z,12Z))[iso6]
Carboprost Tromethamine The tromethamine salt of carboprost. It is used as an abortifacient agent that is effective in both the first and second trimesters of pregnancy.
TG(14:0/20:1(11Z)/22:2(13Z,16Z))
TG(20:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:1(11Z)/18:1(9Z))
TG(18:2(9Z,12Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GT2 (d18:0/18:1(9Z))
PC(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
PC(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
DG(15:0/22:2(13Z,16Z)/0:0)
PE(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/15:0/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/24:0)
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
CL(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/16:1(9Z))
Cer(d18:0/12:0)
Alginic acid
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:1(13Z)/18:1(11Z)/0:0)
Metanephrine
TG(18:3(9Z,12Z,15Z)/o-18:0/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/18:1(11Z)/20:1(11Z))
PIP(18:1(11Z)/18:1(9Z))
DG(22:0/22:0/0:0)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:0/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/20:2n6)
Metyrosine
TG(14:0/20:4(5Z,8Z,11Z,14Z)/18:0)
TG(16:1(9Z)/20:1(11Z)/22:2(13Z,16Z))
TG(18:1(11Z)/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:2(13Z,16Z)/16:1(9Z))
PC(22:1(13Z)/20:2(11Z,14Z))
Methotrimeprazine
PE(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/24:0)
TG(18:2(9Z,12Z)/18:1(9Z)/18:3(6Z,9Z,12Z))[iso6]
TG(18:0/16:1(9Z)/22:1(13Z))
DG(22:1(13Z)/22:1(13Z)/0:0)
Esomeprazole A 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole that has S configuration at the sulfur atom. An inhibitor of gastric acid secretion, it is used (generally as its sodium or magnesium salt) for the treatment of gastro-oesophageal reflux disease, dyspepsia, peptic ulcer disease, and Zollinger-Ellison syndrome.
Alpha-D-Glucose D-Glucopyranose having alpha-configuration at the anomeric centre.
TG(22:2(13Z,16Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:2(9Z,12Z)/20:3n6)
PC(16:1(9Z)/P-16:0)
TG(18:1(9Z)/22:2(13Z,16Z)/20:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(24:0/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/24:0/20:3n6)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/22:0)
PC(o-18:1(9Z)/18:0)
S-6-Hydroxywarfarin
Normetanephrine
17-alpha,20-alpha-Dihydroxypregn-4-en-3-one
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
Quinidine barbiturate
TG(14:1(9Z)/o-18:0/18:2(9Z,12Z))
DG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(18:0/18:2(9Z,12Z)/18:2(9Z,12Z))[iso3]
PC(24:0/20:2(11Z,14Z))
Ezetimibe A beta-lactam that is azetidin-2-one which is substituted at 1, 3, and 4 by p-fluorophenyl, 3-(p-fluorophenyl)-3-hydroxypropyl, and 4-hydroxyphenyl groups, respectively (the 3R,3'S,4S enantiomer).
PIP2(18:1(11Z)/16:0)
TG(14:0/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/o-18:0/18:1(9Z))
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
11b-Hydroxyandrost-4-ene-3,17-dione
TG(22:0/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
PA(16:0e/18:0)
TG(20:0/14:1(9Z)/14:1(9Z))
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/20:3n6)
TG(18:4(6Z,9Z,12Z,15Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Estramustine
Allantoin An imidazolidine-2,4-dione that is 5-aminohydantoin in which a carbamoyl group is attached to the exocyclic nitrogen.
PIP3(18:1(9Z)/20:3(8Z,11Z,14Z))
Lansoprazole A sulfoxide that has formula C16H14F3N3O2S.
DG(22:1n9/0:0/18:4n3)
PE(16:1(9Z)/20:1(11Z))
TG(16:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
PE(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Maleylacetoacetic acid
3-Chloro-2-methylmaleylacetate A halo fatty acid that has formula C7H7ClO5.
TG(18:0/18:2(9Z,12Z)/20:0)[iso6]
TG(20:2n6/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Progesterone A C21-steroid hormone in which a pregnane skeleton carries oxo substituents at positions 3 and 20 and is unsaturated at C(4)-C(5). As a hormone, it is involved in the female menstrual cycle, pregnancy and embryogenesis of humans and other species.
TG(18:1(11Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
PI(20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:1(9Z)/22:1(13Z))
TG(16:0/16:0/20:0)[iso3]
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/15:0/20:2n6)
DG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
LysoPC(20:3(5Z,8Z,11Z))
TG(18:1(11Z)/o-18:0/20:2n6)
TG(20:0/16:0/o-18:0)
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
Floxuridine
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
PIP2(18:1(11Z)/18:0)
TG(15:0/18:1(9Z)/24:0)
TG(20:3n6/22:0/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
Hexacosanoic acid A 26-carbon, straight-chain, saturated fatty acid.
TG(22:2(13Z,16Z)/24:0/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
cis-3-Chloroacrylic acid A 3-chloroacrylic acid that has formula C3H3ClO2.
Trisalicylate-choline
TG(14:0/18:1(11Z)/18:0)
Gentisic acid
TG(20:0/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
Sulfisoxazole A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.
PC(o-22:1(13Z)/22:3(10Z,13Z,16Z))
TG(18:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
3a,7b,12a-Trihydroxyoxocholanyl-Glycine
TG(14:1(9Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/18:1(9Z)/o-18:0)
PI(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/20:0/18:3(6Z,9Z,12Z))
TG(18:0/18:3(9Z,12Z,15Z)/20:2n6)
Enoxacin
Leukotriene D4 A leukotriene that is (7E,9E,11Z,14Z)-icosa-7,9,11,14-tetraenoic acid substituted by a hydroxy group at position 5 (5S) and a L-cysteinylglycinyl group at position 6 (6R).
TG(16:1(9Z)/22:2(13Z,16Z)/18:1(9Z))
TG(14:1(9Z)/24:0/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GT2 (d18:1/24:1(15Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
Durupcoside A
Durupcoside B
TG(20:2n6/20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(15:0/o-18:0/20:1(11Z))
Cholesterol glucuronide
TG(14:0/22:4(7Z,10Z,13Z,16Z)/20:3n6)
LysoPC(22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(18:1(9Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
Pseudoephedrine A secondary amine that has formula C10H15NO.
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(18:3(6Z,9Z,12Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Maltotriose A maltotriose trisaccharide in which the glucose residue at the reducing end is in the aldehydo open-chain form.
TG(14:1(9Z)/24:0/14:1(9Z))
TG(24:0/18:3(9Z,12Z,15Z)/20:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(15:0/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Tetrahydrocortisone
PE(18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(14:0/20:3n6/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:0/20:4(8Z,11Z,14Z,17Z))
Itaconyl-CoA The S-itaconyl derivative of coenzyme A.
Fludarabine
Formoterol
TG(20:0/15:0/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
PC(22:0/18:3(6Z,9Z,12Z))
3-Aminopropionaldehyde
TG(20:1(11Z)/22:2(13Z,16Z)/20:2n6)
PIP2(18:0/20:2(11Z,14Z))
TG(20:0/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(P-18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/20:3n6)
TG(16:1(9Z)/24:1(15Z)/24:1(15Z))
TG(24:0/14:0/20:4(8Z,11Z,14Z,17Z))
TG(14:0/18:0/22:0)
PE(P-16:0/22:4(7Z,10Z,13Z,16Z))
DG(18:3(6Z,9Z,12Z)/18:1(11Z)/0:0)
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(14:0/18:3(9Z,12Z,15Z)/22:1(13Z))
TG(22:2(13Z,16Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:1(11Z)/22:0)
TG(20:1(11Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:2(9Z,12Z)/20:3(8Z,11Z,14Z))
TG(14:0/20:3(5Z,8Z,11Z)/o-18:0)
(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoyl-CoA An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (5Z,8Z,11Z,14Z,17Z)-icosapentaenoic acid. It is a member of n-3 PUFA and by-product of alpha-linolenic acid metabolism.
TG(24:0/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:2(11Z,14Z)/20:3(5Z,8Z,11Z))
Beta-Alanine
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
PIP(16:0/20:3(5Z,8Z,11Z))
TG(18:2(9Z,12Z)/24:0/20:2n6)
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
PC(P-18:0/16:1(9Z))
DG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(18:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(15:0/18:3(6Z,9Z,12Z)/20:2n6)
DG(24:1n9/0:0/20:4n3)
TG(14:0/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:1(11Z)/20:0)
TG(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(22:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
DG(20:4(8Z,11Z,14Z,17Z)/14:1(9Z)/0:0)
CL(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/16:0)
TG(14:0/20:3n6/24:0)
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(o-18:1(9Z)/20:1(11Z))
PE(20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/o-18:0)
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:3(6Z,9Z,12Z)/15:0/0:0)
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(15:0/20:0/20:3n6)
TG(18:1(11Z)/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
DG(18:1n7/0:0/22:4n6)
TG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/22:0/18:1(11Z))
DG(15:0/0:0/18:1n9)
TG(18:0/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/15:0/18:1(11Z))
Ganglioside GM1 (d18:0/22:0)
PC(o-16:0/14:1(9Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(22:2(13Z,16Z)/22:2(13Z,16Z)/0:0)
TG(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
Hydrogen phosphate A phosphate ion that is the conjugate base of dihydrogenphosphate.
PC(P-18:1(9Z)/16:1(9Z))
PI(16:0/22:3(10Z,13Z,16Z))
TG(14:0/18:1(11Z)/18:1(11Z))
TG(16:1(9Z)/20:0/20:0)[iso3]
TG(22:0/16:1(9Z)/o-18:0)
TG(20:0/22:2(13Z,16Z)/20:3n6)
DG(20:3n6/0:0/18:4n3)
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/22:1(13Z)/0:0)
TG(22:0/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:0/16:1(9Z))
Milnacipran
TG(16:0/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
TG(24:0/24:0/24:1(15Z))
TG(15:0/22:2(13Z,16Z)/18:0)
TG(22:0/15:0/22:1(13Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
4-Hydroxycinnamic acid
PE(24:0/18:4(6Z,9Z,12Z,15Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
DG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
TG(22:0/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Phenylacetylglycine A N-acylglycine that is glycine substituted on nitrogen with a phenylacetyl group.
18-Hydroxyarachidonic acid
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:1(11Z)/20:1(11Z))
D-Limonene
TG(18:0/18:1(11Z)/18:0)
PE(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))
PE(20:3(5Z,8Z,11Z)/24:1(15Z))
GDP-L-fucose A GDP-fucose in which the fucosyl residue has L-configuration.
Guanidine An aminocarboxamidine, the parent compound of the guanidines.
TG(18:0/18:3(6Z,9Z,12Z)/18:1(11Z))
TG(20:0/24:0/14:1(9Z))
TG(14:0/18:3(6Z,9Z,12Z)/14:1(9Z))
TG(14:0/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]
TG(22:0/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
TG(22:0/20:3n6/14:1(9Z))
TG(15:0/22:2(13Z,16Z)/16:0)
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(14:0/P-18:0)
TG(18:0/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GQ1c (d18:0/22:0)
2,3,5-Trichlorodienelactone
Rifapentine
N-(o)-Hydroxyarginine
TG(22:0/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(o-18:2(9Z,12Z)/20:0)
PIP(18:3(9Z,12Z,15Z)/18:0)
27-Deoxy-5b-cyprinol
PE(22:5(7Z,10Z,13Z,16Z,19Z)/dm18:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(16:0/20:0/18:0)
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Miglitol
TG(18:2(9Z,12Z)/o-18:0/18:2(9Z,12Z))
DG(24:1(15Z)/22:2(13Z,16Z)/0:0)
TG(20:1(11Z)/20:2n6/20:3n6)
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
Furosemide A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
DG(24:1(15Z)/15:0/0:0)
TG(14:0/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
DG(18:0/20:0/0:0)
DG(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(18:1(11Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GT2 (d18:1/22:1(13Z))
PE(14:1(9Z)/18:2(9Z,12Z))
TG(15:0/24:0/22:0)
TG(20:0/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
Exemestane A 17-oxo steroid that is androsta-1,4-diene-3,17-dione in which the hydrogens at position 6 are replaced by a double bond to a methylene group. A selective inhibitor of the aromatase (oestrogen synthase) system, it is used in the treatment of advanced breast cancer.
Gemcitabine A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.
TG(20:0/16:0/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/20:2n6)
TG(24:1(15Z)/22:2(13Z,16Z)/20:2n6)
TG(18:1(11Z)/18:1(9Z)/18:3(6Z,9Z,12Z))
Hordenine
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
SM(d17:1/24:0)
2,3-Epoxyaflatoxin B1
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(24:0/18:0/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
PE(18:4(6Z,9Z,12Z,15Z)/20:3(8Z,11Z,14Z))
TG(20:0/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(14:0/22:1(13Z))
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Saxagliptin
DG(24:0/0:0/22:4n6)
TG(22:2(13Z,16Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/20:3n6/22:1(13Z))
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GM1 (d18:0/18:1(9Z))
TG(22:0/18:0/14:1(9Z))
TG(14:0/20:0/24:0)
Deoxycholic acid glycine conjugate
DG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(18:1(11Z)/20:0/22:2(13Z,16Z))
PE(P-16:0/18:2(9Z,12Z))
TG(16:1(9Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/16:0/18:1(11Z))[iso6]
TG(20:3n6/22:1(13Z)/22:2(13Z,16Z))
TG(14:1(9Z)/o-18:0/20:3(5Z,8Z,11Z))
CDP-DG(16:0/16:0)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/15:0)
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/24:0/o-18:0)
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/o-18:0)
PIP2(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))
TG(14:0/18:2(9Z,12Z)/20:1(11Z))
TG(15:0/20:1(11Z)/18:0)
TG(14:0/20:0/22:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(22:0/14:0/18:1(9Z))
PE(20:3(5Z,8Z,11Z)/P-18:1(9Z))
TG(18:0/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
Deslanoside
DG(16:0/0:0/22:5n6)
Ganglioside GM1 (d18:0/26:0)
2-(3-Carboxy-3-aminopropyl)-L-histidine A 2-(3-amino-3-carboxypropyl)-L-histidine zwitterion obtained by transfer of a proton from the amino to the carboxy group of 2-[(3S)-3-amino-3-carboxypropyl]-L-histidine residue.
adenosylcob(III)yrinic acid a,c-diamide A cobalt corrinoid that is cob(III)yrinic acid a,c-diamide having a 5'-adenosyl group attached to the central cobalt atom.
PE(24:0/22:5(4Z,7Z,10Z,13Z,16Z))
Butethal
PE(18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
PC(24:1(15Z)/P-18:1(11Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(14:0/18:1(11Z)/20:1(11Z))
PIP2(20:4(5Z,8Z,11Z,14Z)/16:0)
TG(15:0/24:0/14:1(9Z))
TG(20:3n6/o-18:0/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/14:1(9Z)/20:1(11Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/20:3n6)
TG(24:0/18:1(9Z)/20:3n6)
TG(20:1(11Z)/16:0/20:3(5Z,8Z,11Z))
TG(20:0/18:3(9Z,12Z,15Z)/18:1(11Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
Josamycin
Ganglioside GM2 (d18:0/12:0)
Dextromethorphan An organic heterotetracyclic compound that is morphinan substituted by a methoxy group at position 3 and a methyl group at position 7. It is used as an antitussive drug for suppressing cough.
TG(20:0/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:1(11Z)/24:0)
TG(24:1(15Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/20:2n6)
TG(22:0/o-18:0/20:2n6)
TG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
PE(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Glycolic acid A 2-hydroxy monocarboxylic acid that is acetic acid where the methyl group has been hydroxylated.
TG(14:1(9Z)/22:1(13Z)/18:2(9Z,12Z))
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/14:0/18:4(6Z,9Z,12Z,15Z))
TG(20:0/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Cabazitaxel
TG(18:0/18:4(6Z,9Z,12Z,15Z)/22:1(13Z))
Palmitoleic acid A hexadecenoic acid with a cis-double bond at position C-9.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
DG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Adenosine monophosphate
TG(16:1(9Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))[iso3]
TG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:1(9Z)/24:1(15Z))
TG(24:1(15Z)/20:3n6/20:2n6)
7-Dehydrocholesterol
TG(14:0/14:0/20:4(5Z,8Z,11Z,14Z))
PC(16:0/P-16:0)
PE(20:4(5Z,8Z,11Z,14Z)/16:0)
PIP3(18:1(11Z)/20:3(8Z,11Z,14Z))
TG(24:0/18:0/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/22:2(13Z,16Z)/20:1(11Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/24:0/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/14:1(9Z)/20:3n6)
PC(24:0/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(22:0/22:0/18:3(6Z,9Z,12Z))
TG(15:0/14:1(9Z)/20:3n6)
TG(22:1(13Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/20:1(11Z)/18:2(9Z,12Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Hydrochloric acid
TG(16:0/18:2(9Z,12Z)/20:3n6)
TG(20:0/16:0/18:1(9Z))
Homatropine Methylbromide An organic bromide salt that has formula C17H24NO3.Br.
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
GDP-4-Dehydro-6-deoxy-D-mannose
TG(20:4(8Z,11Z,14Z,17Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:1(13Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:1(11Z))
TG(15:0/o-18:0/16:1(9Z))
TG(16:1(9Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/24:1(15Z)/18:2(9Z,12Z))
Pyroglutamic acid
TG(14:0/15:0/18:3(9Z,12Z,15Z))
TG(14:0/24:0/18:3(9Z,12Z,15Z))
Droxidopa A serine derivative that is L-serine substituted at the beta-position by a 3,4-dihydroxyphenyl group. A prodrug for noradrenalone, it is used for treatment of neurogenic orthostatic hypotension
CL(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
PG(16:0/20:3(8Z,11Z,14Z))
DG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(16:1(9Z)/20:0)
PC(24:1(15Z)/P-18:0)
PC(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
Butyryl-CoA A short-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of butyric acid.
PE(P-18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Phytosphingosine-1-P
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
DG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
Ziprasidone A piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.
Isosorbide Dinitrate A glucitol derivative that has formula C6H8N2O8.
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(14:0/20:3(5Z,8Z,11Z)/20:2n6)
TG(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:2(9Z,12Z)/20:3n6)
PE(22:0/P-18:1(11Z))
TG(14:1(9Z)/15:0/18:1(11Z))
TG(16:0/22:2(13Z,16Z)/20:3n6)
DG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
Tetracosapentaenoyl coenzyme A, n-6
TG(14:1(9Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
Adenosine diphosphate ribose
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/24:0/14:1(9Z))
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:3n6)
Methysergide
PIP2(20:3(8Z,11Z,14Z)/18:0)
TG(24:0/15:0/22:2(13Z,16Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/16:0/o-18:0)
N,N'-Diacetylhydrazine A carbohydrazide that has formula C4H8N2O2.
TG(20:2n6/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
DG(16:1(9Z)/14:0/0:0)
DG(24:0/14:1(9Z)/0:0)
TG(24:0/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/15:0/20:3(5Z,8Z,11Z))
DG(22:0/20:0/0:0)
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
DG(18:3n3/0:0/22:5n3)
Ganglioside GM2 (d18:0/18:1(9Z))
Dihomo-gamma-linolenyl coenzyme A
TG(22:2(13Z,16Z)/20:3n6/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(P-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/18:1(9Z)/20:3n6)
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(20:3n9/0:0/22:6n3)
TG(18:2(9Z,12Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/22:1(13Z))
PI(22:5(7Z,10Z,13Z,16Z,19Z)/18:0)
TG(18:1(11Z)/22:0/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
TG(18:0/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/20:2n6/18:3(9Z,12Z,15Z))
PC(14:0/16:0)
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
Ganglioside GD3 (d18:1/12:0)
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GM3 (d18:0/14:0)
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
PE(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
PC(22:1(13Z)/P-18:1(9Z))
TG(14:0/22:2(13Z,16Z)/24:0)
PE(P-18:1(9Z)/20:3(5Z,8Z,11Z))
Ganglioside GD3 (d18:1/14:0)
TG(20:0/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
Uridine 2'-phosphate A pyrimidine ribonucleoside 2'-monophosphate having uracil as the nucleobase
TG(18:3(9Z,12Z,15Z)/16:1(9Z)/o-18:0)
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/14:0)
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(16:1(9Z)/20:1(11Z)/18:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Adenylyl-molybdopterin
PIP(20:2(11Z,14Z)/16:0)
TG(22:2(13Z,16Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Ganglioside GD3 (d18:0/22:1(13Z))
TG(20:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(P-18:1(11Z)/20:3(8Z,11Z,14Z))
DG(20:4n6/0:0/22:6n3)
TG(20:1(11Z)/15:0/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ropinirole An indolone that has formula C16H24N2O.
Dichlorphenamide
Remikiren A N-acyl-amino acid that has formula C33H50N4O6S.
Bosentan
TG(15:0/18:1(9Z)/22:1(13Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GM1 (d18:1/26:0)
TG(24:0/16:0/16:1(9Z))
TG(20:3(5Z,8Z,11Z)/24:0/18:3(6Z,9Z,12Z))
4-Hydroxyphenylacetyl-CoA A phenylacetyl-CoA that has formula C29H42N7O18P3S.
Adenylylselenate The 5'-selenonooxyphosphate ester of adenosine.
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
LysoPE(22:0/0:0)
TG(22:0/14:0/14:1(9Z))
TG(15:0/20:3(5Z,8Z,11Z)/18:1(11Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(16:1(9Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:1(13Z)/20:2n6)
TG(18:1(9Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
Mirtazapine A tetracyclic antidepressant that has formula C17H19N3.
TG(22:0/20:0/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/20:1(11Z))
Ornithine An alpha-amino acid that is pentanoic acid bearing two amino substituents at positions 2 and 5.
TG(24:1(15Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
Vanillylmandelic acid An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
TG(20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/24:0/18:0)
PC(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
cis-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide The 2-chloro derivative of cis-4-carboxymethylenebut-2-en-1,4-olide.
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/15:0/22:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)/o-18:0)
PS(20:3(8Z,11Z,14Z)/16:1(9Z))
TG(20:1(11Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/18:0/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PG(18:3(6Z,9Z,12Z)/16:0)
PE(15:0/P-18:1(9Z))
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
DG(16:1n7/0:0/20:3n6)
TG(24:0/16:0/18:1(11Z))
TG(15:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
CDP-DG(16:0/20:4(8Z,11Z,14Z,17Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/24:0)
PE(20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
PC(22:1(13Z)/15:0)
DG(14:0/0:0/22:2n6)
TG(24:1(15Z)/20:0/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/20:1(11Z)/20:1(11Z))[iso3]
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
Ethynodiol Diacetate A terminal acetylenic compound that has formula C24H32O4.
TG(20:3n6/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/18:2(9Z,12Z)/22:1(13Z))
TG(20:3n6/14:0/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
DG(16:0/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
D-Sedoheptulose 7-phosphate
PC(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
PE(22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:0/22:2(13Z,16Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:3(5Z,8Z,11Z)/16:1(9Z))
TG(20:1(11Z)/14:0/20:1(11Z))
TG(16:1(9Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:0/20:4(5Z,8Z,11Z,14Z))
DG(16:1(9Z)/20:0/0:0)
DG(20:3(8Z,11Z,14Z)/20:0/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/20:2n6/o-18:0)
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(16:0/14:1(9Z)/o-18:0)
TG(15:0/18:0/15:0)
PC(20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
Dihydrouracil
TG(22:0/18:1(9Z)/14:1(9Z))
DG(20:4(5Z,8Z,11Z,14Z)/20:0/0:0)
TG(22:0/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/20:3n6/o-18:0)
TG(24:0/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
Dipivefrin The dipivalate ester of (+-)-epinephrine (racepinephrine). A pro-drug of epinephrine, the hydrochloride is used topically as eye drops to reduce intra-ocular pressure in the treatment of open-angle glaucoma or ocular hypertension.
TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:0)
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
PE(22:2(13Z,16Z)/P-18:1(9Z))
Nateglinide
PC(22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
TG(24:0/22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
TG(22:0/18:2(9Z,12Z)/20:1(11Z))
Ganglioside GD3 (d18:1/24:0)
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(14:0/22:0/22:0)
O-Desmethylverapamil (D-702)
TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:0)
TG(18:2(9Z,12Z)/18:0/18:3(6Z,9Z,12Z))
DG(20:4(8Z,11Z,14Z,17Z)/24:0/0:0)
TG(18:1(11Z)/18:1(9Z)/20:3n6)
L-4-Hydroxyglutamate semialdehyde
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(14:0/20:1(11Z)/16:0)
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
LysoPE(18:3(9Z,12Z,15Z)/0:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(14:0/18:1(11Z)/18:3(9Z,12Z,15Z))
PC(20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
TG(20:2n6/20:0/22:2(13Z,16Z))
TG(20:1(11Z)/18:1(11Z)/24:1(15Z))
TG(14:0/20:1(11Z)/14:0)
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/20:2n6)
Amygdalin A gentiobioside that has formula C20H27NO11.
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
PE(18:0/14:0)
17-beta-Estradiol glucuronide
Zafirlukast A carbamate ester that has formula C31H33N3O6S.
TG(18:2(9Z,12Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
5,6,7,8-Tetrahydromethanopterin A tetrahydromethanopterin that has formula C30H45N6O16P.
Cholic acid A bile acid that is 5beta-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12.
PG(18:1(11Z)/18:3(9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(24:0/0:0/20:3n6)
TG(20:2n6/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
L-Acetylcarnitine
TG(16:0/18:1(9Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(18:0/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
Zinc (II) ion
TG(20:3(5Z,8Z,11Z)/20:0/22:2(13Z,16Z))
PE(14:0/14:1(9Z))
DG(16:1(9Z)/22:2(13Z,16Z)/0:0)
TG(20:0/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
TG(18:1(11Z)/o-18:0/24:1(15Z))
TG(16:0/20:3(5Z,8Z,11Z)/14:1(9Z))
DG(14:0/0:0/14:0)
TG(22:0/14:1(9Z)/18:1(9Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)
CL(22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z))
TG(20:2n6/16:1(9Z)/22:2(13Z,16Z))
DG(24:1n9/0:0/22:6n3)
TG(18:1(11Z)/15:0/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/20:3n6/14:1(9Z))
3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane
Bradykinin A linear nonapeptide messenger belonging to the kinin group of proteins, with amino acid sequence RPPGFSPFR. Enzymatically produced from kallidin in the blood, it is a powerful vasodilator that causes smooth muscle contraction, and may mediate inflammation.
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
PIP2(18:2(9Z,12Z)/18:2(9Z,12Z))
PC(P-18:0/22:2(13Z,16Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(15:0/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/22:1(13Z)/20:3n6)
Permethrin A cyclopropanecarboxylate ester in which the esterifying alcohol is 3-phenoxybenzyl alcohol and the cyclopropane ring is substituted with a 2,2-dichlorovinyl group and with gem-dimethyl groups.
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(15:0/20:0/24:0)
TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(22:0/20:3n6/22:0)
TG(14:1(9Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/14:1(9Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
Deferoxamine
TG(24:1(15Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/24:0/22:4(7Z,10Z,13Z,16Z))
DG(22:1n9/0:0/22:2n6)
TG(20:2n6/16:0/18:4(6Z,9Z,12Z,15Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
D-Glutamic acid An optically active form of glutamic acid having D-configuration.
PC(20:4(5Z,8Z,11Z,14Z)/24:0)
PC(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/o-18:0)
TG(16:1(9Z)/15:0/o-18:0)
TG(20:1(11Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:0/24:0)
TG(24:1(15Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
Chlorambucil
PE(14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
Isopropamide
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/24:0/20:3(5Z,8Z,11Z))
TG(15:0/18:3(9Z,12Z,15Z)/14:1(9Z))
PC(18:3(9Z,12Z,15Z)/24:1(15Z))
TG(22:0/20:3n6/24:0)
5-Methyl-3-oxo-4-hexenoyl-CoA An organic molecule that has formula C28H44N7O18P3S.
TG(15:0/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(14:0/14:0/18:3(6Z,9Z,12Z))
TG(20:0/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
PE(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso3]
Ureidopropionic acid
PG(18:3(6Z,9Z,12Z)/18:0)
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
TG(18:3(6Z,9Z,12Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
PE(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
Pirenzepine
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
PE(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
7 alpha-Hydroxy-3-oxo-4-cholestenoate A bile acid that has formula C27H42O4.
TG(15:0/20:3n6/22:4(7Z,10Z,13Z,16Z))
2-O-(4-O-Methyl-a-D-glucopyranuronosyl)-D-xylose
TG(20:1(11Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(15:0/16:0/20:3(5Z,8Z,11Z))
PC(20:2(11Z,14Z)/20:2(11Z,14Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
N1-Methyl-2-pyridone-5-carboxamide
TG(14:1(9Z)/24:1(15Z)/22:2(13Z,16Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/24:0)
TG(15:0/16:0/18:4(6Z,9Z,12Z,15Z))
4-Hydroxyvalsartan
DG(24:1(15Z)/14:0/0:0)
TG(18:1(11Z)/24:1(15Z)/18:2(9Z,12Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(14:1n5/0:0/22:5n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:2(13Z,16Z)/22:1(13Z))
Dolichyl diphosphate
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
PS(18:0/18:2(9Z,12Z))
3-Hexaprenyl-4-hydroxybenzoic acid A monohydroxybenzoic acid that has formula C37H54O3.
DG(14:0/0:0/22:6n3)
TG(22:2(13Z,16Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PI(20:4(8Z,11Z,14Z,17Z)/20:0)
TG(20:2n6/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PIP(22:5(7Z,10Z,13Z,16Z,19Z)/16:0)
Triflupromazine
TG(18:0/20:1(11Z)/18:0)
TG(18:3(6Z,9Z,12Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/18:2(9Z,12Z))
Plerixafor
TG(22:1(13Z)/18:0/18:4(6Z,9Z,12Z,15Z))
PE(14:0/P-18:0)
TG(20:0/22:0/22:0)
TG(18:1(11Z)/22:1(13Z)/20:3(5Z,8Z,11Z))
TG(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
CE(18:0)
TG(22:1(13Z)/15:0/18:3(9Z,12Z,15Z))
3-Carboxy-1-hydroxypropylthiamine diphosphate A 1,3-thiazolium cation that is 1,3-thiazol-3-ium substituted by a methyl group at position 4, a (4-amino-2-methylpyrimidin-5-yl)methyl group at position 3, a 3-carboxy-1-hydroxypropyl at position 2 and a 2-{[hydroxy(phosphonooxy)phosphoryl]oxy}ethyl group at position 5.
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(24:0/20:2n6/24:0)
TG(14:0/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:2(9Z,12Z)/18:0)
TG(20:2n6/14:0/18:4(6Z,9Z,12Z,15Z))
TG(20:0/22:2(13Z,16Z)/16:1(9Z))
Glucosylceramide Any of the cerebrosides in which the monosaccharide head group is glucose.
TG(14:0/18:3(9Z,12Z,15Z)/18:1(9Z))
TG(22:0/14:1(9Z)/18:1(11Z))
TG(20:2n6/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Decanal A fatty aldehyde formally arising from reduction of the carboxy group of capric acid (decanoic acid).
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
3-Oxooctadecanoyl-CoA A 3-oxo-fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of 3-oxooctadecanoic acid.
TG(16:0/18:0/22:0)
L-Glutamine An optically active form of glutamine having L-configuration.
TG(24:0/20:3n6/22:1(13Z))
Ganglioside GD2 (d18:0/20:0)
PC(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
DG(18:1(11Z)/18:1(9Z)/0:0)
TG(22:2(13Z,16Z)/24:0/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:1(11Z)/18:2(9Z,12Z))[iso3]
DG(22:0/20:4(8Z,11Z,14Z,17Z)/0:0)
PC(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PE(P-18:0/20:2(11Z,14Z))
TG(20:2n6/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
TG(16:1(9Z)/16:1(9Z)/18:0)[iso3]
PE(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
alpha-Fluoro-beta-ureidopropionic acid An organohalogen compound that has formula C4H7FN2O3.
TG(15:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/22:2(13Z,16Z)/18:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
Ganglioside GT1b (d18:1/12:0)
TG(14:0/20:1(11Z)/20:3(5Z,8Z,11Z))
3-(3,5-Diiodo-4-hydroxyphenyl)lactate
TG(20:1(11Z)/15:0/20:3n6)
TG(18:3(6Z,9Z,12Z)/14:0/20:4(5Z,8Z,11Z,14Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:0)
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/16:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Undecanoyl-CoA A medium-chain fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of undecanoic acid.
TG(22:0/18:0/18:3(9Z,12Z,15Z))
PE(18:1(11Z)/22:1(13Z))
Cortexolone
PE(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:2n6)
DG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:1(9Z)/18:1(11Z))
Quinapril An isoquinoline that has formula C25H30N2O5.
TG(22:0/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
Phosphatidylinositol-3,4,5-trisphosphate
TG(20:0/15:0/16:1(9Z))
TG(24:0/22:2(13Z,16Z)/20:2n6)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(15:0/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/20:3n6/o-18:0)
TG(22:0/20:3n6/o-18:0)
TG(16:0/18:3(9Z,12Z,15Z)/24:1(15Z))
TG(20:3n6/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
Formylanthranilic acid
TG(18:1(11Z)/o-18:0/20:3n6)
TG(20:3n6/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
Ganglioside GD2 (d18:1/25:0)
TG(24:0/18:1(9Z)/24:1(15Z))
Acetylphosphate An acyl monophosphate(2-) that has formula C2H3O5P.
TG(24:0/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(22:0/16:0/20:2n6)
TG(20:3n6/20:3(5Z,8Z,11Z)/20:3n6)
Econazole A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections.
TG(20:3n6/22:4(7Z,10Z,13Z,16Z)/20:3n6)
Trovafloxacin
TG(22:5(7Z,10Z,13Z,16Z,19Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
PIP2(20:3(8Z,11Z,14Z)/18:1(11Z))
TG(20:0/o-18:0/22:1(13Z))
Prazepam
TG(18:3(6Z,9Z,12Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
PC(14:1(9Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
CL(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/20:0/22:1(13Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/14:0/18:2(9Z,12Z))[iso6]
TG(16:0/18:4(6Z,9Z,12Z,15Z)/20:0)
TG(14:1(9Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
SM(d18:1/26:0)
TG(20:4(8Z,11Z,14Z,17Z)/18:0/20:4(8Z,11Z,14Z,17Z))
TG(14:0/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Sirolimus
PC(20:0/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/14:1(9Z)/22:2(13Z,16Z))
TG(14:0/20:2n6/20:0)
Cer(d18:0/22:1(13Z))
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
(R)-lipoic acid The (R)-enantiomer of lipoic acid. A vitamin-like, C8 thia fatty acid with anti-oxidant properties.
TG(20:3n6/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/16:0/18:1(9Z))
1,4'-Bipiperidine-1'-carboxylic acid A carboxylic acid that has formula C11H20N2O2.
PC(18:1(11Z)/15:0)
TG(18:2(9Z,12Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Sorbitol-6-phosphate
MG(20:3(8Z,11Z,14Z)/0:0/0:0)
7b,12a-Dihydroxycholanoic acid
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Cyclacillin
TG(20:3n6/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
5,6-DHET A DHET obtained by formal dihydroxylation across the 5,6-double bond of arachidonic acid.
1,3,7,12-Tetrahydroxycholan-24-oic acid
TG(18:1(11Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/20:3n6/20:3(5Z,8Z,11Z))
TG(24:0/15:0/20:4(8Z,11Z,14Z,17Z))
TG(22:0/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso3]
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:1(11Z))
TG(16:0/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/22:2(13Z,16Z)/20:3n6)
TG(15:0/20:1(11Z)/24:0)
TG(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(14:1(9Z)/22:0/20:1(11Z))
TG(14:1(9Z)/18:1(11Z)/18:1(11Z))
PI(16:1(9Z)/16:1(9Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:0/18:1(11Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
PC(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/24:0/20:4(5Z,8Z,11Z,14Z))
TG(15:0/20:0/20:2n6)
TG(18:1(9Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/24:0/22:1(13Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/16:0/24:1(15Z))
DG(20:0/24:1(15Z)/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/o-18:0)
TG(22:1(13Z)/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
TG(22:2(13Z,16Z)/15:0/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:0/18:4(6Z,9Z,12Z,15Z))
Thymidine A pyrimidine 2'-deoxyribonucleoside having thymine as the nucleobase.
TG(20:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Campesterol
PE(22:5(4Z,7Z,10Z,13Z,16Z)/20:2(11Z,14Z))
TG(15:0/20:0/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/15:0/16:1(9Z))
beta-Lactose The beta-anomer of lactose.
TG(15:0/20:3(5Z,8Z,11Z)/16:0)
TG(24:0/16:0/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:2(13Z,16Z)/22:1(13Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
TG(18:2(9Z,12Z)/24:0/20:3n6)
PI(18:2(9Z,12Z)/18:1(11Z))
PC(22:4(7Z,10Z,13Z,16Z)/18:0)
TG(18:0/18:1(9Z)/22:2(13Z,16Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
Ganglioside GD1b (d18:0/23:0)
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/14:0/20:2n6)
TG(14:0/18:3(6Z,9Z,12Z)/20:3n6)
PE(14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:2(9Z,12Z)/22:1(13Z))
TG(20:0/16:0/20:4(8Z,11Z,14Z,17Z))
PC(14:1(9Z)/P-18:1(9Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:3n6/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/24:1(15Z)/22:2(13Z,16Z))
FAD A flavin adenine dinucleotide that has formula C27H33N9O15P2.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/22:0/20:3(5Z,8Z,11Z))
TG(16:0/18:2(9Z,12Z)/18:0)
TG(20:0/16:1(9Z)/20:2n6)
TG(16:0/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:1(11Z)/22:2(13Z,16Z))
TG(22:2(13Z,16Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Kynurenic acid A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
TG(15:0/18:2(9Z,12Z)/o-18:0)
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/22:2(13Z,16Z))
TG(24:0/14:0/18:3(6Z,9Z,12Z))
TG(20:0/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
Trazodone An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
PE(18:3(9Z,12Z,15Z)/20:2(11Z,14Z))
TG(20:4(8Z,11Z,14Z,17Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(14:1(9Z)/20:2(11Z,14Z))
Benazepril A benzazepine that has formula C24H28N2O5.
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6/o-18:0)
LysoPE(14:1(9Z)/0:0)
PE(22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
PE(20:3(5Z,8Z,11Z)/20:1(11Z))
TG(15:0/15:0/24:1(15Z))
TG(15:0/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
2-Hydroxyestradiol
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
MG(22:5(7Z,10Z,13Z,16Z,19Z)/0:0/0:0)
TG(20:0/24:1(15Z)/18:1(9Z))
TG(18:0/14:0/20:4(8Z,11Z,14Z,17Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
TG(18:0/20:0/20:0)[iso3]
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
D-Xylose Any xylose with D-configuration.
TG(24:1(15Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:0/18:3(6Z,9Z,12Z))
PE(18:1(11Z)/20:3(5Z,8Z,11Z))
PC(22:1(13Z)/20:1(11Z))
PE(20:1(11Z)/18:0)
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
3,4-Dihydroxyphenylglycol
CDP-DG(16:0/18:2(9Z,12Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/18:1(9Z))
TG(15:0/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/18:3(6Z,9Z,12Z)/20:3n6)
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
24-Hydroxycalcitriol
TG(22:1(13Z)/20:2n6/o-18:0)
TG(22:0/20:1(11Z)/18:2(9Z,12Z))
TG(22:1(13Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:0/20:2n6)
TG(18:1(11Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Deoxyguanosine
TG(20:3n6/15:0/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
PC(20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:0/16:0)
DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:0/0:0)
CDP-DG(18:0/18:1(9Z))
DG(20:3(5Z,8Z,11Z)/20:0/0:0)
DG(15:0/20:0/0:0)
Ganglioside GD1a (d18:1/18:1(11Z))
TG(22:0/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(20:0/0:0/20:3n6)
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:2n6/16:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:0/o-18:0)
TG(20:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/15:0/22:2(13Z,16Z))
PC(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
PE(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Phenylacetaldehyde An aldehyde that consists of acetaldehyde bearing a methyl substituent; the parent member of the phenylacetaldehyde class of compounds.
TG(16:1(9Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PG(18:2(9Z,12Z)/16:0)
TG(16:0/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PS(16:0/20:3(8Z,11Z,14Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
Ganglioside GT3 (d18:0/24:0)
TG(20:0/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/14:0/22:4(7Z,10Z,13Z,16Z))
Timolol 1,2,5-Thiadiazole substituted at the 3 position by a 3-(tert-butylamino)-2-hydroxypropoxy group and at the 4 position by a morpholin-4-yl group. The (S)-(-) enantiomer, also known as timolol, is a beta-adrenergic antagonist and is used in the mangement of glaucoma, hypertension, angina pectoris and myocardial infarction, and for the prevention of migraine.
TG(14:0/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Adenosine 2',3'-cyclic phosphate
TG(24:0/16:1(9Z)/18:1(9Z))
TG(24:1(15Z)/22:2(13Z,16Z)/20:3n6)
(S)-3-Hydroxyisobutyryl-CoA A hydroxy fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (S)-3-hydroxyisobutyric acid.
Carisoprodol A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.
Ganglioside GT3 (d18:0/22:0)
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(20:0/14:0/18:1(9Z))
TG(22:1(13Z)/14:0/20:4(8Z,11Z,14Z,17Z))
Aciclovir
TG(14:0/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
PIP2(18:0/20:4(5Z,8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
PI(18:1(11Z)/18:2(9Z,12Z))
PE(24:1(15Z)/22:1(13Z))
TG(20:1(11Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
(13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Phenylacetyl-CoA An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of phenylacetic acid.
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(16:1(9Z)/o-18:0/20:1(11Z))
D-Aspartic acid The D-enantiomer of aspartic acid.
TG(16:1(9Z)/14:0/18:1(9Z))[iso6]
TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/18:3(9Z,12Z,15Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0)
TG(18:1(9Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
TG(18:1(9Z)/18:1(9Z)/o-18:0)
Ganglioside GM3 (d18:0/20:0)
TG(15:0/24:0/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
TG(15:0/18:0/o-18:0)
TG(18:2(9Z,12Z)/18:1(11Z)/18:3(9Z,12Z,15Z))
CL(18:2(9Z,12Z)/18:1(11Z)/18:1(11Z)/16:0)
TG(18:0/o-18:0/22:1(13Z))
PC(o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
LysoPE(20:1(11Z)/0:0)
TG(14:0/20:4(8Z,11Z,14Z,17Z)/18:0)
TG(18:2(9Z,12Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:0/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
SM(d18:1/18:0)
TG(18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(14:0/18:0/16:0)
DG(18:0/18:2(9Z,12Z)/0:0)
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
N-Formyl-L-aspartate A doubly-charged N-acyl-L-alpha-amino acid anion resulting from deprotonation of both carboxy groups of N-formyl-L-aspartic acid.
TG(14:1(9Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(16:0/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/20:0/20:4(5Z,8Z,11Z,14Z))
DG(16:1(9Z)/18:2(9Z,12Z)/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))[iso3]
Ganglioside GM3 (d18:0/22:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/22:2(13Z,16Z)/22:1(13Z))
TG(16:1(9Z)/20:0/20:3(5Z,8Z,11Z))
Cholest-5-ene-3-beta,7-alpha-diol The 7alpha-hydroxy derivative of cholesterol.
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
PG(16:0/18:1(11Z))
TG(16:0/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
DG(14:1n5/0:0/18:4n3)
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/15:0/18:3(9Z,12Z,15Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/14:1(9Z)/18:2(9Z,12Z))
TG(16:1(9Z)/o-18:0/20:2n6)
DG(18:2(9Z,12Z)/18:2(9Z,12Z)/0:0)
TG(15:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(24:0/20:2n6/22:1(13Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(18:0/14:1(9Z)/18:1(11Z))
TG(22:0/16:1(9Z)/22:0)
TG(24:1(15Z)/22:1(13Z)/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
Spermine A polyazaalkane that is tetradecane in which the carbons at positions 1, 5, 10 and 14 are replaced by nitrogens. Spermine has broad actions on cellular metabolism.
DG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(24:0/24:0/o-18:0)
Drotaverine
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:0)
TG(15:0/24:1(15Z)/18:2(9Z,12Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:2n6/0:0/18:4n3)
DG(20:3(8Z,11Z,14Z)/18:1(11Z)/0:0)
Uridine diphosphate-N-acetylgalactosamine
TG(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:0/P-18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Lopinavir
TG(18:0/22:2(13Z,16Z)/18:2(9Z,12Z))
TG(20:0/16:0/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
2-Methoxyestrone A 17-oxo steroid that is estrone in which the hydrogen at position 2 is substituted by a methoxy group.
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:0/20:1(11Z))[iso3]
CL(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:0)
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(24:0/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/14:0/18:1(9Z))
PC(18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
TG(14:1(9Z)/20:3n6/18:3(6Z,9Z,12Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(16:0/0:0/22:0)
TG(16:0/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
PE(P-18:0/22:4(7Z,10Z,13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
15-Keto-prostaglandin F2a
TG(24:0/14:0/20:2n6)
PE(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/16:0/o-18:0)
Mannitol A hexitol produced by a variety of organisms including bacteria, fungi, lichens and plants.
TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
Vasopressin A family of cyclic nonapeptide hormones found in most mammals. Synthesised in the hypothalamus and stored in the post-pituitary, vasopressins play a key role in homeostasis, particularly in regulating the body's water content. Together with the similar neuropeptide oxytocin, they are believed to influence social cognition and behaviour.
TG(18:3(6Z,9Z,12Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/22:0/o-18:0)
TG(20:3n6/14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(24:0/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/14:0/20:3(5Z,8Z,11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z)/o-18:0)
TG(18:2(9Z,12Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/16:0/20:4(8Z,11Z,14Z,17Z))
TG(14:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/20:3n6)
PI(18:1(9Z)/20:3(8Z,11Z,14Z))
TG(18:1(11Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:1(11Z)/0:0)
TG(18:1(11Z)/16:0/20:3(5Z,8Z,11Z))
Galacturonic acid
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Galactose 1-phosphate
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:2n6)
PI(22:4(7Z,10Z,13Z,16Z)/16:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:1(11Z)/o-18:0)
TG(14:0/22:0/16:0)
TG(22:1(13Z)/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
Goserelin
Dehydroepiandrosterone 3-glucuronide
TG(14:1(9Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:0/22:1(13Z)/20:3n6)
TG(16:0/o-18:0/18:0)
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z)/0:0)
Nifedipine A dihydropyridine that has formula C17H18N2O6.
DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
(2E)-Hexadecenoyl-CoA An acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of (E)-hexadec-2-enoyl-CoA; major species at pH 7.3.
PG(18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:1n7/0:0/22:5n3)
TG(20:0/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/22:2(13Z,16Z)/15:0)
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:1(9Z)/16:1(9Z))
4,6-Dihydroxyquinoline
L-Pipecolic acid The L-enantiomer of pipecolic acid. It is a metabolite of lysine.
TG(22:4(7Z,10Z,13Z,16Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:0/18:2(9Z,12Z))[iso6]
TG(20:2n6/18:1(9Z)/18:3(9Z,12Z,15Z))
Phenylpropionylglycine
TG(22:0/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PIP(18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
DG(18:0/0:0/24:1n9)
TG(24:0/o-18:0/20:3(5Z,8Z,11Z))
Deoxyinosine
TG(24:1(15Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GD3 (d18:0/16:0)
Lactosylceramide (d18:1/25:0)
TG(16:1(9Z)/22:0/18:1(9Z))
TG(18:0/18:2(9Z,12Z)/22:1(13Z))
TG(24:1(15Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Manganese A manganese group element atom that has formula Mn.
PE(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
TG(16:0/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Dofetilide
Fucose 1-phosphate
(E)-2-Methylglutaconic acid
TG(16:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GT2 (d18:1/26:1(17Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
SM(d18:0/16:1(9Z))
Ganglioside GD3 (d18:0/14:0)
2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone
DG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(15:0/16:1(9Z)/20:1(11Z))
TG(20:3n6/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PE(20:1(11Z)/18:1(9Z))
PE(18:3(9Z,12Z,15Z)/22:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PI(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(18:0/14:0/16:1(9Z))[iso6]
GDP-glucose A GDP-hexose that has formula C16H25N5O16P2.
PE(P-18:0/18:3(9Z,12Z,15Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
DG(18:4(6Z,9Z,12Z,15Z)/22:0/0:0)
PE(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:0/o-18:0/22:0)
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/14:1(9Z))
PE(18:3(9Z,12Z,15Z)/20:0)
TG(14:1(9Z)/16:1(9Z)/18:1(9Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/20:1(11Z)/18:3(6Z,9Z,12Z))
TG(15:0/24:0/22:2(13Z,16Z))
Dodecanol
TG(18:2(9Z,12Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
TG(16:0/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/22:1(13Z)/18:2(9Z,12Z))
S-(PGJ2)-glutathione
TG(15:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
1-Nitronaphthalene-5,6-oxide A nitronaphthalene that has formula C10H7NO3.
TG(15:0/22:1(13Z)/18:0)
PE(20:0/P-16:0)
D-Myo-inositol 4-phosphate
DG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
Retapamulin
TG(20:0/20:2n6/14:1(9Z))
TG(20:3n6/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/14:0/15:0)
Ganglioside GD1a (d18:0/18:1(11Z))
TG(20:0/14:1(9Z)/20:3n6)
dCTP A 2'-deoxycytidine phosphate having cytosine as the nucleobase.
Chlorothiazide 4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension.
TG(20:0/o-18:0/14:1(9Z))
TG(18:1(9Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso3]
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/20:0/18:3(9Z,12Z,15Z))
TG(16:0/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/18:0/20:3n6)
TG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
Glutathione episulfonium ion A peptide that has formula C12H20N3O6S.
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
Ganglioside GT2 (d18:1/18:1(9Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/18:0)
TG(15:0/18:1(11Z)/20:3n6)
TG(16:0/24:0/22:1(13Z))
PC(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(20:2n6/20:2n6/20:4(8Z,11Z,14Z,17Z))
19(S)-HETE A HETE having a (19S)-hydroxy group and all-cis double bonds at positions 5, 8, 11 and 14.
TG(18:0/15:0/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
7-Sulfocholic acid
TG(24:1(15Z)/15:0/20:2n6)
TG(16:0/14:0/18:3(6Z,9Z,12Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(24:1n9/0:0/22:4n6)
TG(20:2n6/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:1(9Z)/o-18:0)
IDP A purine ribonucleoside 5'-diphosphate having inosine as the nucleobase.
TG(18:1(9Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
Cob(I)yrinate a,c diamide A cobyrinic acid a,c diamide that has formula C45H61CoN6O12.
PIP(18:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(15:0/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
Butorphanol Levorphanol in which a hydrogen at position 14 of the morphinan skeleton is substituted by hydroxy and one of the hydrogens of the N-methyl group is substituted by cyclopropyl. A semi-synthetic opioid agonist-antagonist analgesic, it is used as its (S,S)-tartaric acid salt for relief or moderate to severe pain.
TG(14:0/20:3(5Z,8Z,11Z)/22:1(13Z))
TG(18:2(9Z,12Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(16:0/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
PC(18:1(11Z)/20:2(11Z,14Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
TG(22:0/20:0/18:3(6Z,9Z,12Z))
DG(14:1n5/0:0/22:5n3)
TG(16:0/20:2n6/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
Butalbital A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by an allyl group and an isobutyl group. Frequently combined with other medicines, such as aspirin, paracetamol and codeine, it is used for treatment of pain and headache.
TG(18:0/o-18:0/18:0)
Boron
TG(16:0/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/16:0/20:4(5Z,8Z,11Z,14Z))
Gamma-Glutamyl-Se-methylselenocysteine A glutamyl-L-amino acid that has formula C9H16N2O5Se.
DG(20:3n9/0:0/20:4n6)
DG(20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z)/0:0)
(E)-3-(2,3-Dihydroxyphenyl)-2-propenoic acid
DG(20:2(11Z,14Z)/18:0/0:0)
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(22:0/24:1(15Z)/18:1(11Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Caffeine A trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. A purine alkaloid that occurs naturally in tea and coffee.
PE(20:3(8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(16:0/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Desmosterol A cholestanoid that is cholesta-5,24-diene substituted by a beta-hydroxy group at position 3. It is an intermediate metabolite obtained during the synthesis of cholesterol.
Deoxycytidine
TG(18:2(9Z,12Z)/22:0/20:2n6)
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/14:1(9Z)/24:0)
TG(18:2(9Z,12Z)/20:2n6/20:2n6)
Glycodiazine
TG(22:0/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/24:1(15Z)/o-18:0)
DG(18:1(9Z)/14:0/0:0)
TG(16:0/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:3(6Z,9Z,12Z)/18:1(9Z))
TG(18:0/22:0/20:4(8Z,11Z,14Z,17Z))
CE(18:3(9Z,12Z,15Z))
TG(16:1(9Z)/20:0/18:2(9Z,12Z))
TG(20:3n6/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
Salsalate
Echothiophate
DG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/18:2(9Z,12Z)/18:1(9Z))
DG(22:2n6/0:0/22:2n6)
PE(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/18:0/22:4(7Z,10Z,13Z,16Z))
PE(24:1(15Z)/16:1(9Z))
TG(18:0/20:0/20:2n6)
PIP3(18:1(9Z)/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/18:2(9Z,12Z))
1,4-beta-D-Glucan A beta-D-glucan in which the glucose units are connected by (1->4) linkages.
PE(P-16:0/20:0)
TG(18:1(9Z)/20:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:2n6/18:1(9Z))
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Ganglioside GT1b (d18:1/20:0)
TG(20:3(5Z,8Z,11Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
Propynoic acid A terminal acetylenic compound that is a 3-carbon, straight-chain, monounsaturated fatty acid having one acetylenic bond.
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
Ganglioside GT1b (d18:1/22:0)
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Mercaptopurine A member of the class of purines that is 6,7-dihydro-1H-purine carrying a thione group at position 6.
PC(24:1(15Z)/18:1(11Z))
PE(22:2(13Z,16Z)/24:1(15Z))
TG(22:0/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Nabilone
TG(20:1(11Z)/20:1(11Z)/22:1(13Z))
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
Moclobemide
TG(22:0/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:0/20:2n6/o-18:0)
Desflurane
TG(20:0/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:0/14:1(9Z)/24:0)
TG(14:0/18:0/18:3(6Z,9Z,12Z))
TG(16:0/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:1(13Z)/24:1(15Z))
3-Polyprenyl-4,5-dihydroxybenzoate
PE(20:5(5Z,8Z,11Z,14Z,17Z)/P-16:0)
PE(22:4(7Z,10Z,13Z,16Z)/20:0)
PE(18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:3n6)
PE(20:1(11Z)/22:1(13Z))
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:2(11Z,14Z)/18:1(9Z)/0:0)
TG(18:0/22:4(7Z,10Z,13Z,16Z)/24:0)
PC(20:0/14:1(9Z))
TG(18:2(9Z,12Z)/20:0/20:1(11Z))[iso6]
PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:3n6/14:1(9Z))
CL(18:2(9Z,12Z)/18:1(9Z)/18:1(9Z)/16:1(9Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
Naratriptan A heteroarylpiperidine that has formula C17H25N3O2S.
TG(20:1(11Z)/20:0/18:2(9Z,12Z))
TG(24:0/16:0/22:1(13Z))
Glipizide
TG(16:1(9Z)/22:0/18:4(6Z,9Z,12Z,15Z))
TG(14:0/20:2n6/18:4(6Z,9Z,12Z,15Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-16:0)
Glycopyrrolate
TG(24:0/16:1(9Z)/24:1(15Z))
DG(24:1(15Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PC(22:4(7Z,10Z,13Z,16Z)/15:0)
TG(20:0/22:0/20:4(5Z,8Z,11Z,14Z))
Carbamazepine A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
PE(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/14:1(9Z)/24:0)
Desloratadine Loratadine in which the ethoxycarbonyl group attached to the piperidine ring is replaced by hydrogen. The major metabolite of loratidine, desloratadine is an antihistamine which is used for the symptomatic relief of allergic conditions including rhinitis and chronic urticaria. It does not readily enter the central nervous system, so does not cause drowsiness.
TG(14:0/20:0/18:2(9Z,12Z))
TG(20:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(16:0/22:0/18:0)
PC(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/22:1(13Z)/o-18:0)
Retinyl palmitate A palmitate ester of retinol with undefined geometry about the C=C bonds.
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Methyltestosterone A 17beta-hydroxy steroid that is testosterone bearing a methyl group at the 17alpha position.
TG(16:0/14:1(9Z)/18:0)
TG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/18:1(9Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/22:0/20:2n6)
TG(20:0/24:1(15Z)/14:1(9Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z)/0:0)
Quercetin-4'-glucuronide
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/14:0)
TG(22:2(13Z,16Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PIP(16:1(9Z)/18:1(9Z))
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
(3a,5b)-24-oxo-24-[(2-sulfoethyl)amino]cholan-3-yl-b-D-Glucopyranosiduronic acid
TG(22:0/20:3n6/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
PC(16:0/20:1(11Z))
TG(18:0/20:0/18:3(9Z,12Z,15Z))
PE(20:4(5Z,8Z,11Z,14Z)/P-18:1(11Z))
TG(14:0/22:0/o-18:0)
11,14,15-THETA A leukotriene that has formula C20H34O5.
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
PE(24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/o-18:0/16:1(9Z))
PG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(14:0/14:1(9Z)/22:0)
TG(16:0/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:0/22:1(13Z))
Lithocholate 3-O-glucuronide
PIP2(18:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
Sepiapterin A pterin that has formula C9H11N5O3.
Propionyl-CoA An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of propionic acid.
PIP(16:1(9Z)/18:0)
TG(24:0/20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
TG(22:1(13Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)/o-18:0)
5-Dehydroepisterol
PE(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/22:1(13Z)/22:2(13Z,16Z))
TG(18:1(11Z)/14:0/18:3(9Z,12Z,15Z))
Methylarsonite An arsenic oxoanion obtained deprotonation of both arsenite OH groups of methylarsonous acid.
DG(16:0/0:0/20:3n9)
2-Polyprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone
trans-2-Enoyl-OPC4-CoA An organic molecule that has formula C35H54N7O18P3S.
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:0)
CDP-DG(18:1(9Z)/22:3(10Z,13Z,16Z))
TG(20:2n6/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:1n7/0:0/20:3n9)
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/20:2n6/18:2(9Z,12Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(14:0/14:1(9Z)/24:0)
DG(18:1(11Z)/24:1(15Z)/0:0)
5alpha-Dihydrodeoxycorticosterone A 21-hydroxy steroid that has formula C21H32O3.
PE(16:1(9Z)/16:0)
TG(24:1(15Z)/o-18:0/22:2(13Z,16Z))
DG(20:3n9/0:0/22:5n3)
TG(18:1(9Z)/22:0/o-18:0)
TG(20:0/o-18:0/20:3(5Z,8Z,11Z))
TG(18:0/14:0/18:3(6Z,9Z,12Z))
DG(15:0/0:0/16:0)
TG(16:0/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/16:0/20:0)
TG(20:4(5Z,8Z,11Z,14Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(15:0/0:0/18:0)
TG(24:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/o-18:0)
Marimastat A tricarboxylic acid triamide that has formula C15H29N3O5.
TG(16:0/22:2(13Z,16Z)/16:1(9Z))
PE(P-18:1(9Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0)
TG(22:1(13Z)/24:1(15Z)/18:2(9Z,12Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
PE(14:0/20:4(5Z,8Z,11Z,14Z))
Chlorhexidine A bisbiguanide compound with a structure consisting of two (p-chlorophenyl)guanide units linked by a hexamethylene bridge.
TG(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(20:0/18:0/o-18:0)
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
2-Hydroxyglutarate
TG(18:0/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
PE(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/22:2(13Z,16Z)/18:3(6Z,9Z,12Z))
D-Proline The D-enantiomer of proline.
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Estradiol A 3-hydroxy steroid that is estra-1,3,5(10)-triene substituted by hydroxy groups at positions 3 and 17.
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
Ganglioside GT2 (d18:0/22:0)
TG(14:1(9Z)/20:0/14:1(9Z))
TG(15:0/22:1(13Z)/20:3(5Z,8Z,11Z))
PE(18:1(9Z)/P-18:1(9Z))
Ganglioside GT2 (d18:0/20:0)
DG(16:0/16:1(9Z)/0:0)
Rivastigmine
TG(20:3n6/o-18:0/20:4(5Z,8Z,11Z,14Z))
TG(24:0/22:2(13Z,16Z)/18:2(9Z,12Z))
TG(20:2n6/15:0/20:3n6)
PC(18:1(9Z)/16:1(9Z))
PE(20:3(5Z,8Z,11Z)/22:1(13Z))
TG(18:0/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
PC(22:1(13Z)/18:1(9Z))
TG(22:0/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(14:1(9Z)/P-18:1(11Z))
TG(20:3(5Z,8Z,11Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/20:0/16:1(9Z))
TG(20:2n6/24:1(15Z)/20:3n6)
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:3(8Z,11Z,14Z)/16:1(9Z))
PE(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:0)
DG(16:1n7/0:0/24:1n9)
TG(24:1(15Z)/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
DG(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
Benzthiazide
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
Sarcosine
PE(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:3n6/14:1(9Z))
TG(20:0/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
TG(20:3n6/22:0/18:3(9Z,12Z,15Z))
TG(24:0/18:1(9Z)/18:1(11Z))
6a,12a-Dihydroxylithocholic acid
CL(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/16:0/20:4(5Z,8Z,11Z,14Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(18:1(11Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(18:3(9Z,12Z,15Z)/18:0/0:0)
TG(18:0/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
Sapropterin
TG(22:2(13Z,16Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:1(11Z)/20:2n6)
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/20:3n6)
TG(18:1(11Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
PE(18:3(6Z,9Z,12Z)/18:1(11Z))
PE(20:0/16:1(9Z))
TG(20:0/20:0/18:3(9Z,12Z,15Z))
TG(24:1(15Z)/15:0/18:2(9Z,12Z))
TG(18:3(9Z,12Z,15Z)/24:0/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/16:1(9Z))
TG(15:0/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
PC(P-16:0/20:4(5Z,8Z,11Z,14Z))
TG(16:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/24:0/24:1(15Z))
TG(22:0/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/18:3(6Z,9Z,12Z)/20:0)
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
LysoPC(24:1(15Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
DG(22:1(13Z)/24:0/0:0)
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
PC(22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/22:1(13Z)/20:3n6)
Trihexosylceramide (d18:1/9Z-18:1)
DG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(14:1(9Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:4(8Z,11Z,14Z,17Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(14:0/0:0/20:3n6)
TG(14:1(9Z)/22:2(13Z,16Z)/18:2(9Z,12Z))
PC(20:0/P-18:1(9Z))
TG(22:1(13Z)/16:0/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/22:1(13Z)/18:3(9Z,12Z,15Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z)/18:1(11Z))
PC(15:0/P-16:0)
TG(22:0/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/24:0/18:3(9Z,12Z,15Z))
PIP2(16:0/20:2(11Z,14Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/14:0/20:3n6)
PC(15:0/P-18:1(9Z))
TG(20:1(11Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Coproporphyrin III A coproporphyrin that has formula C36H38N4O8.
DG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
TG(15:0/18:3(9Z,12Z,15Z)/20:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(15:0/20:3(8Z,11Z,14Z))
2-(Formamido)-N1-(5-phospho-D-ribosyl)acetamidine A ribose monophosphate that has formula C8H16N3O8P.
TG(16:1(9Z)/18:2(9Z,12Z)/16:1(9Z))
TG(18:1(9Z)/22:0/20:4(5Z,8Z,11Z,14Z))
TG(18:0/18:0/o-18:0)
TG(18:1(9Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))[iso6]
TG(22:0/18:1(11Z)/16:1(9Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
PI(16:2(9Z,12Z)/22:3(10Z,13Z,16Z))
TG(14:0/14:1(9Z)/o-18:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:2(9Z,12Z)/o-18:0)
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Stigmasterol
Chloramphenicol An organochlorine compound that is dichloro-substituted acetamide containing a nitrobenzene ring, an amide bond and two alcohol functions.
TG(20:0/14:0/20:4(5Z,8Z,11Z,14Z))
Hydrocodone An organic heteropentacyclic compound that has formula C18H21NO3.
TG(22:0/14:0/18:1(11Z))
TG(20:1(11Z)/18:2(9Z,12Z)/20:2n6)
TG(20:4(8Z,11Z,14Z,17Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/22:1(13Z)/22:1(13Z))
Phosphohydroxypyruvic acid
TG(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/16:1(9Z)/20:1(11Z))[iso6]
TG(22:2(13Z,16Z)/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:1n9/0:0/24:1n9)
Thiabendazole A member of the class of benzimidazoles carrying a 1,3-thiazol-4-yl substituent at position 2. A mainly post-harvest fungicide used to control a wide range of diseases including Aspergillus, Botrytis, Cladosporium and Fusarium.
TG(18:1(9Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
Dehydroepiandrosterone An androstanoid that is androst-5-ene substituted by an beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/20:3n6)
Adefovir Dipivoxil
CE(20:0)
TG(20:2n6/22:2(13Z,16Z)/22:2(13Z,16Z))
TG(22:0/14:1(9Z)/22:2(13Z,16Z))
Heptadecanoic acid A C17 saturated fatty acid and trace component of fats in ruminants.
TG(20:3n6/14:0/22:2(13Z,16Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(20:3n6/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/16:1(9Z)/24:0)
TG(14:1(9Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
PA(18:1(9Z)/18:1(11Z))
TG(14:1(9Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Ceramide (d18:1/24:0)
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(15:0/18:1(11Z)/22:2(13Z,16Z))
(S)-3-Hydroxyhexadecanoyl-CoA
Acaciabiuronic acid
TG(14:0/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:0)
TG(18:3(6Z,9Z,12Z)/14:0/18:3(6Z,9Z,12Z))
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/18:0/o-18:0)
TG(15:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
Acetylcysteine
TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(14:0/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/15:0/16:1(9Z))
TG(18:3(9Z,12Z,15Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/15:0/20:3n6)
TG(18:0/18:4(6Z,9Z,12Z,15Z)/20:3n6)
Hydrogen peroxide An inorganic peroxide that has formula H2O2.
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z))
MG(22:0/0:0/0:0)
TG(22:0/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
Zolpidem An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
TG(14:0/16:0/22:0)
TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
Capryloylglycine
PE(22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
TG(18:0/14:0/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:2(13Z,16Z)/o-18:0)
TG(16:1(9Z)/18:0/22:4(7Z,10Z,13Z,16Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(9Z))
Lumefantrine
TG(22:0/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
D-Dopachrome The D-enantiomer of dopachrome.
TG(18:1(11Z)/18:1(9Z)/o-18:0)
TG(20:0/22:2(13Z,16Z)/18:1(11Z))
PC(15:0/18:0)
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
N'-Formylkynurenine A non-proteinogenic amino acid derivative that has formula C11H12N2O4.
TG(20:1(11Z)/20:3(5Z,8Z,11Z)/20:3n6)
TG(14:0/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(20:2n6/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z))
PC(24:1(15Z)/24:1(15Z))
Paramethasone
2-Methoxy-estradiol-17b 3-glucuronide
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
TG(16:1(9Z)/22:2(13Z,16Z)/18:2(9Z,12Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:2(13Z,16Z)/o-18:0)
PC(P-18:0/20:0)
Cer(d18:0/18:1(11Z))
TG(14:0/18:1(9Z)/20:3n6)
TG(24:0/22:1(13Z)/22:1(13Z))
PI(16:0/16:1(9Z))
PE(20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0)
Dopamine 4-sulfate
PE(24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Anileridine
TG(22:1(13Z)/20:3n6/18:3(6Z,9Z,12Z))
5'-phosphoribosyl-a-N-formylglycineamidine
Alverine
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/16:1(9Z)/14:1(9Z))
DG(20:4(8Z,11Z,14Z,17Z)/24:1(15Z)/0:0)
TG(18:1(9Z)/24:0/o-18:0)
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/15:0/18:4(6Z,9Z,12Z,15Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso3]
TG(20:3n6/16:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/15:0/20:3n6)
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(18:3(6Z,9Z,12Z)/18:0/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/14:1(9Z)/22:2(13Z,16Z))
TG(14:0/18:0/20:0)
PE(P-18:1(11Z)/22:2(13Z,16Z))
PG(18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z))
4-Amino-1-piperidinecarboxylic acid
TG(18:1(9Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/24:1(15Z)/20:3n6)
TG(22:0/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Lisdexamfetamine
TG(20:3n6/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
PC(22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/18:1(9Z)/18:2(9Z,12Z))
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:3n6)
TG(22:2(13Z,16Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
3a,7a,12b-Trihydroxy-5b-cholanoic acid
Atovaquone
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/15:0/18:3(6Z,9Z,12Z))
Dimethyl-L-arginine
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(24:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:2n6/20:1(11Z))
Dydrogesterone
TG(16:0/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(22:1(13Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
PC(20:0/20:2(11Z,14Z))
PE(20:3(8Z,11Z,14Z)/22:1(13Z))
TG(20:0/16:0/22:2(13Z,16Z))
TG(20:0/18:0/22:2(13Z,16Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(18:2(9Z,12Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
Tranexamic Acid
PE(18:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PI(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
PE(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Dicumarol
TG(16:0/24:1(15Z)/o-18:0)
TG(22:0/20:2n6/18:3(6Z,9Z,12Z))
(S)-Methylmalonic acid semialdehyde
Uridine 5'-diphosphate
TG(16:0/18:1(11Z)/20:1(11Z))
TG(22:0/22:0/24:1(15Z))
TG(24:0/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/18:0/22:4(7Z,10Z,13Z,16Z))
DG(22:5n6/0:0/22:5n3)
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/20:1(11Z)/20:1(11Z))[iso3]
PC(P-18:1(11Z)/20:3(5Z,8Z,11Z))
p-Cresol glucuronide
DG(22:2(13Z,16Z)/18:2(9Z,12Z)/0:0)
TG(14:0/22:2(13Z,16Z)/14:1(9Z))
TG(20:2n6/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(18:2(9Z,12Z)/18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(16:0/20:2n6/24:0)
PE(18:3(9Z,12Z,15Z)/24:1(15Z))
PE(18:1(9Z)/20:1(11Z))
TG(20:2n6/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/o-18:0/16:1(9Z))
TG(18:1(9Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(20:1(11Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/16:0/20:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
TG(15:0/14:1(9Z)/15:0)
PE(P-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:2(9Z,12Z)/22:0)
PE(18:1(11Z)/16:0)
TG(15:0/20:1(11Z)/18:2(9Z,12Z))
TG(22:0/24:0/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Cefamandole
TG(14:1(9Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:1(11Z))
TG(14:1(9Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(16:0/24:1(15Z)/18:3(6Z,9Z,12Z))
DG(14:0/0:0/18:4n3)
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
S-Lactoylglutathione
Methacholine
TG(20:0/18:1(9Z)/o-18:0)
Isobutyrylglycine
3-beta-Hydroxy-4-beta-methyl-5-alpha-cholest-7-ene-4-alpha-carbaldehyde A 3beta-sterol that has formula C29H48O2.
TG(16:0/15:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
21-Hydroxypregnenolone A hydroxypregnenolone that has formula C21H32O3.
TG(18:0/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(15:0/20:1(11Z))
PE(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
Ganglioside GM3 (d18:0/18:1(11Z))
TG(20:1(11Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
Imidazole-4-acetaldehyde An imidazolylacetaldehyde that has formula C5H6N2O.
DG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:2n6/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Sulfadiazine A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
TG(18:0/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
LysoPC(22:1(13Z))
DG(24:0/20:4(5Z,8Z,11Z,14Z)/0:0)
PC(18:3(9Z,12Z,15Z)/P-18:1(9Z))
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
LysoPE(16:1(9Z)/0:0)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(22:1(13Z)/20:0/0:0)
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(22:0/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
Cer(d18:0/20:0)
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/18:2(9Z,12Z))
TG(22:1(13Z)/24:0/20:4(5Z,8Z,11Z,14Z))
TG(24:0/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/24:0/22:0)
TG(14:1(9Z)/18:2(9Z,12Z)/o-18:0)
PS(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z)/0:0)
TG(16:0/18:3(6Z,9Z,12Z)/18:1(9Z))
PE(24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/20:3n6/24:1(15Z))
TG(20:0/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
PI(18:2(9Z,12Z)/16:0)
TG(18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:0/20:4(8Z,11Z,14Z,17Z))
Ganglioside GD2 (d18:1/18:0)
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
TG(18:2(9Z,12Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/24:0/o-18:0)
DG(20:0/0:0/22:2n6)
TG(18:0/16:0/o-18:0)
Methamphetamine A member of the class of amphetamines in which the amino group of (S)-amphetamine carries a methyl substituent.
TG(16:1(9Z)/24:0/20:1(11Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/o-18:0/24:0)
Thiamine triphosphate Trianion of thiamine(1+) diphosphate arising from deprotonation of the four OH groups of the triphosphate.
TG(18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
MG(20:3(11Z,14Z,17Z)/0:0/0:0)
TG(22:1(13Z)/o-18:0/18:3(9Z,12Z,15Z))
PS(16:1(9Z)/20:3(8Z,11Z,14Z))
Ganglioside GM3 (d18:0/18:0)
TG(18:0/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
1-Hydroxy-6-methoxypyrene A pyrene that has formula C17H12O2.
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(14:0/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(15:0/16:1(9Z)/o-18:0)
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
PC(22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
Nicergoline
TG(24:1(15Z)/16:0/18:2(9Z,12Z))
TG(14:0/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
PS(20:4(5Z,8Z,11Z,14Z)/18:0)
TG(20:2n6/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
Moricizine
Benzo[a]pyrene-7,8-oxide A pyrene that has formula C20H12O.
TG(16:0/18:1(11Z)/22:1(13Z))
TG(14:0/22:2(13Z,16Z)/22:2(13Z,16Z))
DG(18:4(6Z,9Z,12Z,15Z)/20:0/0:0)
DG(24:1n9/0:0/20:5n3)
DG(15:0/0:0/20:3n9)
TG(15:0/14:0/o-18:0)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/20:1(11Z))
7-Methyl-3-oxo-6-octenoyl-CoA
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Vinylacetylglycine
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/20:3n6/24:0)
DG(15:0/18:1(11Z)/0:0)
DG(15:0/0:0/20:1n9)
Mazindol
TG(14:0/16:1(9Z)/20:3(5Z,8Z,11Z))
TG(18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(14:0/20:3(5Z,8Z,11Z)/22:0)
Choline A choline that is the parent compound of the cholines class, consisting of ethanolamine having three methyl substituents attached to the amino function.
TG(16:0/22:4(7Z,10Z,13Z,16Z)/24:0)
TG(18:0/18:1(9Z)/24:0)
TG(20:1(11Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Succinylcholine A quaternary ammonium ion that is the bis-choline ester of succinic acid.
TG(18:2(9Z,12Z)/18:1(9Z)/22:2(13Z,16Z))
PC(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Galactitol An optically inactive hexitol having meso-configuration.
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(20:3n6/14:1(9Z)/22:2(13Z,16Z))
TG(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(18:1(11Z)/20:0/22:4(7Z,10Z,13Z,16Z))
DG(15:0/22:0/0:0)
TG(22:1(13Z)/o-18:0/18:3(6Z,9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PIP2(20:2(11Z,14Z)/16:0)
DG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/14:1(9Z))
DG(20:0/0:0/20:0)
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/22:2(13Z,16Z))
TG(24:0/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
PE(18:1(9Z)/24:1(15Z))
TG(16:1(9Z)/16:0/20:3(5Z,8Z,11Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0/o-18:0)
DG(20:0/0:0/22:0)
TG(20:3(5Z,8Z,11Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:1(15Z)/18:2(9Z,12Z)/20:2n6)
TG(14:1(9Z)/18:1(11Z)/18:2(9Z,12Z))
TG(14:1(9Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
Phosphate Salts and esters of phosphoric and oligophosphoric acids and their chalcogen analogues. In inorganic chemistry, the term is also used to describe anionic coordination entities with phosphorus as central atom.
Tetrabenazine
TG(20:4(5Z,8Z,11Z,14Z)/18:0/o-18:0)
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
Deoxyribose 5-phosphate
PG(16:1(9Z)/18:1(9Z))
TG(15:0/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:1(11Z)/18:0/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
PE(16:0/22:1(13Z))
TG(20:3n6/22:0/22:2(13Z,16Z))
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:0/24:1(15Z)/24:1(15Z))
TG(18:3(6Z,9Z,12Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
DG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/0:0)
PC(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
(3S)-3-Hydroxyadipyl-CoA A polyol that has formula C27H44N7O20P3S.
DG(14:0/0:0/20:1n9)
Methaneselenol An organoselenium compound that is a selenium analogue of methanol, comprising a methyl group covalently bound to a selenol group.
TG(15:0/20:2n6/16:0)
TG(20:1(11Z)/22:0/20:3(5Z,8Z,11Z))
3a,6b,7b,12a-Tetrahydroxy-5b-cholanoic acid
PE(20:0/22:0)
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
3-Mercaptolactate-cysteine disulfide
(S)-Propane-1,2-diol A propane-1,2-diol that has formula C3H8O2.
Valaciclovir
TG(15:0/20:2n6/18:0)
Dextroamphetamine
CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)/18:1(11Z)/18:1(9Z))
PC(20:2(11Z,14Z)/24:1(15Z))
TG(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
Metaraminol
PC(22:0/16:1(9Z))
PC(20:5(5Z,8Z,11Z,14Z,17Z)/24:0)
PI(20:4(5Z,8Z,11Z,14Z)/20:0)
PC(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z))
TG(20:2n6/22:4(7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
DG(18:0/0:0/22:6n3)
Octreotide A homodetic cyclic peptide that has formula C49H66N10O10S2.
TG(22:0/18:2(9Z,12Z)/o-18:0)
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
SN38 glucuronide A pyranoindolizinoquinoline that has formula C28H28N2O11.
N-Methyltyramine A tyramine that has formula C9H13NO.
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
Desmopressin A synthetic analogue of vasopressin in which 3-mercaptopropionic acid replaces the cysteine residue at position 1 and D-arginine replaces the residue at position 8. An antidiuretic, it increases urine concentration and decreases urine production, and is used (usually as the trihydrate of the acetic acid salt) to prevent and control excessive thirst, urination, and dehydration caused by injury, surgery, and certain medical conditions. It is also used in the diagnosis and treatment of cranial diabetes insipidus and in tests of renal function.
PE(22:1(13Z)/18:0)
PC(24:1(15Z)/16:1(9Z))
TG(20:0/20:2n6/20:4(8Z,11Z,14Z,17Z))
Methadone A ketone that is heptan-3-one substituted by a dimethylamino group at position 6 and two phenyl groups at position 4.
TG(18:1(9Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/14:1(9Z)/18:1(9Z))
TG(18:3(9Z,12Z,15Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/20:0/22:4(7Z,10Z,13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(20:2n6/16:0/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
DG(18:1(9Z)/16:1(9Z)/0:0)
TG(20:3n6/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Chlordecone An organochlorine compound with insecticidal activity.
TG(20:3n6/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:0)
PC(18:0/18:1(11Z))
TG(14:1(9Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Octanol A fatty alcohol consisting of a hydroxy function at any position of an unbranched saturated chain of eight carbon atoms.
Droperidol An organofluorine compound that is haloperidol in which the hydroxy group has been eliminated with the introduction of a double bond in the piperidine ring, and the 4-chlorophenyl group has been replaced by a benzimidazol-2-on-1-yl group. It is used in the management of chemotherapy-induced nausea and vomiting, and in conjunction with an opioid analgesic such as fentanyl to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon.
TG(16:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:0/22:1(13Z))
PS(14:1(9Z)/16:1(9Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(16:1(9Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
PC(18:2(9Z,12Z)/22:0)
Dihydroergotoxine
TG(20:3n6/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)
TG(14:0/22:4(7Z,10Z,13Z,16Z)/20:2n6)
TG(16:1(9Z)/14:1(9Z)/18:1(11Z))
DG(18:3(6Z,9Z,12Z)/22:0/0:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PG(16:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
PC(14:0/20:1(11Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/18:1(9Z)/16:1(9Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/15:0)
TG(22:0/20:3n6/22:2(13Z,16Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
Chenodeoxycholic acid disulfate
PIP(20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
DG(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z)/0:0)
TG(18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
DG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/0:0)
Naftifine
TG(24:0/18:0/18:4(6Z,9Z,12Z,15Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:0/18:4(6Z,9Z,12Z,15Z))
CL(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(20:3n6/24:0/18:4(6Z,9Z,12Z,15Z))
TG(20:0/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/22:2(13Z,16Z)/o-18:0)
Ganglioside GA2 (d18:1/22:0)
TG(18:3(6Z,9Z,12Z)/14:0/20:2n6)
DG(20:3(5Z,8Z,11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
PE(18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
DG(20:3(5Z,8Z,11Z)/18:1(11Z)/0:0)
TG(18:0/18:2(9Z,12Z)/20:1(11Z))[iso6]
TG(18:1(9Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
Anserine A dipeptide comprising of beta-alanine and 3-methyl-L-histidine units.
TG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
MG(0:0/15:0/0:0)
TG(22:0/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
PC(18:3(9Z,12Z,15Z)/P-18:0)
TG(24:1(15Z)/20:3(5Z,8Z,11Z)/20:2n6)
TG(14:1(9Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(20:0/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/14:0/20:2n6)
TG(14:0/14:0/20:3(5Z,8Z,11Z))
TG(20:4(5Z,8Z,11Z,14Z)/15:0/18:4(6Z,9Z,12Z,15Z))
PC(18:2(9Z,12Z)/24:0)
TG(16:0/14:1(9Z)/20:3n6)
TG(18:1(11Z)/22:0/20:1(11Z))
TG(18:0/18:3(9Z,12Z,15Z)/22:1(13Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:3(9Z,12Z,15Z)/22:1(13Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:0)
TG(22:0/18:0/o-18:0)
TG(20:0/24:1(15Z)/18:3(6Z,9Z,12Z))
TG(22:0/o-18:0/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GA2 (d18:1/20:0)
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/18:2(9Z,12Z))
PE(20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
SM(d18:0/14:0)
TG(22:0/16:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/24:0/20:4(5Z,8Z,11Z,14Z))
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/20:2n6)
3,4-Dihydroxymandelaldehyde An aldehyde consisting of phenylacetaldehyde having three hydroxy substituents located at the alpha-, 3- and 4-positions
PE(dm18:0/18:0)
PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/P-18:1(9Z))
TG(20:1(11Z)/18:0/24:1(15Z))
L-Arabitol
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:0/20:3n6)
LysoPE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
Ganglioside GT1c (d18:0/18:0)
PIP2(20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PC(o-16:1(9Z)/20:0)
DG(14:1n5/0:0/22:1n9)
Menadione A naphthoquinone having a methyl substituent at the 2-position.
TG(20:1(11Z)/24:0/22:2(13Z,16Z))
TG(20:2n6/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:0/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(24:0/0:0/18:1n9)
TG(20:0/18:0/22:0)
TG(16:1(9Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(16:1(9Z)/15:0/22:4(7Z,10Z,13Z,16Z))
PC(P-18:1(9Z)/22:1(13Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:0/18:4(6Z,9Z,12Z,15Z))
DG(22:0/18:0/0:0)
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
Enol-phenylpyruvate A hydroxy monocarboxylic acid anion that has formula C9H7O3.
PC(20:0/18:1(9Z))
TG(20:1(11Z)/16:0/20:1(11Z))
TG(18:0/20:3n6/18:0)
TG(16:0/14:0/18:3(9Z,12Z,15Z))
TG(16:0/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(18:1(9Z)/16:0/20:2(11Z,14Z))[iso6]
PC(20:2(11Z,14Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
DG(24:0/18:1(9Z)/0:0)
TG(18:2(9Z,12Z)/o-18:0/22:4(7Z,10Z,13Z,16Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:0/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:1n9/0:0/20:4n3)
TG(20:2n6/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:0/18:3(9Z,12Z,15Z))
TG(20:3n6/15:0/20:4(5Z,8Z,11Z,14Z))
5-Hydroxy-L-tryptophan The L-enantiomer of 5-hydroxytryptophan.
TG(15:0/20:2n6/o-18:0)
TG(20:1(11Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
dUDP A pyrimidine 2'-deoxyribonucleoside 5'-diphosphate that has formula C9H14N2O11P2.
TG(22:2(13Z,16Z)/14:1(9Z)/o-18:0)
N,N-Dimethylaniline A tertiary amine that is aniline in which the amino hydrogens are replaced by two methyl groups.
TG(18:0/22:2(13Z,16Z)/16:1(9Z))
PC(20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
TG(20:1(11Z)/24:0/18:3(6Z,9Z,12Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/16:1(9Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/18:0/20:3(5Z,8Z,11Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/P-18:0)
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
Pipecuronium
DG(18:1n9/0:0/22:1n9)
TG(22:0/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
PE(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z))
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/14:0/20:4(5Z,8Z,11Z,14Z))
TG(20:1(11Z)/20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Isradipine
PC(18:3(9Z,12Z,15Z)/20:2(11Z,14Z))
TG(24:0/18:3(9Z,12Z,15Z)/20:2n6)
TG(20:3n6/18:2(9Z,12Z)/20:3n6)
TG(20:2n6/20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
LysoPC(22:0) A lysophosphatidylcholine in which the remaining acyl group contains 22 carbons and 0 double bonds. If R1 is the acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphocholine. If R1 is a hydrogen and R2 is the acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphocholine.
TG(16:0/24:0/22:0)
PG(16:1(9Z)/18:0)
PE(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
Chenodeoxycholic acid 3-sulfate
TG(18:0/20:2n6/20:3n6)
TG(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
PE(18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
PG(18:0/18:3(9Z,12Z,15Z))
PE(18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
PC(20:2(11Z,14Z)/20:0)
UDP-D-Xylose
PC(22:2(13Z,16Z)/P-16:0)
TG(16:0/18:1(9Z)/16:1(9Z))
TG(20:0/15:0/18:3(6Z,9Z,12Z))
LysoPC(24:0) A lysophosphatidylcholine in which the remaining acyl group (position not specified) contains 24 carbons and 0 double bonds.
TG(20:0/18:1(11Z)/22:0)
TG(14:1(9Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:0/18:1(11Z)/22:2(13Z,16Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:0/18:0/18:2(9Z,12Z))
PI(18:1(11Z)/16:0)
TG(18:1(11Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
Testosterone sulfate A steroid sulfate that is testosterone substituted by a sulfoxy group at position 17.
DG(20:0/24:0/0:0)
PC(20:4(8Z,11Z,14Z,17Z)/P-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/o-18:0/18:3(9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/14:0/24:0)
TG(18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(18:0/18:1(11Z)/22:2(13Z,16Z))
Cobalt A cobalt group element atom that has formula Co.
Naphazoline
PE(P-18:0/16:1(9Z))
MG(0:0/20:3(11Z,14Z,17Z)/0:0)
TG(16:0/14:0/20:3(5Z,8Z,11Z))
TG(16:0/16:0/20:4(8Z,11Z,14Z,17Z))
DG(16:1(9Z)/18:0/0:0)
PIP(20:3(8Z,11Z,14Z)/18:2(9Z,12Z))
TG(15:0/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Mebendazole A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
2-Amino-4-oxo-6-(1',2'-dioxoprolyl)-7,8-dihydroxypteridine
TG(18:1(11Z)/18:3(9Z,12Z,15Z)/20:1(11Z))
TG(18:1(9Z)/24:0/22:4(7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/15:0/22:5(4Z,7Z,10Z,13Z,16Z))
Furazolidone
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/15:0/22:1(13Z))
TG(18:1(11Z)/24:0/20:1(11Z))
PI(16:2(9Z,12Z)/16:0)
TG(14:1(9Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:1(13Z)/22:0)
TG(20:0/14:1(9Z)/24:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:1(11Z)/o-18:0)
TG(24:0/22:0/18:3(9Z,12Z,15Z))
Methylselenic acid
TG(16:1(9Z)/15:0/20:2n6)
PC(18:0/18:1(9Z))
TG(16:0/24:0/24:0)
Ceruletide A decapeptide comprising 5-oxoprolyl, glutamyl, aspartyl, O-sulfotyrosyl, threonyl, glycyl, tryptopyl, methionyl, aspartyl and phenylalaninamide residues in sequence. Found in the skins of certain Australian amphibians, it is an analogue of the gastrointestinal peptide hormone cholecystokinin and stimulates gastric, biliary, and pancreatic secretion. It is used in cases of paralysis of the intestine (paralytic ileus) and as a diagnostic aid in pancreatic malfunction.
PC(20:2(11Z,14Z)/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
Magnesium
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
DG(18:1n7/0:0/22:6n3)
DG(18:1(9Z)/18:1(11Z)/0:0)
Beta-Alanyl-CoA An acyl-CoA that is the S-(beta-alanyl) derivative of coenzyme A.
TG(24:1(15Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
Penicillin G
PE(18:1(11Z)/P-18:0)
Sulfadimethoxine
TG(20:3(5Z,8Z,11Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
PIP3(16:0/18:1(9Z))
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:0/14:0/22:2(13Z,16Z))
TG(18:1(9Z)/14:0/18:3(9Z,12Z,15Z))
TG(24:0/16:0/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/18:3(9Z,12Z,15Z))
PC(22:1(13Z)/24:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(15:0/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:0)
PE(16:1(9Z)/18:1(11Z))
PC(20:4(5Z,8Z,11Z,14Z)/16:1(9Z))
TG(14:0/18:1(11Z)/14:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PI(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/o-18:0/24:1(15Z))
TG(18:0/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
TG(22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GA2 (d18:1/26:1(17Z))
TG(14:0/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(22:0/24:0/24:1(15Z))
TG(18:1(11Z)/20:2n6/o-18:0)
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)
5-Formiminotetrahydrofolic acid
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
PE(15:0/24:1(15Z))
TG(20:2n6/20:0/20:2n6)
TG(15:0/14:1(9Z)/18:0)
PC(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
LPA(18:1(9Z)/0:0)
PIP(18:1(9Z)/20:3(8Z,11Z,14Z))
Dimethylarsinate The arsenic oxoanion that is the conjugate base of dimethylarsinic acid.
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
DG(24:1n9/0:0/18:4n3)
TG(18:1(11Z)/18:1(9Z)/20:1(11Z))
TG(20:1(11Z)/18:1(9Z)/18:2(9Z,12Z))
TG(18:0/16:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/18:1(11Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(20:1(11Z)/18:0/22:4(7Z,10Z,13Z,16Z))
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/20:0/20:4(5Z,8Z,11Z,14Z))
TG(14:0/20:3(5Z,8Z,11Z)/18:2(9Z,12Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
3-Hydroxymethylantipyrine
TG(20:0/18:4(6Z,9Z,12Z,15Z)/14:1(9Z))
TG(20:3(5Z,8Z,11Z)/16:0/o-18:0)
Ganglioside GD3 (d18:0/24:0)
TG(18:0/18:3(6Z,9Z,12Z)/20:1(11Z))
TG(22:1(13Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
Hyaluronic acid A mucopolysaccharide composed of N-acetylglucosamine and glucuronic acid subunits. It is found in the connective tissues of vertebrates.
TG(24:1(15Z)/14:0/20:4(5Z,8Z,11Z,14Z))
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z)/18:1(9Z))
TG(18:3(9Z,12Z,15Z)/15:0/18:3(9Z,12Z,15Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z)/o-18:0)
PC(18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Glucosylceramide (d18:1/16:0)
PIP2(16:1(9Z)/16:0)
PE(14:1(9Z)/18:1(9Z))
Ganglioside GD3 (d18:0/22:0)
TG(14:1(9Z)/15:0/o-18:0)
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
TG(14:1(9Z)/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
4-Methylumbelliferyl acetate An acetate ester consiting of umbelliferone carrying a 7-O-acetyl group.
7,8-Dihydroneopterin A neopterin where positions C-7 and C-8 have been hydrogenated.
TG(18:2(9Z,12Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/24:1(15Z)/16:1(9Z))
TG(20:1(11Z)/20:2n6/18:3(9Z,12Z,15Z))
Ritodrine
Orphenadrine A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.
trans-2-Enoyl-OPC8-CoA An organic molecule that has formula C39H62N7O18P3S.
(S)-ethylmalonyl-CoA
TG(16:0/22:2(13Z,16Z)/18:2(9Z,12Z))
PC(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
4-Oxoretinal
Betaine
TG(15:0/20:0/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/18:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/24:1(15Z)/24:1(15Z))
Ganglioside GA1 (d18:1/9Z-18:1)
Tramadol
TG(24:0/18:0/16:1(9Z))
LysoPE(0:0/14:1(9Z))
TG(20:2n6/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:2n6/22:2(13Z,16Z))
PC(16:0/20:2(11Z,14Z))
Nedocromil
TG(22:1(13Z)/14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PS(14:1(9Z)/20:3(8Z,11Z,14Z))
TG(14:1(9Z)/18:4(6Z,9Z,12Z,15Z)/18:1(9Z))
TG(18:3(6Z,9Z,12Z)/18:1(9Z)/20:2n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0/18:4(6Z,9Z,12Z,15Z))
PC(22:1(13Z)/P-16:0)
PC(o-22:2(13Z,16Z)/22:2(13Z,16Z))
PC(18:4(6Z,9Z,12Z,15Z)/dm18:0)
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
Raffinose A trisaccharide composed of alpha-D-galactopyranose, alpha-D-glucopyranose and beta-D-fructofuranose joined in sequence by 1->6 and 1<->2 glycosidic linkages, respectively.
PE(16:0/22:0)
TG(18:1(9Z)/18:0/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
PC(20:4(8Z,11Z,14Z,17Z)/P-16:0)
TG(24:0/20:0/16:1(9Z))
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z))
PG(18:1(11Z)/16:1(9Z))
TG(16:0/16:0/16:0)[iso]
TG(20:4(8Z,11Z,14Z,17Z)/20:0/o-18:0)
19-Oxoandrost-4-ene-3,17-dione
TG(14:1(9Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
DG(14:0/0:0/24:0)
TG(14:0/18:2(9Z,12Z)/14:1(9Z))
PE(14:1(9Z)/14:1(9Z))
Oxymetazoline
TG(20:3(5Z,8Z,11Z)/18:1(11Z)/20:2n6)
TG(14:0/24:0/16:0)
TG(24:1(15Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/24:0/o-18:0)
TG(22:2(13Z,16Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(18:0/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
DG(14:0/0:0/20:2n6)
PE(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
PIP(20:4(8Z,11Z,14Z,17Z)/16:0)
TG(20:0/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Adenosine tetraphosphate
DG(14:0/0:0/22:1n9)
PE(16:0/20:0)
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/18:2(9Z,12Z))
Ganglioside GM2 (d18:1/20:0)
DG(24:0/16:1(9Z)/0:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:2n6/o-18:0)
PC(14:1(9Z)/22:2(13Z,16Z))
TG(18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
CL(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
DG(18:0/0:0/22:2n6)
TG(20:1(11Z)/24:1(15Z)/24:1(15Z))
Chloroacetyl chloride An acyl halide that has formula C2H2Cl2O.
9-cis-Retinal A retinal in which the double bond at position 9 has cis configuration, whilst the remaining acyclic double bonds have trans configuration.
TG(18:0/20:0/14:1(9Z))
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(8Z,11Z,14Z))
DG(18:3n6/0:0/20:4n3)
DG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(16:1(9Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:0/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
Pioglitazone A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Theophylline A dimethylxanthine having the two methyl groups located at positions 1 and 3. It is structurally similar to caffeine and is found in green and black tea.
TG(16:1(9Z)/20:3n6/20:3(5Z,8Z,11Z))
TG(24:0/20:0/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:0/22:1(13Z))
TG(16:1(9Z)/20:2n6/o-18:0)
TG(14:1(9Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/22:2(13Z,16Z)/20:3n6)
PE(24:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/14:0/18:1(9Z))[iso3]
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
PE(15:0/18:4(6Z,9Z,12Z,15Z))
TG(15:0/24:1(15Z)/18:3(6Z,9Z,12Z))
PE(20:3(8Z,11Z,14Z)/14:0)
TG(20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/16:1(9Z)/16:1(9Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/16:0)
PI(18:1(9Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/18:2(9Z,12Z)/18:2(9Z,12Z))
TG(20:0/15:0/20:3n6)
trans-Octadec-2-enoyl-CoA
DG(16:0/20:2(11Z,14Z)/0:0)
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:0)
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PE(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
Ganglioside GT3 (d18:1/24:1(15Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/18:0)
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
Pergolide A diamine that is ergoline in which the beta-hydrogen at position 8 is replaced by a (methylthio)methyl group and the hydrogen attached to the piperidine nitrogen (position 6) is replaced by a propyl group. A dopamine D2 receptor agonist which also has D1 and D2 agonist properties, it is used as the mesylate salt in the management of Parkinson's disease, although it was withdrawn from the U.S. and Canadian markets in 2007 due to an increased risk of cardiac valve dysfunction.
PI(18:1(9Z)/18:1(11Z))
PE(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
LysoPE(20:2(11Z,14Z)/0:0)
TG(24:0/15:0/22:4(7Z,10Z,13Z,16Z))
CDP-DG(18:0/20:4(8Z,11Z,14Z,17Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:0/24:0/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:2(13Z,16Z)/20:2(11Z,14Z))
TG(18:0/o-18:0/16:1(9Z))
TG(22:0/18:3(9Z,12Z,15Z)/22:0)
TG(18:0/14:1(9Z)/20:0)
Methylmalonic acid A dicarboxylic acid that is malonic acid in which one of the methylene hydrogens is substituted by a methyl group.
TG(15:0/20:4(5Z,8Z,11Z,14Z)/20:0)
N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole
Ganglioside GT1c (d18:1/18:0)
TG(16:0/o-18:0/20:1(11Z))
Methylscopolamine
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
DG(16:0/20:4(5Z,8Z,11Z,14Z)/0:0)
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
Tinidazole 1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group. It is used as an antiprotozoal, antibacterial agent.
TG(18:0/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
TG(18:1(11Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
6-(N-Acetyl-alpha-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol The alpha-anomer of 6-(N-acetyl-D-glucosaminyl)-1-phosphatidyl-1D-myo-inositol.
TG(16:1(9Z)/20:3n6/18:1(9Z))
DG(18:4(6Z,9Z,12Z,15Z)/24:1(15Z)/0:0)
TG(18:0/24:1(15Z)/18:2(9Z,12Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(20:3n6/18:0/20:4(8Z,11Z,14Z,17Z))
3-Indolebutyric acid
PG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
Benzquinamide
TG(22:0/18:3(9Z,12Z,15Z)/24:0)
TG(22:4(7Z,10Z,13Z,16Z)/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(24:0/18:1(11Z)/14:1(9Z))
TG(14:1(9Z)/24:0/20:3n6)
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/18:3(9Z,12Z,15Z))
Iodide A monoatomic iodine that has formula I.
TG(20:1(11Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)/20:2n6)
TG(16:1(9Z)/14:1(9Z)/o-18:0)
PC(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PC(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/22:2(13Z,16Z))
Tamibarotene A tetralin that has formula C22H25NO3.
DG(20:1n9/0:0/20:4n3)
TG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
PE(16:0/22:2(13Z,16Z))
TG(20:2n6/18:3(6Z,9Z,12Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:0/o-18:0)
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
Ganglioside GA1 (d18:1/12:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:0/22:2(13Z,16Z))
TG(20:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/18:1(9Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/20:0/18:3(9Z,12Z,15Z))
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PC(P-18:1(9Z)/18:3(6Z,9Z,12Z))
PE(22:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/20:0/22:1(13Z))
PE(18:0/24:1(15Z))
TG(14:1(9Z)/20:0/18:1(11Z))
TG(22:0/20:0/20:3(5Z,8Z,11Z))
PI(20:2(11Z,14Z)/20:2(11Z,14Z))
TG(22:1(13Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
PC(20:0/20:4(8Z,11Z,14Z,17Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Liothyronine
TG(15:0/24:0/18:1(11Z))
PIP2(16:2(9Z,12Z)/18:0)
TG(18:4(6Z,9Z,12Z,15Z)/20:0/18:4(6Z,9Z,12Z,15Z))
Acetophenazine
TG(22:2(13Z,16Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(14:0/20:0/0:0)
PC(18:4(6Z,9Z,12Z,15Z)/15:0)
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/14:0/16:1(9Z))
DG(20:2(11Z,14Z)/24:0/0:0)
TG(18:1(11Z)/15:0/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:3n6/20:3(5Z,8Z,11Z))
TG(20:0/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
PC(20:2(11Z,14Z)/22:2(13Z,16Z))
TG(20:3n6/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:0/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:0/14:0/18:1(11Z))
TG(14:0/18:2(9Z,12Z)/20:0)
DG(14:0/0:0/18:2n6)
TG(18:3(6Z,9Z,12Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
DG(24:0/22:2(13Z,16Z)/0:0)
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
Citicoline
3-Dehydro-L-gulonate The conjugate base of 3-dehydro-L-gulonic acid; major species at pH 7.3.
PC(o-18:0/24:0)
DG(18:1(11Z)/22:1(13Z)/0:0)
Epinastine A benzazepine that is 6,11-dihydro-5H-dibenzo[b,e]azepine in which the azepine ring is fused to the e side of 4,5-dihydro-1H-imidazol-2-amine.
TG(14:0/18:1(11Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
PIP2(16:0/18:1(9Z))
PE(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
DG(14:1n5/0:0/18:3n6)
TG(16:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
DG(24:0/18:2(9Z,12Z)/0:0)
TG(18:1(9Z)/20:1(11Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/14:1(9Z)/18:2(9Z,12Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/14:1(9Z))
PE(P-18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:0)
TG(14:0/20:2n6/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/22:1(13Z))
TG(16:0/20:0/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/14:0/o-18:0)
TG(16:0/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
2,3-Dihydro-2-S-glutathionyl-3-hydroxy bromobenzene A peptide that has formula C16H22BrN3O7S.
TG(18:1(11Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/24:1(15Z)/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(15:0/o-18:0/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/20:2n6/20:2n6)
TG(18:0/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(9Z,12Z,15Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
PG(16:0/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/22:0/20:3n6)
TG(15:0/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
(6Z,9Z,12Z,15Z,18Z)-3-Hydroxytetracosapenta-6,9,12,15,18-enoyl-CoA A polyol that has formula C45H72N7O18P3S.
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(14:1(9Z)/22:1(13Z)/22:2(13Z,16Z))
TG(16:1(9Z)/15:0/22:2(13Z,16Z))
TG(22:0/22:1(13Z)/22:2(13Z,16Z))
PG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/0:0)
PE(20:2(11Z,14Z)/22:0)
TG(15:0/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
PC(20:1(11Z)/20:3(5Z,8Z,11Z))
TG(20:3n6/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(16:0/16:0)
PC(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
4,4-Dimethyl-5a-cholesta-8,24-dien-3-b-ol
PC(20:0/14:0)
TG(18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:3(5Z,8Z,11Z)/22:0)
TG(16:0/22:1(13Z)/24:0)
TG(18:1(9Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:2n6/o-18:0/20:3n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/o-18:0)
L-Glutamic acid An optically active form of glutamic acid having L-configuration.
TG(14:0/18:3(6Z,9Z,12Z)/18:2(9Z,12Z))
PG(18:2(9Z,12Z)/18:1(9Z))
TG(18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:0)
CE(22:2(13Z,16Z))
Parathion An organothiophosphate insecticide that has formula C10H14NO5PS.
TG(22:2(13Z,16Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(24:0/18:2(9Z,12Z)/20:2n6)
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
Acetaminophen
TG(22:1(13Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
PC(20:2(11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
DG(18:3(9Z,12Z,15Z)/20:0/0:0)
TG(22:1(13Z)/22:0/o-18:0)
TG(18:3(6Z,9Z,12Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(20:0/16:0)
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(20:2n6/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
CDP-DG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/20:1(11Z)/22:2(13Z,16Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/20:3n6/22:4(7Z,10Z,13Z,16Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
1-Hydroxypyrene A pyrene that has formula C16H10O.
PC(18:0/20:3(8Z,11Z,14Z))
PC(o-18:1(9Z)/24:0)
Lercanidipine
TG(18:0/18:0/18:0)
TG(24:0/15:0/20:4(5Z,8Z,11Z,14Z))
2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone
DG(16:0/0:0/18:0)
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:1(13Z)/22:0)
TG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/22:0/o-18:0)
PC(18:0/24:1(15Z))
PE(P-18:1(11Z)/20:3(8Z,11Z,14Z))
TG(14:0/20:1(11Z)/16:1(9Z))
PC(o-16:1(9Z)/18:0)
TG(14:0/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:3(6Z,9Z,12Z)/24:1(15Z)/0:0)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Trihexosylceramide (d18:1/20:0)
TG(20:3n6/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
DG(18:1n7/0:0/22:2n6)
Tetrahydrofolic acid A group of heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with one or more L-glutamic acid units.
L-Valine The L-enantiomer of valine.
TG(20:4(5Z,8Z,11Z,14Z)/18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/24:0/22:5(4Z,7Z,10Z,13Z,16Z))
D-Lactic acid
TG(18:1(11Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/18:1(11Z)/20:2n6)
TG(20:0/20:2n6/18:2(9Z,12Z))
TG(14:1(9Z)/20:1(11Z)/18:2(9Z,12Z))
TG(20:2n6/22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:0/20:3n6/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/22:0/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
DG(20:3(8Z,11Z,14Z)/20:2(11Z,14Z)/0:0)
PE(22:4(7Z,10Z,13Z,16Z)/15:0)
Atenolol An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
TG(20:2n6/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
PS(18:0/16:1(9Z))
Enflurane An ether in which the oxygen atom is connected to 2-chloro-1,1,2-trifluoroethyl and difluoromethyl groups.
TG(24:0/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/15:0)
PIP3(18:0/16:1(9Z))
TG(20:0/20:0/22:0)
TG(24:0/20:0/18:1(11Z))
TG(16:1(9Z)/20:3n6/20:3n6)
PE(22:5(7Z,10Z,13Z,16Z,19Z)/14:0)
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(16:1(9Z)/18:2(9Z,12Z))
Ganglioside GT2 (d18:1/18:0)
TG(14:1(9Z)/22:0/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
6-Thioinosine-5'-monophosphate
Androsterone glucuronide
TG(15:0/16:0/18:3(9Z,12Z,15Z))
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/o-18:0/20:4(8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/16:1(9Z)/20:2n6)
PC(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/24:0/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/14:1(9Z)/24:1(15Z))
TG(16:0/24:0/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:2n6/20:1(11Z))
TG(24:1(15Z)/18:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:0/15:0/20:5(5Z,8Z,11Z,14Z,17Z))
PC(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/20:1(11Z)/20:1(11Z))[iso3]
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
PC(16:0/P-18:0)
TG(20:0/20:0/20:0)
Epinephrine
P1,P4-Bis(5'-uridyl) tetraphosphate A pyrimidine ribonucleoside 5'-tetraphosphate compound having 5'-uridinyl residues at the P(1)- and P(4)-positions.
PE(22:1(13Z)/14:1(9Z))
TG(15:0/20:3n6/20:4(5Z,8Z,11Z,14Z))
Taurine An amino sulfonic acid that is the 2-amino derivative of ethanesulfonic acid. It is a naturally occurring amino acid derived from methionine and cysteine metabolism.
PC(P-18:0/20:3(5Z,8Z,11Z))
MG(20:3(5Z,8Z,11Z)/0:0/0:0)
N-Heptanoylglycine An N-acylglycine with an acyl group that is heptanoyl.
PE(P-18:1(11Z)/18:1(11Z))
PC(22:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(16:0/16:0)
TG(24:0/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
PE(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
DG(14:0/20:2(11Z,14Z)/0:0)
PE(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(18:1(9Z)/14:0/20:3n6)
Methacrylyl-CoA An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of methacrylic acid.
TG(24:1(15Z)/18:1(9Z)/22:2(13Z,16Z))
Homogentisic acid A dihydroxyphenylacetic acid having the two hydroxy substituents at the 2- and 5-positions.
TG(22:1(13Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
4,5-Dihydro-4-hydroxy-5-S-glutathionyl-benzo[a]pyrene A peptide that has formula C30H29N3O7S.
TG(18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/24:1(15Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
DG(24:1(15Z)/24:1(15Z)/0:0)
PE(20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z))
Pentagastrin
TG(15:0/20:1(11Z)/15:0)
TG(18:0/24:1(15Z)/18:1(9Z))
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/16:1(9Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
TG(18:1(11Z)/22:1(13Z)/18:1(9Z))
PIP3(16:0/16:0)
PS(14:0/20:3(8Z,11Z,14Z))
TG(14:0/22:1(13Z)/20:3n6)
PC(P-18:1(11Z)/18:3(9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/22:4(7Z,10Z,13Z,16Z)/20:0)
Ganglioside GQ1c (d18:0/25:0)
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:3n6)
TG(18:1(11Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PIP(20:1(11Z)/16:0)
TG(16:1(9Z)/18:0/22:2(13Z,16Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
SM(d18:0/24:1(15Z)(OH))
Clemastine 2-[(2R)-1-Methylpyrrolidin-2-yl]ethanol in which the hydrogen of the hydroxy group is substituted by a 1-(4-chlorophenyl)-1-phenylethyl group (R configuration). An antihistamine with antimuscarinic and moderate sedative properties, it is used as its fumarate salt for the symptomatic relief of allergic conditions such as rhinitis, urticaria, conjunctivitis and in pruritic (severe itching) skin conditions.
TG(20:2n6/16:0/18:3(9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
Ganglioside GD1a (d18:1/25:0)
TG(15:0/22:4(7Z,10Z,13Z,16Z)/18:1(11Z))
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:0/o-18:0/16:1(9Z))
TG(18:1(11Z)/18:0/20:3n6)
PC(P-18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
PC(15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:2n6/20:4(5Z,8Z,11Z,14Z))
TG(20:2n6/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(22:1(13Z)/22:1(13Z)/22:2(13Z,16Z))
TG(20:0/18:1(9Z)/24:0)
PC(14:0/16:1(9Z))
Prilocaine An amide-type local anaesthetic in which N-propyl-DL-alanine and 2-methylaniline have combined to form the amide bond.
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(18:4(6Z,9Z,12Z,15Z)/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/20:1(11Z))
TG(22:0/20:3n6/22:1(13Z))
TG(16:1(9Z)/16:1(9Z)/18:1(11Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/20:2n6)
TG(14:0/20:0/20:3n6)
PC(16:0/16:1(9Z))
TG(16:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(22:0/14:1(9Z)/20:3n6)
Lithocholyltaurine
Chloroquine An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
TG(18:2(9Z,12Z)/20:0/o-18:0)
TG(22:4(7Z,10Z,13Z,16Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
6-Hydroxymelatonin A member of the class of tryptamines that is melatonin with a hydroxy group substituent at position 6.
TG(16:1(9Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PIP2(18:1(11Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
3b,12a-Dihydroxy-5b-cholanoic acid
PE(20:1(11Z)/18:3(9Z,12Z,15Z))
DG(20:3n9/0:0/18:4n3)
TG(18:1(11Z)/24:0/18:1(9Z))
TG(16:0/18:0/18:3(6Z,9Z,12Z))
TG(14:0/20:3n6/18:0)
TG(14:0/16:0/20:4(8Z,11Z,14Z,17Z))
Ketazolam
PC(24:1(15Z)/15:0)
TG(20:3(5Z,8Z,11Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/20:3n6/16:0)
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(22:1(13Z)/18:1(9Z)/o-18:0)
TG(18:4(6Z,9Z,12Z,15Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
L-2,4-diaminobutyric acid A 2,4-diaminobutyric acid that has S-configuration.
TG(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(22:1(13Z)/18:4(6Z,9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
DG(15:0/16:1(9Z)/0:0)
PC(o-20:0/20:4(8Z,11Z,14Z,17Z))
LysoPC(10:0)
PC(20:2(11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/16:0/18:3(6Z,9Z,12Z))
Trabectedin A tetrahydroisoquinoline alkaloid obtained from a Caribbean tunicate Ecteinascidia turbinata. Used for the treatment of soft tissue sarcoma and relapsed ovarian cancer.
Retinyl beta-glucuronide
Flunarizine
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/20:3n6/18:3(9Z,12Z,15Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/16:0)
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:4(7Z,10Z,13Z,16Z))
TG(16:0/22:1(13Z)/20:3n6)
TG(18:3(6Z,9Z,12Z)/20:3n6/20:4(5Z,8Z,11Z,14Z))
PE(22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PS(18:3(9Z,12Z,15Z)/14:1(9Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
Deoxyribose 5-monophosphate
TG(15:0/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/20:1(11Z)/18:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
PC(18:1(11Z)/22:2(13Z,16Z))
TG(18:0/15:0/18:1(9Z))
PC(20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z))
TG(14:1(9Z)/20:2n6/18:1(11Z))
TG(18:0/14:0/20:4(5Z,8Z,11Z,14Z))
PC(18:4(6Z,9Z,12Z,15Z)/20:3(8Z,11Z,14Z))
TG(20:0/20:4(8Z,11Z,14Z,17Z)/18:2(9Z,12Z))
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(22:0/o-18:0/20:3(5Z,8Z,11Z))
TG(24:0/o-18:0/24:0)
TG(20:4(5Z,8Z,11Z,14Z)/15:0/22:2(13Z,16Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
PC(18:1(9Z)/24:1(15Z))
TG(18:0/20:0/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/15:0/20:3(5Z,8Z,11Z))
TG(18:1(9Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/14:0/22:4(7Z,10Z,13Z,16Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(14:1(9Z)/14:0/24:1(15Z))
TG(22:1(13Z)/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
Formyl-CoA An acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of formic acid.
Ethyl glucuronide
PIP2(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
DG(22:4(7Z,10Z,13Z,16Z)/15:0/0:0)
TG(22:0/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
Glycerol 3-phosphate
TG(18:0/18:1(11Z)/18:1(11Z))
TG(22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z))
DG(20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z)/0:0)
PC(18:3(6Z,9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/o-18:0/20:4(8Z,11Z,14Z,17Z))
Tartaric acid
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(20:1(11Z)/18:0/o-18:0)
Ganglioside GT1c (d18:1/23:0)
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
PE(P-16:0/14:0)
Diadenosine tetraphosphate
TG(14:0/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(20:0/20:0/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:0/20:4(8Z,11Z,14Z,17Z))
Aminoadipic acid
Pemetrexed
L-Canaline
1b,3a,7a-Trihydroxy-5b-cholanoic acid
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PE(15:0/18:0)
TG(18:1(11Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/24:0/20:1(11Z))
TG(24:0/20:2n6/20:3(5Z,8Z,11Z))
TG(24:0/20:2n6/18:3(9Z,12Z,15Z))
TG(14:0/18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(11Z)/18:3(6Z,9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(9Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/o-18:0)
TG(24:0/o-18:0/24:1(15Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
NNAL-N-glucuronide An amino acid that has formula C16H23N3O8.
TG(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Sulfolithocholic acid
TG(22:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:0/o-18:0)
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
Glucosylceramide (d18:1/22:0)
DG(24:0/0:0/22:1n9)
Glucosylceramide (d18:1/20:0)
TG(24:0/20:4(8Z,11Z,14Z,17Z)/16:1(9Z))
TG(22:4(7Z,10Z,13Z,16Z)/20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Spironolactone A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(24:0/18:3(9Z,12Z,15Z)/20:3n6)
TG(20:0/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(16:0/24:0/16:0)
TG(18:0/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
PE(22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
Eugenol
TG(14:0/22:0/22:2(13Z,16Z))
TG(24:0/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
PC(P-16:0/20:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GD2 (d18:0/18:1(9Z))
TG(20:0/20:3n6/22:1(13Z))
TG(22:1(13Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PC(20:3(5Z,8Z,11Z)/P-18:0)
TG(14:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:2(11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(20:1(11Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:2(13Z,16Z)/o-18:0)
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
Astemizole
PI(18:0/16:1(9Z))
TG(14:1(9Z)/24:1(15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/22:2(13Z,16Z)/22:2(13Z,16Z))
PG(18:1(11Z)/16:0)
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:0)
Tetrahexosylceramide (d18:1/9Z-18:1)
TG(16:0/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
TG(15:0/22:1(13Z)/22:2(13Z,16Z))
PS(16:1(9Z)/16:1(9Z))
TG(22:1(13Z)/22:2(13Z,16Z)/24:1(15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/18:0/18:3(9Z,12Z,15Z))
PC(14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
Tipranavir A pyridine-2-sulfonamide substituted at C-5 by a trifluoromethyl group and at the sulfonamide nitrogen by a dihydropyrone-containing m-tolyl substituent. It is an HIV-1 protease inhibitor.
TG(15:0/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
TG(14:0/18:0/20:2n6)
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z))
DG(20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
DG(24:1n9/0:0/22:5n3)
PC(16:0/P-18:1(11Z))
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:0)
TG(24:0/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
PC(22:5(7Z,10Z,13Z,16Z,19Z)/20:0)
TG(16:0/16:0/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/20:3n6)
TG(20:3(5Z,8Z,11Z)/14:0/24:1(15Z))
TG(22:0/22:0/20:3n6)
DG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
TG(18:0/22:2(13Z,16Z)/20:1(11Z))
PC(20:2(11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:0/18:1(9Z)/20:2n6)
Galactinol
TG(18:1(11Z)/14:1(9Z)/20:3(5Z,8Z,11Z))
4a-Methylfecosterol
2-(S-Glutathionyl)acetyl glutathione A peptide that has formula C22H34N6O13S2.
TG(14:1(9Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
Estriol 3-sulfate 16-glucuronide
Phenylacetic acid A monocarboxylic acid that is benzene substituted with a carboxymethyl functional group.
TG(20:1(11Z)/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/22:1(13Z)/14:1(9Z))
TG(22:1(13Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:1(15Z)/20:0/18:2(9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
DG(14:0/0:0/14:1n5)
TG(20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/18:3(9Z,12Z,15Z)/20:2n6)
TG(18:1(11Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
17a,21-Dihydroxypreg-nenolone
TG(20:1(11Z)/24:1(15Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:2n6/20:2n6/18:3(9Z,12Z,15Z))
PC(20:0/18:2(9Z,12Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:0/18:3(9Z,12Z,15Z))[iso6]
PIP2(16:2(9Z,12Z)/22:3(10Z,13Z,16Z))
TG(22:0/22:4(7Z,10Z,13Z,16Z)/18:1(9Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(6Z,9Z,12Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/24:1(15Z)/18:1(9Z))
TG(24:1(15Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(18:2n6/0:0/22:6n3)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(15:0/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(20:3n6/20:3n6/18:3(9Z,12Z,15Z))
DG(14:1(9Z)/14:1(9Z)/0:0)
DG(20:1n9/0:0/22:6n3)
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/14:0/18:1(11Z))[iso6]
TG(14:1(9Z)/16:0/20:1(11Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:0/16:0)
PE(20:2(11Z,14Z)/15:0)
TG(18:1(9Z)/20:0/o-18:0)
TG(20:0/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
PE(20:4(5Z,8Z,11Z,14Z)/P-18:0)
TG(22:0/24:0/22:2(13Z,16Z))
TG(14:0/20:0/14:0)
TG(20:3n6/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
PC(18:4(6Z,9Z,12Z,15Z)/16:1(9Z))
PS(18:0/20:4(8Z,11Z,14Z,17Z))
15,15'-Dihydroxy-beta-carotene A carotenol obtained by formal dihydroxylation across the 15,15'-double bond of beta-carotene.
TG(20:0/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
N-Acetyl-D-glucosamine The pyranose form of N-acetyl-D-glucosamine.
PE(P-18:0/22:1(13Z))
DG(14:0/0:0/16:0)
1,2-Dibromoethane A bromoalkane that is ethane carrying bromo substituents at positions 1 and 2. It is produced by marine algae.
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(16:1(9Z)/24:1(15Z)/22:1(13Z))
TG(16:0/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
TG(20:1(11Z)/14:0/20:4(5Z,8Z,11Z,14Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/20:2n6/22:1(13Z))
TG(18:1(11Z)/20:0/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
Benzatropine Tropane in which a hydrogen at position 3 is substituted by a diphenylmethoxy group (endo-isomer). An acetylcholine receptor antagonist, it is used (particularly as its methanesulphonate salt) in the treatment of Parkinson's disease, and to reduce parkinsonism and akathisia side effects of antipsychotic treatments.
1-Pyrroline-2-carboxylic acid The product resulting from formal oxidation of DL-proline by loss of hydrogen from the nitrogen and from the carbon alpha to the carboxylic acid, with the formation of a C=N bond.
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/0:0)
3a,7a-Dihydroxy-5b-cholestanoyl-CoA
TG(20:1(11Z)/20:3n6/22:2(13Z,16Z))
Coumarin
TG(16:1(9Z)/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(15:0/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
Guanosine triphosphate
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/24:1(15Z))
TG(16:1(9Z)/18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
Nickel Chemical element (nickel group element atom) with atomic number 28.
Sevoflurane An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
TG(16:0/22:2(13Z,16Z)/18:0)
Quinolinic acid A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.
TG(14:1(9Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
PE(20:3(8Z,11Z,14Z)/22:0)
Fluphenazine A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.
Phenylpyruvic acid
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
TG(20:3n6/20:3(5Z,8Z,11Z)/22:2(13Z,16Z))
TG(20:0/o-18:0/20:4(8Z,11Z,14Z,17Z))
PC(P-16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/16:1(9Z)/22:0)
TG(18:0/18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:0)
PE(14:0/20:3(5Z,8Z,11Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:0)
TG(24:0/18:3(9Z,12Z,15Z)/18:2(9Z,12Z))
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PE(P-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/20:3n6/22:5(4Z,7Z,10Z,13Z,16Z))
PC(24:1(15Z)/22:1(13Z))
DG(22:5n6/0:0/20:4n3)
TG(18:1(11Z)/20:1(11Z)/18:2(9Z,12Z))
Aminofructose 6-phosphate A phospho sugar that has formula C6H14NO8P.
TG(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:1(9Z)/18:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/22:0)
TG(16:1(9Z)/22:4(7Z,10Z,13Z,16Z)/20:3n6)
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
Epimelibiose A glycosylgalactose composed of alpha-D-mannopyranose and alpha-D-galactopyranose units.
Caffeic acid A hydroxycinnamic acid that is cinnamic acid in which the phenyl ring is substituted by hydroxy groups at positions 3 and 4. It exists in cis and trans forms; the latter is the more common.
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso3]
TG(20:1(11Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(22:0/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(18:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))[iso6]
DG(22:5(7Z,10Z,13Z,16Z,19Z)/18:0/0:0)
TG(18:2(9Z,12Z)/22:1(13Z)/18:3(6Z,9Z,12Z))
TG(14:0/20:3(5Z,8Z,11Z)/16:1(9Z))
TG(18:1(11Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:1(11Z)/18:2(9Z,12Z))
TG(14:0/o-18:0/18:1(11Z))
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(16:1(9Z)/24:0/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/o-18:0)
TG(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
DG(22:1n9/0:0/22:4n6)
TG(18:0/20:3(5Z,8Z,11Z)/24:1(15Z))
TG(18:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/18:1(9Z)/18:1(11Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/20:2n6)
TG(18:2(9Z,12Z)/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Desogestrel
TG(18:1(9Z)/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/16:1(9Z)/20:3(5Z,8Z,11Z))
TG(20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
DG(15:0/0:0/18:2n6)
TG(20:2n6/20:0/20:3n6)
TG(22:2(13Z,16Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
TG(20:0/o-18:0/18:1(9Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
PE(20:4(8Z,11Z,14Z,17Z)/15:0)
Diphenoxylate A piperidinecarboxylate ester that is the ethyl ester of difenoxin.
Ethinamate
TG(20:0/14:0/20:1(11Z))
TG(24:1(15Z)/20:3n6/24:1(15Z))
PC(18:2(9Z,12Z)/22:2(13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
3,17-Androstanediol glucuronide
TG(14:0/18:1(11Z)/18:1(9Z))
TG(24:0/24:1(15Z)/20:1(11Z))
DG(22:4(7Z,10Z,13Z,16Z)/18:0/0:0)
TG(14:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:0/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/20:3n6/22:2(13Z,16Z))
TG(18:0/22:2(13Z,16Z)/24:0)
TG(18:1(9Z)/15:0/20:4(5Z,8Z,11Z,14Z))
TG(14:0/18:2(9Z,12Z)/20:2n6)
TG(20:3n6/20:2n6/22:2(13Z,16Z))
TG(20:3n6/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z))
TG(24:0/22:5(7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/P-18:1(11Z))
PC(P-18:1(11Z)/18:0)
PC(20:1(11Z)/18:1(9Z))
TG(22:0/14:0/20:4(8Z,11Z,14Z,17Z))
PG(18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
TG(18:3(6Z,9Z,12Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Dexfenfluramine
PC(20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
Dexrazoxane A razoxane that has formula C11H16N4O4.
TG(14:1(9Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
TG(22:1(13Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Metoprolol A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
TG(14:0/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
Propanal An aldehyde that consists of ethane bearing a formyl substituent. The parent of the class of propanals.
PC(18:4(6Z,9Z,12Z,15Z)/P-16:0)
Mitiglinide
TG(22:0/14:0/20:4(5Z,8Z,11Z,14Z))
CE(14:0)
TG(20:1(11Z)/14:0/20:4(8Z,11Z,14Z,17Z))
TG(24:1(15Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
TG(16:1(9Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z)/o-18:0)
TG(20:3(5Z,8Z,11Z)/16:0/24:1(15Z))
5,10-Methenyltetrahydrofolic acid
(R)-3-Hydroxy-hexadecanoic acid
Enprofylline Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Dicyclomine The ester resulting from the formal condensation of 1-cyclohexylcyclohexanecarboxylic acid with 2-(diethylamino)ethanol. An anticholinergic, it is used as the hydrochloride to treat or prevent spasm in the muscles of the gastrointestinal tract, particularly that associated with irritable bowel syndrome.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
3-Polyprenyl-4-hydroxy-5-methoxybenzoate
PE(20:0/18:0)
PC(20:1(11Z)/22:2(13Z,16Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
PC(24:0/20:3(5Z,8Z,11Z))
CE(16:0)
TG(18:2(9Z,12Z)/24:1(15Z)/22:2(13Z,16Z))
TG(22:2(13Z,16Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))[iso3]
TG(20:4(5Z,8Z,11Z,14Z)/16:0/18:4(6Z,9Z,12Z,15Z))
DG(22:0/0:0/24:0)
TG(20:0/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
DG(20:3(8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/0:0)
TG(22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:3(9Z,12Z,15Z))
PE(20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
TG(18:1(11Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/18:3(9Z,12Z,15Z)/20:2n6)
Glycine The simplest (and the only achiral) proteinogenic amino acid, with a hydrogen atom as its side chain.
TG(18:1(9Z)/20:2n6/24:1(15Z))
TG(20:0/18:2(9Z,12Z)/20:0)
Diltiazem A 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate in which both stereocentres have S configuration. A calcium-channel blocker and vasodilator, it is used as the hydrochloride in the management of angina pectoris and hypertension.
TG(20:1(11Z)/16:0/18:4(6Z,9Z,12Z,15Z))
DG(24:1(15Z)/18:0/0:0)
TG(20:0/18:2(9Z,12Z)/22:0)
TG(22:1(13Z)/18:3(9Z,12Z,15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:1(13Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
CL(18:2(9Z,12Z)/18:1(11Z)/18:1(9Z)/16:0)
Trans-3-hydroxy-L-proline The (3S)-trans-diastereomer of 3-hydroxy-L-proline.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
PG(16:0/18:3(6Z,9Z,12Z))
TG(18:0/20:3(5Z,8Z,11Z)/16:1(9Z))
TG(18:1(9Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
3-Hydroxyhippuric acid
TG(20:1(11Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GM2 (d18:0/14:0)
TG(14:0/20:1(11Z)/20:1(11Z))
TG(22:2(13Z,16Z)/20:1(11Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(15:0/18:0/16:1(9Z))
TG(20:3n6/16:1(9Z)/o-18:0)
TG(22:0/o-18:0/18:1(11Z))
PC(20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z))
TG(22:0/24:0/18:3(6Z,9Z,12Z))
PIP(18:0/18:3(6Z,9Z,12Z))
PE(22:1(13Z)/20:3(8Z,11Z,14Z))
TG(20:1(11Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:2n6/22:4(7Z,10Z,13Z,16Z))
TG(18:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GT2 (d18:0/18:1(11Z))
TG(24:1(15Z)/20:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(8Z,11Z,14Z,17Z)/o-18:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:2n6/18:3(6Z,9Z,12Z)/22:2(13Z,16Z))
TG(22:0/18:1(11Z)/24:0)
TG(18:1(11Z)/14:0/20:2n6)
DG(16:1(9Z)/20:3(5Z,8Z,11Z)/0:0)
PE(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS(20:3(8Z,11Z,14Z)/18:0)
PE(14:1(9Z)/14:0)
TG(14:0/20:0/22:2(13Z,16Z))
TG(18:0/o-18:0/14:1(9Z))
Halofuginone
PE(14:1(9Z)/16:0)
DG(15:0/14:1(9Z)/0:0)
TG(18:2(9Z,12Z)/22:2(13Z,16Z)/o-18:0)
TG(20:2n6/22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
PS(20:3(8Z,11Z,14Z)/16:0)
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PC(14:1(9Z)/18:1(9Z))
TG(20:3(5Z,8Z,11Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Ganglioside GA2 (d18:1/16:0)
1,2-Dioctadecanoyl-3-(galactosyl-B-1-6-galactosyl-B-1)-glycerol
TG(22:0/24:1(15Z)/14:1(9Z))
TG(18:3(6Z,9Z,12Z)/22:0/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(14:0/14:1(9Z)/18:2(9Z,12Z))
TG(14:0/14:1(9Z)/20:1(11Z))
N(6)-(1,2-dicarboxyethyl)AMP The N(6)-(1,2-dicarboxyethyl) derivative of adenosine 5'-monophosphate.
PIP2(18:0/16:2(9Z,12Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
PC(18:2(9Z,12Z)/P-18:1(9Z))
Isovalerylglucuronide
TG(15:0/20:3n6/18:1(11Z))
TG(22:1(13Z)/20:3n6/18:2(9Z,12Z))
LysoPC(0:0/18:0)
TG(18:1(11Z)/18:4(6Z,9Z,12Z,15Z)/20:2n6)
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/20:0)
TG(18:2(9Z,12Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(22:1(13Z)/24:1(15Z)/22:2(13Z,16Z))
MG(14:0/0:0/0:0)
TG(20:0/20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
TG(20:3n6/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
PE(14:1(9Z)/20:4(5Z,8Z,11Z,14Z))
5-L-Glutamyl-taurine
TG(18:0/14:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
PE(18:0/20:1(11Z))
TG(20:0/18:1(11Z)/18:3(9Z,12Z,15Z))
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/14:1(9Z))
DG(18:1(11Z)/16:1(9Z)/0:0)
PE(20:2(11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/22:2(13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
PE(22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
Ceftizoxime
PC(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(15:0/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
PE(20:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:0/18:0/18:1(11Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/24:1(15Z))
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(24:1(15Z)/24:0/20:5(5Z,8Z,11Z,14Z,17Z))
MG(0:0/18:1(9Z)/0:0)
TG(14:1(9Z)/24:0/18:2(9Z,12Z))
DG(14:0/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/16:1(9Z)/o-18:0)
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z))
TG(20:0/20:3n6/22:2(13Z,16Z))
TG(16:0/16:1(9Z)/18:0)[iso6]
TG(18:3(9Z,12Z,15Z)/18:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
DG(24:1(15Z)/22:0/0:0)
DG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/0:0)
TG(14:0/18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))
dermatan L-iduronate
PC(22:5(4Z,7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))
TG(18:0/16:0/16:1(9Z))
3a,6b,7b-Trihydroxy-5b-cholanoic acid
TG(20:2n6/18:2(9Z,12Z)/22:2(13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/20:0/22:5(7Z,10Z,13Z,16Z,19Z))
Dexamethasone A fluorinated steroid that is 9-fluoropregna-1,4-diene substituted by hydroxy groups at positions 11, 17 and 21, a methyl group at position 16 and oxo groups at positions 3 and 20. It is a synthetic member of the class of glucocorticoids.
11b,21-Dihydroxy-3,20-oxo-5b-pregnan-18-al
TG(20:0/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(6Z,9Z,12Z))
PC(o-14:0/16:0)
TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/o-18:0/22:2(13Z,16Z))
TG(15:0/16:1(9Z)/24:0)
TG(16:1(9Z)/20:2n6/20:5(5Z,8Z,11Z,14Z,17Z))
PI(18:3(9Z,12Z,15Z)/18:1(11Z))
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(14:0/16:1(9Z)/15:0)
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
TG(18:0/18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z))
Ganglioside GD1a (d18:0/22:1(13Z))
DG(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
DG(24:0/0:0/14:1n5)
TG(18:0/20:4(8Z,11Z,14Z,17Z)/22:2(13Z,16Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:1(11Z)/22:1(13Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(22:4(7Z,10Z,13Z,16Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:3(5Z,8Z,11Z)/18:0)
TG(20:0/16:1(9Z)/o-18:0)
TG(16:0/20:3n6/20:3n6)
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:2(13Z,16Z)/24:1(15Z)/22:2(13Z,16Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z))
TG(16:1(9Z)/14:1(9Z)/20:3(5Z,8Z,11Z))
TG(24:0/18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:2n6)
TG(14:0/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
Levocabastine
TG(14:0/15:0/20:3(5Z,8Z,11Z))
TG(24:1(15Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
PE(18:3(6Z,9Z,12Z)/P-16:0)
TG(22:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:3n6)
PC(P-16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
SM(d16:1/24:1(15Z))
TG(14:0/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:2n6/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/16:1(9Z)/22:1(13Z))
TG(18:1(11Z)/24:0/o-18:0)
Levomethadyl Acetate
Ticagrelor
TG(20:4(5Z,8Z,11Z,14Z)/14:0/18:3(9Z,12Z,15Z))[iso6]
PC(20:5(5Z,8Z,11Z,14Z,17Z)/20:0)
Thymidine 3',5'-cyclic monophosphate
PC(P-18:0/20:2(11Z,14Z))
TG(24:1(15Z)/24:0/20:4(8Z,11Z,14Z,17Z))
TG(16:0/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
PG(18:0/18:1(9Z))
TG(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
PS(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/15:0/20:4(8Z,11Z,14Z,17Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GD1b (d18:1/18:1(9Z))
TG(18:3(6Z,9Z,12Z)/22:0/20:2n6)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/18:0)
TG(18:2(9Z,12Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]
TG(16:1(9Z)/18:1(11Z)/18:1(9Z))
TG(14:0/15:0/18:1(9Z))
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Bifonazole
TG(22:0/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
PI(18:3(9Z,12Z,15Z)/22:3(10Z,13Z,16Z))
TG(16:0/16:1(9Z)/18:1(11Z))
TG(22:2(13Z,16Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/20:0)
TG(18:1(11Z)/20:2n6/22:1(13Z))
Methohexital A barbiturate, the structure of which is that of barbituric acid substituted at N-1 by a methyl group and at C-5 by allyl and 1-methylpent-2-ynyl groups.
TG(15:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:1(11Z))
TG(24:1(15Z)/18:1(11Z)/o-18:0)
TG(15:0/20:1(11Z)/20:2n6)
TG(22:1(13Z)/22:0/20:3n6)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/20:4(8Z,11Z,14Z,17Z)/24:0)
Hydroxycotinine
PG(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
PE(24:0/20:3(8Z,11Z,14Z))
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/14:1(9Z)/18:0)
TG(20:0/18:1(9Z)/16:1(9Z))
PE(22:4(7Z,10Z,13Z,16Z)/16:1(9Z))
TG(18:0/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(16:1(9Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/18:1(9Z)/20:3(5Z,8Z,11Z))
TG(18:0/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:2(9Z,12Z)/20:2n6/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/22:0/20:4(8Z,11Z,14Z,17Z))
Inosine A purine nucleoside in which hypoxanthine is attached to ribofuranose via a beta-N(9)-glycosidic bond.
Bethanidine
N1-Acetylspermidine An acetylspermidine having the acetyl group at the N1-position.
9-cis-Retinoic acid A retinoic acid in which the exocyclic double bonds have 7E,9Z,11E,13E geometry.
TG(24:0/20:3n6/22:2(13Z,16Z))
TG(18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/22:1(13Z))
SM(d18:0/18:1(11Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PS(18:0/18:0)
PE(22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/22:5(7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:0/18:1(11Z)/24:1(15Z))
TG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:0/18:4(6Z,9Z,12Z,15Z)/18:0)
TG(15:0/20:4(8Z,11Z,14Z,17Z)/18:1(9Z))
TG(22:0/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
Homocarnosine A modified histidine derivative with a aminobutanoyl group substituted on the alpha-amino group.
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/16:0/18:0)[iso3]
TG(15:0/20:0/18:0)
3,7-Dimethyluric acid An oxopurine that is 7,9-dihydro-1H-purine-2,6,8(3H)-trione substituted by methyl groups at N-3 and N-7.
TG(24:1(15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PIP2(22:5(7Z,10Z,13Z,16Z,19Z)/16:0)
TG(18:1(9Z)/18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/22:1(13Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Citric acid A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
TG(24:1(15Z)/20:2n6/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
PI(20:4(8Z,11Z,14Z,17Z)/18:1(11Z))
TG(22:4(7Z,10Z,13Z,16Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/20:3n6/20:4(8Z,11Z,14Z,17Z))
Homo-L-arginine
Xylulose 5-phosphate A xylulose phosphate carrying a phospahte group at position 5. It is an intermediate metabolite in the pentose phosphate pathway.
TG(20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
3-Oxododecanoyl-CoA
TG(24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
DG(16:0/22:0/0:0)
Fluvoxamine A 5-methoxyvalerophenone O-(2-aminoethyl)oxime that has formula C15H21F3N2O2.
TG(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/22:0/18:3(9Z,12Z,15Z))
Selenohomocysteine A selenoamino acid that is the selenium analogue of L-homocysteine.
TG(18:1(11Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:1(13Z)/o-18:0/22:1(13Z))
Gulonic acid A hexonic acid formed by oxidising the aldehyde group of gulose to a carboxylic acid group.
TG(16:1(9Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PE(15:0/15:0)
TG(20:1(11Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z))
Ganglioside GD2 (d18:0/12:0)
TG(22:5(7Z,10Z,13Z,16Z,19Z)/18:0/o-18:0)
Estazolam A triazolo[4,3-a][1,4]benzodiazepine having a phenyl group at position 6 and a chloro substituent at position 8. A short-acting benzodiazepine with general properties similar to diazepam, it is given by mouth as a hypnotic in the short-term management of insomnia.
TG(24:1(15Z)/20:3n6/18:2(9Z,12Z))
TG(22:4(7Z,10Z,13Z,16Z)/24:0/18:4(6Z,9Z,12Z,15Z))
PS(16:0/20:4(5Z,8Z,11Z,14Z))
PG(16:1(9Z)/18:2(9Z,12Z))
TG(20:3n6/20:0/20:4(5Z,8Z,11Z,14Z))
TG(16:1(9Z)/18:0/18:1(11Z))[iso6]
Guanosine diphosphate mannose
TG(20:3(5Z,8Z,11Z)/18:1(9Z)/22:1(13Z))
TG(18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(14:1(9Z)/24:1(15Z)/18:3(9Z,12Z,15Z))
TG(14:1(9Z)/14:1(9Z)/18:1(9Z))
PE(18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
TG(18:1(9Z)/15:0/20:3(5Z,8Z,11Z))
DG(22:0/16:0/0:0)
TG(22:2(13Z,16Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PI(18:0/22:4(10Z,13Z,16Z,19Z))
TG(22:0/18:0/22:1(13Z))
TG(15:0/22:2(13Z,16Z)/24:1(15Z))
TG(18:0/18:0/24:1(15Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
DG(18:4(6Z,9Z,12Z,15Z)/20:3(8Z,11Z,14Z)/0:0)
Trimethylamine N-oxide An N-oxide derived from triethylamine.
PE(14:1(9Z)/15:0)
TG(22:0/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(20:0/20:2n6/20:3(5Z,8Z,11Z))
TG(24:0/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Allylestrenol
PI(18:0/16:2(9Z,12Z))
TG(14:0/18:0/20:3(5Z,8Z,11Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
DG(14:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
DG(18:0/0:0/18:3n3)
PE(P-18:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:2(13Z,16Z)/18:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:0/18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/20:2n6/18:0)
TG(18:1(9Z)/14:1(9Z)/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/24:1(15Z))
Ganglioside GA1 (d18:1/26:0)
DG(20:2n6/0:0/18:4n3)
6-Methylmercaptopurine
TG(20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/18:1(9Z)/18:3(6Z,9Z,12Z))
TG(22:0/22:2(13Z,16Z)/22:1(13Z))
TG(16:0/22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PIP2(18:2(9Z,12Z)/20:2(11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:0/o-18:0)
TG(16:1(9Z)/20:1(11Z)/20:3(5Z,8Z,11Z))
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
24-Methylenelophenol
TG(18:1(9Z)/18:1(11Z)/22:1(13Z))
Tizanidine 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.
TG(18:3(9Z,12Z,15Z)/18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/16:1(9Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/22:0/18:2(9Z,12Z))
TG(22:0/18:0/16:1(9Z))
TG(22:0/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(22:2(13Z,16Z)/22:1(13Z)/0:0)
TG(18:2(9Z,12Z)/14:0/o-18:0)
DG(18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)/0:0)
TG(20:1(11Z)/18:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/0:0)
DG(15:0/18:2(9Z,12Z)/0:0)
TG(18:3(9Z,12Z,15Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(22:0/0:0/22:4n6)
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0)
TG(16:0/o-18:0/22:1(13Z))
TG(24:1(15Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
8-Methoxykynurenate
TG(18:0/14:1(9Z)/14:1(9Z))
Uroporphyrinogen III An uroporphyrinogen that has formula C40H44N4O16.
TG(18:1(11Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/22:2(13Z,16Z))
Ganglioside GT3 (d18:1/24:0)
TG(22:1(13Z)/16:1(9Z)/18:2(9Z,12Z))
TG(20:0/18:3(9Z,12Z,15Z)/18:1(9Z))
DG(18:3(6Z,9Z,12Z)/18:2(9Z,12Z)/0:0)
TG(20:2n6/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
N-Acetylneuraminic acid 9-phosphate An amino sugar phosphate that has formula C11H20NO12P.
Ganglioside GT3 (d18:1/26:0)
TG(16:0/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/18:2(9Z,12Z)/14:1(9Z))
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)
TG(20:3(5Z,8Z,11Z)/20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z))
TG(24:1(15Z)/18:1(11Z)/20:3n6)
TG(22:4(7Z,10Z,13Z,16Z)/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PC(18:0/14:1(9Z))
Succinic acid semialdehyde
TG(14:1(9Z)/20:2n6/16:1(9Z))
DG(22:2(13Z,16Z)/18:1(11Z)/0:0)
DG(20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
(S)-Hydroxyhexanoyl-CoA
PE(15:0/18:1(9Z))
PI(18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
PI(18:3(6Z,9Z,12Z)/18:1(9Z))
TG(14:0/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(14:0/18:3(9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PG(16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:1(9Z)/18:0/22:4(7Z,10Z,13Z,16Z))
D-Glucurono-6,3-lactone A glucuronolactone that has formula C6H8O6.
TG(22:1(13Z)/18:1(9Z)/22:1(13Z))
TG(14:1(9Z)/20:4(5Z,8Z,11Z,14Z)/20:2n6)
TG(18:1(9Z)/18:4(6Z,9Z,12Z,15Z)/o-18:0)
2-Oxo-3-hydroxy-4-phosphobutanoic acid
TG(16:1(9Z)/18:3(6Z,9Z,12Z)/22:1(13Z))
TG(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3(5Z,8Z,11Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/22:0/o-18:0)
Guanosine diphosphate
TG(20:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
TG(16:0/22:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:2n6/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
TG(22:1(13Z)/18:1(9Z)/20:3n6)
TG(18:1(11Z)/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
NADH A coenzyme found in all living cells; consists of two nucleotides joined through their 5'-phosphate groups, with one nucleotide containing an adenine base and the other containing nicotinamide.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(22:5(7Z,10Z,13Z,16Z,19Z)/22:0/o-18:0)
NADP
TG(22:0/18:3(9Z,12Z,15Z)/16:1(9Z))
Thiocyanate A pseudohalide anion obtained by deprotonation of the thiol group of thiocyanic acid.
TG(20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:0)
TG(16:1(9Z)/15:0/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/22:1(13Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:1(13Z)/20:2n6/18:2(9Z,12Z))
TG(18:2(9Z,12Z)/16:1(9Z)/18:2(9Z,12Z))
TG(14:1(9Z)/18:3(6Z,9Z,12Z)/16:1(9Z))
TG(22:1(13Z)/20:4(8Z,11Z,14Z,17Z)/20:3n6)
Chlorzoxazone A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
TG(24:0/24:0/18:4(6Z,9Z,12Z,15Z))
PE(P-18:1(11Z)/14:1(9Z))
cis-4-Hydroxy-D-proline D-proline in which a hydrogen at the 4-position of the pyrrolidine ring is substituted by a hydroxy group (R-configuration).
PI(18:2(9Z,12Z)/20:2(11Z,14Z))
DG(22:2(13Z,16Z)/24:1(15Z)/0:0)
TG(14:0/20:0/20:2n6)
Lomustine
TG(18:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:0/18:3(6Z,9Z,12Z)/16:1(9Z))
Ipratropium bromide The anhydrous form of the bromide salt of ipratropium. An anticholinergic drug, ipratropium bromide blocks the muscarinic cholinergic receptors in the smooth muscles of the bronchi in the lungs. This opens the bronchi, so providing relief in chronic obstructive pulmonary disease and acute asthma.
TG(20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z))
Torasemide An N-sulfonylurea obtained by formal condensation of [(3-methylphenyl)amino]pyridine-3-sulfonic acid with the free amino group of N-isopropylurea.
Carboplatin A platinum coordination entity with cis square-planar geometry in which platinum(II) is coordinated to two ammonia ligands and a bidentate cyclobutane-1,1-dicarboxylate ligand.
TG(22:0/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
Ganglioside GD2 (d18:1/26:1(15Z))
TG(16:0/22:0/20:2n6)
PC(16:1(9Z)/18:1(9Z))
TG(20:1(11Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
PS(20:3(8Z,11Z,14Z)/18:3(9Z,12Z,15Z))
Docosanoyl-CoA An acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of behenoyl-CoA; major species at pH 7.3.
TG(22:5(7Z,10Z,13Z,16Z,19Z)/15:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Bacitracin A mixture of at least nine closely related homodetic cyclic peptides produced by Bacillus subtilis and B. licheniformis, which is particularly active against Gram-positive bacteria.
TG(22:2(13Z,16Z)/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:0/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z))
Glycochenodeoxycholate-3-sulfate
Benzoyl phosphate An acyl monophosphate that has formula C7H7O5P.
TG(20:3(5Z,8Z,11Z)/20:2n6/22:2(13Z,16Z))
TG(14:1(9Z)/20:0/o-18:0)
TG(18:0/14:0/18:1(9Z))[iso6]
TG(16:0/24:0/20:4(8Z,11Z,14Z,17Z))
Danazol A 17beta-hydroxy steroid that has formula C22H27NO2.
Mefloquine A racemate composed of (+)-(11R,2'S)- and (-)-(11S,2'R)-enantiomers of mefloquine. An antimalarial agent which acts as a blood schizonticide; its mechanism of action is unknown.
TG(22:0/22:1(13Z)/o-18:0)
TG(20:0/18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z))
DG(20:3(5Z,8Z,11Z)/18:3(6Z,9Z,12Z)/0:0)
LysoPE(20:3(11Z,14Z,17Z)/0:0)
PI(18:1(9Z)/18:3(6Z,9Z,12Z))
TG(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
Resveratrol
DG(22:5(4Z,7Z,10Z,13Z,16Z)/18:1(11Z)/0:0)
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/24:1(15Z))
TG(20:1(11Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
PE(14:0/P-16:0)
Aldophosphamide A nitrogen mustard that has formula C7H15Cl2N2O3P.
TG(16:0/22:0/18:4(6Z,9Z,12Z,15Z))
TG(18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/20:3(5Z,8Z,11Z)/20:1(11Z))
5-Deoxyribose-1-phosphate
TG(20:3n6/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/14:1(9Z)/18:2(9Z,12Z))
Protoporphyrinogen IX A porphyrinogen that has formula C34H40N4O4.
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/16:1(9Z)/22:2(13Z,16Z))
DG(22:0/22:2(13Z,16Z)/0:0)
TG(18:3(9Z,12Z,15Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(20:1(11Z)/o-18:0/18:3(6Z,9Z,12Z))
PE(P-16:0/22:1(13Z))
TG(22:1(13Z)/24:0/22:2(13Z,16Z))
TG(20:3n6/20:5(5Z,8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:3(6Z,9Z,12Z)/14:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PS(16:0/14:1(9Z))
TG(18:4(6Z,9Z,12Z,15Z)/20:0/o-18:0)
TG(16:1(9Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Ganglioside GT1b (d18:0/20:0)
DG(20:1(11Z)/16:0/0:0)
PS(16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
TG(20:0/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/18:0/24:1(15Z))
Dolasetron
TG(20:1(11Z)/22:1(13Z)/22:2(13Z,16Z))
TG(16:1(9Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/o-18:0)
TG(16:1(9Z)/22:2(13Z,16Z)/24:1(15Z))
DG(15:0/22:1(13Z)/0:0)
Tetrahydrocorticosterone A 21-hydroxy steroid that has formula C21H34O4.
Escitalopram
17-HETE A HETE that consists of arachidonic acid bearing an additional hydroxy substituent at position 17.
TG(24:1(15Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z))
TG(20:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/20:2n6)
TG(18:0/16:0/20:4(5Z,8Z,11Z,14Z))
PIP2(18:1(11Z)/18:3(9Z,12Z,15Z))
CE(20:4(8Z,11Z,14Z,17Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
MG(0:0/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(18:3(9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(22:0/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(18:0/14:0/24:1(15Z))
DG(15:0/0:0/18:3n3)
TG(14:0/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/18:1(9Z)/20:1(11Z))[iso6]
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(24:0/16:0/20:3(5Z,8Z,11Z))
Nicotinate D-ribonucleoside
Ganglioside GD2 (d18:0/25:0)
PC(P-16:0/22:4(7Z,10Z,13Z,16Z))
4-Phosphopantothenoylcysteine
trans-3-Hexenoyl-CoA
TG(22:1(13Z)/20:3n6/18:4(6Z,9Z,12Z,15Z))
TG(20:0/22:5(4Z,7Z,10Z,13Z,16Z)/18:3(6Z,9Z,12Z))
TG(14:0/16:1(9Z)/16:1(9Z))
DG(18:0/0:0/20:0)
(R)-b-aminoisobutyric acid
DG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/0:0)
TG(20:3(5Z,8Z,11Z)/20:1(11Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GD2 (d18:1/24:0)
TG(18:0/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(24:0/20:5(5Z,8Z,11Z,14Z,17Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:2(9Z,12Z)/22:0/20:4(5Z,8Z,11Z,14Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z)/o-18:0)
3-Methylthiopropionic acid A thia fatty acid acid consisting of propionic acid with a methylthio substituent at the 3-position; an intermediate in mammalian methionine metabolism in vitro. The simplest known phytotoxin, it is a blight-inducing toxin produced by the cassava pathogen Xanthomonas campestris manihotis.
TG(18:1(11Z)/20:3n6/22:1(13Z))
2-Naphthaldehyde A naphthaldehyde that is naphthalene substituted by a formyl group at position 2.
TG(15:0/18:1(9Z)/18:2(9Z,12Z))[iso6]
TG(16:0/16:1(9Z)/24:1(15Z))
TG(20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Cyproheptadine The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
TG(15:0/18:4(6Z,9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:0/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Beta-D-Galactose A D-galactopyranose having beta-configuration at the anomeric centre.
PC(22:4(7Z,10Z,13Z,16Z)/20:2(11Z,14Z))
TG(22:0/o-18:0/18:3(6Z,9Z,12Z))
CL(20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z)/18:2(9Z,12Z)/16:1(9Z))
TG(16:0/22:1(13Z)/14:1(9Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0)
TG(22:0/20:3n6/24:1(15Z))
TG(18:1(9Z)/14:1(9Z)/22:1(13Z))
TG(16:1(9Z)/14:0/20:3n6)
TG(16:0/20:4(8Z,11Z,14Z,17Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(14:0/14:1(9Z)/24:1(15Z))
Oxaliplatin A platinum coordination entity that has formula C6H14N2.C2O4.Pt.
TG(22:5(4Z,7Z,10Z,13Z,16Z)/15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:0/15:0/20:1(11Z))
TG(20:2n6/o-18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z))[iso6]
TG(20:3(5Z,8Z,11Z)/18:0/18:3(6Z,9Z,12Z))
TG(20:0/20:1(11Z)/20:0)
TG(24:0/o-18:0/20:1(11Z))
Lumiracoxib An amino acid that is phenylacetic acid which is substituted at position 2 by the nitrogen of 2-chloro-6-fluoroaniline and at position 5 by a methyl group. A highly selective cyclooxygenase 2 inhibitor, it was briefly used for the treatment of osteoarthritis, but was withdrawn due to concersns of hepatotoxicity.
Bleomycin A glycopeptide antibiotic produced by the bacterium Streptomyces verticillus. The term, 'bleomycin' refers to a family of structurally related compounds. When used as an anti-cancer agent, the chemotherapeutical forms are primarily bleomycin A2 and B2.
TG(18:1(9Z)/16:1(9Z)/o-18:0)
TG(18:1(9Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
O-Phospho-4-hydroxy-L-threonine
TG(20:3(5Z,8Z,11Z)/22:2(13Z,16Z)/18:3(9Z,12Z,15Z))
TG(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0)
Angiotensin I A peptide that has formula C63H91N17O13.
TG(22:2(13Z,16Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(16:1(9Z)/20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
TG(20:1(11Z)/20:3n6/22:5(7Z,10Z,13Z,16Z,19Z))
Etiocholanolone glucuronide
TG(16:0/20:5(5Z,8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z))
TG(14:0/18:0/20:3n6)
21-Deoxycortisol A deoxycortisol that has formula C21H30O4.
Phentolamine
TG(22:2(13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))
2-Methylbutyrylglycine
TG(18:3(9Z,12Z,15Z)/16:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
(E)-2-Butenal
TG(18:1(11Z)/18:1(11Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/14:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(20:3n6/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:0/24:0/24:0)
PC(22:0/14:1(9Z))
TG(24:1(15Z)/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:0/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
DG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z)/0:0)
TG(18:1(11Z)/16:0/18:1(9Z))[iso6]
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:1(11Z)/18:4(6Z,9Z,12Z,15Z)/18:2(9Z,12Z))
NTP
TG(18:0/20:3n6/18:1(11Z))
TG(20:3n6/o-18:0/22:4(7Z,10Z,13Z,16Z))
DG(24:1n9/0:0/22:2n6)
TG(20:0/20:1(11Z)/22:0)
TG(16:1(9Z)/14:0/22:5(4Z,7Z,10Z,13Z,16Z))
Ganglioside GM2 (d18:1/22:0)
TG(16:0/22:2(13Z,16Z)/18:1(11Z))
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(20:3n6/22:0/20:3n6)
TG(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/o-18:0)
TG(20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
Cysteic acid An amino sulfonic acid that is the sulfonic acid analogue of cysteine.
TG(20:0/22:2(13Z,16Z)/o-18:0)
TG(18:0/18:1(11Z)/22:0)
TG(22:0/24:0/18:4(6Z,9Z,12Z,15Z))
TG(18:2(9Z,12Z)/18:0/20:2n6)
PE(20:3(5Z,8Z,11Z)/14:1(9Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z))
Hydrogen sulfide A sulfur hydride consisting of s single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
TG(20:0/22:1(13Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/16:0/20:3n6)
TG(18:2(9Z,12Z)/16:0/22:4(7Z,10Z,13Z,16Z))
TG(18:0/24:0/22:0)
PG(18:0/22:5(4Z,7Z,10Z,13Z,16Z))
Bambuterol
DG(18:3n3/0:0/20:4n3)
TG(15:0/18:3(6Z,9Z,12Z)/20:0)
PC(18:4(6Z,9Z,12Z,15Z)/P-18:1(9Z))
Dihydrotestosterone
TG(20:1(11Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
PC(P-18:1(9Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/20:3n6/14:1(9Z))
TG(15:0/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z))
TG(24:1(15Z)/18:1(9Z)/20:3n6)
TG(18:4(6Z,9Z,12Z,15Z)/22:1(13Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/20:2n6/22:5(7Z,10Z,13Z,16Z,19Z))
TG(24:0/o-18:0/18:3(6Z,9Z,12Z))
Homovanillic acid A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
TG(20:2n6/14:0/20:4(8Z,11Z,14Z,17Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z)/18:4(6Z,9Z,12Z,15Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/24:1(15Z))
Guanosine monophosphate
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/o-18:0)
PE(P-18:1(9Z)/18:2(9Z,12Z))
PC(24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PC(18:0/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/14:0/20:3n6)
DG(20:2n6/0:0/22:6n3)
Loperamide A synthetic piperidine derivative, effective against diarrhoea resulting from gastroenteritis or inflammatory bowel disease.
LysoPC(18:3(6Z,9Z,12Z))
TG(22:0/20:3(5Z,8Z,11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:3(6Z,9Z,12Z)/18:1(11Z)/18:4(6Z,9Z,12Z,15Z))
TG(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:1(9Z))
TG(14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z))
TG(22:0/18:1(9Z)/22:1(13Z))
PI(18:1(11Z)/20:1(11Z))
PE(P-16:0/24:0)
TG(18:3(6Z,9Z,12Z)/18:4(6Z,9Z,12Z,15Z)/20:3n6)
TG(15:0/22:0/18:3(9Z,12Z,15Z))
Dehydroisoandrosterone 3-glucuronide A steroid glucosiduronic acid having dehydroepiandrosterone as the steroid component.
TG(14:0/20:3(5Z,8Z,11Z)/14:0)
TG(20:1(11Z)/24:1(15Z)/22:2(13Z,16Z))
TG(20:2n6/18:1(11Z)/20:4(5Z,8Z,11Z,14Z))
TG(18:1(9Z)/22:2(13Z,16Z)/20:3(5Z,8Z,11Z))
Isoproterenol
TG(18:0/18:3(6Z,9Z,12Z)/14:1(9Z))
TG(18:1(9Z)/16:1(9Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:2n6/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:1(13Z)/15:0/18:2(9Z,12Z))
TG(14:0/22:2(13Z,16Z)/20:3n6)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/22:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:3n6/20:0/o-18:0)
PE(14:0/22:5(4Z,7Z,10Z,13Z,16Z))
Ramipril A dipeptide that is the prodrug for ramiprilat, the active metabolite obtained by hydrolysis of the ethyl ester group. An angiotensin-converting enzyme (ACE) inhibitor, used to treat high blood pressure and congestive heart failure.
Ganglioside GM3 (d18:0/12:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/16:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(22:1(13Z)/24:0/24:1(15Z))
TG(18:0/20:4(8Z,11Z,14Z,17Z)/14:1(9Z))
TG(20:2n6/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(18:0/20:3(5Z,8Z,11Z)/18:4(6Z,9Z,12Z,15Z))
(S)-3-Hydroxydodecanoyl-CoA
TG(20:2n6/20:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(20:2n6/16:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:1(11Z)/20:0/18:3(9Z,12Z,15Z))
PC(o-24:0/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(15:0/20:1(11Z)/18:3(9Z,12Z,15Z))
TG(18:0/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z))
TG(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:3n6)
TG(22:0/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
PE(18:2(9Z,12Z)/22:1(13Z))
TG(20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:2(13Z,16Z))
PE(20:4(8Z,11Z,14Z,17Z)/18:3(6Z,9Z,12Z))
DG(18:4(6Z,9Z,12Z,15Z)/18:1(9Z)/0:0)
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:4(5Z,8Z,11Z,14Z)/o-18:0/22:2(13Z,16Z))
PI(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z))
DG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/0:0)
S-Glutaryldihydrolipoamide
TG(20:2n6/18:0/18:3(9Z,12Z,15Z))
TG(20:1(11Z)/18:2(9Z,12Z)/20:3(5Z,8Z,11Z))
Saquinavir
TG(14:0/20:1(11Z)/24:1(15Z))
TG(22:1(13Z)/22:1(13Z)/20:4(5Z,8Z,11Z,14Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/14:1(9Z)/o-18:0)
TG(24:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(16:0/20:1(11Z)/o-18:0)
TG(18:0/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:3(5Z,8Z,11Z)/o-18:0/22:5(7Z,10Z,13Z,16Z,19Z))
6-Hydroxy-5-methoxyindole glucuronide
TG(24:0/22:0/22:2(13Z,16Z))
TG(16:0/22:0/16:0)
TG(18:1(9Z)/22:0/22:4(7Z,10Z,13Z,16Z))
3-Keto-4-methylzymosterol
TG(20:1(11Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(14:0/15:0/16:0)
Clotiazepam
TG(20:0/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
PIP2(20:4(5Z,8Z,11Z,14Z)/18:1(11Z))
TG(14:1(9Z)/18:2(9Z,12Z)/24:1(15Z))
TG(18:1(11Z)/18:1(11Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:4(5Z,8Z,11Z,14Z)/16:0/o-18:0)
Ethoxzolamide 1,3-Benzothiazole substituted a sulfonamide and an ethoxy group at positions 2 and 6, respectively. A carbonic anhydrase inhibitor, it has been used in the treatment of glaucoma, and as a diuretic.
Roxatidine acetate
TG(24:0/24:1(15Z)/o-18:0)
PC(18:0/20:2(11Z,14Z))
(-)-trans-Carveol
TG(22:0/20:0/22:0)
5alpha-Pregnane-3alpha,20alpha-diol A corticosteroid hormone that has formula C21H36O2.
TG(18:1(11Z)/22:0/22:4(7Z,10Z,13Z,16Z))
TG(22:2(13Z,16Z)/20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:3(5Z,8Z,11Z)/18:3(9Z,12Z,15Z)/20:3n6)
TG(20:2n6/22:0/18:3(9Z,12Z,15Z))
TG(22:0/22:1(13Z)/20:2n6)
PC(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
CE(22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/14:0/20:3(5Z,8Z,11Z))
DG(24:0/0:0/22:5n6)
TG(22:0/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
Bilirubin glucuronide
Cer(d18:0/14:0)
TG(18:1(11Z)/22:0/20:2n6)
TG(18:1(9Z)/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(14:0/15:0/14:0)
TG(20:4(5Z,8Z,11Z,14Z)/14:1(9Z)/22:2(13Z,16Z))
TG(18:2(9Z,12Z)/20:0/20:0)[iso3]
TG(22:2(13Z,16Z)/16:1(9Z)/22:2(13Z,16Z))
4-Aminohippuric acid
TG(18:0/20:3(5Z,8Z,11Z)/18:1(11Z))
TG(24:0/16:1(9Z)/18:3(6Z,9Z,12Z))
TG(20:3n6/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z))
PS(14:1(9Z)/16:0)
TG(16:0/20:2n6/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:0/o-18:0/18:3(9Z,12Z,15Z))
Triiodothyronine glucuronide
TG(20:1(11Z)/24:0/22:5(7Z,10Z,13Z,16Z,19Z))
TG(14:0/18:0/20:1(11Z))
TG(15:0/24:0/20:2n6)
PS(14:1(9Z)/14:0)
TG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:1(9Z)/20:3n6/22:2(13Z,16Z))
PE(18:0/22:1(13Z))
TG(16:1(9Z)/18:0/20:4(5Z,8Z,11Z,14Z))[iso6]
TG(18:1(9Z)/18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
D-Serine The R-enantiomer of serine.
Hydroxypropanedioic acid A dicarboxylic acid that is malonic acid substituted by a hydroxy group at position 2.
Galactaric acid A hexaric acid resulting from formal oxidative ring cleavage of galactose.
TG(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/20:2n6/20:4(5Z,8Z,11Z,14Z))
PIP(20:3(5Z,8Z,11Z)/18:0)
TG(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z))
D-Glyceraldehyde 3-phosphate A glyceraldehyde 3-phosphate that has formula C3H7O6P.
PE(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
CDP-DG(18:1(9Z)/18:0)
DG(18:3n3/0:0/18:4n3)
Bisnorcholic acid
13-cis-Retinoic acid
PC(24:1(15Z)/20:0)
TG(16:0/22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))
Midodrine An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
PC(16:0/24:1(15Z))
TG(22:2(13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)/o-18:0)
PC(20:0/20:1(11Z))
L-Methionine The L-enantiomer of methionine.
TG(20:1(11Z)/24:0/20:3n6)
Bromobenzene-3,4-oxide An epoxide that has formula C6H5BrO.
PE(P-16:0/20:4(8Z,11Z,14Z,17Z))
TG(22:2(13Z,16Z)/14:0/o-18:0)
TG(20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
TG(16:0/24:0/20:3n6)
TG(18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)/22:4(7Z,10Z,13Z,16Z))
TG(18:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z))
TG(18:3(6Z,9Z,12Z)/24:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(18:1(11Z)/20:0/20:4(8Z,11Z,14Z,17Z))
TG(24:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z))
PE(22:4(7Z,10Z,13Z,16Z)/P-18:1(11Z))
TG(18:0/18:1(9Z)/18:3(6Z,9Z,12Z))
PC(P-16:0/18:3(6Z,9Z,12Z))
Bilirubin diglucuronide
TG(16:1(9Z)/18:1(11Z)/22:1(13Z))
TG(15:0/24:1(15Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PE(20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:1(9Z)/14:1(9Z))
TG(18:1(11Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:1(9Z)/20:3(5Z,8Z,11Z)/o-18:0)
PE(20:3(5Z,8Z,11Z)/18:1(11Z))
TG(20:2n6/24:0/22:2(13Z,16Z))
TG(16:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:1(11Z))
TG(18:1(9Z)/14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(15:0/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
PC(20:0/P-16:0)
PG(16:1(9Z)/16:1(9Z))
PE(16:1(9Z)/18:0)
TG(22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z)/18:4(6Z,9Z,12Z,15Z))
Ganglioside GT1b (d18:0/22:1(13Z))
TG(16:0/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
TG(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0/o-18:0)
TG(18:0/o-18:0/20:1(11Z))
TG(18:1(9Z)/20:1(11Z)/20:1(11Z))[iso3]
DG(22:0/22:1(13Z)/0:0)
TG(15:0/18:1(11Z)/o-18:0)
PE(20:3(8Z,11Z,14Z)/18:0)
Acetylisoniazid
TG(18:2(9Z,12Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z))[iso3]
TG(22:0/22:5(4Z,7Z,10Z,13Z,16Z)/o-18:0)
TG(14:1(9Z)/16:1(9Z)/20:2n6)
TG(20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:0/18:3(9Z,12Z,15Z)/22:2(13Z,16Z))
TG(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)/22:4(7Z,10Z,13Z,16Z))
TG(22:5(4Z,7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z)/o-18:0)
TG(24:1(15Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
All-trans-13,14-dihydroretinol A retinol that has formula C20H32O.
PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z))
TG(18:0/14:1(9Z)/18:4(6Z,9Z,12Z,15Z))
Sucrose Sucrose is a disaccharide formed by glucose and fructose units joined by an acetal oxygen bridge from hemiacetal of glucose to the hemiketal of the fructose.
TG(20:1(11Z)/18:2(9Z,12Z)/20:3n6)
Vancomycin A complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile.
Doxapram A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
DG(18:3(6Z,9Z,12Z)/18:1(9Z)/0:0)
TG(20:0/14:1(9Z)/20:2n6)
TG(18:3(9Z,12Z,15Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
Bilirubin A member of the class of biladienes that is a linear tetrapyrrole, product of heme degradation. It is produced in the reticuloendothelial system by the reduction of biliverdin and transported to the liver as a complex with serum albumin.
Benzphetamine Dextroamphetamine in which the the hydrogens attached to the amino group are substituted by a methyl and a benzyl group. A sympathomimetic agent with properties similar to dextroamphetamine, it is used as its hydrochloride salt in the treatment of obesity.
TG(22:0/20:3n6/20:2n6)
TG(16:0/18:3(9Z,12Z,15Z)/20:3n6)
TG(24:0/20:0/22:2(13Z,16Z))
Citalopram A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
TG(18:3(9Z,12Z,15Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z))
TG(16:1(9Z)/24:0/22:4(7Z,10Z,13Z,16Z))
Biotin amide A monocarboxylic acid amide derived from biotin.
TG(20:2n6/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
TG(24:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
TG(20:2n6/14:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
DG(18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/0:0)
TG(18:1(11Z)/22:0/18:3(6Z,9Z,12Z))
TG(24:0/24:0/22:2(13Z,16Z))
Ganglioside GM3 (d18:0/24:0)
Phosphoenolpyruvic acid A monocarboxylic acid that is acrylic acid substituted by a phosphonooxy group at position 2. It is a metabolic intermediate in pathways like glycolysis and gluconeogenesis.
TG(14:1(9Z)/22:4(7Z,10Z,13Z,16Z)/22:1(13Z))
TG(14:0/22:1(13Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:2(13Z,16Z)/14:1(9Z)/20:4(8Z,11Z,14Z,17Z))
Tridihexethyl
DG(18:0/20:3(8Z,11Z,14Z)/0:0)
TG(18:1(9Z)/16:0/24:1(15Z))
TG(18:0/22:0/14:1(9Z))
TG(20:3n6/20:3n6/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:0/18:0/22:4(7Z,10Z,13Z,16Z))
TG(15:0/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
DG(18:2n6/0:0/20:4n6)
PC(18:1(9Z)/22:4(7Z,10Z,13Z,16Z))
TG(14:1(9Z)/22:2(13Z,16Z)/20:4(8Z,11Z,14Z,17Z))
TG(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:2n6)
PE(14:0/22:4(7Z,10Z,13Z,16Z))
PE(24:0/20:2(11Z,14Z))
PC(18:3(9Z,12Z,15Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z))
TG(20:3(5Z,8Z,11Z)/24:1(15Z)/20:5(5Z,8Z,11Z,14Z,17Z))
TG(16:1(9Z)/22:0/18:1(11Z))
TG(18:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:3(9Z,12Z,15Z))
TG(18:1(11Z)/22:0/24:1(15Z))
TG(18:3(6Z,9Z,12Z)/24:1(15Z)/20:2n6)
DG(20:4(8Z,11Z,14Z,17Z)/22:0/0:0)
Alcophosphamide A nitrogen mustard that has formula C7H17Cl2N2O3P.
TG(18:4(6Z,9Z,12Z,15Z)/14:0/20:4(8Z,11Z,14Z,17Z))
DG(22:5(7Z,10Z,13Z,16Z,19Z)/16:0/0:0)
TG(18:3(9Z,12Z,15Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))[iso6]
TG(18:4(6Z,9Z,12Z,15Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z))
TG(22:1(13Z)/18:2(9Z,12Z)/20:2n6)
TG(24:1(15Z)/16:1(9Z)/18:3(9Z,12Z,15Z))
D-Pantothenoyl-L-cysteine
TG(18:0/20:3n6/20:3n6)
TG(18:1(9Z)/18:1(11Z)/18:2(9Z,12Z))[iso6]
Lithium An alkali metal atom that has formula Li.
TG(14:0/22:0/22:4(7Z,10Z,13Z,16Z))
PC(18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z))
TG(20:1(11Z)/20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
Sphinganine A 2-aminooctadecane-1,3-diol having (2S,3R)-configuration.
8-Oxo-dGMP A purine 2'-deoxyribonucleoside 5'-monophosphate having 8-oxo-7,8-dihydroguanine as the nucleobase.
Tioconazole
Procarbazine
TG(18:1(9Z)/18:2(9Z,12Z)/20:1(11Z))[iso6]
MG(0:0/18:1(11Z)/0:0)
LysoPE(24:6(6Z,9Z,12Z,15Z,18Z,21Z)/0:0)
TG(18:0/22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
Uridine triphosphate
PC(20:1(11Z)/22:5(7Z,10Z,13Z,16Z,19Z))
TG(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:5(5Z,8Z,11Z,14Z,17Z))
DG(22:0/24:1(15Z)/0:0)
PE(18:0/18:1(9Z))